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Summary 
Chronic musculoskeletal pain (MSK) affects one in four people worldwide and negatively impacts on 
individuals’ physical, mental and financial health. With the ageing population the prevalence of MSK 
is expected to increase and so is the burden of MSK. Thus, it is important to provide effective and 
safe analgesic treatment. Acupuncture has been used clinically and is reported to be safe and cost-
effective for the treatment of MSK. However, there is no validated and optimal acupuncture 
treatment protocol to guide clinical practice. Conflicting results about the efficacy of acupuncture for 
MSK were found. Some studies reported that acupuncture was more effective than sham 
acupuncture in treating MSK while others reported no difference between the two. It is thought that 
acupuncture responder and non-responder subgroups were not differentiated during the trial 
recruitment phase, and this could have diluted the results leading to the lack of difference between 
real and sham acupuncture. Participants’ characteristics such as pain history and expectancy to 
acupuncture were reported to be associated with acupuncture pain relief. It is unknown if other 
characteristics such as potency of endogenous inhibitory controls, which were reported to be 
related to acupuncture, could impact on acupuncture analgesia. This project aimed to investigate 
such hypothesis by conducting two systematic reviews and four experimental studies using 
psychophysical methods. The relationship between potency of pain adaptability, conditioned pain 
modulation (CPM) and local acupuncture was explored.  
 
The first systematic review of this project assessed the effects of local points and distant points in 
the treatment of MSK. The meta-analysis (17 studies, n=693) found that needling local points 
reduced pain more than the distant points, and among the local points, stimulation of Ashi points 
(tender points) showed a better efficacy than the classical acupuncture points. These results 
contributed to the design of the acupuncture protocol for the Acupuncture Response Study. 
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The second systematic review (14 studies, n=1788) investigated the possibility of identifying 
psychophysical subgroups in individuals with knee osteoarthritis (OA). Qualitative analysis found that 
pressure pain threshold (PPT) and temporal summation of mechanical punctate pain were potential 
measures to subgroup knee OA participants. 
 
The first experimental study, the Segmental Inhibition Study (n=21), investigated whether vibration 
could be used to induce segmental inhibition (SEG) and if SEG differed between the pain adaptive 
(PA) or pain non-adaptive (PNA) healthy participants. The findings showed that vibration did not 
induce analgesia. Thus, it could not be determined whether the PA and PNA had different potency of 
SEG. Since this protocol of vibration failed to induce SEG, it was not used in the Acupuncture 
Response Study, and thus there were no subgroups based on SEG in that study.  
 
The second experimental study, the Pain Adaptability and Acupuncture Analgesia Study, investigated 
whether pain adaptability impacted on acupuncture analgesia in healthy participants. A cross-over 
design with real and sham acupuncture at the left arm was used. Acupuncture analgesia was 
measured using PPT at the right and left arms and at the right leg. The PA showed better analgesia 
from the sham acupuncture than real acupuncture whereas the PNA responded to both forms of 
acupuncture similarly. Further, irrespective of the mode of acupuncture used, the PA showed a 
better analgesic effect at the right arm and right leg, whereas the PNA showed a better analgesic 
effect at the left arm. This shows that PA and PNA responded differently to different modes of 
acupuncture. 
 
The third experimental study, the Pain Adaptability and MSK Study, aimed to determine an 
appropriate protocol to identify PA and PNA among MSK participants (n=43), to further explore their 
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characteristics (demographics, potency of endogenous pain controls and autonomic activity), and to 
compare their pain adaptability with healthy participants (n=23). Cold pressor tests (CPT) at 2°C and 
7°C were used to determine their pain adaptability. PA and PNA were identified in the MSK 
participants at both temperatures. There was no difference in the distribution of PA and PNA, and no 
difference in completion rate between the two CPTs. It was thus concluded that both temperatures 
could be used to determine pain adaptability in MSK participants. No difference was found in 
demographics, potency of endogenous pain controls and autonomic activity between the PA and 
PNA MSK participants. The only significant difference found was that PA reached their maximum 
experimental pain faster than the PNA during the CPT, which is in line with previous pain adaptability 
studies in healthy participants. Trends were found that the PA had less pain in the 24 hours 
preceding the CPT and less comorbidities. No difference in pain adaptability was found between the 
MSK and healthy participants.  
 
The final experimental study, the Acupuncture Response Study, examined whether the potency of 
CPM or pain adaptability impacted on the analgesic effect of local acupuncture in MSK participants 
(n=35). Overall, the MSK participants reported an improvement in their clinical pain and physical 
health after eight sessions of local acupuncture. Those with severer pain or poorer CPM at baseline 
showed better improvement in the intensity of their clinical pain. PA individuals had shortened pain 
duration (hours in pain), but did not differ in pain reduction compared with PNA after acupuncture. 
Local acupuncture improved pain modulation as those with poorer CPM at baseline showed an 
improvement in their potency of CPM after acupuncture; and PNA individuals became more pain 
adaptive. In summary, individuals’ potency of CPM and the status of pain adaptability influenced 
response to local acupuncture and in different manners. 
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This exploratory project had a small size and the Acupuncture Response Study did not have a control 
group. Further larger studies with proper controls are necessary to confirm that local acupuncture 
analgesia is dependent on the status of CPM and pain adaptability and on the mode of needling so 
as to guide practice and predict clinical outcomes. Local acupuncture has great potential for clinical 
use for its safe and easy application. Distant needling and the combined local and distant needling 
should also be studied in relevance to individual differences in pain modulation 
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 Chapter 1 : Introduction 
 
Chronic musculoskeletal pain  
Chronic musculoskeletal pain (MSK) is a condition where pain is present in the muscles, joints, 
tendons or ligaments for more than three months (Cimmino et al., 2011). It affects one in four 
people in the world (Vos et al., 2012). Current estimates of people affected worldwide are: over 630 
million people suffer from low back pain, over 330 million from neck pain, over 250 million from 
osteoarthritis (OA) of the knee and over 560 million from other musculoskeletal conditions (Vos et 
al., 2012). The prevalence of MSK is increasing (McBeth and Jones, 2007, Woolf and Pfleger, 2003) 
with the ageing world population, thus the burden of MSK is also expected to increase.  
 
In addition to the discomfort from pain, MSK impacts on individuals’ quality of life and finance 
(Tüzün, 2007). A Belgian study found that arthritis and low back pain were among the main 
contributors to mild and severe disability (measured based on the extent to which participants could 
perform activities of daily living) across all age ranges (Yokota et al., 2015). Another study ranked low 
back pain as the top contributor to years lived with disability worldwide (Vos et al., 2012). 
Furthermore, the need for frequent treatments is a great cost to the society and the individuals. The 
expenditure of Australian government on MSK in financial year of 2004 to 2005 was $4.0 billion 
(Australian dollar, AUD), the third most costly condition after cardiovascular and mental disorders 
(National Centre for Monitoring Arthritis and Musculoskeletal Conditions, 2009, Access Economics, 
2007). A systematic review reported that the total annual impact (direct and indirect costs) of knee 
and hip OA per patient worldwide ranged from about 700 to 12,000 € (about $1,040 to $17,845 AUD) 
(Salmon et al., 2016). 
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The common management strategies for MSK comprise pharmacological treatments such as non-
steroidal anti-inflammatory drugs (NSAID) and weak opioids; and non-pharmacological treatment 
such as physical therapies, acupuncture and surgeries, including joint replacement (Balagué et al., 
2012, Hochberg et al., 2012). Despite the various treatments available, the therapeutic effects are 
not satisfactory due to side effects from medication and transient pain relief or little improvement 
with time. Long-term use of NSAIDs is associated with gastrointestinal, cardiovascular or renal side 
effects (Schnitzer, 2006). The most common adverse effects of opioids are constipation, nausea and 
dependence and addiction which impact on individuals’ quality of life (Baldini et al., 2012). Some 
postoperative patients still suffer from pain. In a study of 866 knee OA patients who underwent total 
knee replacement 44% reported having chronic postoperative pain, with 15% of them still reporting 
severe to extreme pain at three to four years after surgery (Wylde et al., 2011a). Therefore, there is 
a need for safe and more effective analgesic treatments. 
 
MSK and acupuncture  
Non-pharmacological treatments are increasingly being used to treat MSK (Bremander and Bergman, 
2008). Acupuncture is commonly used for MSK as it is safe and cost effective (White, 2006). In a 
study by Macpherson (MacPherson et al., 2001), 43 minor adverse events (mainly nausea, sweating, 
dizziness) out of 34407 acupuncture treatments were reported by practitioners; and they required 
no further medical intervention. The evidence for the safety of acupuncture was further 
strengthened by a study on patients’ reports. Out of 6348 patients, 682 reported having at least one 
adverse event, mostly tiredness and pain at the site of needling (Macpherson et al., 2004). A 
systematic review reported that acupuncture (with or without usual care) is more cost-effective than 
waiting list or usual care (£ 3855, about $6,713 AUD/quality-adjusted life years for OA) (Kim et al., 
2012) 
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A systematic review examining, more than 17,000 individual data, found that acupuncture 
significantly decreased pain compared with their controls (educative sessions, conventional 
treatments) and sham acupuncture for chronic neck and back pain and for OA (Vickers et al., 2012). 
Other systematic reviews also reported that acupuncture was more effective in the treatment neck 
pain, ankle sprain, knee OA and chronic non-specific low back pain (LBP) compared with sham 
acupuncture (Furlan et al., 2005, White et al., 2007, Yuan et al., 2015, Ezzo et al., 2001, Park et al., 
2013). Previous studies also found that the duration of analgesia was sustained after acupuncture to 
at least 24hrs in healthy humans and in individuals with chronic pain compared with after sham 
acupuncture or placebo acupuncture which lasted about 1.4hrs (Zheng et al., 2010b, Molsberger and 
Hille, 1994). However, the effectiveness of acupuncture is still being questioned as some studies 
found little or no evidence that the analgesic effect of acupuncture is superior to that of sham 
acupuncture (Furlan et al., 2005, Ezzo et al., 2000, Madsen et al., 2009). 
 
One of the contributors to the discrepancy may be due to the study design. Previous systematic 
reviews discussed that the sample size of acupuncture studies in MSK were too small, and that the 
acupuncture controls used might be inappropriate (Furlan et al., 2005, Ezzo et al., 2000). Typically, 
the types of acupuncture controls used include sham acupuncture (invasive control, for example 
shallow needling) and placebo acupuncture (non-invasive control, for example blunt needle). Both 
types of controls are not inert as they can activate certain parts of the peripheral nervous systems 
such as the polymodal-type receptors (Kenjil and White, 2010, Lund et al., 2009). 
 
The optimal acupuncture treatment is yet to be determined; factors such as needle manipulation 
(Spaeth et al., 2013), retention time (Leung et al., 2008), depth of needling (Itoh et al., 2011), 
number of needles used (Paley and Johnson, 2015) and treatment frequency (Hao et al., 2013) have 
previously been shown to affect the analgesic effect of acupuncture. The effect of needle placement 
(in terms of local and distant points) on acupuncture analgesia is another factor yet to be examined.  
8 
 
The narrow contrast or lack of contrast between real and sham acupuncture analgesia may also be 
due to variations in individual characteristics, which are often not taken into account. Previous 
studies have found that acupuncture analgesia may depend on expectations or pain history of the 
patients (Linde et al., 2007, MacPherson and Fitter, 1998, Witt et al., 2011). For instance, those with 
higher expectations or shorter pain history showed a better pain relief from acupuncture (Linde et 
al., 2007). 
 
It is possible that the variation in acupuncture response was due to the difference in the potency of 
endogenous pain controls. Studies have found that acupuncture is related to some endogenous pain 
controls (Bing et al., 1990, Han, 2004, Mayer et al., 1977). Further, it has been found that individuals 
suffering from the same condition may vary in their potency of endogenous pain controls (Egsgaard 
et al., 2015). The relationship between potency of endogenous pain controls and acupuncture 
analgesia is an area yet to be investigated. 
 
Little knowledge is available on the effects of needle placement (in term of local and distant points) 
and potency of endogenous pain controls on acupuncture when treating MSK. Figure 1.1 illustrates 
the possible relationships between acupuncture analgesia, needle placement and endogenous pain 
controls. 
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Figure 1.1: Possible relationships between acupuncture, needle placement and potency of endogenous pain controls 
 
 
Needle placement and acupuncture 
Conventionally, acupuncture treatment consists of needling acupuncture points at the painful area 
(local points) and away from the painful area (distant points). However, there is no clear 
understanding of the independent effects of needling local or distant points alone or if combined 
local and distant points is better than either alone. Few studies comparing the effects of local and 
distant acupuncture points have been conducted. The study conducted by Irnich and his colleague 
(Irnich et al., 2002) suggested that the immediate pain reduction induced by needling distant points 
was significantly better than needling local points or sham acupuncture treatment for chronic neck 
pain. However, the study from Matsubara and colleagues (Matsubara et al., 2011) shows that 
acupressure at local point was more effective than at distant points or no treatment in female 
participants with chronic neck pain. There is no consensus on the optimal pain management, that is, 
when to choose local points, distant points or the combination of both. 
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Endogenous pain controls and acupuncture 
Acupuncture is believed to activate endogenous pain control systems to exert its analgesia (Bing et 
al., 1990, Han, 2004, Mayer et al., 1977). The most studied pain control systems are segmental 
inhibition (SEG) and conditioned pain modulation (CPM). SEG is activated by the application of a 
non-painful stimulus, such as vibration, or painful stimulation, such as needling of local points, at or 
close to the painful site (Yarnitsky et al., 1997, Handwerker et al., 1975). CPM on the other hand is 
activated by a painful stimulation (such as acupuncture) away from the painful part of the body 
(Yarnitsky et al., 2010, Le Bars et al., 1979a, Le Bars et al., 1979b, Le Bars and Willer, 2002). The 
potency of CPM impacted on the response to medication in participants with diabetic neuropathic 
pain (Yarnitsky et al., 2012). It is yet to be explored whether the potency of endogenous pain 
controls impact on acupuncture analgesia. 
 
Pain adaptability is another factor that is possibly related to endogenous pain controls. So far it has 
only been studied in healthy participants, and it varies in individuals. A recent study found that 
among the 41 healthy participants who received cold conditioning stimulation, one group was 
identified as pain adaptive (PA) and the other as pain non-adaptive (PNA) (Zheng et al., 2014). The 
PA group reported the peak pain faster, and also their pain intensity was lower at the end of the cold 
stimulation compared to the pain PNA group. The potency of “local inhibition” (SEG) and pain 
adaptability were found to be positively correlated (Zheng et al., 2014). It is possible that pain 
adaptability is also a form of pain inhibitory control and thus may affect acupuncture analgesia. 
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Psychophysics and endogenous pain controls 
Psychophysics is a science examining the responses to a stimulus (Gescheider, 1997), and is 
commonly applied to pain research. The psychophysical tests used in pain research are known as 
quantitative sensory test (QST). It enables the quantification of sensory thresholds or pain 
magnitude to standardized stimuli delivered onto the testing sites (Arendt-Nielsen and Yarnitsky, 
2009). Different stimuli such as thermal, mechanical, electrical and chemical can be reliably 
delivered to different tissues such as skin or muscles. Sensory response at and away from the painful 
or affected sites can be measured. The potency of endogenous pain controls can be measured using 
those techniques. For instance, the potency of SEG can be measured by testing the pain intensity or 
pain threshold at the site of pain before and after a conditioning stimulation at the site of pain. The 
potency of CPM can be measured by applying a noxious stimulus at an area further away, and 
measuring the change in pain intensity or pain threshold at the site of pain. The extent of the 
decrease in pain or increase in pain thresholds indicates the potency of the endogenous pain 
controls. 
 
The effect of needle placement and the potency of endogenous pain controls on acupuncture 
analgesia is an understudied area. It is important to conduct such studies as their outcomes could 
contribute to the design of optimal, individualised treatment for MSK and a better understanding of 
acupuncture with regards to pain control systems. 
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Aim of PhD project  
The aim of this project is to examine the effects of needle placement, pain adaptability and 
endogenous pain controls on acupuncture analgesia in the treatment for MSK. The finding will help 
develop targeted acupuncture treatment for individuals suffering from MSK. 
 
In order to achieve this aim, two systematic reviews and four experimental studies were completed. 
The results of the two systematic reviews contributed to the design of the experimental studies. Two 
of the experimental studies were conducted in healthy participants to test whether vibration could 
be used to induce SEG, and to investigate the relationship between acupuncture analgesia and pain 
adaptability respectively. The remaining two experimental studies were conducted in MSK 
participants; one study explored pain adaptability in the MSK participants, and the other 
investigated whether the potency of their endogenous pain controls and pain adaptability impacted 
on acupuncture analgesia induced with local needling. 
 
Outline of the thesis  
The following is a summary of each chapter in this thesis. Figure 1.2 illustrates how each chapter 
contributes to the overall aims. 
 
Chapter 1 is the introduction chapter, providing an overview of the whole project and the rationale 
for this project.  
 
Chapter 2 reviews literature on psychophysical tests applied in pain research, acupuncture and 
needle placement in the treatment of MSK and acupuncture mechanisms associated with 
endogenous pain controls, and identifies knowledge gaps. 
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Chapter 3 is a systemic review examining the effects of needle placement in MSK participants; the 
difference between local and distant points, and the difference between combined points and either 
local or distant points alone. Randomized controlled and quasi-randomised controlled trials in adult 
MSK participants using acupuncture were selected. Meta-analyses were conducted (Wong Lit Wan 
et al., 2015). The results of the review helped to develop the acupuncture protocol used in the study 
on acupuncture response in MSK participants. 
 
Chapter 4 is a systematic review investigating the psychophysical profiles of knee OA. Studies on QST 
and knee OA participants were selected to determine which methods could be used to subgroup 
knee OA participants.  
 
Chapter 5 is the method chapter, describing the materials and methods used in the four 
experimental studies. It includes: the selection criteria for healthy and MSK participants, the design 
of each experimental studies, the QSTs used in the four experimental studies, questionnaires used, 
the protocol for vibration and acupuncture and the statistical methods chosen. 
 
Chapter 6 describes the methods and the results of a healthy human study on SEG induced by 
vibration (SEG Study) The purpose of this study was to determine whether the protocol could be 
used to induce SEG in order to subgroup the participants based on the potency of their SEG, and to 
investigate the relationship between SEG and pain adaptability. The results of the study could not 
support the use of vibration to induce SEG. Thus, vibration was not used in later studies in this 
thesis. 
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Chapter 7 outlines the methodology and results of a healthy human study on pain adaptability and 
acupuncture analgesia (Pain Adaptability and Acupuncture Analgesia Study). The effects of real and 
sham acupuncture were compared in the PA and PNA to test whether pain adaptability impacted on 
acupuncture analgesia in healthy participants. 
 
Chapter 8 presents a controlled study on pain adaptability in MSK participants (Pain Adaptability and 
MSK Study). The objective of this study was to develop a feasible protocol to examine pain 
adaptability in MSK participants and to compare the clinical and experimental pain characteristics 
between PA and PNA. Those characteristics were also compared between healthy controls (age- and 
gender- matched) and the MSK participants. 
 
Chapter 9 reports the methods and results for the study on the response to local acupuncture 
needling in MSK participants (Acupuncture Response Study). In this chapter the acupuncture 
response was compared between PA and PNA to identify the factors contributing to acupuncture 
analgesia induced by local needling. 
 
Chapter 10 is the discussion and conclusion chapter, summarising the findings of this project. This 
chapter also points out the limitations of this project and implications for future studies. 
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Figure 1.2: Thesis outline and summary of each chapter 
Acu= acupuncture; OA=osteoarthritis; SR=systematic review; SEG=segmental inhibition; MSK=chronic musculoskeletal pain; 
=Chapter 1.
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 Chapter 2 : Literature review on psychophysical assessments in pain 
research and acupuncture for pain management 
 
Psychophysics tests such as QST have become widely applied in pain research in the last two 
decades due to its safety profile and its easy application in measuring the potency of endogenous 
pain controls (Arendt-Nielsen and Yarnitsky, 2009). Likewise pain research has a growing interest in 
acupuncture. This ancient intervention has been shown to be safe and effective in reducing 
musculoskeletal pain such as neck pain and low back pain (Yuan et al., 2015, MacPherson et al., 
2001). Nevertheless, acupuncture still faces some challenges in the treatment of MSK (Madsen et al., 
2009, Ernst et al., 2011). This chapter will describe QST and its advantages and disadvantages, and 
challenges faced by acupuncture research. The knowledge gaps and aims of this PhD project are 
described at the end of this chapter.  
 
 
Psychophysical assessments and their application in assessing endogenous 
pain control 
Quantitative sensory tests 
Psychophysics is a science where responses to a stimulus are examined (Gescheider, 1997). The 
branch of psychophysics commonly used in pain research is known as QST, and consists of 
measurements of sensory (detection, pain and tolerance) thresholds from different stimuli: thermal, 
chemical, mechanical or electrical (Arendt-Nielsen and Yarnitsky, 2009). In QST, invasive or non-
invasive standardized stimuli can be delivered to different parts of the body. For instance, sensory 
responses at and away from the painful or affected areas can be measured, enabling the study of 
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the peripheral and central pain pathways (Pavlaković and Petzke, 2010, Arendt-Nielsen and Yarnitsky, 
2009). Another advantage of using QST is that it can assess the function of both somatic small and 
large fibres (Shukla et al., 2005). For instance, in a study of 14 participants diagnosed with small fibre 
neuropathy, 93% of them showed abnormal heat pain threshold however, all the participants 
presented with normal nerve conduction velocities (Magda et al., 2002). 
 
Pain cannot be objectively measured due to the complexity of the phenomenon. Nonetheless, using 
QST, the sensory abnormalities in responses to painful or non-painful stimuli in individuals with pain 
can be assessed and compared with healthy individuals. The sensory responses from those with pain 
can then be described as being more sensitive or less sensitive than the healthy individuals. QST can 
also compare responses at a painful site and responses at a non-painful site in individuals. Thus, 
normative data is very important when performing QST. Consideration should be taken to use the 
same test modality, test sites, measuring instruments and protocol, and same age group for both 
healthy and pain participants/sites (Hafner et al., 2015). 
 
QST can be divided into static QST and dynamic QST (Kong et al., 2013b, Arendt-Nielsen and 
Yarnitsky, 2009). Static QST examines the sensory threshold or magnitude to one stimulus, reflecting 
the state of the peripheral nervous system. Table 2.1 shows the different variables measured in 
static QST (Backonja et al., 2013, Hansson et al., 2007, Cruz-Almeida and Fillingim, 2014). 
 
In dynamic QST, the variables are used in repetition or in conjunction with other variables (Table 2.2). 
Pain processing mechanisms such as CPM or temporal summation (TS) of pain are examined through 
dynamic QST (Arendt-Nielsen and Yarnitsky, 2009). CPM is more commonly tested using a 
combination of painful thermal stimuli such as noxious heat stimulus or a CPT combined with 
pressure pain thresholds (PPT). Other types of stimuli include Ischemic, electrical and chemical 
stimuli used as conditioning or test stimulus (Lewis et al., 2012b). TS of pain is measured by the 
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change in pain magnitude from the same stimulus delivered at equal time intervals. For example, the 
increase in pain intensity from a pin-prick applied 10 times at a frequency greater than 0.3 Hz can be 
used to measure the strength of TS of pain (Price, 1972, Arendt-Nielsen et al., 1994). 
 
Table 2.1: Static QST variables (Backonja et al., 2013, Hansson et al., 2007, Cruz-Almeida and Fillingim, 2014) 
Stimuli Nerve fibres 
Central 
pathways Stimulating device QST variables 
Cold 
temperature Aδ 
spinothalamic 
computer controlled 
thermal testing 
device  
thermal detection 
thresholds Warm 
temperature C 
Cold pain C, Aδ 
thermal pain thresholds, 
thermal pain tolerance Heat pain 
Static light 
touch 
Aβ lemniscal 
calibrated Von Frey 
hairs allodynia 
Vibration vibrameter 
vibration detection 
thresholds 
Brushing brush allodynia 
Pinprick Aδ, C spinothalamic 
calibrated blunt pins mechanical detection threshold 
Blunt 
pressure algometer pain pressure threshold 
QST=quantitative sensory tests. 
 
 
Table 2.2: Dynamic QST variables (Arendt-Nielsen and Yarnitsky, 2009) 
Type of 
pain 
processing 
Methods of measuring Stimulating device QST variables 
Pain 
inhibition 
change in pain threshold or pain 
rating to conditioning stimulus 
during or after the test stimulus is 
applied 
cold pressor, heat 
noxious stimulus, 
capsaicin, ischemic 
pressure cuff 
, PPT, ratings to supra-
threshold painful 
stimulation, vibration 
CPM 
SEG 
Pain 
facilitation 
increased sensitivity or decreased 
sensory thresholds to repetitive 
stimuli at equal time intervals  
pinprick, Von Frey hairs, 
algometer, PPT, heat 
stimulus 
TS of pain 
QST=quantitative sensory tests; PPT=pressure pain threshold; CPM=conditioned pain modulation; SEG=segmental 
inhibition; TS=temporal summation. 
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The two most frequently used QST protocol to measure sensory thresholds is the method of limits 
and levels (Yarnitsky and Ochoa, 1990b, Yarnitsky and Ochoa, 1990a, Fruhstorfer et al., 1976, 
Hansson et al., 2007). Other methods include staircase (Fowler et al., 1987) and multiple random 
staircase (Gracely et al., 1988) and thermal sensory limen/Marstock method (Fruhstorfer et al., 
1976).  
 
In the method of limits, the stimulus is gradually increased at a fixed rate until the participants 
perceive the required sensation from the stimulus, such as when they just feel pain, and they stop 
the stimulation by pressing on a switch or verbally inform the assessor that the required sensation 
has been felt (Hansson et al., 2007). This process is performed several times and the average is 
calculated to determine the sensory threshold (detection, pain or tolerance threshold).  
 
The method of levels consists of applying a stimulus at a predetermined intensity (step), and 
participants are required to inform the assessor if they can sense the stimulus or not (Yarnitsky, 
1997). Usually if they can sense the stimulus, the next step is half the intensity of the stimulus in the 
present step, and if they cannot feel the stimulus the next step is twice the intensity of the stimulus 
in the present step (Fowler et al., 1987). The mean of the steps where they start to sense the 
stimulus and where they cannot sense the stimulus anymore is calculated to determine the sensory 
threshold. This method does not depend on the reaction time, however, it is time consuming 
compared with the limits method, and has more potential for misreading if the participants are not 
fully alert to each step (Hansson et al., 2007). Therefore, the limits method is used more often. 
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Methods for QST 
Thermal detection thresholds and thermal pain thresholds 
The thermal detection and pain thresholds are usually used to assess the function of small nerve 
fibres, (Aδ and C) (Backonja et al., 2013). A computer controlled thermal testing device is used to 
deliver the thermal stimuli (cold and hot), and the responses to those stimuli are recorded. These 
responses are recorded as temperatures. The temperatures at which participants first perceive and 
sense cold or warmth or the temperatures at which the participants first feel pain from the cold or 
heat are recorded as the cool or warm detection threshold or cold or heat pain threshold, 
respectively (Figure 2.1). This process is repeated usually three to five times and an average is 
calculated to determine the thermal detection or pain thresholds (Rolke et al., 2006).  
 
 
Figure 2.1: Measuring thermal sensitivity 
Top right corner, screen with the software to control and record temperatures; participant to be tested holding the 
response unit in the right hand, while the thermode is attached to the left wrist. 
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Testing thermal detection and pain thresholds has been shown to be highly reproducible, but 
depends on the sequence order in which the tests are performed (Heldestad et al., 2010, Knutti et 
al., 2014). Cold and warm detection thresholds were found be to higher when they were measured 
after the cold and heat pain thresholds than when they were measured before the pain thresholds. 
Thus, weaker stimuli are to be applied followed by stronger stimuli to decrease carry-over effects 
(Riley et al., 2014). 
 
Most of the studies on thermal variables of QST have been carried out in healthy humans. Thermal 
detection and pain thresholds vary depending on age and testing sites (Harju, 2002). Older 
individuals have higher thresholds compared with younger individuals, meaning that they are less 
sensitive than the younger individuals (Hafner et al., 2015, Rolke et al., 2006). The detection and 
pain thresholds are lower on the hand compared with the foot (Hagander et al., 2000). Thermal 
detection and pain thresholds have also been studied in neuropathic or MSK participants. It is 
reported that thermal sensitivity is lower in pain participants compared to healthy participants, that 
is, pain participants have higher warm detection and heat pain thresholds and lower cold detection 
and cold pain thresholds compared with healthy participants at the affected sites (Jensen et al., 1991, 
Wylde et al., 2012, Harden et al., 2013). Generally, cold and warm thresholds are elevated whereas 
heat cold pain thresholds are lower in patients with neuropathic pain than in healthy individuals. 
This is perhaps due to the damage to the Aδ and C fibres, leading to a poor ability to sense warmth 
or cold and an increased sensitivity to pain (Flor et al., 2016, Pfau et al., 2014). This increase in pain 
sensitivity in pain patients may also be due to the presence of central sensitization. For instance, a 
previous study found that fibromyalgia participants showed a lower heat pain threshold than 
healthy participants (Petzke et al., 2003); another study found that fibromyalgia participants 
presented with enhanced central sensitisation compared with healthy individuals (Staud et al., 
2003a). 
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These tests have been used clinically to detect or diagnose neuropathic pathologies in diabetic 
participants and uremic participants among other peripheral nerve disorders (Lindblom and Tegner, 
1985, Jensen et al., 1991, Vinik et al., 1995). Abnormal thermal sensitivity was found in 30% of a 
sample (n=64) of non-diabetic uremic patients (Lindblom and Tegner, 1985). In a study of 34 diabetic 
participants, an increased thermal detection threshold was found compared to healthy participants. 
As the thresholds increased, the severity of neuropathy worsened (Jensen et al., 1991). In MSK 
participants, subgroups have been found based on their thermal sensitivity. Among a sample of LBP 
participants, 24% of the participants with mechanical LBP and 84% of the participants with non-
mechanical LBP had a cold pain threshold higher than 15°C when compared with the remaining of 
the sample (O'Sullivan et al., 2014). These results showed that a greater proportion of those with 
non-mechanical LBP were more sensitive to cold pain compared with a smaller proportion of those 
with mechanical LBP. These two groups also differed in their clinical characteristics. The mechanical 
LBP group had lower scores for Widespread Pain Index and Roland Morris Disability Questionnaire 
when compared with the non-mechanical LBP group, meaning their pain areas were more focused 
and were less disabling compared with the non-mechanical LBP group. 
 
Pinprick- mechanical threshold 
Calibrated pinpricks, of diameter 0.2mm and exerting forces between 8 and 512 mN, are usually 
used to measure mechanical detection threshold (Rolke et al., 2006). The pinpricks are applied 
perpendicularly to the skin in ascending order of the forces exerted until the participants first 
perceive the prick. Then, the pins are applied in descending order until the participants cannot feel 
the prick. Series of the pinpricks are applied in this way and the mean is calculated to find the 
detection threshold. Pain sensitivity to pinprick stimulation can also be used to assess cutaneous 
hyperalgesia, allodynia or mechanical TS of pain, which are indications of increased sensitivity 
(Arendt-Nielsen and Yarnitsky, 2009). This test can be used to monitor treatment response for 
neuropathic pain (Backonja et al., 2013). 
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Pressure pain threshold 
PPT is measured using an algometer, a pressure gauge device with a probe. The algometer is placed 
perpendicularly to the site to be tested and, force is exerted (Figure 2.2). The force applied is 
gradually increased until the participants perceive pain (Rolke et al., 2006, Petrini et al., 2015). The 
pressure at which the participants start to feel pain is the PPT. The average of several measurements 
determines the PPT. PPT has been shown to be reliable in knee OA, LBP and healthy participants 
(Wylde et al., 2011b, Paungmali et al., 2012, Mutlu and Ozdincler, 2015, Vuilleumier et al., 2015). It 
showed less variability over one week compared with thermal detection and pain thresholds and 
light touch threshold (Wylde et al., 2011b). 
 
 
Figure 2.2: Measuring PPT using an algometer 
 
 
It is argued that there is age and gender difference for PPT. In a study of 240 healthy participants the 
female group had lower mean PPT at the first dorsal interosseous muscle compared to male 
participants (female= 30.5N vs male 42.7N, P<0.0005) (Chesterton et al., 2003). In other healthy 
human studies, PPTs at the location of 18 tender points used in the diagnosis of fibromyalgia were 
lower in female participants compared with male participants (Maquet et al., 2004, Garcia et al., 
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2007). Another study reported that male participants in the elderly group (mean age of 73.6 ± 6.6 
years) had a significantly lower PPT than the males in the young group (mean age of 24.6 ± 3.6 years) 
at the index fingers and trapezius (Petrini et al., 2015). However, another study found that PPT at 
temporal muscle increased with age(Jensen et al., 1992b). 
 
PPT also differs depending on the testing sites. It was found that PPT was lower at a “muscle/nerve” 
site (brachioradialis where the superficial radial nerve branches pass underneath) compared to a 
bony site (lateral epicondyle of humerus) or a “pure muscle” site (belly of extensor carpi ulnaris) in 
healthy female participants (Kosek et al., 1999). MSK participants had significantly lower PPT than 
the healthy participants at the painful sites or at non-affected sites (Maquet et al., 2004, Imamura et 
al., 2008, Neziri et al., 2012a). 
 
PPT can also be affected by the physical features of the individual. It was reported that PPT inversely 
correlated with body mass index (BMI) in both healthy and MSK participants (Imamura et al., 2013, 
Zhang et al., 2013), that is individuals with greater BMI have lower PPT.  
 
Subgroups of MSK participants may have varied PPTs. In knee OA the subgroups with more negative 
psychological characteristics or more knee pain presented lower PPTs than the subgroups with more 
positive psychological characteristics and less knee pain (Arendt-Nielsen et al., 2010, Cruz-Almeida et 
al., 2013, Finan et al., 2013, King et al., 2013, Skou et al., 2014). 
 
PPT is often used to measure pain processing mechanisms such as CPM and TS of pain. More 
information on this topic will be discussed in the following sections. Lower PPTs or a decrease in 
PPTs reflects an enhanced sensitivity. When compared with healthy controls, participants with 
chronic pain may display lower PPTs at the sites away from to the painful/affected area. This wide-
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spread lower PPT reveals the presence of central sensitization (pain facilitation) (Coronado et al., 
2014, Starkweather et al., 2016). Lower PPTs limited to the site of pain in patients with chronic pain 
may reflect local or peripheral sensitization (pain facilitation) (Coronado et al., 2014, Starkweather et 
al., 2016). Changes in PPT after interventions, such as vibration and cold pressor also help determine 
the strength of pain inhibition, including SEG and CPM (Staud et al., 2011, Kosek and Ordeberg, 
2000). An increase in PPT at a site close to stimulated area indicates the potency of SEG whereas an 
increase in PPT at a site away from the stimulated area will indicate the potency of CPM. 
 
Endogenous Pain controls 
The body has its own way to supress pain, and this ability is known as endogenous pain controls. 
Pain research is taking more interest in the endogenous pain inhibitory systems, mainly SEG and 
CPM. SEG is activated when a painful or non-painful stimulus is applied to a site close to the painful 
area (Yarnitsky et al., 1997), whereas CPM is the reduction of pain by a painful stimulus away from 
the site of pain (Le Bars and Willer, 2002, Graven-Nielsen et al., 1998). The exact mechanisms of 
these inhibition systems are yet to be demystified, however they are related to either opioid, 
serotonergic or noradrenergic pathways (Oliveras et al., 1978, Chitour et al., 1982, Hammond et al., 
1985). 
 
Conditioned pain modulation 
CPM is the commonest method used to assess endogenous pain inhibition. It is considered 
homologous to the diffuse noxious inhibitory controls reported from animal studies (Yarnitsky et al., 
2010, Le Bars et al., 1979a, Le Bars et al., 1979b). The neuronal mechanism underlying CPM is still 
unknown. It is suggested that the activation of CPM involves supraspinal systems such as the 
medulla (Bouhassira et al., 1992, De Broucker et al., 1990) which triggers the descending inhibition 
involving serotonergic (Dickenson et al., 1981) and opioidic (Willer et al., 1990) systems to suppress 
the pain signals from the first stimulus. For instance, studies reported that a noxious stimulus to the 
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hand did not decrease the nociceptive RIII reflex activity at the contralateral leg in tetraplegic 
participants compared with healthy participants (Le Bars et al., 1992, Roby-Brami et al., 1987). The 
infusion of hypertonic saline into the tibialis anterior increased PPT at heterotopic sites (the ankle 
and arm) but not at the homotopic site (tibia) (Graven-Nielsen et al., 1998). 
 
The protocol for CPM involves two heterotopic stimuli: one stimulus is used to assess the extent of 
pain modulation (test stimulus), and the other stimulus is used to induce the pain modulation 
(conditioning stimulus) (Yarnitsky et al., 2010). The test stimulus is applied first then the conditioning 
stimulus is applied simultaneously with the test stimulus or after the test stimulus. The difference in 
pain rating or pain thresholds to the test stimulus before and during or before and after the 
conditioning stimulation is calculated to determine the state of the inhibition system (Pud et al., 
2009). A decrease in pain rating or an increase in pain threshold to the test stimulus during or after 
the conditioning stimulus indicates that pain inhibition has occurred, otherwise pain perception is 
unchanged or pain facilitation occurred. This is summarised by formulae below (Figures 2.3 and 2.4). 
If a study is using pain rating to measure the change in pain, a negative value will indicate a decrease 
in pain rating, hence pain inhibition, otherwise a positive value will indicate an increase in pain rating, 
hence pain facilitation (Chalaye et al., 2013, Yarnitsky et al., 2015) (Figure 2.3). On the other hand, if 
pain thresholds are used to measure the change in pain, a positive value will indicate an increase in 
pain threshold, thus pain inhibition and a negative value will indicate a decrease in pain threshold, 
thus pain facilitation (Chalaye et al., 2013, Yarnitsky et al., 2015) (Figure 2.4). 
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Figure 2.3: Formula to calculate the state of endogenous pain controls using pain rating (source: adapted from Yarnitsky 
et al., 2015) 
Pain rating= pain rating from test stimulus; before= before the application of conditioning stimulus; during= concomitant 
application of test stimulus and conditioning stimulus; after= after application of conditioning stimulus. 
 
 
Figure 2.4: Formula to calculate the state of endogenous pain controls using (a) pain rating and (b) pain threshold from 
test stimulus (source: adapted from Yarnitsky et al., 2015) 
Pain threshold= pain threshold from test stimulus; before= before the application of conditioning stimulus; during= 
concomitant application of test stimulus and conditioning stimulus; after= after application of conditioning stimulus. 
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So far, there is no standard protocol for the measurement of CPM. The most popular protocols use 
thermal painful stimulation as the test and conditioning stimuli: cold water (CPT) and hot noxious 
stimuli (Pud et al., 2009, Lewis et al., 2012b). Other methods to deliver conditioning stimuli include 
chemical (capsaicin), electrical or mechanical (ischemic pressure cuff) stimuli, and other methods for 
test stimuli include mechanical (algometer or ischemic pressure) or electrical (Arendt-Nielsen and 
Yarnitsky, 2009, Nir and Yarnitsky, 2015). Some of these stimuli are represented in the diagram 
below (Figure 2.5). The conditioning stimulus and the test stimulus are applied heterotopically. 
 
 
Figure 2.5: Examples of test and conditioning stimuli 
 
 
Good reliability has been found for CPT, mechanical pressure and ischemic pressure cuff as the 
conditioning stimuli (Oono et al., 2011a, Lewis et al., 2012a, Biurrun Manresa et al., 2014, Graven-
Nielsen et al., 2015). Moreover, CPT has been reported to have more intra and inter-session 
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reliability when compared with the ischemic pressure cuff or mechanical pressure (Oono et al., 
2011a, Lewis et al., 2012a). 
 
It is debated that CPM can be elicited by both painful (Le Bars and Willer, 2002) and non-painful 
conditioning stimulus (Lautenbacher et al., 2002). It is often assumed that a stronger conditioning 
stimulus would induce a greater CPM. However, studies reported conflicting results on this topic. On 
one hand studies found a positive relationship between the intensity of the conditioning stimulus 
and the potency of CPM (Fujii et al., 2006, Arendt-Nielsen et al., 2008); on the other hand studies 
also reported the absence of a correlation between the intensity of conditioning stimulus and the 
potency of CPM (Baad-Hansen et al., 2005, Pud et al., 2005, Razavi et al., 2014). 
 
The location where the conditioning stimulus is applied also affects the potency of CPM. In a study 
on temporomandibular disorders, when the testing stimulus was applied to a pain free extra-
segmental site (forearm) a more potent CPM was produced compared with when the testing 
stimulus was applied to a painful segmental site (masseter) (Oono et al., 2014). 
 
CPM is transient and usually lasts the same duration as the conditioning stimulus (Svensson et al., 
1999). Some studies also reported that CPM lasted after the conditioning stimulus terminated and 
the duration ranged from 5 minutes to 1 hour (Graven-Nielsen et al., 1998, Fujii et al., 2006, Tuveson 
et al., 2006, Lewis et al., 2012a). 
 
The potency of CPM varies in individuals; the possible factors leading to this variation include age, 
gender, autonomic activity (blood pressure), psychological factors or medication intake. CPM is 
related to age. Younger participants showed more potent CPM compared with older participants 
using the CPT and noxious heat stimuli (Edwards et al., 2003, Grashorn et al., 2013). Gender 
difference in CPM is still inconclusive; some studies reported no significant differences between 
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male and female participants (France and Suchowiecki, 1999, Baad-Hansen et al., 2005, Pud et al., 
2005, Lautenbacher et al., 2008, Oono et al., 2011b, Zheng et al., 2014) whereas other reported less 
potent CPM in female participants (Staud et al., 2003, Serrao et al., 2004, Granot et al., 2008). 
Studies argued that this gender difference may be due to the difference in pain perception or due to 
the type of stimuli applied when measuring CPM (Popescu et al., 2010, Arendt-Nielsen et al., 2008). 
 
CPM was found to be related to blood pressure change during conditioning in healthy participants 
and participants with fibromyalgia: an increase in systolic blood pressure was correlated with a more 
efficient CPM (Chalaye et al., 2013, Chalaye et al., 2014). However, another study, using CPT and 
tourniquet test as conditioning stimuli in a cross-over design, found that there was no relationship 
between the potency of CPM and blood pressure change in 25 healthy male participants (Nilsen et 
al., 2014). 
 
Psychological factors impact on the potency of CPM. A healthy human study found that participants 
with greater harm avoidance presented with less efficient CPM (Nahman-Averbuch et al., 2016). 
Another healthy human study reported that participants with higher level of pain catastrophizing 
showed less efficient CPM (Weissman-Fogel et al., 2007). A recent systematic review reported no 
relationship between psychological factors and potency of CPM (Nahman-Averbuch et al., 2015). 
However, subgroup analyses from that study revealed that anxiety, depression and pain 
catastrophizing were related to the potency of CPM depending on which type of stimulation was 
used as the test stimulus. Higher level of anxiety, depression and pain catastrophizing were 
associated with a poorer CPM when a pressure, heat or electrical stimulation was used as the test 
stimulus respectively. 
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Medications such as pain killers and contraceptives may alter CPM; it may decrease or increase CPM 
or has no effect on CPM. Niesters and colleagues reported that after an infusion of ketamine, a N-
Methyl-D-aspartate receptor antagonist, no CPM was observed, instead there was an increase in 
pain to the test stimulus in healthy humans (Niesters et al., 2011). Another study reported that a low 
dose of dexmedetomidine, a selective α2-adrenoceptor agonist, inhibited CPM in healthy humans 
(Baba et al., 2012). In Rezaii’s study, the group of healthy women who were not taking oral 
contraceptives had a better CPM than those taking oral contraceptives (Rezaii and Ernberg, 2010). 
Apomorphine, a dopamine agonist, was found to improve CPM by 27.3% compared with placebo 
(4%) in healthy participants (Treister et al., 2013). In a study on chronic low back pain, tropisetron 
was reported to improve CPM, however there was no difference between the group receiving 
tropisetron compared with the placebo group (Neziri et al., 2012b). Hence, the authors of that study 
concluded that tropisetron had no effect on CPM. 
 
Potency of CPM in people with chronic pain has generated great interest in pain research as pain 
participants with OA, fibromyalgia, temoporomandibular disorders, headache, migraine, pancreatitis, 
irritable bowel syndrome or interstitial cystitis, presented less potent or impaired CPM compared 
with healthy humans (Kashima et al., 1999, Kosek and Ordeberg, 2000, Staud et al., 2003, Sandrini et 
al., 2006, Song et al., 2006, Wilder-Smith and Robert-Yap, 2007, King et al., 2009, Arendt-Nielsen et 
al., 2010, Perrotta et al., 2010, Potvin et al., 2010, Ness et al., 2014). It is unknown if the impaired 
CPM is the result or the cause of chronic pain. Studies have found that the impaired CPM is 
reversible in osteoarthritic patients after joint replacement surgery (Kosek and Ordeberg, 2000, 
Graven-Nielsen et al., 2012). The potency of CPM may also predict treatment response. Yarnitsky 
and colleague found that diabetic neuropathy participants with less potent CPM responded better to 
duloxetine, an antidepressant, compared with those who had more potent CPM (Yarnitsky et al., 
2012). In a recent study of knee OA, cluster analysis revealed that a portion of knee OA participants 
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had equally or more potent CPM compared with healthy humans (Egsgaard et al., 2015). It seems 
that potentcy of CPM varies among individuals and it is important to understand the clinical 
implication of this phenomenon. 
 
Segmental inhibition 
Unlike CPM, SEG is an under studied area. SEG is believed to be activated through a segmental 
dorsal horn mechanism induced by activation of the large mylienated Aβ or Aδ fibres by non-noxious 
or noxious stimuli based on the “gate theory of pain control” proposed by Melzack and Wall 
(Melzack and Wall, 1965). For instance, rubbing a painful area or close to a painful area (within the 
same segment) activates Aβ fibres, which in turn can stimulate an inhibitory nerve in the spinal cord 
and reduces the pain sensation at that area. 
 
QST can be used to measure the potency of SEG. An increase in pain thresholds or decrease in pain 
sensitivity at the painful or stimulated site or within the same segment as the painful or stimulated 
site suggests the activation of SEG (Valeriani et al., 2005, Baeumler et al., 2015). It is thought that 
vibration-induced analgesia indicates the potency of SEG. Previous studies have used various 
vibration protocols to induce of SEG (Lundeberg, 1984, Yarnitsky et al., 1997); a reliable way to 
measure SEG is yet to be determined.  
 
Factors such as site of stimulation, surface area being stimulated and duration of stimulation affect 
the extent of vibration- induced analgesia, thus the potency of SEG. Studies reported that vibration-
induced analgesia was more potent when the vibration was applied to sites close to the painful area 
than to sites further away from the painful area (Lundeberg, 1983, Lundeberg et al., 1984, Staud et 
al., 2011). The extent of SEG was also related to the surface area being stimulated and duration of 
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stimulus applied. Lundeberg and colleagues reported that a bigger probe (200cm2) size delivering 
vibration reduced musculoskeletal pain more as opposed to using a smaller probe size (6cm2), 
implying that there might be a more potent SEG when a larger area is stimulated (Lundeberg et al., 
1984). Lundeberg and colleagues also found that the duration of stimulation affected the analgesic 
effect of vibration (Lundeberg, 1984). A minimum of 10 minutes of vibratory stimulation was 
required to induce pain reduction; optimum pain reduction could be seen after 25-45 minutes of 
stimulation; stimulation beyond 45 minutes did not increase the analgesic effect (Lundeberg et al., 
1984). However, a more recent study, demonstrated that 10s of vibratory stimulus could increase 
the heat pain thresholds of healthy and chronic pain participants significantly (Staud et al., 2011). 
 
In the current literature, there is a lack of understanding of SEG. It is unknown if factors such as age 
or gender impact on the potency of SEG. Studies have shown that some chronic pain participants 
have similar potency of SEG compared with healthy participants (Staud et al., 2011). More studies 
are needed to confirm these results, and to establish reliable protocols to induce SEG in healthy and 
chronic pain participants. 
 
 
Pain facilitation 
Increased pain sensitivity may occur as a result of pain facilitation. This may involve phenomenon 
such as peripheral or central sensitization. Peripheral sensitization is an increase in excitability of the 
nociceptors when compared with normal sensory state (healthy human). Proinflammatory 
substances, such as substance P, reduce nociceptors’ response threshold at the site of pain, and 
increase their response to painful (Defrin and Lurie, 2013). Central sensitization is the increase in 
excitability of the neurons within the central nervous system (Latremoliere and Woolf, 2009, Woolf 
et al., 1988, Starkweather et al., 2016). Neurotransmitters, such as glutamate or prostagladins, 
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decrease the activation threshold and enlarge the receptive fields of neurons, and enhance and 
sustain synaptic activitiy of the central nervous system (Woolf, 2011). This leads to increased 
sensitivity to both noxious and innocuous stimuli. Peripheral sensitization thus is characterised by 
localised (confined to the site of pain, primary hyperalgesia) enhanced pain sensitivity whereas 
central sensitization is characterised by enhanced pain sensitivity away from the affected site or 
primary site of pain, sometimes presenting as widespread pain (secondary hyperalgesia). 
 
QST can be used to measure the presence of peripheral and central sensitization. A decrease in pain 
thresholds at the site of pain will determine the presence of peripheral sensitization while a 
decrease in pain thresholds away from the site of pain will determine the presence of central 
sensitization (Coronado et al., 2014, Starkweather et al., 2016). Dynamic QST techniques such as TS 
of pain can also determine the presence of central sensitization (Starkweather et al., 2016). 
 
TS of pain is the increase in pain magnitude from repetitive stimulation of equal intensities (Price, 
1972). Mechanical pressure (Graven-Nielsen et al., 2015, Cathcart et al., 2009), thermal (Kong et al., 
2013a) or electrical stimuli (Arendt-Nielsen et al., 2000) have been shown to reliably measure TS of 
pain. The extent of TS of pain may depend on the type of stimulus or site used. Lautenbacher and 
colleagues found that elderlies had an enhanced TS of pain compared with the younger participants 
when using heat stimulus to measure TS of pain but not when using pressure stimulus (Lautenbacher 
et al., 2005). Other studies found an enhanced TS of heat pain in elderlies compared to young 
participants at the forearm but not at the leg (Harkins et al., 1996, Riley et al., 2014). The inter 
stimulus interval or the surface area being stimulated may also affect TS of pain. In Nie’s study, TS of 
pressure pain in healthy participants was unchanged irrespective of the sizes of probes used to 
deliver the pressure stimulus when an inter stimulus interval of one second was used (Nie et al., 
2009). Greater inter stimulus intervals (5s and 30 s) and larger probes (2cm2, 4cm2 and 8cm2) 
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resulted in an enhanced TS of pressure pain compared with smaller probes (0.5 cm2 and 1cm2) (Nie 
et al., 2009). 
 
It is argued that age and gender affects TS of pain. Studies looking at the relationship between age 
and TS of pain found that elderlies had an enhanced TS of heat pain at the forearm (Harkins et al., 
1996, Riley et al., 2014). A 2009 review reported that out of four studies investigating gender and TS 
of heat pain, three studies found a gender difference in TS of pain: females had higher TS than males 
(Fillingim et al., 2009). Other studies also reported an enhanced TS of mechanical pain in females 
(Sarlani et al., 2004, Sarlani and Greenspan, 2002). 
 
Previous studies found that participants with chronic pain such as knee OA (Arendt-Nielsen et al., 
2010), temporomandibular disorders (Raphael et al., 2009), fibromyalgia (Staud et al., 2001) or 
irritable bowel syndrome (Zhou et al., 2011), have enhanced TS of pain compared to healthy humans. 
Some researchers believe that this increased TS of pain in chronic pain participants may be due to 
their impaired CPM. For instance, knee OA participants were found to have an enhanced TS of 
pressure pain at knee and tibia compared with their healthy controls, and in the same study, the 
knee OA participants presented an impaired CPM compared with the healthy participants (Arendt-
Nielsen et al., 2010). TS could be important in determining treatment response. A recent study 
found a positive correlation between pre-operative TS of mechanical pain and post-operative pain 
after knee surgery in knee OA participants (Petersen et al., 2015). 
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Pain adaptability 
Pain adaptability has been described in healthy humans. Zheng and colleagues distinguished two 
groups of participants based on their pain rating to a CPT (Zheng et al., 2014). Participants were 
asked to immerse their dominant hand in cold water at 1-4°C for 5 minutes. During those 5 minutes, 
they were asked to rate their pain to the cold water using an electronic visual analogue scale of 0-10, 
10 being the worst pain possible. At the end of the test, one group showed a decrease in pain rating 
from their maximum pain, of at least 2 on the 0-10 scale, whereas the other group exhibited no 
change or an increase in pain (Figure 2.6). The former was categorised as the PA group (n= 16) and 
the latter pain PNA group (n=25). This study found that the PA reaches their maximum pain from the 
cold pressor faster than the PNA. PPT was measured at their arms and leg to measure their potency 
of SEG and CPM respectively. Zheng and colleagues found a weak positive correlation between the 
potency of SEG and pain adaptability (Zheng et al., 2014). Moreover, no relationship was found 
between CPM and pain adaptability. This suggests that pain adaptability is possibly related to SEG. 
 
 
Figure 2.6: Graph of pain rating to cold pressor, (source: Zheng et al., 2014) 
 
 
Devoize and colleagues used similar protocol to categorise PA and PNA in healthy participants 
(Devoize et al., 2015). They used a cold pressor at 7°C and hot immersion at 47.5°C at the right arm 
for five minutes, at two different sessions. Nine PA and 17 PNA were identified using the CPT and 8 
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PA and 18 PNA were identified using the hot immersion. Their findings were similar to Zheng’s study; 
PA reached their maximum pain faster than PNA, and there was no difference in their intensity of 
maximum pain. In Devoize study, the researchers also investigated the relationship between 
cardiovascular responses (blood pressure and heart rate) and pain adaptability. They found that 
there was no relation between cardiovascular responses and pain adaptability (Devoize et al., 2015). 
 
Another study subgrouped healthy participants into “adapting” and “non-adapting” using a CPT a 
3°C for three minutes (Polianskis et al., 2002). However, the way the participants were categorised 
was based on whether the participants could complete the three-minute CPT or not. Using this 
method, 10 “adapting” and 6 “non-adapting” participants were identified. With this different 
approach, the researchers found that the “non-adapting” participants reached their maximum pain 
faster and that they had a maximum pain higher than the “adapting” participants. 
 
So far pain adaptability has only been studied in healthy young participants (Zheng et al., 2014, 
Devoize et al., 2015, Polianskis et al., 2002). It is unknown whether the elderlies or individuals with 
MSK would have the same response. A protocol to measure pain adaptability in individuals with MSK 
is yet to be designed. 
 
 
Psychophysical subgroups and treatment response 
In pain research there is a greater focus on subgrouping pain participants in order to further 
investigate diagnosis and prognosis. Studies have examined subgroups based on psychophysics in 
knee OA and LBP. Knee OA participants with more positive psychological characteristics presented 
with higher PPT at the knee, forearm and trapezius (Cruz-Almeida et al., 2013). Non-mechanical LBP 
participants reported more clinical pain and had higher odds of having a cold pain threshold higher 
than 15°C compared with the mechanical LBP participants (O'Sullivan et al., 2014). 
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Yartnitsky and colleagues reported that duloxetine was more effective in diabetic neuropathic pain 
patients with inferior CPM (Yarnitsky et al., 2012). Another study found that patients with post-
herpetic neuralgia who had mechanical allodynia responded better to lidocaine (Attal et al., 2004). 
Pain tolerance was found to be related to the outcome of a weight loss treatment for obese 
participants with knee OA (Jorgensen et al., 2012). Participants with lower pressure pain tolerance 
were found to be less responsive to the diet intervention than those with a higher pain tolerance. 
 
 
Summary 
QST can be reliably applied to healthy and pain participants. These tests can be used to assess pain 
sensitivity and also to understand how some MSK could be related to certain pain mechanisms. A 
literature review examined pain sensitivity in LBP participants and reported that participants with 
LBP are heterogeneous in their pain sensitivity: some participants had widespread pain while others 
did not (Roussel et al., 2013). Previous studies have also examined the psychophysical characteristics 
of knee OA participants. However, no reviews have investigated the psychophysical subgroups in 
knee OA. It is unclear which forms of psychophysical test should be used to subgroup patients with 
knee OA. It is yet to be determined if the dichotomy of pain adaptability (PA and PNA) is also present 
in individuals with MSK. Different protocols were used to assess pain adaptability in healthy humans. 
It is unknown which is the more suitable and safe protocol for participants with MSK, and thus there 
is no protocol yet to test for pain adaptability in MSK participants. No studies have probed into the 
relationship between pain adaptability and treatment response in healthy or MSK participants. Being 
able to adapt to pain or not may affect the outcomes of pain management. It is possible that being 
PA enable individuals to counteract any stress exerted on them more easily than the PNA do. Thus, 
PA individuals may have a better response to treatment compared to the pain non-adaptive. This is 
yet to be tested. 
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Acupuncture  
Manual acupuncture 
Acupuncture is mainly known as a practice of inserting fine filiform needles into the skin or muscles 
to treat diseases or pain. This is termed as manual acupuncture. There are other forms of 
acupuncture which involve different types of invasive and non-invasive stimulation such as electro-
acupuncture (electrical stimulation), laser acupuncture (light stimulation), acupressure (mechanical 
pressure stimulation), transcutaneous electrical acupoint stimulation (electrical stimulation over the 
skin) or moxibustion (heat stimulation). 
 
Manual acupuncture is more commonly used. It involves inserting the needles at the chosen points 
to a certain depth followed by manipulation; the needle is then left at the inserted site for the 
duration of the treatment and finally removed. Point selection is the main component for the 
treatment. Points may be selected based on Chinese Medicine Theory, symptoms or the location of 
ailment (Yang and He, 1985). Based on Chinese Medicine Theory, each point has specific properties 
and can be used together with other points, like in a Chinese medicine herbal formula with different 
herbs, to alleviate the symptoms. There are also some popular empirical points for certain 
conditions, which have been gathered through experience. Points can also be selected based on 
their location with respect to the affected body area or painful area. For instance, for a LBP patient 
diagnosed with kidney deficiency according to the Chinese Medicine Theory, points for the lower 
back (local and distant points) and points to strengthen the kidney (such as BL23 or KI3 in Figure 2.7) 
could be chosen (Lu, 2007). The concept of local needling and distant needling will be further 
described in the following section on acupuncture and MSK. 
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Figure 2.7: Location of acupuncture points BL23 and KI3 which can be used for low back pain diagnosed with kidney 
deficiency according to the Chinese Medicine Theory 
 
After needle insertion at the chosen points, the needle is rotated bi-directionally. During this 
manipulation the individual receiving acupuncture may feel a transient sensation such as numbness, 
distension, tingling, heaviness, warmth or soreness (Hui et al., 2007). This sensation is termed as 
Deqi (得气), which is translated as the “arrival of the qi”. According to the Chinese Medicine Theory, 
qi (气) is the vital energy that runs through the meridians. Therefore, Deqi is an important aspect of 
an acupuncture treatment. In a study of 30 knee OA participants the real acupuncture group 
reported stronger Deqi sensation and better pain reduction and function improvement than the 
sham acupuncture group (Spaeth et al., 2013). The sham intervention consisted of needling non-
acupuncture points using a Streitberger needle (retractable and blunt needle). Thus, the sham 
acupuncture was non-invasive and less or no Deqi sensation was felt. This study suggested that the 
strength of Deqi may be related to therapeutic outcomes of acupuncture (Spaeth et al., 2013). 
Another study, found that the group with needle manipulation showed a higher increase in PPT than 
the groups without needle manipulation (Choi et al., 2013). Conversely, studies also found a lack of 
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relationship between Deqi sensation and acupuncture analgesia. No difference in pain reduction and 
functional improvement was found between real and sham acupuncture in a study on knee OA 
(Scharf et al., 2006). In that study the sham acupuncture involved shallow needling without the 
elicitation of Deqi sensation as opposed to real acupuncture involving deep needling with needle 
stimulation to elicit Deqi sensation. 
 
Other aspects of an acupuncture treatment that may contribute to the therapeutic outcomes are 
depth of needling, needling retention time, number of needles used and treatment frequency 
(Leung et al., 2008, Hao et al., 2013, Itoh et al., 2011). Itoh and colleagues found that needling 
through the muscle at tender points increased the electrical pain threshold at those points, but 
needling through the skin or no treatment did not (Itoh et al., 2011). A healthy human study 
reported that heat pain threshold was increased and sustained longer after 15 or 30 minutes of 
needle retention of electro-acupuncture compared with five minutes of needle retention (Leung et 
al., 2008). Further, the group of participants receiving 15 minutes of electro-acupuncture presented 
with analgesic effect earlier than those receiving 30 minutes of needle retention (Leung et al., 2008). 
A systematic review on tension type headache reported that 30 minutes of needle retention of 
manual acupuncture showed less days with headache compared with those without needle 
retention (Hao et al., 2013). The same review found that two treatments per week were more 
effective in reducing the number of days with headache than one treatment per week (Hao et al., 
2013). The number of needles used could potentially affect acupuncture analgesia. A study in 
healthy participants found that the about 93% of the participants in the group using four needles 
showed significant pain reduction from heat stimulus within three minutes of intervention 
compared with 67% of the participants in the group using two needles (Paley and Johnson, 2015). 
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Manual acupuncture is considered to be of low risks of side effects. The York acupuncture safety 
study surveyed 34407 consultations with report of 43 cases of minor adverse events and no serious 
adverse events (MacPherson et al., 2001). The minor adverse events were nausea, sweating, 
dizziness, aggravation of symptoms, bruising, prolonged pain, psychological reactions and burns 
from mosxibustion.  
 
Acupuncture for MSK and individual variations 
Acupuncture has been used to treat MSK to relieve pain and increase function. Studies have found 
that acupuncture can reduce pain in conditions such as neck pain, ankle sprain, knee OA and LBP 
(Furlan et al., 2005, White et al., 2007, Yuan et al., 2015, Ezzo et al., 2001, Park et al., 2013) 
compared with usual care or no treatment. However, there is no consensus on the evidence of 
whether acupuncture analgesia is superior to placebo or sham acupuncture. Systematic reviews 
have been conducted on the effects of acupuncture on MSK. Some found that acupuncture was not 
effective (Ezzo et al., 2000) and other found limited evidence that acupuncture was more effective 
than sham acupuncture, placebo or no treatment (Furlan et al., 2005). These systematic reviews 
suggested that the lack of consensus may be due to the poor design or high heterogeneity among 
the acupuncture studies: different selection of points or different types of sham acupuncture used. 
 
The nature of acupuncture treatment itself also contributes to these variations. In practice, the 
treatment is tailored to the individual according to the Chinese Medicine Theory or symptoms 
present. This makes it hard to compare the therapeutic outcome in clinical trials. Different sham 
controls were adopted in various studies. Non-invasive sham acupuncture such as blunt needles and 
refractory needles (Streitberger and Kleinhenz, 1998) (Figure 2.8) or invasive sham acupuncture such 
as shallow needling (Scharf et al., 2006) or needling of non-acupuncture points were used (Zaslawski 
et al., 2003). However, it is thought that these methods of sham acupuncture are not completely 
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inert; non-invasive sham acupuncture still has non-specific effects (Langevin et al., 2011, Sanchez 
Aranjo, 1998) and the invasive sham acupuncture has therapeutic effect since it stimulates the skin 
and cutaneous nerves (Kenjil and White, 2010, Lund et al., 2009). This could have influenced the 
treatment outcomes in the participants receiving sham acupuncture, and explain the lack of 
disparity between real and sham acupuncture in some studies. 
 
 
Figure 2.8: Streitberger needle (left and middle), real acupuncture needle (right); source: (Streitberger and Kleinhenz, 
1998) 
Other factors leading to the individual variations in acupuncture response have also been 
investigated. Studies have found that acupuncture analgesia may be affected by the patients’ and 
practitioners’ expectations and the patients’ pain history (Linde et al., 2007, MacPherson and Fitter, 
1998, Witt et al., 2011). Participants with higher expectations or shorter pain history showed a 
better pain relief from acupuncture (Linde et al., 2007). 
 
Characteristics of the participants such as the potency of endogenous pain controls may also affect 
the therapeutic effect of acupuncture. Some researchers believe that heterogeneity among the 
patients may have diluted the effect of acupuncture in clinical trials (Langevin et al., 2011). The 
analgesic mechanism of acupuncture is still not fully understood. However, it is related to the 
endogenous pain controls, which will be discussed later on. Some individuals may respond better to 
acupuncture compared to others based on their endogenous pain controls. So far, no studies have 
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investigated whether individuals, either with clinical pain or without pain, respond differently to 
acupuncture based on the potency of their endogenous pain controls. 
 
Acupuncture points selection could also be a contributing factor to the variations in treatment 
response. The optimal acupuncture treatment for MSK is still unknown. In acupuncture treatment 
for MSK, like any acupuncture treatment, the selection of points is also dictated by the Chinese 
Medicine Theory, symptoms or location of the painful area. Conventionally, a combined approach of 
local and distant points is used. Points located close to the site in pain are known as local points and 
those away from the site in pain are called distant points. For example, in a case of LBP, the points 
on the lower back are considered the local points and the commonly used empirical point for low 
back pain, BL40, located at the back of the knee, is considered the distant point (Figure 2.9). Few 
studies have used the local points and distant points separately, and have compared their 
therapeutic effect (Irnich et al., 2002, Wu, 2012). There is no consensus on whether a treatment 
using local points only would be more effective than one using distant points only or vice versa. It is 
also unclear if the common approach, that is the combined point selection, is more effective than 
using local or distant points alone. 
 
 
Figure 2.9: Local and distant acupuncture in a case of Low back pain 
45 
 
Mechanism of acupuncture analgesia 
Acupuncture analgesia is thought to be the product of several endogenous pain control systems 
working together. The need for an intact nervous system suggests that acupuncture analgesia is 
closely related to the nervous system. Animal studies have shown that lesions at the supraspinal 
sites such as periaqueductal grey, rostral ventromedial medulla or hypothalamus reduced 
acupuncture analgesia (Cao, 2002). In a study comparing the analgesic effect of acupuncture with 
intramuscular morphine in an experimental pain model, the researchers found that acupuncture and 
morphine both increased the participants’ electrical pain threshold similarly (Research Group of 
Acupuncture Anesthesia, 1973). Also they found that when local anaesthetic injection of 2% 
procaine was injected at the acupuncture points, no analgesic effect was observed after 
acupuncture (Research Group of Acupuncture Anesthesia, 1973). Moreover, another study found 
that direct stimulation of peripheral nerve fibres increased pain threshold similarly like acupuncture 
(Lim et al., 1977). Those studies emphasize the relationship between acupuncture analgesia and the 
nervous system. 
 
Animal studies on acupuncture suggested that acupuncture analgesia is induced via central pain 
control mechanisms, thus psychophysical methods may be important in studies on acupuncture 
analgesia, and may contribute to a better understanding of acupuncture analgesia. Psychophysical 
methods such as QSTs have been used in acupuncture studies on healthy and chronic pain 
participants (Zheng et al., 2010b, Tobbackx et al., 2013, Lang et al., 2010, Kong et al., 2013b). The 
following sections elaborate the possible mechanisms of acupuncture analgesia and illustrate 
examples of psychophysical studies investigating acupuncture analgesia. 
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Acupuncture and segmental inhibition  
It has been hypothesised that acupuncture analgesia from needling local points is elicited through 
SEG. When a needle is inserted in a certain dermatome, it can induce analgesia at other areas in the 
same neural segment that innervates the skin, muscles or even bones (Filshie and White, 1998). In a 
study of 24 healthy participants, three different modes of acupuncture were delivered to each 
participant at one leg in a crossover design; each participant received manual acupuncture, electro-
acupuncture with low frequency, electro-acupuncture with high frequency (Lang et al., 2010). PPT 
was measured before and after the acupuncture sessions at the leg receiving acupuncture and the 
contralateral leg. There was a significant increase in PPT at both the ipsilateral and contralateral legs 
after all three of the acupuncture modes (Lang et al., 2010). Similarly, another healthy human study 
found a significant increase in the electrical pain threshold at the ipsilateral and contralateral legs 
after electro-acupuncture at one leg (Zheng et al., 2010b). Thus, acupuncture has local and 
segmental effects. It is speculated that mechanisms such as the gate control theory proposed by 
Melzack and Wall contributes to this SEG (Melzack and Wall, 1965). It is possible that individuals 
with different potency of SEG may experience different extent of acupuncture analgesia at the local 
and segmental sites induced by local needling. No studies have explored this possibility so far. 
 
Acupuncture and endogenous opioid peptides 
Studies have also shown that acupuncture analgesia is related to the release of endogenous opioids. 
The level of endogenous opioids in the cerebrospinal fluid increased in rats and humans after 
acupuncture (Clement-Jones et al., 1980, Pert et al., 1981). A study found that naloxone reduced the 
analgesic effect of acupuncture on experimental pain at the teeth (Mayer et al., 1977). In that study 
20 healthy participants received acupuncture at the point LI4 (between the thumb and the index 
finger) to test the analgesic effect of acupuncture on their pain threshold from electrical stimulation 
at the teeth. The participants were randomized to receive saline or naloxone five minutes after the 
acupuncture. The electrical pain threshold of those who received naloxone decreased whereas the 
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electrical pain threshold of those who received saline did not change. The same study aslo had a no 
treatment control group. It was reported that the decrease in pain threshold caused by naloxone 
after acupuncture almost reached the same level of pain threshold as the no treatment group 
(Mayer et al., 1977). Animal studies on electro-acupuncture also reported that depending on the 
frequency used, different types of endogenous opioids are released. Electro-acupuncture at 2Hz 
induces the release of encephalin, β-endorphin and endomorphin whereas a frequency of 100Hz 
increases the release of dynorphin (Han, 2004). A combination of both frequencies will increase the 
release of the four endogenous opioids, resulting in a better analgesic effect (Han, 2004). 
 
Acupuncture and CPM  
Another hypothesis is that acupuncture induces pain relief via CPM. This may explain why needling a 
distant point could induce pain reduction to the painful site. Animal studies have shown that 
acupuncture can activate wide dynamic range neurons similarly as a noxious stimulus, which is 
usually required to induce CPM (Bing et al., 1991). Another animal study found that acupuncture at 
the hind paw could supress trigeminal convergent neurons activities, evoked by applying electrical 
stimulus to the nuzzle of the rat, during the intervention similarly as immersing the hind paw in hot 
water did (Bing et al., 1990). In recent years, studies that investigated the relationship between 
acupuncture and CPM in healthy (Schliessbach et al., 2012) and MSK participants (Tobbackx et al., 
2013) have been conducted. 
 
In the healthy human study, acupuncture analgesia was compared with CPM induced by cold pressor 
using a crossover design (Schliessbach et al., 2012). CPM was evoked with a CPT for 2 minutes at the 
hand (side not specified) and its potency was measured using PPT at the ipsilateral second toe. 
Acupuncture was delivered at the point LI4 (between the thumb and the index finger) for five 
minutes without manipulation (the researchers did not report whether acupuncture was delivered 
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unilaterally or bilaterally). The researchers reported that the increase in PPT immediately after the 
CPT (from 298.9 KPa to 467.0 KPa) was significantly higher than the increase in PPT after 
acupuncture (from 298.9 KPa to 364.1 KPa). Thus, they concluded that acupuncture analgesia was 
not comparable to CPM (Schliessbach et al., 2012). 
 
In a study of patients with chronic whiplash associated disorders, Tobbackx and colleagues 
investigated whether acupuncture activated CPM when compared to relaxation (Tobbackx et al., 
2013). They used the combination of local and distant points, including ear acupuncture points, in a 
single acupuncture session of 20 minutes. The acupuncture points were selected based on pain 
presentation of individual participant; a semi-standardised treatment plan was used. The points 
could be chosen from within a list of local and distant points and other additional points were also 
allowed. Deqi was sometimes elicited at needle insertion, and no other needle manipulations were 
performed. The relaxation group underwent guided imagery and listening to relaxation music. The 
potency of CPM was measured before and after the acupuncture or the relaxation sessoin. CPM was 
induced using a pressure cuff at the right arm as the conditioning stimulus; and pain intensity from 
10 repeated pressure stimuli (TS of pain) at the left trapezius and the left calf were the testing 
stimuli. There was a decrease in the intensity of neck pain in the acupuncture group (from 49.1 ± 
26.5 mm to 42.1 ± 26.6 on a 100mm visual analogue scale) and no change in the relaxation group, 
however, there was no group by time interaction observed. There was no significant change in their 
potency of CPM at both the trapezius (acupuncture: pre=0.37 ± 1.30, post=0.47 ± 1.06, p>0.05; 
relaxation: pre=0.72 ± 1.43, post= 0.59 ± 1.23, p>0.05) and the calf (acupuncture: pre=0.50 ± 1.37, 
post=0.18 ± 1.29, p>0.05; relaxation: pre=0.23 ± 1.81, post= -0.03 ± 1.31, p>0.05) after acupuncture 
or relaxation. The researchers reported that acupuncture had no effect on CPM and concluded that 
acupuncture analgesia was induced by other endogenous mechanisms such as release of 
endogenous opioids (Tobbackx et al., 2013). 
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Although those two studies concluded that acupuncture was not related to CPM in humans, their 
study designs are flawed. It is known that the pain intensity of the conditioning stimulus affect the 
extent of CPM, that is the stronger the conditioning the stronger the CPM induced (Arendt-Nielsen 
et al., 2008, Fujii et al., 2006). For instance one study showed that participants experienced more 
pain from a CPT compared with saline evoked muscle pain, and the CPM induced using the CPT was 
stronger than that induced using saline (Arendt-Nielsen et al., 2008). It should be noted that in 
Schliessbach’s study, pain rating to acupuncture needling was at 2.4 out 10, far less than that pain 
induced by the cold pressor (7.1) (Schliessbach et al., 2012). Moreover, one acupuncture point with 
five minutes of needle retention significantly departs from the common clinical practice, where 5-10 
points are needled for over 20 minutes (Schliessbach et al., 2012). In Tobbackx’s study, acupuncture 
duration was extended to 20 minutes, however only one single session of acupuncture was applied 
to patients with chronic pain (Tobbackx et al., 2013). Clinically, some patients might experience pain 
relief immediately after one session of acupuncture whereas others require repeated treatment. A 
study in healthy participants reported that acupuncture analgesia was stronger at 24 hours after 
acupuncture than at 30 minutes after acupuncture (Zheng et al., 2010b). Furthermore, clinically, six 
to eight sessions of acupuncture are needed for stable clinical effect (Smith et al., 2011). One session 
of acupuncture might not have been sufficient to recover or improve the potency of CPM in 
Tobbackx’s study (Tobbackx et al., 2013). Future studies should assess if repeated acupuncture may 
enhance the potency of CPM in patients with chronic pain.  
 
One similarity between acupuncture and CPM that is shown both in animal and human studies is 
their rapid extra-segmental analgesic effect, which refers to the analgesic effect detected 
immediately following acupuncture or the conditioning stimulus away from the site of needling or 
painful stimulation (Bing et al., 1990, Schliessbach et al., 2012). However, the two also differ. The 
analgesic effect of acupuncture usually maintains for a longer duration compared with the analgesic 
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effect induced by CPM (Bing et al., 1990, Schliessbach et al., 2012). In Bing’s animal study the effect 
of CPM decreased to a greater extent than the analgesic effects of acupuncture within seconds after 
the conditioning stimulus was removed (Bing et al., 1990). Shliessbach and colleagues reported that 
the CPM effect decreased significantly in healthy participants at two minutes and five minutes after 
the CPT (Schliessbach et al., 2012). However, the analgesic effect of acupuncture did not show any 
significant changes at those time points (Schliessbach et al., 2012). Further, the analgesic effect of 
acupuncture can still be detected at 24 hours after acupuncture (Zheng et al., 2010b) whereas the 
effect of CPM usually lasts the duration of the conditioning stimulus (Svensson et al., 1999). 
 
In summary, acupuncture analgesia is not equal to CPM. It is possible, that CPM contributes only 
partly to acupuncture analgesia, especially in the rapid presentation of analgesia, and that, other 
endogenous mechanisms such as endogenous opioid-mediated analgesia are responsible for the 
long lasting effect of acupuncture. Therefore, it is possible that the potency of those endogenous 
pain controls may influence acupuncture analgesia. For instance individuals with more potent CPM 
may experience better immediate acupuncture analgesia compared with those with poorer CPM. To 
the author’s best knowledge, there has not been any report of such studies. 
 
 
Other mechanisms  
It is also worth mentioning that acupuncture analgesia may present as generalised analgesia due 
stress-induced analgesia or placebo analgesia. Stress-induced analgesia is a form of endogenous pain 
control where pain inhibition is activated through opioid or serotonergic systems due to exposure to 
a stressful or fearful stimulus such as acupuncture needling (Butler and Finn, 2009). It has been 
debated that acupuncture analgesia is related to placebo effect, a complex physiological and 
psychological process. Similar to other types of treatment, the interaction between the patient and 
51 
 
acupuncturist has a strong emotional and psychosocial context. It has been shown that expectation 
of both the patients and acupuncturist impact on treatment response (Linde et al., 2007). For 
instance previous positive acupuncture experience may enhance expectation and thus leading to a 
better treatment response. On the other hand, there is some evidence that acupuncture has specific 
effects beyond the placebo. Some studies showed that expectation is not always associated with 
treatment outcomes of acupuncture (Wechsler et al., 2011).  
 
A summary of knowledge gaps  
Acupuncture studies on MSK showed inconclusive results; some studies reported that acupuncture is 
more effective than sham treatment while other studies reported that there was no difference 
between real and sham acupuncture. It is possible that individual variations in response to pain, pain 
adaptability and endogenous pain controls may have introduced much heterogeneity into the trials 
and diluted the results. Further, the optimal acupuncture treatment for MSK is still unclear. Thus, it 
is important to investigate and determine the optimal treatment and those who will respond better 
to acupuncture. This can be achieved by investigating the response to acupuncture. 
 
Previously, it has been shown that treatment factors such as type of needle stimulation, needling 
depth, number of needles, duration of needle retention and frequency of treatment can impact on 
the response to acupuncture when treating MSK. It is yet to be determined if needle placement in 
terms of local points, distant points or the combination of both would also impact on the response 
to acupuncture in the treatment of MSK. Previous studies have also reported that practitioners’ and 
patients’ characteristics could influence the response to acupuncture. Patient’s characteristics such 
as pain history and expectation have been shown to be correlated with acupuncture analgesia when 
treating MSK. So far, no studies have probed into the possibility that the potency of endogenous 
pain controls or the status of pain adaptability could affect the response to acupuncture. With the 
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advent of new methods, such as QST, a useful tool to assess pain sensitivity, pain modulation, pain 
facilitation or pain adaptability, response to acupuncture can be appraised in a semi-objective way. 
For instance, the differences in PPT, pain ratings to suprathreshold pressure stimulus or pin prick 
measured before and after acupuncture can be used to determine the extent of acupuncture 
analgesia.  
 
These tests not only allow the evaluation of the extent of acupuncture analgesia, but they could also 
be potentially used to identify subgroups in patients with MSK based on the potency of endogenous 
pain controls such as CPM or SEG, or based on their status of pain adaptability. A reliable procedure 
to measure the potency of CPM in healthy and MSK participants is the CPT. The CPT can also be used 
to determine pain adaptability. So far pain adaptability has been identified in healthy individuals 
only. It is unclear whether the dichotomy of pain adaptability also exists in MSK participants. 
 
Subgroup identification helps stratify participants and thus enables the investigation of their 
treatment response. This may contribute to the development of individualised acupuncture 
treatment based on potency of endogenous pain controls and improvement of efficacy of 
acupuncture. Figure 2.10 summarises the gaps investigated in this project. Moreover, these tests will 
help us understand if repeated acupuncture modulates or improves endogenous pain controls in 
people with chronic pain. 
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Figure 2.10: Summary of knowledge gap investigated in this project 
MSK=chronic musculoskeletal pain; QST=quantitative sensory tests; PPT= pressure pain thresholds; PIN=pain intensity to pin prick; SUPRA=pain intensity to suprathreshold pressure stimulus; CPM=conditioned 
pain modulation; SEG=segmental pain inhibition; TS=temporal summation of pain; =knowledge gap identified. 
 
54 
 
Aim and objectives of this project 
The overall aim of this project is to examine the effects of needle placement, pain adaptability and 
potency of endogenous pain controls on acupuncture analgesia in the treatment of MSK. This aim 
was achieved by addressing the following objectives through six studies respectively: 
1. To identify the difference in analgesia induced by local and distant acupuncture and to 
determine whether combined points stimulation was better than local or distal points 
alone by conducting a systematic review so as to develop the acupuncture protocol for 
the Acupuncture Response Study; 
2. To identify the psychophysical tests that could potentially be used to differentiate 
subgroups of knee OA through systematically reviewing studies reporting the 
psychophysical characteristics of subgroups in knee OA participants; 
3. To assess whether vibration could be used to induce analgesia so as to determine the 
potency of SEG and to investigate whether PA and PNA differed in vibration analgesia; 
4. To explore if pain adaptability impacted on acupuncture analgesia in healthy humans; 
5. To develop a feasible protocol to determine whether pain adaptability exists in MSK 
participants; to investigate if there was any differences in demographics, thermal 
sensitivity, clinical pain, endogenous pain controls and autonomic response between PA 
and PNA; and to compare pain adaptability and potency of CPM between healthy and 
MSK participants; 
6. To examine the effects of local acupuncture on the clinical characteristics, pain 
adaptability and endogenous pain controls; to investigate the relationship between 
baseline characteristics and changes in clinical and psychophysical outcomes after local 
acupuncture treatment; and to compare the effect of local acupuncture between PA and 
PNA individuals. 
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 Chapter 3 : Local and distant acupuncture point stimulation for 
musculoskeletal pain- a systematic review 
 
Introduction  
MSK is pain in the muscles, joints, tendons and ligaments for more than three months (Cimmino et 
al., 2011). The current global prevalence of MSK is about 25% (Vos et al., 2012). Pharmacological 
treatments for MSK involve long-term use of analgesics, which are associated with gastrointestinal 
and cardiovascular side effects, drug tolerance or drug overdose (Provenzano and Viscusi, 2014). 
MSK impairs physical functioning (Bjornsdottir et al., 2013) and is a financial burden. The cost for 
rheumatoid arthritis was about £4.8 billion in the United Kingdom in 2009 (Parsons and Symmons, 
2014), and is likely to grow due to the increasingly ageing population. Hence, there is a need for 
effective and safer treatments. 
 
Acupuncture points stimulation, mostly used in the form of acupuncture needling, is increasingly 
being used to alleviate symptoms of MSK (White, 2006). A meta-analysis, examining more than 
17,000 individual data on acupuncture for chronic pain, suggested that acupuncture significantly 
decreased pain more than their control groups (educative sessions, conventional treatments) and 
sham acupuncture for chronic neck and back pain and for OA (Vickers et al., 2012). Acupuncture has 
also been demonstrated to be safe and cost-effective for MSK (Dorsher, MacPherson et al., 2001). 
 
In practice, acupuncture uses a combination of local and distant points stimulation for MSK. Local 
points are those points adjacent to painful sites, and distant points those located further away from 
the painful sites. Local and distant points could be classical acupuncture points or Ashi points. The 
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latter is a Chinese medicine term for tender points that are off the classical meridians, with neither 
specific name nor definite location and are painful on pressure (Birch, 2003, World Health 
Organization, 2007). Trigger points are the tender points used in dry-needling (Cagnie et al., 2013) 
that are painful on pressure, can produce referred pain and may not have fixed anatomic location 
(Simons et al., 1999). In this review, Ashi points and trigger points are considered the same (Birch, 
2003) and are termed as “tender points”. In all included studies, tender points are located at or close 
to the painful sites and therefore are classified as local points. There is no clear understanding of the 
independent effects of local and distant point stimulation. It is believed that local point stimulation 
acts through peripheral mechanisms such as vasodilation and SEG whereas distant point stimulation 
involves central mechanisms such as opioid mediated pain inhibition and CPM (Carlsson, 2002). Few 
studies have performed the direct comparison between the two. One study on chronic neck pain 
suggested that distant point stimulation reduced pain more than local stimulation (Irnich et al., 2002) 
while another study on the same condition found no difference between the two (Wu, 2012). 
Currently, no systematic review compares the effects between local and distant point stimulation or 
between combined point stimulation and either alone. 
 
This study aimed to determine the short and long term effects of local or distant acupuncture point 
stimulation alone in comparison with controls including no treatment, sham interventions or 
conventional treatments; differences between local and distant stimulation; difference between 
combined points stimulation and local or distant points alone; and adverse events. 
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Methods 
Selection Criteria 
Only published randomized controlled trials (RCTs) and quasi-randomised trials including adults (≥
18years) with pain of more than three months in the muscles, joints, ligaments or tendons were 
considered. Post-operative patients and secondary pain due to defined systemic diseases such as 
cancer or diabetes were excluded. 
 
Studies comprising techniques that involved stimulation of distant or local acupuncture points were 
included, for example: manual acupuncture, electro-acupuncture, dry-needling, laser acupuncture, 
acupressure, transcutaneous electric acupoint stimulation or moxibustion. Auricular acupuncture 
and scalp acupuncture were excluded as they are not included in the local or distant point 
classifications. They are known as micro-system acupuncture where the distribution of the points is 
confined to a specific region of the body which is described as a smaller representation of the whole 
body (Wang, 2009). Studies that did not provide the names of acupuncture points or location of 
points used were also excluded. The control interventions included no treatment, placebo or sham 
acupuncture and other therapeutic interventions such as use of analgesics or stretching exercises. 
Studies that used co-interventions were included if the control group also received the same co-
interventions. The types of comparisons included: 
• Local /distant points alone vs. no treatment/sham acupuncture/conventional treatment 
• Local / distant points + co-interventions vs co-interventions 
• Local points vs distant points 
• Local /distant points alone vs Local + distant points 
 
The primary outcome measure was pain severity, measured using the Visual Analogue Scale (VAS) or 
validated specific pain questionnaires such as Neck Pain Index Questionnaire. The secondary 
outcome measures were: functional status, quality of life and adverse events of acupuncture. 
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Search methods 
English databases (PubMed, Cochrane Library, CINAHL, and Scopus) and Chinese databases (CNKI, 
VIP) were searched from their inception to May 2013 with no language limitation. Reference lists of 
all included studies were also searched. The search strategy had three parts: “design”, “condition” 
and “intervention” (Figure 3.1). The search for “design” (Table 3.1) was carried out according to the 
Cochrane high sensitive search strategy for identifying randomised trials in MEDLINE (Lefebvre C et 
al., 2011). “Condition” referred to the different types of MSK. “Intervention” covered the terms for 
techniques of acupoint stimulation (Group 1) and distant and local points (Group 2) (Table 3.1). 
Similar search strategy and terms were used for all the English databases with modification to adapt 
to the databases. A sample of the search strategy used in Pubmed is available in Appendix 1. The 
same strategy was used to search the Chinese databases; the Chinese search terms used are in the 
Appendix 2. 
 
 
Figure 3.1: Illustration of search strategy 
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Table 3.1: English search terms 
Design Condition Intervention 
(#1) randomized controlled    
trial [pt] 
(#2) controlled clinical trial [pt] 
(#3) randomized [tiab] 
(#4) placebo [tiab]  
(#5) clinical trials as topic   
[mesh:noexp]  
(#6) randomly [tiab] 
(#7) trial [ti] 
(#8) #1 OR #2 OR #3 OR #4 OR 
#5 OR #6 OR #7 
(#9) animals [mh] NOT humans 
[mh] 
(#10) #8 NOT #9 
 
musculoskeletal pain [tiab] 
Muscular pain [tiab] 
Musculoskeletal [tiab] 
Neck pain [tiab] 
neck ache [tiab] 
Shoulder pain[tiab] 
Elbow pain [tiab] 
Back pain [tiab] 
Low back pain [tiab] 
Back ache [tiab] 
Lumbago [tiab] 
Chronic pain [tiab] 
Persistent pain [tiab] 
Joint pain [tiab] 
Knee pain [tiab] 
Ankle pain [tiab] 
Arthralgia [tiab] 
Osteoarthritis [tiab] 
Rheumatoid [tiab] 
Fibromyalgia [tiab] 
Cervical [tiab] 
Spondylosis [tiab] 
Prolapsed [tiab] 
 
GROUP  1 
Acupuncture [mh] 
Acupuncture therapy [mh] 
Acupuncture analgesia [mh] 
Acupunc* [tiab] 
Electroacupunc* [tiab] 
Electro-acupuncture [tiab] 
Electroacupuncture [tiab] 
Dry-needling [tiab] 
Needling [tiab] 
Laser acupuncture[tiab] 
Acupressure[tiab] 
Transcutaneous [tiab] 
Acupoint[tiab] 
Acupuncture point[tiab] 
Moxibustion [tiab] 
GROUP 2 
Distal [tw] 
Distant [tw] 
Distance [tw] 
Distal points [tw] 
Distal needling [tw] 
Distal acupoint [tw] 
Remote needling [tw] 
Non-local [tw] 
Non-local point [tw] 
Non-local acupoint [tw] 
Non- segmental [tw] 
Non- segmental acupoint [tw] 
Non-segmental point [tw] 
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Heterotopic [tw] 
limb [tw] 
Local point [tw] 
Local acupoint [tw] 
Local needling [tw] 
Segmental point [tw] 
Regional [tw] 
Regional point [tw] 
 
 
Study selection 
After removing the duplicates, DW and YW screened the titles and the abstracts according to the 
selection criteria. The full-texts of the studies that could not be excluded by screening the title or 
abstract were retrieved and assessed. Any disagreements were resolved through consensus and if 
necessary through discussion with a third researcher (ZZ). The different steps of the screening are 
represented in Figure 3.2. 
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Figure 3.2: Inclusion and screeing of studies 
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Data extraction and data analysis 
Two review researchers conducted the extraction of data. They categorized the time points for the 
recording of measurements into three groups: the short-term effects were classified in two groups, 
immediate follow-up/ effects (0-2 weeks after the end of the treatment) and intermediate follow-
up/ effects (2-6 weeks after the end the treatment) and, the third group consisted of long-term 
follow-up/ effects (more than three months). If a study had more than one set of data for a time-
point, the last data for this time-point was included in the meta-analysis. For crossover trials, the 
data before the crossover were extracted. The data synthesis protocol was adopted from a Cochrane 
systematic review (Deare et al., 2013). The meta-analysis was conducted in the software RevMan 5.2. 
If significant heterogeneity among the trials was detected with I2 statistic (I2≥ 50%), a random-
effects model was used. Otherwise, a fix-effects model was used. Data was presented as standard 
mean difference (SMD). Subgroup analysis was conducted if sufficient data were available. 
 
The risk of bias assessment was carried out using the Cochrane Grading system. Two review authors 
used the guidelines from The Cochrane Collaboration’s tool for assessing risk of bias (Higgins JPT et 
al.) to judge if a study was of low risk, high risk or unclear. Any disagreement was resolved by a third 
researcher (ZZ). The reporting bias was not assessed as the authors did not have access to the 
protocols of the studies. 
 
Quality for acupuncture treatment and the confidence of treatment were judged based on 
information from the checklist of Standards for Reporting Interventions in Controlled Trials of 
Acupuncture (STRICTA) (MacPherson et al., 2010), and followed the method used by Deare (2013) 
(Table 3.2). 
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Table 3.2: STRICTA items extracted 
 Items Details 
Adequacy of treatment 
Details of needling 
• Number of needle insertions per subject per 
session (mean and range where relevant) 
• Names (or location if no standard name) of 
points used (uni/bilateral) 
• Depth of insertion, based on a specified unit of 
measurement, or on a particular tissue level 
• Response sought (e.g. Deqi or muscle twitch 
response) 
• Needle stimulation (e.g. manual, electrical) 
• Needle retention time 
• Needle type (diameter, length, and 
manufacturer or material) 
Treatment regimen • Number of treatment sessions 
• Frequency and duration of treatment sessions 
confidence of treatment 
and treatment design 
Acupuncture rationale 
• Style of acupuncture (e.g. Traditional Chinese 
Medicine, Japanese, Korean, Western medical, 
Five Element, ear acupuncture, etc) 
• Reasoning for treatment provided, based on 
historical context, literature sources, and/or 
consensus methods, with references where 
appropriate 
• Extent to which treatment was individualised 
Practitioner’s 
background 
• Description of participating acupuncturists 
(qualification or professional affiliation, years in 
acupuncture practice, other relevant 
experience) 
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Results 
Included studies 
Of the 3,441 studies found, 19 were eligible for inclusion in this systematic review. Four studies 
could not be included in the meta-analysis because of unavailability of the data (Lu et al., 2010, 
Molsberger and Hille, 1994, Näslund et al., 2002, Smith et al., 2007). Several attempts were made to 
contact their respective authors. Only one of them replied and was not willing to share the data. In 
total, the systematic review consisted of 19 studies and the meta-analysis 15 studies (Table 3.3). 
Sixteen (16) studies were published in English, two in Chinese and one in Japanese. The Japanese 
article was an abstract; further information was obtained from researcher Dr Andrea Furlan. In total 
766 participants were included, and 568 were included in the meta-analysis. The included studies 
reported seven MSK conditions and were from eight countries and districts. Participants were from 
hospitals, communities and outpatient pain clinics. 
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Table 3.3: Details of included studies 
Author 
Year Country 
Comparison 
sub-group Type of pain 
Total No. 
of 
participants 
Design 
Intervention Comparator Outcome 
measures 
Measurement 
methods Time points No. of participants No. of participants 
Chou 2009 Taiwan 
local or distant 
VS sham 
intervention 
Unilateral 
chronic 
shoulder pain 
20 RCT 
manual acupuncture at LI11 
and TE5 
sham acupuncture at LI11 and 
TE5 with rubber connector to 
avoid skin penetration pain NRS immediate 
10 10 
Chou 2011 Taiwan 
local or distant 
VS sham 
intervention 
Unilateral 
chronic 
shoulder pain 
because of 
active MTrPs 
30 RCT 
manual acupuncture at LI11 
and TE5 
sham acupuncture at LI11 and 
TE5 without skin penetration pain NRS immediate 
15 15 
the total number of participants was 45, the simple needling group (n=15) was excluded 
Inoue 2009 Japan 
local or distant 
VS conventional 
treatment 
Low back pain 26 RCT 
manual acupuncture at 2-5 
most tender parts in the low 
back 
local anaesthetic 
pain VAS 
immediate 
intermediate 13 13 
Itoh 2006 Japan 
local or distant 
VS sham 
intervention 
Low back pain 
(in elderly) 19 
RCT; 
cross-
over 
trial 
trigger point acupuncture in 
the lower back region 
sham acupuncture (blunt 
needles) at trigger points 
pain VAS immediate 
intermediate 
functional 
status 
Roland Morris 
Questionnaire 
immediate 
19 19 
Itoh 2007 Japan 
local or distant 
VS sham 
intervention 
Chronic neck 
pain 15 RCT 
trigger point acupuncture in 
the neck region 
sham acupuncture (blunt 
needles) at trigger points 
pain VAS 
immediate 
intermediate 
functional 
status 
Neck disability 
index 
immediate 
intermediate 
8 7 
total number of participants was 31, combined group (n=8) and the non-trigger point group (n=8) excluded 
Itoh 2008 Japan 
local or distant 
VS sham 
intervention 
Knee 
osteoarthritis 16 RCT 
manual acupuncture at ST34, 
ST35, ST36, SP9, SP10,GB34 
sham acupuncture (blunt 
needles) at trigger points pain VAS 
immediate 
intermediate 
9 7 long-term 
total number was 24, trigger group (n=8) excluded 
Itoh 2012 Japan 
local or distant 
VS sham 
intervention 
Temporomand
ibular 
disorders. 
15 RCT 
trigger point acupuncture in 
the masticatory and cervical 
muscles 
sham acupuncture (blunt 
needles) at trigger points without 
skin penetration 
pain VAS immediate 
intermediate 
ROM 
maximal 
mouth 
opening 
immediate 
7 8 
66 
 
Kumnerdee 
2012 
 
Thailand 
local or distant 
as adjunct 
therapy 
chronic plantar 
faciitis 30 RCT 
electro-acupuncture at 2-6 
most tender points over the 
anteromedial aspect of the 
heels + conventional 
treatments 
conventional treatments 
Pain  VAS immediate 
functional 
status 
Foot function 
index immediate 15 15 
Liang 2011 P.R.China 
local or distant 
VS sham 
intervention 
Chronic neck 
pain 178 RCT 
manual acupuncture at DU14 , 
SI15 , Ex-HN15 + infrared 
radiation on cervical region 
placebo acupuncture on the 
sham points 1 cm lateral to the 
standard acupuncture points 
selected in the study group + 
infrared radiation on cervical 
region 
pain VAS 
immediate 
intermediate 
long-term 
functional 
status NPQ
 
immediate 
intermediate 
long-term 
quality of 
life SF-36 
immediate 
intermediate 
long-term 
88 90 
Lu 2010 
 Taiwan 
local or distant 
VS sham 
intervention 
Knee OA excluded from meta-analysis RCT 
Electro-acupuncture at GB4, 
SP9, SP10, SP34, ST36 
sham de-activated electro-
acupuncture at 1cm to the left of 
the points used for real electro-
acupuncture 
pain VAS immediate 
Ma 2010 P.R.China 
local or distant 
as adjunct 
therapy 
Unilateral 
Myofascial 
pain upper 
trapezius 
muscle 
28 RCT 
trigger point acupuncture in 
the upper trapezius + 
stretching exercises 
stretching exercises 
pain VAS immediate 
ROM degree of lateral bending immediate 15 13 
total number was 43, miniscalpel group (n=15) excluded 
Matsubara 
2011 Japan 
local or distant 
VS no 
treatment 
Chronic neck 
pain 33 RCT 
local acupressure at GB21, SI14 
and SI15 no treatment 
pain verbal rating 
scale 0 to 3 
immediate 
11 11 
local or distant 
VS no 
treatment 
distant acupressure LI4, LI10, 
LI11 no treatment 
11 11 
local VS distant 
local acupressure at GB21, SI14 
and SI15 distant acupressure LI4, LI10, LI11 functional 
status 
Neck disability 
index 
immediate 
11 11 
Molsberger 
1994 Germany 
local or distant 
VS sham 
intervention 
Chronic tennis 
elbow 
excluded from 
meta-analysis 
 
RCT distant manual acupuncture at GB34 on the ipsilateral leg 
sham distant acupuncture at 
BL13, using a pencil-like probe pain 
11-point box 
scale 
immediate 
 
Naslund Sweden local or distant Idiopathic excluded from RCT local electro-acupuncture at ST superficial sham electro- pain 100mm VAS immediate 
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2002 VS sham 
intervention 
anterior knee 
pain 
meta-analysis 34, ST36, ST38, SP9, SP10, GB 
34 
acupuncture at points 1” away 
from the traditional points in the 
same dermatome 
intermediate 
long-term 
Ren 2011 P.R.China 
local or distant 
VS sham 
intervention 
Knee 
osteoarthritis 59 RCT 
moxibustion on EX-LE4, ST35, 
Ashi point 
sham moxibustion with an 
insulator at the same point as the 
study group 
pain 
VAS (from 
WOMAC) immediate 
functional 
status WOMAC immediate 31 28 
Shen 2007 United States 
local or distant 
VS sham 
intervention 
Myofascial 
pain- 
temporomandi
-bular 
disorders 
15 RCT 
manual acupuncture at LI4 
through foam pad 
sham acupuncture (blunt 
needles) at 1 cm away from LI4 
though foam pad, without 
penetration of the skin 
pain 
11- point 
Numeric 
Rating Scale (0 
to 10) 
immediate 
9 6 
Smith 2007 
 
United 
Kingdom 
local or distant 
VS sham 
intervention 
 
Temporomandi-
bular disorders 
 
 
 
excluded from 
meta-analysis 
 
RCT 
 
Local manual acupuncture at 
ST7 
 
sham local acupuncture using 
park sham device 
 
pain 10cm VAS immediate 
functional 
status 
10 cm VAS immediate 
ROM Vernier style bite gauge immediate  
Takeda 
2001 Japan local VS distant Low back pain 18 RCT 
manual acupuncture at BL23 , 
BL26 , EX-B7 + placebo 
intervention at BL37 , BL40, 
BL58 
manual acupuncture at BL37 , 
BL40 , BL58 + placebo 
intervention at BL23 , BL26 , EX-
B7 
pain VAS immediate 
functional 
status 
Activities of 
daily living immediate 
9 9 
Wu 2012 P.R.China local VS distant  
Chronic neck 
pain 66 RCT 
electro-acupuncture with 
strong stimulus Ex-HN15, SI15 
electro-acupuncture with strong 
stimulus GB34, ST36 pain VAS immediate 
16 18 
electro-acupuncture with weak 
stimulus Ex-HN15, SI 15 
electro-acupuncture with weak 
stimulus GB34, ST36 functional 
status 
NPQ, McGill 
questionnaire 
Immediate 
15 17 
NRS= Numerical rating scale (0-no pain, 10-worst imaginable pain); VAS= visual analogue scale; MTrPs= Myofascial trigger points; ROM= Range of motion; WOMAC= Western Ontario and McMaster Universities 
Osteoarthritis Index; NPQ= Neck Pain Questionnaire. 
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Adequacy of acupuncture and Confidence of treatment  
Seventeen studies were evaluated. The acupuncture procedure was generally well described. For the 
adequacy of acupuncture treatment, five studies were rated with moderate reporting quality 
(Takeda and Nabeta, 2001, Lu et al., 2010, Molsberger and Hille, 1994, Näslund et al., 2002, Wu, 
2012) and the rest with good quality. The points LI4, LI11 and SI15 were the most used points (3 
times). Detailed information is outlined in Table 3.4. For the confidence of treatment two studies 
were rated poor (Takeda and Nabeta, 2001, Wu, 2012), four moderate (Inoue et al., 2009, 
Kumnerddee and Pattapong, 2012, Lu et al., 2010, Molsberger and Hille, 1994) and the rest good 
(Table 3.5). Overall the quality of acupuncture was moderate because the treatments were delivered 
by skilled acupuncturists and the stimulation parameters were adequate, but the rationale for point 
selection was poorly described.  
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Table 3.4: Data extraction for adequacy of treatment 
Author Year 
Details of needling Treatment regimen 
No. of 
needles 
used 
Points used Depth of insertion 
Response 
sought Needle stimulation Retention time Needles used 
No. of 
treatment 
sessions 
Frequency 
of 
treatment 
Chou 2009 2 LI11, TE5 (unilaterally on the affected side) 
"the regular 
depth in the 
subcutaneous 
layer" 
Deqi 
sensation 
the technique of MTrP injection 
(suggested by Simmons et al, 
and Hong), the needle was 
moved "in and out" into 
different directions at a speed 
of about 2cm/s 
• TE5 treated first.  
• LI11 point treated with the 
same procedure 5 minutes later 
• Needle remained in TE5 
continuously without needle 
movement 
• Five minutes of needle 
manipulation at LI11, 
• both points were manipulated 
and then stayed quietly for 3 
minutes. 
size #30 and 
length of 25 
mm or 37 mm 
1 single treatment 
Chou 2011 2 LI11, TE5  (unilaterally on the affected side) 
"the regular 
depth in the 
subcutaneous 
layer" 
Deqi 
sensation 
the technique of MTrP injection 
(suggested by Simmons et al, 
and Hong), the needle moved 
"in and out" into different 
directions at a speed of about 
2cm/s 
• TE5 treated first.  
• LI11 point treated with the 
same procedure 5 minutes later 
• Needle remained in TE5 
continuously without needle 
movement 
• Five minutes of needle 
manipulation at LI11, 
• both points were manipulated 
and then stayed quietly for 3 
minutes. 
size of #30 and 
length of 25 
mm or 37 mm 
1 single treatment 
Inoue 2009 2- 5 2-5 most painful points on the lower back 10- 20mm deep 
Deqi 
sensation 
the sparrow pecking method 
(manipulation technique with 
repetitive application of lifting 
and thrusting of the needle) 
20s Size 0.18mm x length 40mm 4 
1/week 
for 4 
weeks 
Itoh 2006 mean 3.6 
trigger points in the 
following muscles: 
quadratus lumborum, 
iliopsoas, piriformis, gluteus 
maximus, iliocostalis 
lumborum, gluteus medius, 
hamstring 
10-40mm deep local twitch response sparrow pecking' technique 10 min 
size 0.2mm x 
length 50mm 3 
1/week 
for 3 
weeks 
(phase 1 
of cross-
over trial) 
Itoh 2007 mean 2.3 trigger point acupuncture in the following muscle: 20mm deep 
Deqi 
sensation sparrow pecking' technique 10 min 
size 0.2mm × 
length40mm 3 
1/week 
for 3 
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splenius capitis, trapezius, 
sternocleido, scalenus, 
levator scapulae, 
paravertebral muscle, 
suboccipitales 
weeks 
Itoh 2008 mean 3.3 
ST34, ST35, ST36, SP9, SP10, 
GB34 (did not mention if 
unilateral or bilateral) 
10mm deep Deqi sensation sparrow pecking' technique 10 min 
size 0.2mm x 
length40mm 5 
1/week 
for 5 
weeks 
Itoh 2012 mean 4.2 
trigger point acupuncture in 
the following muscle: 
temporalis, masseter, lateral 
pterygoid, disgastricus, 
trapezius, splenius capitis 
5-15mm deep Local twitch response sparrow pecking' technique 15 min 
size 0.2 mm x 
length 50mm 5 
1/week 
for 5 
weeks 
Kumnerdee 
2012 2- 6 
2- 6 most tender points 
over the anteromedial 
aspect of the heels 
approximately 1 
cm deep or until 
the increase in 
tissue resistance 
was felt 
throbbing 
sensation 
no manual stimulation, only 
electric manipulation 30 min 
size 0.25mmx 
length 25 mm 10 
2/week 
for 5 
weeks 
Liang 2011 6 DU14, SI15, Ex-HN15 (bilaterally) 20mm deep 
Deqi 
sensation manual manipulation 20 min 
size 0.3mm × 
length40mm, 9 3/week 
Lu 2010 
not 
mentioned 
GB4, SP9, SP10 , SP34, ST36 
(did not mention if 
unilaterally or bilaterally) 
10-15mm deep Deqi sensation electrical stimulation 30 min not mentioned 1 
single 
treatment 
Ma 2010 not mentioned 
trigger points on one side of 
the trapezius muscle 
30mm - 35mm 
deep 
Local twitch 
response manual manipulation not mentioned 
size 0.30mm x 
length 50mm 1 
single 
treatment 
Molsberger 
1994 1 GB34 on the ipsilateral leg 20 mm deep 
Deqi 
sensation manual manipulation 5 min not mentioned 1 
single 
treatment 
Naslund 
2002 6 
ST34, ST36, ST38, SP9, SP10, 
GB34 (unilaterally) not mentioned 
Deqi 
sensation electrical stimulation 30 min 
size0.3 mm x 
length 30mm 
(for 
experimental 
group) 
15 
2/week 
for 7-8 
weeks 
Shen 2007 1 LI4 on the left hand 10- 20 mm deep not mentioned manual manipulation 15min 
Acupuncture 
needles Seirin 
30 gauge 
1 single treatment 
smith 2007 2 ST7 (bilaterally) 6-12mm 
resistance 
or pain manual manipulation 20min 
0.35mm x 
length 70 mm 6 2/week 
Takeda 2001 not mentioned 
BL23, BL26, Ex-B7 (with 
Placebo intervention at 
BL37, BL40, BL58, didn't 
10- 20 mm deep not mentioned sparrow pecking' technique 
after sparrow picking 
techinique was performed 5 
times 
size 0.2 mm x 
length40mm 6 
2/week 
for 3 
weeks 
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mention if bilateral or 
unilateral) 
Wu 2012 not mentioned 
Ex-HN15 and SI15 (not 
mentioned if unilateral or 
bilateral) 
0.5- 1 cun deep Deqi sensation 
manual manipulation followed 
by electric stimulation 30 min 
size0.30mm x 
length25mm 10 2-3/per 
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Table 3.5: Data extraction for confidence of treatment 
Author 
Year 
Acupuncture rationale 
Acupuncturist's 
background Style of 
acupuncture Reasoning for treatment provided 
Extent to 
which 
treatment 
was varied 
Chou 2009 not mentioned 
Points selected based on review of 
acupuncture literature and the clinical 
experience 
formula 
acupuncture licensed acupuncturist 
Chou 2011 not mentioned 
Frequently selected points for neck and 
shoulder pain treatment. Satisfactory 
results obtained in a previous study.  
formula 
acupuncture 
well-trained 
acupuncture instructor  
Inoue 2009 not mentioned not mentioned 
2-5 most 
painful points 
acupuncturist with 
more than 5 years of 
clinical experience  
Itoh 2006 trigger point acupuncture 
Previous study suggested deep needling 
at trigger point may be more effective on 
low back pain in elderly patients than 
standard needling of conventional points. 
1-4 trigger 
points 
An acupuncturist with 
four years of 
acupuncture training 
and seven years of 
clinical experience. 
Itoh 2007 not mentioned 
After a literature review on acupuncture 
for neck pain, only widely accepted 
acupuncture points selected. 
formula 
acupuncture 
The acupuncturists of 4 
years of acupuncture 
training and 2 or 7 years 
of clinical experience. 
Itoh 2008 not mentioned 
After a literature review on acupuncture 
for knee pain, only widely accepted 
acupuncture points were selected. 
formula 
acupuncture 
The two acupuncturists 
of four years of 
acupuncture training 
and three and eight 
years of clinical 
experience. 
Itoh 2012 trigger point acupuncture 
The most important masticatory and 
cervical muscles were examined for 
myofascial trigger points 
trigger points 
4 years of acupuncture 
training and 3 years of 
clinical experience 
Kumnerdee 
2012 
not 
mentioned not mentioned 
2-6 most 
tender points 
A physiatrist who 
completed a two-year 
training course from 
China and had another 
six years of experience 
in acupuncture.  
Liang 2011 Chinese acupuncture 
Acupuncture point selection based on the 
consensus of senior Chinese medicine 
doctors and acupuncturists in the hospital 
formula 
acupuncture 
well-trained 
acupuncture doctors  
Lu 2010 
not 
mentioned not mentioned 
formula 
acupuncture 
experienced 
acupuncturist 
Ma 2010 Chinese acupuncture 
Previous studies suggested dry or 
acupuncture needling treatment of 
trigger points is effective for pain relief.  
trigger points 
more than 5 years’ 
experience and an 
acupuncture license 
from China Association 
for Acupuncture and 
Moxibustion  
Naslund 
2002 
not 
mentioned 
The acupuncture points chosen based on 
a western approach, from an anatomic 
and neurophysiologic background, and 
are all commonly used points in the knee 
region. In an uncontrolled study 
acupuncture had a clear and durable 
formula 
acupuncture 
two physiotherapists, 
clinically experienced 
with almost daily 
practice in acupuncture 
treatment for 15 years 
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effect in reducing pain and improving 
function for patients with patello-femoral 
pain 
Molsberger 
1994 
Chinese 
acupuncture not mentioned 
formula 
acupuncture 
orthopaedic doctor, 
trained in Chinese 
acupuncture 
Shen 2007 not mentioned 
LI4 commonly used for head and neck 
pain. A single needle acupuncture 
treatment modality used for this study 
because past studies showed it was 
enough to obtain a clinical result. 
formula 
acupuncture 
state certified dental 
acupuncturist 
Smith 2007 not mentioned 
Acupuncture reported to have a 
beneficial role in the management of 
TMD ; ST 7 is located inferior to the 
zygomatic arch, immediately anterior to 
the condyle of the mandible in the 
depression posterior to the masseter 
muscle. Its location is facilitated by 
palpating underneath the zygomatic arch, 
asking the patient to open and close the 
jaw whilst locating the anterior aspect of 
the mandibular condyle, and then asking 
the patient to clench the jaw, in order to 
locate the posterior aspect of the 
masseter muscle. 
formula 
acupuncture 
experienced in the use 
of acupuncture 
Takeda 
2001 
not 
mentioned not mentioned 
formula 
acupuncture not mentioned 
Wu 2012 Chinese acupuncture not mentioned 
formula 
acupuncture not mentioned 
 
 
Acupuncture point Treatments 
In the selected studies, no clear boundary was described between the local and distant points. The 
two types of points were described relative to the region of the painful area in six studies (Chou et 
al., 2011, Chou et al., 2009, Itoh et al., 2007, Matsubara et al., 2011, Takeda and Nabeta, 2001, Wu, 
2012). Local points were the points around the painful region whereas distant points were those 
points away from the painful area. For example, Matsubara and collleagues (Matsubara et al., 2011), 
in their study on neck pain, defined points GB21, SI14 and SI15 on the neck as “local acupuncture 
points” and points LI4, LI10 and LI11 on the hand and forearm as “distant traditional acupuncture 
points”. Another example is Chou and colleagues. (Chou et al., 2009), describing the points LI11 and 
TE5 located on the forearm as “regions remote to the painful site” in their study for chronic shoulder 
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pain. Wu and colleagues (Wu, 2012) described the distant points as “non-segmental”. Four studies 
used trigger points, describing them as “a taut muscle band” at or close to the pain sites (Itoh et al., 
2012, Itoh et al., 2006, Itoh et al., 2007, Ma et al., 2010). Seven studies did not report a definition of 
local or distant points (Liang et al., 2011, Ren et al., 2011, Shen and Goddard, 2007, Lu et al., 2010, 
Molsberger and Hille, 1994, Näslund et al., 2002, Smith et al., 2007); however based on the 
description of point location, judgement of local and distant points was made (Table 3.6). 
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Table 3.6: Local and distant points 
Studies Condition Comparison Local points# Location Distant points Location# 
Chou 2009 chronic shoulder pain distant VS sham N/A N/A 
LI11 (曲池, 
Quchi) 
anterior lateral elbow joint, 
midpoint between radial side of 
elbow crease and lateral 
epicondyle of humerus (elbow is 
flexed at 90°C) 
TE5 (外关, 
Waiguan) 
dorsal forearm, 2 cun* proximal 
to dorsal wrist crease, midpoint 
between ulna and radius bone 
Chou 2011 chronic shoulder pain distant VS sham N/A N/A 
LI11 (曲池, 
Quchi) 
anterior lateral elbow joint, 
midpoint between radial side of 
elbow crease and lateral 
epicondyle of humerus (elbow is 
flexed at 90°C) 
TE5 (外关, 
Waiguan) 
dorsal forearm, 2 cun* proximal 
to dorsal wrist crease, midpoint 
between ulna and radius bone 
Inoue 2009 chronic low back pain local VS local anaesthetics Ashi points in the lower back  lower back region N/A N/A 
Itoh 2006 chronic low back pain local VS sham acupuncture 
trigger points in the following 
muscles: quadratus lumborum, 
iliopsoas, piriformis, gluteus 
maximus, iliocostalis lumborum, 
gluteus medius, hamstring 
lower back and posterior thigh 
region 
N/A N/A 
Itoh 2007 chronic neck pain local VS sham acupuncture 
trigger point acupuncture in the 
following muscle: splenius capitis, 
trapezius, sternocleido, scalenus, 
levator scapulae, paravertebral 
muscle, suboccipitales neck region 
N/A N/A 
Itoh 2008 Knee osteoarthritis local VS sham 
GB34 (阳陵泉, Yanglingqua,) 
in fossa anterior and inferior to 
head of fibula 
N/A N/A SP9 (阴陵泉, Yinlingquan) 
in fossa inferior to medial condyle 
of tibia, same level as inferior 
margin of tibial tuberosity 
SP10 (血海, Xuehai) 
anteromedial aspect of the thigh, 2 
cun* superior to medial end of 
patella 
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ST34 (梁丘, Liangqiu) 
anterolateral aspect of the thigh, 2 
cun* superior to lateral end of 
patella 
ST35 (犊鼻, Dubi) 
anterior aspect of the knee, fossa 
lateral to patellar ligament 
ST36 (足三里, Zusanli) 
in fossa 1 finger width lateral to 
tibia, 3 cun* inferior to depression 
lateral to patellar ligament  
Itoh 2012 Temporomandibular disorder local VS sham 
trigger point acupuncture in the 
following muscle: temporalis, 
masseter, lateral pterygoid, 
disgastricus, trapezius, splenius capitis 
jaw, neck region N/A N/A 
Kumnerdee 
2012  Plantaar fasciitis 
local + conventional 
treatment VS 
conventional 
treatment 
2- 6 most tender points over the 
anteromedial aspect of the heels  
heel region N/A N/A 
Liang 2011 chronic neck pain local VS sham 
GV14 (大椎, Dazhui) 
posterior region of the neck, 
inferior to spinous process of 7th 
cervical vertebra 
N/A N/A 
Ex-HN15 (颈百劳, Jingbailao)  
posterior region of the neck, 2 cun* 
superior to spinal process of 7th 
cervical vertebra 
SI15 (肩中俞, Jianzhongshu) 
2 cun* lateral to spinous process of 
7th cervical vertebra, in fossa 
medial superior angle of scapula 
Ma 2010 
myofascial pain 
syndrome in the upper 
trapezius 
local + exercise VS 
exercise trigger points on one side of the trapezius muscle 
shoulder region N/A N/A 
Matsubara 
2011 chronic neck pain 
comparison 1- 
local VS distant GB21 (肩井, Jianjing,) 
posterior region of the neck, at the 
midpoint of the line connecting the 
spnious process of the 7th cervical 
vertebra with the lateral end of the 
acromion LI4 (合谷, Hegu) 
dorsum of the hand, radial to the 
midpoint of the 2nd metacarpal 
bone 
comparison 2-  
local VS no 
treatment 
SI14 (肩外俞, Jianwaishu) 
upper back region, same level as 
the inferior border of the 1st 
thoracic vertebra (3cun* lateral) 
LI10 (手三里 , 
Shousanli) 
posterolateral aspect of the 
forearm 
comparison 3- 
distant VS no 
treatment 
SI15 (肩中俞, Jianzhongshu) 
2 cun* lateral to spinous process of 
7th cervical vertebra, in fossa 
medial superior angle of scapula 
LI11 ( 曲 池 , 
Quchi) lateral aspect of the elbow 
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Ren 2011 Knee OA local VS sham 
Ex-LE5 (内膝眼, Neixiyan) 
anterior aspect of knee, fossa 
medial to the patellar ligament 
N/A N/A 
ST35 (犊鼻, Dubi) 
anterior aspect of knee, fossa 
lateral to patellar ligament 
Ashi points in the knee region knee region 
Shen 2007 Temporomandibular disorder distant VS sham N/A N/A LI4 (合谷, Hegu) 
dorsum of the hand, radial to the 
midpoint of the 2nd metacarpal 
bone 
Takeda 
2001 chronic low back pain 
real local +sham 
distant VS sham local 
+ real distant 
BL23 (肾俞, Shenshu) 
lumbar region, same level as 
inferior border of 2nd lumbar 
vertebra 
BL37 ( 殷 门 , 
Yinmen) posterior aspect of the thigh 
BL26 (关元俞, Guanyuanshu) 
lumbar region, same level as 
inferior border of 5th lumbar 
vertebra 
BL40 ( 委 中 , 
Weizhong) 
posterior aspect of the knee, 
midpoint of the popliteal crease 
EXB7 (腰眼, Yaoyan) 
lumbar region, inferior to 4th 
lumbar vertebra (3.5-4 cun lateral) 
BL58 ( 飞 扬 , 
Feiyang) 
posterolateral aspect of  lower 
leg 
Wu 2012 chronic neck pain 
comparison 1- local 
(weak stimulus) VS 
distant (weak 
stimulus)  Ex-HN15 (颈百劳, Jingbailao)  
posterior region of the neck, 2 cun* 
superior to spinal process of 7th 
cervical vertebra 
GB34 (阳陵泉 , 
Yanglingquan) 
in fossa anterior and inferior to 
head of fibula 
comparison 2- local 
(strong stimulus) VS 
distant (strong 
stimulus) SI15 (肩中俞, Jianzhongshu) 
2 cun* lateral to spinous process of 
7th cervical vertebra, in fossa 
medial superior angle of scapula 
ST36 (足三里 , 
Zusanli) 
anterior aspect of the leg, on the 
tibialis anterior muscle 
*=traditional measurements for points location, B-cun methods were used (Yin et al., 2005); #= point location based on the World Health Organization standard acupuncture point locations (World Health 
Organization, 2008); N/A= not applicable. 
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Assessment of risk of bias 
The 19 studies were of moderate quality (Table 3.7). Randomisation was considered moderate. 
Fifteen studies clearly explained their randomisation procedure: computerized randomisation (Chou 
et al., 2011, Chou et al., 2009, Inoue et al., 2009, Itoh et al., 2012, Itoh et al., 2008, Itoh et al., 2006, 
Itoh et al., 2007, Kumnerddee and Pattapong, 2012, Liang et al., 2011, Ma et al., 2010, Ren et al., 
2011, Smith et al., 2007, Wu, 2012), randomisation based on order of involvement (Shen and 
Goddard, 2007) and draws (Takeda and Nabeta, 2001). The remaining four studies did not mention 
the randomisation procedure (Matsubara et al., 2011, Lu et al., 2010, Molsberger and Hille, 1994, 
Näslund et al., 2002). 
 
Allocation concealment was poor (Figure 3.3); only four studies reported it , with three using opaque 
sealed envelopes (Liang et al., 2011, Wu, 2012, Smith et al., 2007) and in one study the specific 
methods were not described (Kumnerddee and Pattapong, 2012). 
 
Blinding of the participants and personnel was rated moderate. Five studies did not mention blinding 
(Inoue et al., 2009, Ma et al., 2010, Matsubara et al., 2011, Näslund et al., 2002, Wu, 2012) and for 
one study blinding was not possible (Kumnerddee and Pattapong, 2012). Blinding of the outcome 
assessment was moderate as well. Eight studies involved independent investigators (Chou et al., 
2011, Itoh et al., 2012, Itoh et al., 2008, Itoh et al., 2006, Itoh et al., 2007, Ren et al., 2011, 
Molsberger and Hille, 1994, Smith et al., 2007); and the other studies did not give details about the 
assessors. 
 
Nine studies did not have missing data (Lu et al., 2010, Molsberger and Hille, 1994, Chou et al., 2011, 
Chou et al., 2009, Inoue et al., 2009, Kumnerddee and Pattapong, 2012, Ma et al., 2010, Matsubara 
et al., 2011, Shen and Goddard, 2007), nine studies had drop outs and performed per protocol 
analysis (Itoh et al., 2012, Itoh et al., 2008, Itoh et al., 2006, Itoh et al., 2007, Liang et al., 2011, Ren 
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et al., 2011, Takeda and Nabeta, 2001, Smith et al., 2007, Wu, 2012) and one study had drop outs, 
but did not report if the drop outs were included in the data analysis (Näslund et al., 2002). 
 
Table 3.7: Summary of risk of bias 
  
      : low risk
      : unclear
      : high risk
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Figure 3.3: Risk of bias graph 
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Adverse events 
Adverse events were reported in eight studies and observed in seven of these studies. No adverse 
events needed medical intervention. For detailed information see Table 3.8. 
Table 3.8: Adverse events 
Studies 
 
intervention 
Sample 
size 
No. of adverse events 
Adverse events Study  
group 
Control 
group 
Inoue 2009 acupuncture 26 0 0 N/A 
Itoh 2006 acupuncture 19 1 0 deterioration of symptoms 
Itoh 2007 acupuncture 15 1 1 deterioration of symptoms 
Itoh 2012 acupuncture 15 1 0 worsening of symptoms 
Kumnerdee 
2012 
acupuncture 
30 3 0 few days of post-treatment soreness  
Liang 2011 
acupuncture 
178 
3 4 fainted during treatment 
4 2 
feeling numb and aching in the treated 
points 
not 
mentioned 
not 
mentioned local bleeding 
Ma 2012 
acupuncture 
28 
3 0 coldness 
4 0 burning sensation 
4 0 soreness 
Ren 2011 moxibustion 59 10 0 blisters 
N/A=not applicable. 
 
 
Effect of intervention  
Three comparisons were performed. When data were available, meta-analyses and subgroup 
analyses were carried out (Table 3.9). 
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Table 3.9: Comparison groups 
Comparisons Comparison sub-groups 
No. of 
studies 
Sample 
size Types of participants 
Types of 
intervention 
Time-points 
No. of studies: subclasses P/ FS / ROM 
Immediate 
effects (0-2 
weeks at the 
end of 
treatment) 
intermediate 
effects (2-6 
weeks at the 
end of 
treatment) 
Long-term 
effects (≥3 
months at the 
end of 
treatment) 
Local or distant VS 
controls 
local or distant VS 
no treatment 1 33 chronic neck pain acupressure 1/ 1/ 0 0 0 
local or distant VS 
sham 
intervention 
9 367 
chronic neck pain, knee 
osteoarthritis, chronic 
low back pain, 
temporomadibular 
disorders 
individual 
acupuncture, trigger 
point acupuncture, 
moxibustion 9/ 4/ 2 6/ 2/ 0 2/ 2/ 0 
local or distant VS 
conventional 
treatment 
1 26 
chronic low back pain, 
chronic neck and 
shoulder pain 
manual acupuncture, 
electro-acupuncture 1/ 0/ 0 1/ 0/ 0 0 
local VS distant 3 106 chronic neck pain, chronic low back pain 
manual acupuncture, 
electro-acupuncture, 
acupressure 3/ 3/ 1 0 0 
local or distant as 
adjunct therapy 2 58 
chronic plantar fasciitis, 
Myofascial pain 
syndrome in one side of 
the upper trapezius 
muscle 
eletro-acupuncture + 
conventional 
treatment, 
acupuncture + 
stretching 2/ 1/ 1 0 1/ 0/ 1 
Local VS distant N/A  3 106 chronic neck pain, chronic low back pain 
manual acupuncture, 
electro-acupuncture, 
acupressure 3/ 3/ 1 0 0 
Local or distant VS 
combined N/A N/A N/A N/A N/A N/A N/A N/A 
P= Pain severity; FS= Functional Status; ROM= Range of Motion; += and; N/A: Not applicable. 
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Local or distant point stimulation vs controls and Subgroup analysis of local vs distant 
point stimulation  
Fifteen studies were under this comparison. Local points and distant points were significantly more 
effective than their controls for the outcome measure, pain intensity (local stimulation: SMD -0.90, 
95% CI (-1.32, -0.49), Z=4.29, P<0.0001; distant stimulation: SMD -1.14, 95% CI (-1.14, -0.17), Z=2.10, 
P=0.04). For functional status, at the immediate follow-up local point stimulation was better than 
the controls (SMD -0.55, 95% CI (-1.05, -0.04), Z=2.11, P=0.003), but not distant stimulation (SMD -
0.28 95% CI (-0.79, 0.24), Z=1.06, P=0.29). Subgroup analysis showed no significant difference 
between the effects of local points and distant points for either pain reduction (Chi²=0.16, P=0.69) or 
functional status (Figures 3.4 and 3.5). 
 
 
Figure 3.4: Immediate effect of local and distant points stimulation versus controls for the outcome measure pain. Data 
from Itoh 2008, 2012 and Matsubara 2011 were interpreted from graphed results 
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Figure 3.5: Immediate effect of local and distant points stimulation versus controls for the outcome measure functional 
status. Data from Itoh 2008 and Matsubara 2011 were interpreted from graphed results 
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Five studies with only single treatment session were then removed from the analysis as the 
treatment was considered inadequate. Among the remaining 10 studies, the immediate effects of 
local points were significantly more effective than the distant points (Chi²=5.67, P=0.02) in pain 
reduction when more than one treatment session was given (Figure 3.6). The heterogeneity was 70% 
among the local point studies and 0% among the distant points studies. The intermediate and long-
term effects could not be assessed as no data were available for the distant point stimulation. 
 
 
Figure 3.6: Immediate effect of local and distant points stimulation versus controls with multiple treatments for the 
outcome measure pain. Data from Itoh 2008 and 2012 were interpreted from graphed results 
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Due to a higher heterogeneity (I2=70 % and P=0.0001), the studies using local points were further 
examined through the comparison of stimulating local acupuncture point or local tender points, that 
is, Ashi points or trigger points, with their controls in pain reduction. Both acupuncture and tender 
points stimulation were significantly more effective than their controls. Subgroup analysis showed 
that tender points or Ashi points stimulation, used in five studies, significantly reduced pain more 
than local classical acupuncture points, used in 5 studies, at the end of treatments (Chi²=11.73, 
P=0.0006) (Figure 3.7). 
 
 
Figure 3.7: Immediate effect of classical local points and tender points stimulation versus controls with multiple 
treatments for the outcome measure pain. Data from Itoh 2008 and Itoh 2012 were interpreted from graphed results 
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Direct comparison of local versus distant point stimulation 
Three studies including 106 participants directly compared the effects of local and distant point 
stimulation (Matsubara et al., 2011, Takeda and Nabeta, 2001, Wu, 2012). No significant differences 
were found between the local points and distant points groups in pain reduction (SMD 0.05, 95% CI 
(-0.33, 0.43), Z=0.28, P=0.80), functional status (SMD 0.21 95% CI (-0.18, 0.60), Z=1.07, P=0.29) and 
range of motion (SMD 0.35, 95% CI (-0.58, 1.29), Z=0.74, P=0.46) at the immediate follow-up. No 
data were available for this comparison for the intermediate and long-term follow-up. 
 
Local or distant versus combination of both 
No Study was eligible for this comparison. However, one study (Itoh et al., 2007) compared local 
trigger points and combined acupuncture points stimulation. This comparison was considered of 
poor validity as the local points in the two groups were not the same. Thus, the comparison of these 
two groups was not included in the review. 
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Discussion  
Summary of the results 
This review showed moderate evidence of local or distant points stimulation in reducing pain at the 
end of the treatment when compared with control groups. Subgroup analysis revealed that 
immediate effects of local point acupuncture were significantly more effective than distant point 
acupuncture in pain reduction when more than one treatment session was given. Only three studies 
carried out the direct comparison between local and distant points, with inadequate evidence to 
differentiate the effect between local and distant point stimulation based on pain intensity changes. 
However, among studies with more than one session of treatment, subgroup analysis revealed that 
local tender points stimulation significantly reduced pain more than local acupuncture points 
stimulation at the end of treatment. The effects of local or distant stimulation alone compared with 
the combination of both could not be determined. All stimulations were well tolerated by 
participants. 
 
Limitations and strengths  
This review included various types of MSK, such as chronic neck pain, low back pain and knee pain 
because each type of pain had only a small number of studies available. This wide range of pain 
conditions could have introduced a higher level of heterogeneity. However, it could not have 
contributed to a lack of difference between local and distant points. When five studies of chronic 
neck pain, were analysed, the heterogeneity was low at 42%; but still subgroup analysis of the local 
and distant points stimulation did not show any significant difference (Chi²=0.18, P=0.68). The result 
was consistent with the overall finding of this review. Furthermore, in this review local and distant 
points were relevant to the location of pain, and not to a fixed set of points. It is unlikely that types 
of pain have impacted on the overall finding. 
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There are a number of strengths of this review. Firstly key Chinese databases were searched 
together with English databases. Secondly, this review assessed the difference between local and 
distant point stimulation as well as the use of local or distant points alone when compared with 
different types of controls. Thirdly, the review only looked at RCTs and quasi-randomized trials, 
which are the appropriate study design to determine the effects of interventions (Stolberg et al., 
2004). 
 
Interpretation of the results  
Quality of the acupuncture treatment and its impact on treatment results 
Reporting quality defines the reproducibility of the acupuncture protocol (Smith et al., 2011). It is 
also important in the judgement of the quality of acupuncture treatment. Reporting quality of 
acupuncture treatment of the selected studies was generally good but the quality of acupuncture 
treatment delivered was moderate. The contributing factors could be the poor rationale of point 
selection and inadequate number of treatment sessions. 
 
Only three studies supported their point selection with the hypotheses that the points were selected 
based on the meridian theory (Chou et al., 2011), their physiological effects on the brain (Shen and 
Goddard, 2007) or their anatomical aspects (Smith et al., 2007). The specific analgesic mechanism of 
acupuncture is still unknown, and different hypotheses have been made (Carlsson, 2002). Thus, it is 
important to report the rationale of point selection to further develop research in this field. A poor 
rationale for point selection would infer a poor quality of acupuncture treatment. 
 
The number of treatment sessions is an important factor of quality acupuncture (MacPherson et al., 
2013). Six sessions are considered to be the minimum number of treatments for chronic conditions 
(Smith et al., 2011). The treatment session number in the included studies varied from one to 10. 
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The varied number of treatment sessions could have contributed to the high heterogeneity. When 
studies with one session of treatment were removed from meta-analysis, significant difference was 
found between local and distant point stimulation with local treatment being better. Previous 
studies suggested other possible factors affecting the quality of acupuncture including the depth of 
needle insertion and the duration of needle retention (Baldry, 2002, Loyeung and Cobbin, 2013). 
These factors were not examined in this review due to insufficient data. 
 
Definition of local and distant points   
The definition of local and distant points in the included studies are based on their location relative 
to the painful site; however, no clear boundary is set in the literature to state how close is 
considered to be local and how far is considered to be distant. “WHO International Standard 
Terminologies on Traditional Medicine”, the most authoritative book on acupuncture point location, 
describes “distant points” as the points away from the disease sites without further information on 
how far away is considered to be distant (World Health Organization, 2007). Some textbooks define 
distant points as those on the arms and legs when considering diseases in the head or torso (Norris, 
2001, Jarmey and Bouratinos, 2008). 
 
Although not all selected studies in the current review clearly defined local and distant points, all of 
them either provided the names of the acupuncture points or location of the points used. The 
description allowed a judgement according to definitions set in this study and to decide if the 
description was consistent with the intention of the authors. One study was excluded due to this 
inconsistency (Irnich et al., 2002). In the RCT for chronic neck pain, the point GV14, located inferior 
to the spinous process of the seventh cervical vertebra, was used as a distant point together with 
five points located on the arm and leg. Based criteria in this study and textbooks criteria, GV14 
should be a local point for neck pain. As a result, this study was excluded. 
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In the current review, local points included local classical acupuncture points and local tender or Ashi 
points on the local or adjacent muscles of the pain site. Trigger points at or close to the pain site 
were considered as local Ashi points. For example, in the Itoh study on low back pain (Itoh et al., 
2006), the trigger points in the gluteus muscles were considered as local points. Distant points were 
those at least one region further away. For instance, the point BL40 (located on the midpoint of the 
popliteal crease) in the Takeda study (Takeda and Nabeta, 2001) on chronic low back pain was 
considered as a distant point. 
 
Selecting local and distant points 
Acupuncture points or tender points at or near the painful area can easily be considered local points. 
The basis for selecting distant points is more complex. Points can be selected based on their location 
on the same meridian where the pain is, Chinese medicine diagnosis or the accompanying symptoms 
(Yang and He, 1985). Distant points are thought to assist local points in pain reduction (Stux et al., 
1987). For instance, low back pain with weak back and knee is considered to be pain with deficiency 
of the kidney qi, and distant points such as KI3 on the ankle can be added. For low back pain with 
neck stiffness, GV14 below the seventh cervical vertebra can be used (Lu, 2007). Another method is 
to choose distant tender points. For instance, for treating shoulder pain, tender points on the 
anterior tibialis can be selected (Chen, 2008). 
 
Traditionally, combined local and distant points for pain and other conditions are used in preference 
to either alone. There is however little evidence supporting this approach. Furthermore, no clear 
guideline exists for when to use either local or distant points alone and when to use the combined 
approach. Indeed, no suitable studies were found for the comparison of the combined points against 
local or distant alone. In a study for frozen shoulder, the group of participants treated with distant 
tender points (points on the anterior of the leg between ST36 and ST37) and three local points (LI15, 
SI9 and TE14, commonly known as “Three needles for shoulder”) showed better pain reduction than 
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the group treated with only the three local points (Chen, 2008). This study was however excluded, 
because it presented the effect of acupuncture on both acute and chronic conditions in a single set 
of data. 
 
Due to a lack of studies, it could not be determined whether a combination of local and distant 
points is better than either alone. Local tender points could be important in the treatment of MSK. 
However, the finding was from subgroup analysis, and the results need to be interpreted with 
caution for clinical implementation. For instance, it is not known if this method also applies to the 
treatment of widespread pain such as fibromyalgia. People with this condition experience pain in 
different areas of the body. Needling local tender points would require more needles, and could be 
very painful and unbearable to patients. Distant points could be used in this case. However, there is 
no consensus on the rationale for point selection. 
 
Conclusion  
Moderate evidence supports either local or distant point stimulation for MSK when compared with 
no treatment or sham controls. It is however unclear if local point stimulation is better than distant 
point stimulation for MSK. The benefit of combining local and distant point could not be determined. 
Indirect evidence shows that multiple sessions of local tender point stimulation could be more 
effective than local classical acupuncture point stimulation in relieving MSK in the short-term. These 
findings have limitations and should be interpreted with caution. Future studies need to investigate 
the direct comparison of local and distant points stimulation, and examine the combined effect of 
local and distant points versus either local or distant point stimulation alone. 
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Update  
This systematic review has been published in the European journal of pain in 2015 (Wong Lit Wan et 
al., 2015). A search was carried out in February 2016 to update the systematic review. The search 
was carried out using the same search strategy mentioned above, and publication date was limited 
to June 2013 till January 2016. The database searches resulted in 339 studies, and hand search 
resulted in 3 studies. Of these 342 studies, 302 of them were excluded based on their title or 
abstract, the full text of the remaining 40 studies was screened. Thirty-seven studies did not fit the 
inclusion criteria and were excluded (Table 3.10). Three studies met the selection criteria.  
 
Table 3.10: Reasons for excluding studies found in the updated search (June 2013 – Feb 2016) 
Reasons for exclusion No. of studies 
Not RCT 2 
Not ≥ 18 years old 2 
Not > 3months 9 
Not involving stimulation of local or distant point alone 20 
Not receiving the same co-interventions 4 
Total 37 
RCT=randomized controlled trial 
 
 
Description of studies  
The types of MSK in the three studies were: shoulder pain (Itoh et al., 2014), knee OA (Zhao et al., 
2014) and temporomandibular disorders (Gonzalez-Perez et al., 2015). Two of the included studies 
compared trigger point acupuncture with sham acupuncture (Itoh et al., 2014) and medication 
(Gonzalez-Perez et al., 2015), and the remaining one study compared moxibustion with sham 
moxibustion (Zhao et al., 2014). The details of the three included studies are in Table 3.11. Only two 
of these studies were added to the meta-analysis. The remaining one study could not be included in 
the meta-analysis due to insufficient data as the data was presented in median (Gonzalez-Perez et al., 
2015). The corresponding authors were contacted for additional data but none of them replied. 
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Table 3.11: Included studies found in the updated search (June 2013 – Feb 2016) 
Author 
Year Country 
Comparison 
sub-group Type of pain 
No. 
of 
participants 
Design 
Intervention Comparator 
Outcome 
measures 
Measurement 
methods Time points No. of 
participants 
No. of 
participants 
Gonzalez 
2015 Spain 
local or distant 
VS  
conventional 
treatment 
Myofascial pain- 
temporomandi-
bular disorders 
48 RCT 
trigger point 
acupuncture in 
lateral pterygoid 
muscle 
conventional 
treatments 
(analgesics) 
Pain 
ROM 
VAS 
Ruler 
immediate, 
long-term 
24 24 
Itoh 2014 Japan 
local or distant 
VS  
sham 
intervention 
Chronic shoulder 
pain 15 RCT 
trigger point 
acupuncture in 
the shoulder 
region 
sham 
acupuncture 
(blunt needles) 
Pain 
Function 
VAS 
CMS 
immediate, 
long-term 
9 8 
Zhao 2014 China 
local or distant 
VS 
 sham 
intervention 
Knee OA 110 RCT 
moxibustion on 
EX-LE4 , ST35 , 
Ashi point at the 
knee 
sham 
moxibustion 
with an 
insulator at the 
same point as 
the study group 
Pain 
Function WOMAC 
immediate, 
intermediate, 
long-term 
55 55 
RCT= randomised controlled trial; ROM= range of motion; VAS= visual analogue scale; CMS= Constant Murley score; WOMAC= Western Ontario and McMaster Universities osteoarthritis index; immediate= 0-2 
weeks after treatment; intermediate=2-6 weeks after treatment; long-term= more than 3 months after treatment.  
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Adequacy and confidence of treatment 
Two of the included studies are acupuncture studies, and were appraised for their adequacy of 
treatment (Table 3.12) and confidence of treatment (Table 3.13) based on the STRICTA guidelines. 
One study was rated as poor due to insufficient data: number of needles used, depth of insertion, 
type of stimulation, needle retention time and acupuncturist’s background were not specified 
(Gonzalez-Perez et al., 2015). The other acupuncture study was rated as moderate (Itoh et al., 2014) 
as only the rationale for treatment was not mentioned. 
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Table 3.12: Details of needling in studies found in the updated search (June 2013 – Feb 2016) 
 
 
 
Author 
Year 
Details of needling Treatment regimen 
No. of 
needles 
used 
Points used Depth of insertion 
Response 
sought 
Needle 
stimulation 
Retention 
time Needles used 
No. of 
treatment 
sessions 
Frequency 
of 
treatment 
Gonzalez 
2015 
not 
mentioned 
trigger points in the 
lateral pterygoid 
muscle 
not 
mentioned 
local muscle 
twitch response not mentioned 
not 
mentioned 
size 0.25 mm x 
length 40mm 3 
1/week for 
3 weeks 
Itoh 2014 4.1 
trigger points in the 
following muscles: 
trapezius, 
supraspinatus, 
infraspinatus, teres 
minor, teres major, 
subcapularis, 
latissimus dorsi, 
pectoralis minor, 
bicep brachii 
5-15mm local muscle twitch response 
sparrow pecking' 
technique 10 min 
size 0.2 mm x 
length 50mm 5 
1/week for 
5 weeks 
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Table 3.13: Data extraction for confidence of treatment for the studies found in the updated search (June 2013 – Feb 2016) 
Author 
Year 
Acupuncture rationale 
Acupuncturist's 
background Style of 
acupuncture 
Reasoning for 
treatment 
provided 
Extent to which 
treatment was 
varied 
Gonzalez 
2015 
dry needling of 
painful trigger 
points 
Literature 
supports safety, 
efficacy and low 
cost of this 
treatment 
approach 
trigger points not mentioned 
Itoh 2014 
trigger point 
acupuncture not mentioned trigger points 
two acupuncturists 
who had 4 years of 
acupuncture 
training and 3 or 
10 years of clinical 
experience 
 
 
Risk of bias assessment 
The three studies were rated low risk for selection bias because all three studies reported that the 
randomisation sequence was generated using a computer (Table 3.14). Two studies were rated unclear 
for the allocation concealment (Itoh et al., 2014, Gonzalez-Perez et al., 2015) and the remaining one was 
rated low risk (Zhao et al., 2014) for using codes to assign the groups. Two studies were rated low risk 
for performance bias, detection bias and attrition bias, for using sham devices that had similar 
appearance to the real treatment device, independent assessors and for explaining their analysis and 
reasons for drop outs respectively (Itoh et al., 2014, Zhao et al., 2014). The Gonzalez study was rated 
high risk for performance bias, as blinding was not possible when they compared acupuncture with 
medications (Gonzalez-Perez et al., 2015). Due to insufficient data, this study was rated unclear for 
selection bias and detection bias (Gonzalez-Perez et al., 2015). 
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Table 3.14: Risk of bias summary for the three studies found in the updated search (June 2013 – Feb 2016) 
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Effect of intervention  
For the immediate effect, each of the three studies found that the treatment groups showed a better 
pain reduction compared to the control groups (Itoh et al., 2014, Zhao et al., 2014, Gonzalez-Perez et al., 
2015). Further, each of them also found a significant difference in the function and range of motion 
between the treatment groups and their controls. In Itoh’s study on shoulder pain, the local trigger point 
group improved their Constant-Murley scores compared with the sham acupuncture group, indicating a 
better function of the shoulder (Itoh et al., 2014). In the study on knee OA, the Western Ontario and 
McMaster Universities Osteoarthritis Index decreased (improved function) significantly in the treatment 
group compared with the sham group (Zhao et al., 2014). The Local trigger point acupuncture group also 
showed better improvement in their range of motion (lateral movements and protrusion of the jaw) 
compared with the medication group at the immediate follow-up in Gonzalez’s study on 
temporomandibular disorders (Gonzalez-Perez et al., 2015). This study was not added to the meta-
analysis due to insufficient data.  
 
Immediate effect  
Ithoh’s and Zhao’s study were added to the meta-analysis for the comparison of local and sham controls 
at the immediate follow-up (Itoh et al., 2014, Zhao et al., 2014). The addition of these two studies did 
not affect the initial results of this review. Local treatment was found to be more effective than sham 
treatment in reducing pain at the immediate follow-up (updated local stimulation: SMD -0.86, 95% CI (-
1.20, -0.52), Z=4.98, P<0.01 vs previous local stimulation: SMD -0.90, 95% CI (-1.32, -0.49), Z=4.29, 
P<0.01) (Figure 3.8). Local treatment was also more effective in improving functional status at the 
immediate follow-up (updated local stimulation: SMD -0.59, 95% CI (-0.98, -0.19), Z=2.90, P<0.01 vs 
previous local stimulation: SMD -0.55, 95% CI (-1.05, -0.04), Z=2.11, P<0.01) than the sham treatment 
(Figure 3.9). No subgroup difference was found in pain reduction (updated data: Chi²=0.24, P=0.63 vs 
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previous data Chi²=0.16, P=0.69) and function improvement (updated data: Chi²=0.87, P=0.35 vs 
previous data Chi²=0.53, P=0.47) between local and distant treatment when both the studies with 
multiple treatments and studies with single treatment were pooled together (Figures 3.8 and 3.9). 
 
 
Figure 3.8: Immediate effect of local and distant points stimulation versus controls for the outcome measure pain 
#= studies added to the analysis. Data from Itoh 2008, 2012, 2014 and Matsubara 2011 were interpreted from graphed results. 
 
# 
# 
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Figure 3.9: Immediate effect of local and distant points stimulation versus controls for the outcome measure function 
#= studies added to the analysis. Data from Itoh 2008, 2012, 2014 and Matsubara 2011 were interpreted from graphed results. 
 
 
 
 
 
 
 
 
# 
# 
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When only those studies with multiple treatments were compared a significant difference between local 
and distant treatments was found, with the local treatment being more efficient in reducing pain 
(Chi²=5.73, P=0.02) than the distant treatment (Figure 3.10). This was similar to the previous results 
(Chi²=5.67, P=0.02). 
 
 
Figure 3.10: Immediate effect of local and distant points stimulation versus controls with multiple treatments for the 
outcome measure pain 
#= studies added to the analysis. Data from Itoh 2008, 2012 and 2014 were interpreted from graphed results. 
 
 
 
 
 
# 
# 
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The local treatment group was further analysed because of the high heterogeneity (I2=65%) (Figure 3.11). 
Subgroup analysis showed that decreases in pain were significantly greater in the local tender points 
subgroup than in the local acupuncture points subgroup (Chi²=12.58, p=0.0004), which was similar to 
the previous findings (Chi²=11.73, p=0.0006) (Wong Lit Wan et al., 2015). 
 
 
Figure 3.11: Immediate effect of local and tender points stimulation versus controls with multiple treatments for the 
outcome measure pain 
#= studies added to the analysis. Data from Itoh 2008, 2012 and 2014 were interpreted from graphed results. 
 
 
 
 
# 
# 
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Intermediate and long-term effects 
The study on knee OA found that the treatment group showed a better pain reduction at the 
intermediate and long-term follow-ups (Zhao et al., 2014). In the same study, the treatment group 
improved their function significantly compared with the sham group at the intermediate follow-up but 
not in the long-term follow-up (Zhao et al., 2014). In Itoh’s study on shoulder pain, there was no 
difference in pain reduction or improvement of function between the trigger point acupuncture group 
and the sham group at the long-term follow-up (2014). In Gonzalez study on temporomandibular 
disorder, the trigger point acupuncture group showed a better reduction in pain at rest and pain in 
mastication at the long-term follow-up compared with the medication group (2015). Further, the 
acupuncture group also showed a better improvement in their range of motion (lateral movements and 
protrusion of the jaw) compared with the medication group at the long-term follow-ups (Gonzalez-Perez 
et al., 2015). No measurements were taken at the intermediate follow-up for this study.  
 
Comparisons for the intermediate and long-term follow-ups could not be performed as no study on 
distant treatment was available for these time points.  
 
 
Conclusion 
The inclusion of these three studies has not impacted on the findings and conclusion of the published 
review. Acupuncture needling of local tender points may play an important role in the treatment of MSK 
in the short-term. Further studies are needed to confirm these findings. 
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 Chapter 4 : Detecting and profiling subgroups of patients with painful knee 
osteoarthritis – systematic review of psychophysical studies 
 
Introduction 
Knee OA is associated with knee pain and reduced physical function (Michael et al., 2010). It reduces 
work productivity and increases socioeconomic burdens (Agaliotis et al., 2014, Cross et al., 2014). In 
2010, the global prevalence of knee OA was 3.8 %, affecting about 260 million people (Cross et al., 2014). 
Since age is a major risk factor for knee OA (Neogi, 2013, Oliveria et al., 1995, Mannoni et al., 2003, 
Zheng and Chen, 2015), it is speculated that the burden of knee OA will continue to increase with the 
world’s ageing population with a seven fold increase in joint replacements over the next 15 years (Kurtz 
et al., 2011). 
 
The current management of knee OA pain includes pharmacological, non-pharmacological therapies and 
surgery (Hochberg et al., 2012). Despite the availability of these treatment options, not all knee OA 
sufferers attain satisfactory pain relief and functional improvement (Beswick et al., 2012, da Costa et al., 
2014). This difference in treatment response may be due to the heterogeneity in pain sensitization 
among knee OA patients (Knoop et al., 2011, Hinman and Crossley, 2007). For instance, knee OA studies 
found that participants with enhanced pre-operative TS of pain showed less post-operative pain relief 
compared with those with a lower pre-operative TS of pain (Petersen et al., 2015, Petersen et al., 2016). 
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QST, such as assessing pain thresholds, is a branch of psychophysics examining pain responses to 
invasive or non-invasive thermal, mechanical, electrical or chemical stimuli (Arendt-Nielsen and 
Yarnitsky, 2009). It has been shown to be reliable and safe in individuals with neuropathic and chronic 
pain conditions (Geber et al., 2011, Wylde et al., 2011b). These psychophysical tests have shown their 
potential in identifying subgroups among individuals with knee OA (Arendt-Nielsen et al., 2014a, Finan 
et al., 2013) of different pain sensitivities so as to better understand the varied response to treatments. 
However, the ideal QST have not yet been defined for this purpose.  
 
QST may also help elucidate the underlying mechanisms of pain. For instance, lower pain thresholds at 
the sites away from the pain may indicate widespread sensitization (Starkweather et al., 2016). This is in 
contrast to lowered pain threshold limited to the pain sites only, indicating localized sensitization 
(Starkweather et al., 2016). A previous study reported that knee OA participants with more severe knee 
pain had lower PPT at the trapezius, a site distant to the knee, than those with mild knee pain (Finan et 
al., 2013). However, these two groups did not differ in their PPT at the site close to the knee. This finding 
suggests that some knee OA individuals might be more affected by widespread sensitization than others. 
 
This study aimed to identify the QST that could potentially be used to differentiate these subgroups of 
knee OA through systematically reviewing studies reporting the psychophysical characteristics of 
subgroups in knee OA participants.  
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Methods  
Study identification and selection  
This review followed the PRISMA reporting guidelines (Moher et al., 2009) for systematic reviews. 
Studies on knee OA and psychophysics were searched in PubMed, Scopus and EMBASE from inception 
to January 2015. The search terms used were: “conditioned pain modulation”, “DNIC”, “diffuse noxious 
inhibitory control”, “psychophysics”, “temporal summation”, “QST”, “quantitative sensory test”, “cold 
pressor”, “endogenous pain control”, “sensitivity”, “hypersensitivity”, “pressure pain threshold”, 
“threshold”, “tolerance”, “knee pain”, “knee osteoarthritis”, “knee” and “pain”. A sample search history 
is included in Appendix 3. The reference lists of the included studies and review articles were also 
searched but not included, to identify relevant studies. There was no language limitation. The inclusion 
criteria were (1) any studies reporting psychophysical data on subgroups or correlation in adult knee OA 
participants (2) available in full-text and (3) reporting the methodology of psychophysics measurements 
such as modality and testing sites. The exclusion criteria were: (1) any knee OA study that did not report 
psychophysical data for subgroups or correlations, (2) abstracts or reviews and (3) psychophysics studies 
with groups subdivided based on ethnicity or gender. The screening procedure is illustrated in Figure 4.1. 
Two reviewers (DW and ZZ) screened and selected the studies. 
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Figure 4.1: Flow chart of study selection 
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Data extraction and processing 
One reviewer (DW) extracted data on: demographics, modality of psychophysical tests, testing sites, 
device used, number of trials per modality and correlations. Authors of the included studies were 
contacted for any missing or unclear data. The included studies were classified into two categories: 
those that reported subgroup data and those that only reported data on the correlation between 
psychophysical characteristics and clinical symptoms. Due to the high heterogeneity of the included 
studies, meta-analysis could not be conducted, qualitative analysis was performed to summarise the 
results from the included studies. In this chapter, the term “punctate” was used to describe Von Frey or 
non-noxious pin prick stimulation, and “pressure” was used to describe the use of algometer to evoke TS 
of mechanical pain. 
 
Assessment of risk bias  
The risk of bias assessment of the included studies was adapted from a systematic review on 
conditioned pain modulation (Lewis et al., 2012b). Two reviewers (DW and ZZ) independently assessed 
the risk of bias of the studies using the following criteria: 1) blinding of outcome assessor (performance 
bias), 2) cases representative of the population (selection bias), 3) description of psychophysics tests 
(QST) and 4) controlled risk of known confounders. The assessment of criteria 1, 2 and 4 followed the 
protocol by Lewis (Lewis et al., 2012b). Each criterion was rated as low, moderate or high risk. Any 
disagreement was resolved by consensus. The assessment of blinding of assessor was based on the 
reporting if the researchers conducting the psychophysical tests were blinded from participants’ 
characteristics to reduce performance bias. This is to ensure that the stimuli are delivered to all the 
participants in a similar manner, without any interference from the assessor’s expectations. Studies that 
explicitly reported the procedure for blinding of the assessor were rated as low risk. Those that implied 
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blinding was used but did not specify their methodology were rated as moderate risk and those that did 
not mention about blinding were classified as high risk. The assessment of cases representative of the 
population was based on the reporting of inclusion/diagnostic criteria and recruitment procedure. The 
controlled risk of known confounders was assessed based on the number of controlled confounders. The 
comparability of cases and control used in Lewis’ study was irrelevant to this review as no healthy 
controls are involved, and was thus removed from the quality assessment. The extent to which the 
psychophysics tests were described may affect the reproducibility of the studies and also the appraisal 
of methodological quality, and was therefore added as a selection criterion (Huwiler-Müntener et al., 
2002, Cook et al., 2013). The included studies were rated as low risk if they contained a clear description 
of the psychophysics tests to enable replication of the study; moderate risk if the description of 
psychophysics tests was not sufficient for proper replication of the study; or high risk if there was no 
description of the psychophysics tests and the procedure could not be replicated. 
 
 
Results 
Description of studies  
Databases and reference lists searches resulted in 1466 studies. Thirty-six full-texts were retrieved. 
Fourteen studies met the selection criteria and were included. Severity and location of pain, physical 
disability and other non-knee related symptoms such as optimism (Cruz-Almeida et al., 2013, Goodin et 
al., 2013), pain hypervigilance (Herbert et al., 2014, Cruz-Almeida et al., 2013) and sleep (Wideman et al., 
2014) were found to be associated with pain threshold (Arendt-Nielsen et al., 2010, Finan et al., 2013, 
Herbert et al., 2014) and TS of pain (Cruz-Almeida et al., 2013, Finan et al., 2013, King et al., 2013). The 
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modalities of psychophysical tests used were PPT (Arendt-Nielsen et al., 2010, Finan et al., 2013), 
thermal detection threshold (warm) (King et al., 2013), thermal pain thresholds (cold and heat pain 
thresholds) (Cruz-Almeida et al., 2013, King et al., 2013), thermal pain tolerance (hot and cold pain 
tolerance) (Cruz-Almeida et al., 2013, King et al., 2013, Finan, 2013 #107), CPM (Finan et al., 2013, King 
et al., 2013) and TS of pain (thermal, pressure mechanical and punctate mechanical) (Arendt-Nielsen et 
al., 2010, Egsgaard et al., 2015, Finan et al., 2013, King et al., 2013). None of the studies assessed 
stimulus-response functions. Only one study recorded the location of knee pain (Creamer et al., 1998). 
The tested sites included the knee (patella, medial and lateral aspects of the knee) (Arendt-Nielsen et al., 
2010, King et al., 2013), muscles around the knee (quadriceps and tibialis anterior)(Arendt-Nielsen et al., 
2010, Finan et al., 2013) and sites away from the knee (forearm, finger and trapezium) (Cruz-Almeida et 
al., 2013, Finan et al., 2013, Skou et al., 2014, Arendt-Nielsen et al., 2010). 
 
Eight studies (1124 participants) were included under the subgroup data category and six (664 
participants) under the correlation data category. Table 4.1 summarises the demographics of the 
included participants in the subgroup and correlation category and Table 4.2 the psychophysical tests 
used in the subgroup and correlation category. More details of individual studies of the subgroup data 
category are available in Appendices 4-11. 
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Table 4.1: Summary of demographics for the included participants in the subgroup category and correlation category (mean ± SD) 
Subgroup data 
Studies Total sample size subgroup; sample size (Male/Female) Age / yr BMI Pain duration  
Arendt-Nielsen 
2010 48 
VAS>6; 24 (12/12) 63.6 ± 1.5 29.3 ± 0.8 95.6 ± 15.4 mon 
VAS <6; 24 (12/12) 61.7 ± 1.7 27.7 ± 1.0 78.5 ± 10.9 mon 
Arendt-Nielsen 
2014 217 
VAS 10-39; 81 (35/46) 62.8 ± 8.3  27.5 ± 3.7 
not reported for the subgroups VAS 40-69; 70 (34/36) 64.9 ± 7.6  28.0 ± 3.3 
VAS 70-100; 66 (33/33) 63.8 ± 8.1  29.6 ± 5.1 
Creamer 1998 58 
medial knee pain; 23 (9/14) 64.3 ± 29.9 31.2 ± 5.5 7.7 ± 4.8 yr 
generalized knee pain;  
35 (9/26) 66.4 ± 10.7 31.2 ± 7.6 8.1 ± 7.6 yr 
Cruz- Almeida 
2013 194 
cluster 1; 54 (18/36) 56.5 ± 7.8 
Data not available Data not available 
cluster2; 45 (9/36) 60.2 ± 9.4 
cluster 3; 63 (23/40) 56.7 ± 6.8 
cluster 4; 32 (9/23) 54.3 ± 5.4 
Egsgaard 2015 212 
profile A; 27 (16/11) 61.8 ± 8.2 26.6 ± 2.9 9.1 ± 5.7 yr 
profile B; 59 (29/30) 63.9 ± 8.1 28.2 ± 3.9  8.4 ± 7.2 yr 
profile C; 85 (36/49) 63.5 ± 7.7 28.0 ± 3.9 9.8 ± 7.8 yr 
profile D; 41 (17/24) 65.4 ± 7.7 30.4 ± 5.2 10.5 ± 8.7 yr 
Finan 2013 113 
low pain and low knee OA grade; 24 (8/16) 62.0 ± 9.3 27.2 ± 7.1 6.2 ± 5.6 yr 
high pain and high knee OA grade; 32 (7/25) 61.6 ± 9.6 33.6 ± 6.1 6.9 ± 4.8 yr 
low pain and high knee OA grade; 27 (14/13) 63.8 ± 8.6 30.9 ± 5.8 6.9 ± 5.5 yr 
high pain and low knee OA grade; 30 (10/20) 57.2 ± 7.1 30.7 ± 5.7 6.0 ± 6.2 yr 
King 2013 209 
WOMAC≤33; 113 (31/82) 58.1 29.3 24.7 mon 
WOMAC≥34; 96 (32/64) 56.4 33.5 57.8 mon 
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Skou 2014 73 
group 1; 26 (16/10) 64.1 ± 1.5 28.9 ± 1.1 86.6 ± 14.1 mon 
group 2; 27 (12/15) 61.4 ± 1.6 28.3 ± 0.7 89.1 ± 13.8 mon 
group 3; 10 (3/7) 61.4 ± 3.1 29.3 ± 1.9 152.2 ± 24.1 mon 
group 4; 10 (3/7) 61.5 ± 1.8 32.1 ± 1.5 181.8 ± 39.1 mon 
Correlation data 
Studies Sample size (Male/Female) Age/yr BMI  Pain duration  
Goodin 2013 140 (36/104) 56.7 ± 7.2 not assessed not assessed 
Herbert 2014 168 (44/124) 56.9 ± 6.6 not assessed not assessed 
Martinez 2007 20 (1/19) 69.0 ± 2.0 not assessed 3.8 ± 3.3 yr 
Rackel 2014 75 (29/46) 56.0 ± 1.42 36.3 ± 0.9 6 yr (range 3-10 yr) 
Wideman 2014 107 (32/75) 60.8 ± 10.1 not assessed not assessed 
William 2004 154 (52/102) 65.7 ± 9.1 not reported for the whole group not assessed 
VAS= Visual analogue scale; mon= months; yr= years; WOMAC= Western Ontario & McMaster Universities Index of Osteoarthritis; cluster 1= high optimism and low negative affect; cluster 2= low 
positive affect; cluster 3= low optimism; cluster 4= pain hypervigilance; group 1= Knee osteoarthritis participants with high mean PPT; group 2= Knee osteoarthritis participants with low mean PPT; 
group 3= post-operative participants with high mean PPT; group 4= post-operative participants with low mean PPT; profile A= higher pain threshold and a higher CPM effect than those of controls; 
profile B= enhanced temporal summation as compared with controls; profile C= lower pressure pain thresholds, enhanced pain responses to temporal summation compared with controls; profile 
D= higher scores in physical health questionnaires, and pain catastrophizing than profile C. 
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Table 4.2: Summary of psychophysical tests used in the included studies in the subgroup category 
Subgroup data 
Studies Basis of subgrouping PPT 
Thermal 
detection 
threshold 
Thermal 
pain 
threshold 
Thermal 
pain 
tolerance 
TS of 
pressure 
pain 
TS of 
thermal 
pain 
TS of 
punctate 
stimuli 
Saline 
injection CPM 
Arendt-
Nielsen 
2010 
clinical pain intensity: VAS>6; VAS <6 ∆              
Arendt-
Nielsen 
2014 
clinical pain intensity: VAS (10-39); 
VAS(40-69); VAS (70-100)        ∆       ∆ 
Creamer 
1998 
location of pain: generalized knee pain; 
medial knee pain                  
Cruz- 
Almeida 
2013 
cluster analysis of clinical symptoms 
and psychological factors ∆       ∆ ∆    
Egsgaard 
2015 
cluster analysis of physical 
impairments, pain responses (PPT, 
CPM,TS) , psychological factors and 
biochemical markers 
∆       ∆       ∆ 
Finan 
2013 
knee pain scores and radiographic 
grade  ∆         ∆ ∆    
King 
2013 
WOMAC scores (WOMAC<33: 
WOMAC≥34) ∆       ∆    
Skou 
2014 
PPT from peripatellar region (based on 
the median) ∆       ∆         
Correlation data 
Studies Punctate pain threshold PPT 
Thermal 
detection 
threshold 
Thermal 
pain 
threshold 
Thermal 
pain 
tolerance 
TS of 
pressure 
pain 
TS of 
thermal 
pain 
TS of 
punctate 
stimuli 
Saline 
injection CPM 
Goodin 
2013           
Herbert 
2014           
Martinez 
2007            
Rackel 
2014           
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Wideman 
2014           
William 
2004           
PPT= Pressure pain threshold; TS= temporal summation of pain; CPM= Conditioned pain modulation; VAS= Visual analogue scale; WOMAC= Western Ontario & McMaster Universities Osteoarthritis 
index; =modality was applied in the study; Δ=group difference was found,              =modality not applied in the study. 
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Subgroup data 
In the subgroup data category, seven out of the eight included studies subdivided the groups based 
on clinical symptoms and then examined their psychophysical characteristics (Creamer et al., 1998, 
Cruz-Almeida et al., 2013, Finan et al., 2013, King et al., 2013, Arendt-Nielsen et al., 2014a, Arendt-
Nielsen et al., 2010, Egsgaard et al., 2015). Only one study subdivided the participants based on their 
psychophysics response (mean PPT at the patella), then further examined their other psychophysical 
characteristics (PPT away from the knee and TS of pain at and away from the knee) (Skou et al., 
2014). 
 
The forearm and the knee were used in all the eight studies as the sites for QST. Two studies 
reported the results as means of a number of sites (2-8 sites). PPT (Creamer et al., 1998, Cruz-
Almeida et al., 2013, Finan et al., 2013, King et al., 2013, Skou et al., 2014, Arendt-Nielsen et al., 
2014a, Arendt-Nielsen et al., 2010, Egsgaard et al., 2015) and CPM (Finan et al., 2013, King et al., 
2013, Arendt-Nielsen et al., 2014a, Arendt-Nielsen et al., 2010, Egsgaard et al., 2015) were the most 
used tests and thermal detection threshold (King et al., 2013) and saline injection (Arendt-Nielsen et 
al., 2010) were the least used. 
 
Four studies reported significant group differences in PPTs measured at the knee with a lower PPT in 
the subgroups with severer knee pain, more knee OA symptoms as shown in Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC) or negative psychological factors (Cruz-
Almeida et al., 2013, King et al., 2013, Arendt-Nielsen et al., 2010, Egsgaard et al., 2015). 
Subgrouping was based on intensity of knee pain, WOMAC scores, cluster analysis and psychological 
characteristics in those four studies. Difference in PPT was also found at sites away from the knee 
among those subgroups (Finan et al., 2013, Skou et al., 2014, Cruz-Almeida et al., 2013) in three 
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studies. No group difference was found in PPT when the groups were subdivided based on knee pain 
location, that is, medial knee pain and generalized knee pain (Creamer et al., 1998). Figure 4.2 shows 
the testing sites and the studies measuring PPT. 
 
 
Figure 4.2: Testing sites and studies measuring PPT 
Fig 2: Testing sites and studies measuring PPT 
PPT= Pressure pain threshold; 2= number of studies; studies using trapezius: Cruz Almeida 2013 and Finan 
2013 (group difference), King 2013 (no group difference); studies using forearm Cruz Almeida 2013 and Skou 
2014 (group difference); King 2013 and Arendt- Nielsen 2010 (no group difference); studies using quadriceps: 
Cruz Almeida 2013 ( group difference); Finan 2013 and King 2013 (no group difference); studies using knee: 
Cruz Almeida 2013, King 2013, Arendt- Nielsen 2010 and Egsgaard 2015 (group difference); studies using tibia: 
Skou 2014 (group difference), Arendt Nielsen 2010 (no group difference); studies using means of sites: 
Creamer1998, and Adrendt- Nielsen 2014 (no group difference). 
 
 
Three studies measured TS of mechanical punctate pain at and away from the knee. Two of these 
studies (Cruz-Almeida et al., 2013, King et al., 2013) found a group difference at the knee and at the 
hand while the remaining one study found a group difference at the finger but not at the knee (Finan 
et al., 2013) (Figure 4.3). The “high knee pain and low knee radiographic grade” group had more 
severe TS of mechanical punctate pain at the finger than the other groups, and the “pain 
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hypervigilance” and “high symptomatic” groups a higher TS of mechanical punctate pain at the knee 
and hand than the other groups did. Subgroup difference was found in two out of three studies 
measuring TS of thermal pain; the groups having high knee pain or pain hypervigilance showed 
stronger TS of heat pain at the forearm (Finan et al., 2013) and at the knee (Cruz-Almeida et al., 2013) 
than the groups with low knee pain or high optimism did. Four studies assessed the TS of pressure 
pain (Arendt-Nielsen et al., 2010, Skou et al., 2014, Arendt-Nielsen et al., 2014b, Egsgaard et al., 
2015). No group difference was found at the forearm (Figure 4.3). Two out of three studies reported 
a subgroup difference at the knee, and one out of three studies reported a subgroups difference at 
the tibia. The remaining one study reported subgroup difference in the mean TS of pressure 
stimulation of different sites (Arendt-Nielsen et al., 2014b). 
 
 
Figure 4.3: Testing sites and studies measuring temporal summation of pain 
2= number of studies; unspecified =means of sites; Pressure mechanical pain: studies using knee= Skou 
2014(group difference), Arendt- Nielsen 2010 (no group difference); studies using tibia= Skou 2014(group 
difference), Arendt- Nielsen 2010 (no group difference); studies using forearm= Egsgaard 2015 and Arendt-
nielsen 2010 (no group difference); studies using means of sites= Arendt-Nielsen 2014 (group difference); 
Thermal pain: studies using forearm= Finan 2013 (group difference), Cruz Almeida 2013 and King 2013 (no 
group difference); studies using knee= Cruz Almeida 2013 (group difference), King 2013 (no group difference); 
Punctate mechanical pain: studies using hand= Cruz Almeida 2013 and King 2013 (group difference); studies 
using finger= Finan 2013 (group difference); studies using knee= Cruz Almeida 2013 and King 2013 (group 
difference), Finan 2013 (no group difference) 
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Out of six studies measuring CPM, only two studies found significant group difference in the potency 
of CPM (Arendt-Nielsen et al., 2014a, Egsgaard et al., 2015). The groups with a mild maximum knee 
pain in the last 24 hours or higher PPT at the knee had more efficient CPM compared with those 
having a more intense maximum knee pain in the last 24 hours.  
 
No significant difference was found for thermal detection threshold (King et al., 2013), thermal pain 
threshold (Cruz-Almeida et al., 2013, King et al., 2013), thermal pain tolerance (Cruz-Almeida et al., 
2013, King et al., 2013) and saline injection (Arendt-Nielsen et al., 2010). 
 
 
Correlation data  
In the correlation data category, the most used test modality was PPT (Williams et al., 2004, Herbert 
et al., 2014, Rakel et al., 2014, Wideman et al., 2014) and the most tested site was the knee 
(Williams et al., 2004, Martinez et al., 2007, Herbert et al., 2014, Rakel et al., 2014, Wideman et al., 
2014). One study reported that TS of mechanical punctate pain at the dorsal of the middle finger 
increased as sleep quality deceased (Wideman et al., 2014). Three studies reported the relationship 
among PPT, pain sensitivity and physical function. As PPT at the knee and shoulder increased, 
physical function increased (Williams et al., 2004, Wideman et al., 2014, Rakel et al., 2014) and the 
strength of TS of mechanical punctate pain at the knee decreased (Wideman et al., 2014). Two 
studies reported the relationship between knee pain and PPT. Knee pain increased as PPT at the 
knee and tibia decreased (Rakel et al., 2014, Wideman et al., 2014). Negative psychological factors 
such as pain hypervigilance and depressed mood were found to be negatively correlated (Herbert et 
al., 2014, Wideman et al., 2014) with PPT at the knee, quadriceps, trapezius and shoulder. Optimism 
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was negatively correlated with TS of heat pain at the forearm (Goodin et al., 2013) whereas pain 
hypervigilance was positively correlated with TS of heat pain at the knee and forearm (Martinez et 
al., 2007). One study reported that pain intensity to a suprathreshold heat stimulus pre-surgery was 
positively correlated to morphine use over the first 24 hours post-surgery. A summary of the 
correlation data is presented in Figure 4.4. In summary as the severity of poor sleep, disability, knee 
pain and negative psychological factors increased, PPT at and away from the knee decreased and the 
strength of TS of pain at and away from the knee increased.  
 
 
Figure 4.4: Diagram representing relation between clinical symptoms, PPT and TS of pain. 
PPT= pressure pain threshold; TS= temporal summation of pain. 
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Risk of bias assessment  
The blinding of outcome assessor was poor on the overall since no study reported this item. Only 
two studies were rated with low risk for this item in the subgroup category as they used cluster 
analysis (Cruz-Almeida et al., 2013, Egsgaard et al., 2015). The rest was rated as high risk. Ten out of 
the 14 studies were considered to be of low risk for the cases representative of the population 
(Arendt-Nielsen et al., 2010, Cruz-Almeida et al., 2013, Finan et al., 2013, King et al., 2013, Skou et al., 
2014, Goodin et al., 2013, Herbert et al., 2014, Wideman et al., 2014, Egsgaard et al., 2015, Arendt-
Nielsen et al., 2014a) as their participants were screened based on the American College of 
Rheumatology diagnostic criteria of OA and the setting for recruiting participants reported. The rest 
of the studies did not report either their diagnostic criteria or recruitment setting, and were rated as 
moderate risk. Eleven out of 14 studies were rated as low risk on the description of QST used as the 
description in the studies or referenced studies was sufficient for replication; three were of 
moderate risk because they did not report the number of trials per modality, device used or testing 
sites (Creamer et al., 1998, Williams et al., 2004, King et al., 2013). The respective authors were 
contacted for additional data, two replied and data was available from only one of them. Thirteen 
out of 14 studies adequately controlled for confounders and were rated as low risk. The confounders 
were age, gender, BMI, duration of pain, radiography and refrainment of medication intake prior to 
the tests. In the remaining one (Martinez et al., 2007) although factors such as gender, age and 
weight were measured there was no report whether those factors were included in the analysis, 
thus this study was rated as moderate risk (Figure 4.5). Overall, the included studies were of 
moderate quality. 
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Figure 4.5: Summary of risk of bias of the included studies 
 
 
Discussion 
Summary of results  
This review included 14 studies with 1788 participants. Eight reported subgroup data and six 
reported correlation data. The results of those two types of studies consistently showed that lower 
PPT at the knee and enhanced TS away from the knee were associated with severe knee pain, knee 
OA symptoms or negative psychological factors, and may reflect a state of widespread sensitization. 
The quality of the included studies was rated moderate due to the high risk on the blinding of 
outcome assessor. 
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PPT and TS of pain at and away from the osteoarthritic knee  
Previous studies demonstrated that PPT at and away from the knee are lower in individuals with 
knee OA than in the healthy controls (Suokas et al., 2012), indicating individuals with knee OA pain 
may have a sensitized central nervous system when compared with healthy controls. 
 
This study further adds to the literature that this widespread sensitization varies among individuals 
with knee OA based on two key features: PPT around the osteoarthritic knee and TS of punctate pain 
away from the osteoarthritic knee. A lower PPT at the most painful knee or enhanced TS of punctate 
pain away from the knee were reported in the subgroups with more severe knee OA symptoms or 
more negative psychological factors (Cruz-Almeida et al., 2013, Finan et al., 2013, King et al., 2013, 
Egsgaard et al., 2015, Arendt-Nielsen et al., 2010). In contrast the subgroups with higher PPTs 
around the osteoarthritic knee, or mild TS of pain away from the osteoarthritic knee often reported 
milder pain. 
 
The consistency in subgroup difference in PPT at the knee implies that the pain mechanism in knee 
OA is localized. The level of PPT at the knee indicates the extent of local sensitization: those with a 
lower PPT have enhanced local sensitization while those with a higher PPT have lesser local 
sensitization. This could be due to peripheral inputs. For example, increased joint loading or 
increased muscle tension that may lead to increased sensitization. It is also possible that central 
mechanisms contributed to this difference in local sensitization (measured with PPT at the knee). 
This is supported by the findings of this study which show that both lowered PPT at the knee and TS 
of punctate pain away from the knee are associated with negative psychological factors or severe 
knee pain (Cruz-Almeida et al., 2013, Finan et al., 2013, Egsgaard et al., 2015). The discussion on the 
relationship of PPT and TS is beyond the scope of this review, but is an important question that 
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future studies should consider. The findings indicate that PPT at the knee could be potentially used 
to subgroup knee OA participants. Larger studies are needed to confirm these findings. 
 
In this study, TS of punctate pain, a measure for central sensitization, also consistently showed a 
significant group difference at sites away from the knee (Cruz-Almeida et al., 2013, Finan et al., 2013, 
King et al., 2013) whereas the results of TS of thermal pain or pressure pain were inconsistent 
among studies. This may be due to the difference in methodology, including types of stimulus used 
or the way of categorizing the subgroups. To the author’s knowledge no studies compared TS of 
punctate pain with TS of thermal pain or pressure pain. Often punctate stimulus is delivered at a 
fixed strength to induce TS of pain, which might have been at supra-pain threshold level to the 
majority of participants. The pressure stimulation used to measure TS of pain was often individually 
determined based on their PPT. This could have led to inconsistent results on TS pain. Nevertheless, 
these findings are to be interpreted with caution due to the small number of included studies, and 
two of the studies were from the same research group. TS of pain at and away from the pain site 
remain to be an important test for assessing widespread sensitization. It is necessary to compare TS 
pain induced with different methods. Consensus is needed on the type and the level of mechanical 
stimulation for TS of pain. 
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CPM  
Interestingly only two out of six studies that tested the potency of CPM found a group difference, 
and the remaining four studies did not. From this review, it is unclear if potency of CPM is a reliable 
test for subgrouping. The discrepancies among the six studies may be due to two reasons. Firstly, the 
methods used to measure the potency of CPM or to subgroup participants. The conditioning 
stimulus was different among the studies, with three using ischemic compression cuffs (Arendt-
Nielsen et al., 2014a, Arendt-Nielsen et al., 2010, Egsgaard et al., 2015) and the other three CPT 
(Cruz-Almeida et al., 2013, Finan et al., 2013, King et al., 2013). The testing stimulus was also 
different with four studies using PPT (Finan et al., 2013, Arendt-Nielsen et al., 2014a, Arendt-Nielsen 
et al., 2010, Egsgaard et al., 2015) and two heat stimulus (Cruz-Almeida et al., 2013, King et al., 2013). 
Four studies subgrouped the participants based on knee pain intensity (Arendt-Nielsen et al., 2014a, 
Finan et al., 2013, King et al., 2013, Arendt-Nielsen et al., 2010), and the remaining two on their 
psychological status, physical impairments, QST (PPT, CPM, TS) and biochemical markers by cluster 
analysis (Cruz-Almeida et al., 2013, Egsgaard et al., 2015). Secondly, the inconsistent results may 
indicate a lack of correlation between CPM and clinical pain severity. Cluster analysis from one of the 
included studies revealed that a group of knee OA participants had equally potent CPM with their 
healthy controls (Egsgaard et al., 2015). Further, results of CPM in other chronic pain conditions 
were also inconclusive, with one study reporting no relationship between clinical pain severity and 
potency of CPM in temporomandibular disorder participants (Oono et al., 2014) and another a 
positive relationship in post-herpetic neuralgia participants (Pickering et al., 2014). However, none of 
the included studies subgrouped participants based on potency of CPM, instead CPM was compared 
among groups based on clinical features, such as pain intensity and psychological status. Finally, it is 
Important to note that significant intra- and inter-rater variability exists in the measurement of CPM 
(Oono et al., 2011a). Further studies are needed to standardise the measurement of CPM and test if 
CPM potency differs in those with knee OA pain. 
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Risk of bias assessment 
The main weakness of the included studies based on the risk of bias assessment is the blinding of 
assessors. Only two studies were rated low risk for blinding as cluster analysis was conducted and 
the assessors were unaware of the subgroup allocation prior to the tests. The remaining studies did 
not report any blinding procedure. It is important to blind the outcome assessors, and to report how 
this practice is conducted. Blinding the assessor from being aware of the participants’ pain intensity, 
duration of pain or psychological status is necessary as those are key factors of sub-grouping, and 
could influence the assessor’s conduct of the experiment. Good reporting quality enhances 
replicability of the studies and enables comparisons of various confounding factors such as the 
modality of tests, device used, testing sites and number of test trials. Future studies should consider 
implementing and reporting the appropriate blinding of the assessor and further reviews should 
assess reporting quality of QST. 
 
Implications for research and treatment  
The current study highlights the lack of standardized protocols for QST in knee OA participants, 
which calls for further studies to determine those standard protocols. The setting up of guidelines 
for reporting of psychophysical tests should also be considered to enable the comparison and 
appraisal of studies. Larger studies are also needed to confirm the findings of this review.  
 
Once subgroups are identified, their treatment response can be investigated. This may lead to the 
development of tailored and optimised treatments for individuals with knee OA. QST, such as PPT at 
the knee and TS of punctate pain away from the knee, could be considered to identify the 
“widespread sensitization” subgroups, and those subgroups can be further examined. A recent study 
found that severe TS of punctate pain at the knee before the surgery was associated with more 
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severe post-operative pain after total knee replacement surgery (Petersen et al., 2015). More of 
such studies are warranted so as to guide clinicians to select the appropriate treatment regimens. 
 
Limitations 
Only published full texts were included, and the small number of studies could have underestimated 
the potential of other psychophysical tests in identifying the subgroups. Within the included studies, 
some studies were from the same research groups. Only English databases were searched. However, 
Pubmed, Scopus and Embase also index non-English texts, and only one paper in German was 
identified, but was excluded because the comparison was between the healthy controls and those 
with knee OA.  
 
Conclusion 
Moderate level of evidence supports the validity of two key tests, PPT at the most affected knee and 
TS of punctate pain away from the knee, in subgrouping knee OA sufferers. These two tests are likely 
to reflect the involvement of widespread sensitization in some with knee OA. The two tests are non-
invasive, easy and quick to perform, and can be readily accepted by individuals with pain. Further 
studies should use proper blinding and develop a standardized psychophysical protocol for sub-
grouping of knee OA individuals so as to eliminate various biases. This would contribute to the 
identification of subgroups, and to further examine their treatment response to pain therapies. 
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 Chapter 5 : Methodologies of experimental studies 
 
Introduction  
Four experimental studies were designed to address the overall aim of investigating the relationship 
between endogenous pain controls, pain adaptability and treatment response from acupuncture in 
individuals with MSK. The first study attempted to investigate the relationship between SEG induced 
using vibration and pain adaptability in healthy participants (Chapter 6). The second study examined 
whether pain adaptability impacted on acupuncture analgesia in healthy participants (Chapter 7). 
The third study explored whether pain adaptability could be identified in MSK participants (Chapter 
8). The fourth study assessed the treatment response to local acupuncture in MSK participants and 
the impact of pain adaptability on this response (Chapter 9). Those four studies will be referred to as 
the SEG Study, the Pain Adaptability and Acupuncture Analgesia Study, the Pain Adaptability and 
MSK Study and the Acupuncture Response Study respectively. This chapter describes the 
methodology of those four experimental studies: QST procedures, vibration protocol to induce SEG, 
CPT used to assess pain adaptability and acupuncture protocol. 
 
Pain adaptability and the potency of endogenous pain controls were measured using QST. CPT has 
been found to be a reliable method to induce CPM in healthy and MSK participants (Oono et al., 
2011a, Lewis et al., 2012a). The CPT has also been recently used to determine pain adaptability of 
healthy participants (Zheng et al., 2014, Devoize et al., 2015). In two of the experimental studies, the 
CPT was used as the conditioning stimuli and PPT as a test stimulus. Through a systematic review 
(Chapter 4), PPT was found to be a reliable method of distinguishing subgroups, and was thus 
chosen as one of the primary outcome measures in the experimental studies. 
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There is currently no standard protocol for vibration induced analgesia. The vibration protocol used 
in the SEG study was designed based on the methodologies used in previous studies. Frequencies of 
50-200Hz (Tardy-Gervet et al., 1993) were reported to induce analgesia in MSK participants and the 
optimum analgesic response from vibration was found after 20-25 minutes of stimulation 
(Lundeberg et al., 1984). The protocol used in the SEG Study (Chapter 6) was chosen within those 
parameters and will be described in this chapter. 
 
The findings of the systematic review on the effects of needle placement on MSK participants 
(Chapter 3) contributed to the design of the acupuncture protocol for the Acupuncture Response 
Study. An Expert opinion of a clinician was also sought to design the acupuncture protocol. 
 
Validated questionnaires were used to measure secondary outcome measures such as the 
psychological characteristics, quality of life, physical function and sleep quality of the participants. 
Other secondary outcome measures included number of adverse events, blood pressure and 
temperature of the foot immersed in the CPT. 
 
The methodologies of those four studies are further described in the following sections. Figure 5.1 
summarises the methods for the primary outcome measures used in the respective studies. This 
chapter also outlines the ethics component, general study design and data analysis procedures of 
the studies. The results of those four studies are reported in chapters 6, 7, 8 and 9 respectively. 
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Figure 5.1: Aims and main outcome measures in the four experimental studies 
SEG= segmental inhibition; PAD= pain adaptability; AA=acupuncture analgesia; MSK=chronic musculoskeletal pain; Acu=acupuncture; PPT=pressure pain threshold; LBP=chronic non-specific low back pain 
participants; OA=knee osteoarthritis participants; VAS=visual analogue scale; CPM= conditioned pain modulation 
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Ethics approval 
The SEG Study and Pain Adaptability and Acupuncture Analgesia Study were collaborative projects 
conducted at the Center for Sensory-Motor Interaction, Aalborg University, Aalborg, Denmark, and 
were approved by the local ethics committee on the 4th December 2012 (project number 20120079) 
(Appendix 12).; and the approval was endorsed by the RMIT University Human Research Ethics 
Committee on the 16th October 2013 (application number 19156) (Appendix 13). 
 
Human ethics approval was obtained for the other two studies from the RMIT Human Research 
Ethics Committee on the 16th January 2015 (project number 48/14, Appendix 14). 
 
The studies were conducted with fairness and honesty. The student researcher and acupuncturists 
were made aware of their obligations and responsibilities. Participants were also informed about 
their rights and were given a copy of the signed consent form (Appendices 15-17).  
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Recruitment of participants 
Table 5.1 describes the methods of recruiting participants in the four studies. 
 
Table 5.1: Recruitment plan 
Approach Healthy participants* Healthy and MSK participants# 
Location Aalborg, Denmark Melbourne, Australia 
Websites/ 
social media 
Aalborg University Webpage RMIT webpage, RMIT Facebook 
page, Arthritis Victoria 
Flyers/ 
presentations 
Aalborg University campus RMIT campus, RMIT teaching clinic 
and senior citizens clubs 
Posters Aalborg University campus RMIT campus, local libraries, sports centres and retirement villages. 
Emails/ 
newsletters 
Aalborg University Healthy Volunteer 
list 
RMIT update, professional 
associations (Federation of Chinese 
Medicine & Acupuncture Societies of 
Australia, Australian Osteopathic 
Association, Australian Association of 
Massage Therapists, Massage 
Association of Australia, Australia 
integrative medicine association) 
disease associations (chronic pain 
Australia, Arthritis and Osteoporosis 
Victoria, Arthritis Australia) 
Newspapers local press Whittlesea Leader, Diamond Valley Leader, Preston Leader 
MSK=chronic musculoskeletal pain; RMIT=Royal Melbourne Institute of technology; *=for the SEG Study and the Pain 
Adaptability and Acupuncture Analgesia Study; #=for the Pain adaptability and MSK Study and the Acupuncture Response 
Study. 
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Selection criteria 
The screening was carried out by ZZ for studies in healthy participants in Aalborg, and by the student 
researcher in the studies on MSK participants at RMIT University. 
 
The selection criteria that the studies have in common are explained next, and the specific selection 
criteria for the healthy and MSK participants are outlined in the following subsections. 
 
Since the tests and questionnaires were rated by the participants, an adequate level of English was 
required in all the studies. Participants were excluded if they were pregnant or intended to become 
pregnant; breast feeding; had brain tumour, cancer or haemophilia so as not to interfere with their 
treatments or affect their health. Also individuals with frequent recreational drug use, excessive 
alcohol use or mental illnesses were excluded to ensure that the included participants would be able 
to cooperate throughout the study. Individuals using anti-convulsant, anti-depressant or opioid 
medication for pain were excluded as these medications either cannot be suddenly stopped 24 
hours before the tests or they could interfere with the endogenous pain controls. Individuals with 
injuries at the testing sites were excluded. To ensure their blinding from real and sham acupuncture 
and to reduce any carry over effects from previous acupuncture treatments, those who had 
acupuncture treatment in the three months preceding the Pain Adaptability and Acupuncture 
Analgesia Study and the Acupuncture Response Study were excluded. Since the CPT may affect 
blood pressure individuals with uncontrolled hypertension were excluded. 
 
 
 
 134 
 
Healthy participants (Zheng et al., 2014) 
The included healthy participants were required to be without any ongoing or chronic pain. In the 
SEG Study and the Pain Adaptability and Acupuncture Analgesia Study, the required age range was 
of 20 to 60 years old. In Pain Adaptability and MSK Study, healthy controls were included, and age 
limit was extended to 80 years old as the healthy controls needed to match the MSK participants’ 
gender and age. Table 5.2 outlines the selection criteria for the healthy participants. 
 
Table 5.2: Selection criteria for healthy humans (SEG study, Pain Adaptability and Acupuncture Analgesia Study and Pain 
Adaptability and MSk Study)  
Inclusion criteria for 
healthy volunteers (SEG 
Study and Pain Adapt 
ability and Acupuncture 
Analgesia Study) 
Inclusion criteria for MSK matched 
healthy controls (Pain 
Adaptability and MSK Study) 
Exclusion criteria 
• Aged 20-60 years  • Aged 20-80 years  • Pregnancy or intent to 
become pregnant, breast 
feeding, brain tumor, 
cancer, hemophilia 
• Free from ongoing/ 
chronic pain 
• Free from ongoing/ chronic 
pain 
• Regular use of analgesics, 
including simple analgesia 
and NSAIDs 
• Adequate 
conversational English 
• Adequate conversational 
English 
• Frequent recreational 
drug or excessive alcohol 
use 
• Previous neurologic or 
mental illnesses  
• Lack of ability to 
cooperate  
• Uncontrolled 
hypertension  
• Injuries in areas to be 
tested 
• Received acupuncture 
treatment in the last 3 
months 
NSAID=non-steroidal anti-inflammatory drug. 
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Chronic non-specific low back pain participants (Koes et al., 2006, Chou et al., 2007, Deyo 
et al., 2014) 
Since there are no golden guidelines for the diagnosis of LBP, the participants were selected based 
on the recommendations of previous studies (Koes et al., 2006, Chou et al., 2007, Deyo et al., 2014). 
Those with low back pain caused by radicular neuropathy, osteoporosis, surgery or previous 
fractures of the spine, acute trauma in the spine, inflammation, malignant or autoimmune disease 
were excluded (Chou et al., 2007) (Table 5.3). Individuals suffering from both LBP and knee OA were 
excluded. 
 
Table 5.3: Selection criteria for participants with chronic non-specific low back pain (Pain Adaptability and MSK Study 
and Acupuncture Response Study) 
Inclusion criteria Exclusion criteria  
• Aged 20-65 years • Regular anti-convulsant, anti-depressant 
or opioid use for pain 
• Diagnosed with LBP pain by a general 
practitioner or registered health care 
practitioner (ex: chiropractor, 
physiotherapist, osteopath) or meeting the 
recommendations from the American College 
of Physicians and the American Pain Society 
(Chou et al., 2007) 
• People with LBP who also have OA 
• Experienced ongoing pain at or above two out 
of 10 on a 0-10 numerical rating scale  
(0 being no pain at all and 10 the worst pain 
possible) in the previous week 
• Radicular pain, osteoporosis, surgery or 
previous fractures of the spine, history of 
acute trauma in the spine, low back pain 
caused by inflammatory, malignant, or 
autoimmune disease (low back pain from 
specific reasons) 
• Adequate conversational English and ability to 
cooperate 
• Pregnancy or intent to become pregnant, 
breast feeding, brain tumour, cancer, 
hemophilia, diabetic neuropathic pain or 
peripheral neuropathy 
• Frequent recreational drug or excessive 
alcohol use 
• Uncontrolled hypertension 
• Injuries in areas to be tested 
• Received acupuncture treatment in the 
last 3 months 
LBP=chronic non-specific low back pain; OA=knee osteoarthritis. 
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Knee osteoarthritis participants (Altman et al., 1986) 
Included participants were diagnosed with knee OA by health practitioners or based on the 
guidelines of the American college of Rheumatology (Altman et al., 1986). The selection criteria are 
described in Table 5.4. 
 
Table 5.4: Selection criteria for participants with knee osteoarthritis  
Inclusion criteria Exclusion criteria 
• Aged 40- 80 years • Regular anti-convulsant, anti-
depressant or opioid use for pain. 
• Diagnosed with OA (by a general 
practitioner or rheumatologist) in 
one/both knees that has lasted more than 
six months or knee pain with at least 
three out of six of the following criteria as 
recommended by the American College of 
Rheumatology (Altman et al., 1986): 
o -Age>50 years 
o -Stiffness<30minutes 
o -Crepitus 
o -Bony tenderness 
o -Bony enlargement 
o -No palpable warmth 
• People with OA who also have LBP 
 
• Experienced ongoing pain at or above two 
out of 10 on a 0-10 numerical rating scale 
(0 being no pain at all and 10 the worst 
pain possible) in the previous week 
• Pregnancy or intent to become 
pregnant, breast feeding, brain tumor, 
cancer, hemophilia, diabetic 
neuropathic pain or peripheral 
neuropathy.  
• Adequate conversational English • Frequent recreational drug or excessive 
alcohol use.  
• Uncontrolled hypertension 
• Injuries in areas to be tested 
• Received acupuncture treatment in the 
last 3 months 
LBP=chronic non-specific low back pain; OA=knee osteoarthritis. 
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Design and general procedure 
Potential participants who expressed their interest in taking part in the studies were administered a 
screening questionnaire via the phone or email (Appendices 18-19). Eligible participants were then 
sent more information about the procedure of the study and the consent form. They were given 
opportunities to consider about their participation. If they agreed to take part in the study, they 
were invited to attend face to face sessions to sign the consent form, take the tests and receive the 
acupuncture. The MSK participants were asked to stop pain medication 24 hours prior to testing as 
pain medication may affect the tests of pain sensitivity and state of their endogenous pain control 
(Olesen et al., 2010, Finan et al., 2013). 
 
In all the studies, demographic data and baseline data were collected at the beginning of the studies 
(Table 5.5): 
 
Table 5.5: Baseline characteristics of healthy and pain participants 
Baseline characteristics Healthy participants MSK participants 
Demographic   
Gender and age   
Body mass index   
Sleep quality   
Quality of life   
Comorbidities   
Pain and pain medication 
history 
N/A  
Psychophysics tests 
 (PPT, SUPRA PIN, 
thermal sensitivity) 
 (PPT, SUPRA, thermal 
sensitivity) 
= data collected; MSK=chronic musculoskeletal pain, PPT=pressure pain threshold; SUPRA=pain intensity to 
suprathreshold stimulus; PIN=pain intensity to pinprick. 
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All studies had a pre- and post- design, that is a set of QST was administered prior to and after the 
intervention. The types of interventions varied in each study, according to the aims. The test 
interventions were vibration, real and sham acupuncture, cold pressor and local acupuncture. 
Specifically, healthy participants in the SEG Study had one session of 20 minutes of vibration with 
QSTs before and after the vibration (Figure 5.2). 
 
 
Figure 5.2: General procedure for SEG Study in healthy participants 
HH=healthy participants; test=QST including PPT, SUPRA and PIN. 
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In the Pain Adaptability and Acupuncture Analgesia Study, healthy participants received two 
acupuncture sessions, once weekly over two weeks with a cross-over design between real and sham 
acupuncture (Figure 5.3). QSTs were conducted before and after the acupuncture at these two 
sessions. 
 
 
Figure 5.3: General procedure for Pain Adaptability and Acupuncture Analgesia Study 
HH=healthy participants; RA= real acupuncture; SA=sham acupuncture. 
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The Pain Adaptability and MSK Study included both healthy and MSK participants. All participants 
received 3 sessions of tests including one session for thermal sensitivity, two sessions for potency of 
endogenous pain controls and pain adaptability (Figure 5.4). 
 
 
Figure 5.4: General procedure for Pain Adaptability and MSK Study 
HH=healthy participants; LBP= chronic non-specific low back pain participants; OA=knee osteoarthritis participants; 
Psychophysics testing= psychophysics test including cold pressor test, pressure pain threshold and pain intensity to 
suprathreshold stimulus; Wk=week. 
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The Acupuncture Response Study only included the LBP and knee OA participants who participated 
in the Pain Adaptability and MSK Study (Figure 5.5). The participants received a twice weekly 
acupuncture treatment for four weeks, followed by one last session of psychophysics tests. They 
were asked to complete a one-week pain diary at baseline, and before and after the acupuncture 
treatment. 
 
 
Figure 5.5: General procedure for Acupuncture Response Study 
LBP= chronic non-specific low back pain participants; OA=knee osteoarthritis participants; test= psychophysics test 
including cold pressor test, pressure pain threshold and pain intensity to suprathreshold stimulus; acu= acupuncture 
treatment; Wk= week. 
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Outcome measures  
QST procedures  
All the QSTs were conducted by the student researcher. Before each test, a demonstration was given 
on the dorsum of the forearm (at an area that was not tested) (Rolke et al., 2006) to familiarise the 
participants with the procedure of the tests. 
 
Testing sites 
In the SEG Study and the Pain Adaptability and Acupuncture Analgesia Study, the participants were 
tested at both arms at the extensor carpi radialis, at 3 cm distal to the lateral end of the cubital 
crease on the elbow, and on the right leg at the soleus, 8 cm proximal to medial malleolus (Zheng et 
al., 2014) (Figure 5.6). 
 
 
Figure 5.6: Testing sites for the SEG Study and the Pain Adaptability and Acupuncture Analgesia Study 
(a)=extensor carpi radialis site; (b)= soleus site 
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In the Pain Adaptability and MSK Study and the Acupuncture Response Study participants were 
tested at their knees, lower back and wrists. The knee site was at 3cm medial to the mid-point on 
the medial edge of patella (Wylde et al., 2012, Graven-Nielsen et al., 2012). The site on the lower 
back was, 2-3cm lateral to L4 spinous process (Imamura et al., 2013, O'Neill et al., 2011). The site for 
the wrists was midpoint of dorsal aspect of the wrist joint line (O'Sullivan et al., 2014) (Figure 5.7). 
 
 
Figure 5.7: Testing sites for the Pain Adaptability and MSK Study and the Acupuncture Response Study  
(a)= knee sites, (b)=lower back sites; (c)=wrists sites 
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Thermal sensitivity 
The cold and warm detection thresholds and cold and heat pain thresholds of the participants were 
measured using the Thermal Sensory Analyser II (TSA-II, Medoc, Ramat Yishai, Israel) at all the six 
sites (Figure 5.7) in the pain adaptability and MSK study. A thermode (Figure 5.8) of area 30x30mm2 
was applied to the testing sites. Participants were given a switch (Figure 5.8) and were asked to 
press on it as soon as they felt cool, warm, cold pain or hot pain from the thermode. The method of 
limits was used with a baseline temperature of 32°C and a temperature returning rate of 4°C/s. For 
the assessment of the cold and warm detection thresholds, the temperature was decreased or 
increased at a rate of 1°C/s until the participants started to feel cool or warm and pressed on the 
switch. Three consecutive cold or warm stimuli were delivered at each site with an inter-stimulus 
interval ranging from 3 to 5 seconds (Rolke et al., 2006, Blumenstiel et al., 2011). For the assessment 
of cold pain and heat pain thresholds, the temperature was changed at a rate of 3°C/s until the 
participants pressed the switch when they started to feel pain. Three consecutive cold stimuli and 
three consecutive hot stimuli were delivered with an interval of 20s respectively (Heldestad et al., 
2010, Hagander et al., 2000). The safety cut-off temperatures were set at 0°C for testing cold pain 
threshold and 50°C for testing heat pain threshold. For participants whose pain threshold was 
beyond this range, 0°C and 50°C were recoded as their cold and heat pain thresholds respectively. 
 
 
Figure 5.8: Thermal sensory analyser, TSA-II, Medoc 
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Pressure pain threshold 
Hand held algometers with a circular probe of surface area 1 cm2 were used to deliver the pressure 
stimulus to measure PPT. In the SEG Study and the Pain Adaptability and Acupuncture Analgesia 
Study, a Somedic algometer (Somedic, Sweden) was used (Figure 5.9), at all the sites (arms and right 
leg). For the Pain Adaptability and MSK Study and the Acupuncture Response Study, a Medoc 
algemether was used (Algomed, Medoc, Ramat Yishai, Isreal) at all the six sites (knee, lower and 
wrists bilaterally) before the CPTs, and at three sites (knee, lower and wrists unilaterally) during and 
after the CPTs (Figure 5.10). In all PPT tests, the participants were given a switch to press on as soon 
as they started to feel pain from the pressure applied at the testing sites. The algometers were 
applied perpendicularly to the sites, and pressure was gradually increased at a rate of 30KPa/s 
(Zheng et al., 2014) until the participant pressed on the switch. The pressure reading at this 
particular point was the PPT. Two readings of PPT were taken at each site and the average was 
calculated.  
 
 
Figure 5.9: Algometer (Somedic) used in the SEG Study and the Pain Adaptability and the Acupuncture Analgesia Study 
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Figure 5.10: Algometer (Algomed Medoc) used in the Pain Adaptability and MSK Study and the Acupuncture Response 
Study 
 
 
Suprathreshold stimulation 
In the SEG Study and the Pain Adaptability and Acupuncture Analgesia Study, the intensity of 
suprathreshold pressure stimulus was calculated to 150% of the mean PPT at each site. A force 
gauge (FG5020, Lutron Electronics, Taipei, Taiwan, 0.01 to 20 kg) with a probe of surface area 1cm2 
was used to deliver this pressure twice at each site (Figure 5.11). The force gauge was applied 
perpendicularly to the site. Pressure was gradually increased until the required pressure was 
reached. Participants were then asked to rate the pain intensity from the suprathreshold pressure 
stimulus (SUPRA) on a 0-10 numerical scale, where 0 was for no sensation, 5 just when they started 
to feel pain and 10 for the worst pain possible. If it was too painful, the participants could interrupt 
the intervention even if the required pressure was not reached. At this point, the SUPRA was 
recorded as 10. 
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Figure 5.11: Force gauge, Lutron Electronics, used in the SEG Study and the Pain Adaptability and Acupuncture Analgesia 
Study 
 
 
In the Pain Adaptability and MSK Study, after the measurements for PPT, a suprathreshold stimulus 
was applied using the algometer (Algomed, Medoc, Ramat Yishai, Isreal) (Figure 5.10) at a pressure 
of 130% of the average PPT at each of the sites before the CPT and at three sites (knee, lower back 
and wrist unilaterally). Participants were asked to verbally rate their SUPRA measured at each site on 
a numerical scale of 0-10, where 0 indicates no sensation, 5 just when they started to feel pain and 
10 the worst pain possible.  
 
Pin Prick 
A weight calibrated pin-prick (512 mN and 0.2 mm diameter, Aalborg University, Denmark) was 
applied once at all the test sites in the SEG Study and the Pain Adaptability and Acupuncture 
Analgesia Study (Figure 5.12). The participants were then asked to verbally rate the pain intensity 
from the pin prick (PIN) on a numerical rating scale of 0-10 where 0 was for no sensation, 5 being 
just painful and 10 the worst pain possible. 
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Figure 5.12: 512 mN pin prick (Aalborg University) 
 
 
Cold pressor test  
The CPT is a standard test to assess the potency of CPM. This test was also used to assess pain 
adaptability in healthy humans (Zheng et al., 2014). In a previous study participants were asked to 
immerse their hand in cold water (1-4°C) for five minutes and continuously rate the pain from the 
cold water during the five minutes. The pain adaptability of the participants in the SEG Study and the 
Pain Adaptability and Acupuncture Analgesia Study was determined in the study mentioned above 
(Zheng et al., 2014). 
 
In the Pain Adaptability and MSK Study and the Acupuncture Response Study, during the CPT, 
participants were asked to immerse their foot to 3cm above the level of their ankle (Correa et al., 
2013) in a cold water bath at 2-4°C for up to 5 minutes or 7-9°C for up to 7 minutes on two different 
days (Zheng et al., 2014, Nouwen et al., 2006, Ahles et al., 1983). For convenience, the temperatures 
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of 2-4°C and 7-9°C will be referred to as 2°C and 7°C respectively in this chapter and the Chapter 8. 
The foot ipsilateral to the most painful knee or most painful side of the lower back for the MSK 
participants was used for the CPT, and the right foot was used for the healthy humans (Figure 5.13). 
 
 
Figure 5.13: Cold pressor test  
 
 
While their foot was in the cold water, participants were asked to rate their pain continuously using 
a 0-10 electronic visual analogue scale (eVAS, Aalborg university, Aalborg, Denmark) (Figure 5.14), 
where 0 indicated no pain at all and 10 the worst pain. They moved a slider forward or backward to 
rate their pain, and the pain intensity was shown on the indicator and recorded by a computer 
automatically. The recording was sampled at 200Hz. The pain adaptability of the participants was 
determined following the protocol in Zheng’s study (Zheng et al., 2014). 
Cold water at 2-4°C or 7-9°C 
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Figure 5.14: Electronic visual analogue scale (eVAS, Aalborg university) 
 
 
Before immersion in the cold water, all participants immersed the foot to be tested in a water bath 
at 20°C for 2 minutes (Nouwen et al., 2006) to standardise the initial foot temperature. Participants 
were informed that the cold pressor would be very painful however would cause no tissue damage. 
Participants were encouraged to put the foot in the water bath for the required duration; yet they 
were free to remove their foot at any time if it was too painful. 
 
 
 
 
Slider 
Indicator 
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Endogenous pain controls and analgesia 
In the SEG Study and the Pain Adaptability and Acupuncture Analgesia Study, vibration and 
acupuncture were applied on the left arm. PPT was measured at both arms and the right leg before 
and after vibration or acupuncture. The increase in PPT at the arms (site close to vibration and same 
position on the contralateral side) after vibration reflects the potency of SEG (Figure 5.15). The 
change in PPT at the three sites indicates after acupuncture the extent of acupuncture analgesia 
experienced. 
 
   
Figure 5.15: Methods of measuring potency of endogenous pain controls in the SEG Study and the Pain Adaptability and 
Acupuncture Analgesia Study 
Acu= acupuncture; Vib= vibration; AA=acupuncture analgesia; SEG=segmental inhibition;     =acupuncture points, 
PPT=pressure pain threshold.  
 
In the Pain Adaptability and MSK Study and the Acupuncture Response Study, CPTs were given as 
the conditioning stimulus and PPT was measured before, during and after the CPT at the wrist, knee 
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and lower back. During the CPT, an increase in PPT at the knee ipsilateral to the foot immersed in 
the cold water would indicate the potency of SEG whereas an increase in PPT at the wrist or lower 
back would indicate the potency of CPM (Figure 5.16). 
 
                   
Figure 5.16: Methods for measuring endogenous pain controls in the Pain Adaptability and MSK Study and the 
Acupuncture Response Study 
CPT=cold pressor test; CPM= conditioned pain modulation, SEG= segmental inhibition, PPT=pressure pain threshold. 
 
 
Psychological factors  
Psychological factors play an important role in pain perception. A set of validated questionnaires 
(English versions) was given to the participants during baseline assessments and before each 
psychophysics test to control for confounding factors.  
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Pain catastrophizing scale (PSC), which is a validated questionnaire (Osman et al., 2000, Osman et al., 
1997), was used to assess the participants’ feeling and thoughts when they were in pain (Sullivan et 
al., 1995) (Appendix 20). Participants were asked to rate how often they experienced the 13 
thoughts and feelings listed when they were in pain. The total score was calculated, a higher score 
indicates a higher extent of catastrophizing. 
 
The participants’ levels of depression, anxiety and stress were recorded using the Depression 
Anxiety and Stress Scale- 21 items (DASS-21) (Lovibond and Lovibond, 1995). This questionnaire, 
with proven psychometric properties (Brown et al., 1997), contains three subscales each containing 
seven items for depression, anxiety and stress, respectively (Appendix 21). The scores for each 
subscale were summed and compared with the reference values shown in Table 5.6 (Lovibond and 
Lovibond, 1995). 
 
Table 5.6: Cut-off scores for severity labels for depression, anxiety and stress measured using DASS-21 
 Depression Anxiety Stress 
Normal 0-4 0-3 0-7 
Mild 5-6 4-5 8-9 
Moderate 7-10 6-7 10-12 
Severe 11-13 8-9 13-16 
Extremely Severe 14+ 10+ 17+ 
 
The validated Spielberger State-Trait Anxiety Inventory (STAI) was used to assess the “state” anxiety 
(Spielberger et al., 1983, Ortuno-Sierra et al., 2016). Participants were asked to answer how they felt 
“right now” of the 20 items on the questionnaire on a four point scale (Appendix 22). A higher score 
would indicate greater anxiety. 
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The validated English version (Mao et al., 2010) of the Acupuncture Expectancy Scale (AES) was used 
to record the expectation of the participant in relation to the acupuncture treatment on a likert scale 
before the acupuncture (Mao et al., 2010). Participants were asked how much they agree with the 
four statements on their expectations (Appendix 23). The possible scores ranges from 4 to 20, higher 
scores indicates greater expectancy. 
 
 
Quality of life and functionality  
The validated short form Health Survey (SF-36) was used to measure the quality of life (Ware et al., 
2008, Brazier et al., 1992). This Questionnaire assessed both the physical and mental health of the 
participants (Appendix 24). A higher score indicates a better quality of life.  
 
A validated modified Roland Morris Questionnaire (RMQ) was used to assess the functional status of 
chronic pain participants (Roland and Morris, 1983, Asghari, 2011). This questionnaire contains 24 
items which participants were to check if any statement that applied to them (Appendix 25). The 
total number of checked statement was calculated; the greater the score, the more severe is the 
disability (Jensen et al., 1992a, Asghari and Nicholas, 2001). 
 
The sleep quality was measured using the validated questionnaire, Pittsburgh Sleep Quality Index 
(PSQI) (Buysse et al., 1989, Grandner et al., 2006, Mollayeva et al., 2016). Participants were asked 
about their sleep pattern in the last month. A score of five or less was associated with a good sleep 
quality, otherwise a score greater than five was associated with poor sleep quality (Appendix 26). 
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Sleep quality was also measured using a numerical scale of 0-10 where 0 means worst sleep quality 
and 10 means the best sleep quality. 
 
 
Measurements of the outputs of the autonomic nervous system 
The sympathetic nervous system affects the way the body reacts to pain (Sacco et al., 2013). 
Sympathetic nervous system factors were monitored by taking the blood pressure before, during 
and after the CPT. Beat-by-beat blood pressure readings were taken using the Human NIBP system 
(ADinstruments, Australia). A finger cuff was placed on the middle finger of the hand which was not 
a site for PPT measurement during the CPT (Figure 5.17). 
 
 
Figure 5.17: Methods for measuring blood pressure 
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Skin temperature 
The skin temperature of the foot was recorded by taking snapshots using an infrared camera with 
0.1°C accuracy (Testo 890, thermal imager, Testo, Germany) prior to the CPT. Only the thermal 
images of the participants’ arms and legs were recorded. No identifiable image was recorded (Figure 
5.18). The temperature at the foot to be immersed in the cold pressor was measured at the 
midpoint between the tip of the middle toe and the anterior aspect of the ankle level with the 
malleoli. This point was chosen as this part of the foot was fully immersed in the cold pressor, and 
the malleoli are protuberances that are easily identified on the thermal images. 
 
 
 
Figure 5.18 Thermal images from infrared camera- snapshot of the foot before the CPT 
 
 
Pain and medication diary 
In the acupuncture response study, the MSK participants were given pain and medication diaries to 
record their daily level of pain (pain intensity and unpleasantness) from the lower back or the most 
affected knee, as well as the duration of pain during the day (measured in hours), and any pain 
medication (types and dosage) taken during one week (Appendix 27). 
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Adverse events 
The number and types of adverse events were recorded at each QST and acupuncture session. For 
example participants were asked if they felt dizziness during the CPT or acupuncture, or if they felt 
any needling pain, sweating, or drowsiness after acupuncture. 
 
Summary of outcome measures used 
Table 5.7 lists the outcome measures used in the four studies.  
 
Table 5.7: Outcome measures used in the four experimental studies 
Outcome measures SEG Study PAD and AA Study 
PAD and 
MSK Study 
Acu 
response 
Study 
Thermal sensory thresholds      
Pressure pain threshold (PPT)     
Pain intensity to supra-threshold 
stimulus (SUPRA)     
Pain intensity to pin prick (PIN)     
Pain intensity to cold pressor test 
(VAS)     
Pain catastrophizing level (PCS)     
Anxiety (STAI or DASS)     
Expectancy to acupuncture (AES)     
Quality of life (SF-36)     
Sleep quality(PSQI)     
Functional status (RMQ)     
Skin temperature     
Blood pressure     
Pain level and medication intake     
Adverse events     
= not used in study; = used in study; SEG= segmental inhibition; PAD=pain adaptability; MSK=chronic musculoskeletal 
pain; Acu=acupuncture. 
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 Interventions 
Vibration 
The vibrometer (Vibrameter type IV, Somedic AB, Sweden) was applied at the left forearm for 20 
minutes with a pressure of the weight of the device at a frequency of 100Hz (Figure 5.19). The 
amplitude ranged from 200 to 300µm (microns) determined by individual response. Participants 
were given an electronic Visual Scale Analogue device (eVAS, Aalborg university, Aalborg, Denmark) 
to rate their sensation throughout the whole duration of the vibration on a 0-10 scale, where 0 
means no sensation at all, 5 means start to feel pain and 10 the worst pain. The level of stimulation, 
that is the amplitude of vibration, was adjusted at the start of the vibration to a rating of 2-3 on the 
same scale. The amplitude was adjusted also during the vibration and reduced if the participants felt 
that the vibration was too painful 
 
 
Figure 5.19: Vibrameter type IV 
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Acupuncture  
Acupuncture was delivered by qualified and experienced health practitioners. Needles of gauges 
0.25 x 30mm and 0.25 x 40mm were used (Phoenix medical, direct LTD UK and Hwato, Suzhou 
Medical Instrument Factory, China). 
 
In the Pain Adaptability and Acupuncture Analgesia Study, real acupuncture was delivered at the 
points LI4 and LI10 (Figure 5.20). Points LI4 is located “on the dorsum of the hand, radial to the 
midpoint of the second metacarpal bone” and LI10 is located “on the posterolateral aspect of the 
forearm on the line connecting LI5 and LI11 2B-cun inferior to the cubital crease” (World Health 
Organization, 2008). These points were chosen because they are often used for pain reduction. 
Sham acupuncture was delivered superficially at about one finger breadth away from the 
acupuncture points LI4 and LI10. Table 5.8 illustrates the methods used for real and sham 
acupuncture. 
 
 
Figure 5.20: Location of points LI4 and LI10 
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Table 5.8: Methods for real and sham acupuncture. 
 RA SA 
Needle 
placement  
LI4 and LI10 left side of the forearm  Sham LI4 and LI10 (see end of the 
table for explanation), avoid any 
known acupuncture points and 
meridians.  
Insertion 10–20 mm 2–3 mm 
Duration 20 min 20 min  
Manipulation Needles were manipulated in a bi-
directional manner for 1 min after 
insertion. The manipulation was 
repeated every 10 min for a total of 
three times. 
 
The needles were touch and moved 
gently after insertion for 5 seconds. 
This procedure was repeated every 10 
min for a total of three times. 
 
But the acupuncturist then sat with 
the participants for the remaining one 
minute to match the contact time in 
the RA session.   
Deqi Yes Deqi avoided 
RA= real acupuncture; SA= sham acupuncture;LI4: On the dorsum of the hand, between the 1st and 2nd metacarpal bones, 
approximately in the middle of the 2nd metacarpal bone on the radial side; LI10: About four finger width below the lateral 
epicondyle of the humerus. On the radial side of the radius, the extensor carpi radialis brevis and longus muscles; Location 
of sham LI4: On the dorsal part of the wrist, about 1 finger breath above the wrist crease and between the styloid process 
of the radius and midline of the dorsal aspect of the forearm. Location of sham LI 10: On the medial aspect of the forearm, 
between the midline and the lateral edge of the radius, four finger breadth distal to the cubital fossa. De Qi: described as a 
numb, distended and aching sensation, and indicates the desired effect of acupuncture stimulation being achieved 
 
 
In the Acupuncture Response Study, there were 8 sessions of acupuncture, twice a week over four 
weeks. Based on the systematic review (Chapter 3) (Wong Lit Wan et al., 2015) and an experienced 
clinician’s opinion, four to eight Ashi points (tender points) around the knee or low back were used. 
Ashi point is a Chinese medicine term for tender points that can be on or off the classical meridians, 
with no specific name and no definite location, and are painful on pressure (Birch, 2003, World 
Health Organization, 2007). The Ashi points were selected: (1) within the area between 10 cun above 
the apex of the patella and eight cun below the apex of the patella of the most painful knee of knee 
OA participants and (2) within the area between the region level to the inferior border of the 
spinous process of the twelve thoracic vertebra and the gluteal crease on the lower back of the LBP 
 161 
 
participants (Figure 5.21). The points selected at each session were recorded. The needles were 
inserted to a depth of 10- 20mm with needle manipulation to elicit the Deqi sensation. Manual 
needle manipulation in a bi-directional manner was performed every 10 minutes. More information 
about the acupuncture procedure can be found in the appendix (Appendix 28). 
 
 
Figure 5.21: Region where Ashi points were chosen on the lower back and knee 
 
 
Randomisation and blinding procedure 
In the Pain Adaptability and Acupuncture Analgesia Study, randomisation was carried out for the 
cross-over trial of real and sham acupuncture. Group A received real acupuncture first followed by 
sham acupuncture. Group B received sham acupuncture first followed that real acupuncture. The 
randomisation number was produced from Excel. The subjects drew a number which corresponded 
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to the code A or B. Only the acupuncturist was aware of the meaning of the code. The participants 
and the assessor were blinded from the group allocation. A pillow was placed on the participants’ 
chest while they were in the sitting position so that they could not see the intervention applied to 
the forearm. The psychophysics tests were performed at all the sites in different orders for each 
participant. 
 
In the Pain Adaptability and MSK Study, the participants were randomly allocated to a group 
receiving either a 2°C cold pressor test followed by a 7°C one or another group which received 7°C 
cold pressor test followed by a 2°C one. The methods for randomisation and group allocation were 
similar to those described above for the Pain Adaptability and Acupuncture Analgesia Study. An 
Excel generated randomisation sequence was used and the participants were randomised in blocks 
of 10. The order of sites for the psychophysics tests was also randomised. 
 
The acupuncturists and the researcher who delivered vibration were not involved in any outcome 
assessments. They were also blinded from the pain adaptability of the participants. 
 
 
Sample size 
To the author’s best knowledge, no studies looking at the relationship between pain adaptability and 
response to acupuncture or vibration in healthy humans or MSK participants have been carried out. 
For the SEG Study and the Pain Adaptability and Acupuncture Analgesia Study, participants were 
recruited as part of another study on pain adaptability (Zheng et al., 2014). For the pain adaptability 
and MSK study and the Acupuncture Response Study, the sample size was estimated based on a 
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previous healthy human study with a sample size of 41, reporting the two groups of pain 
adaptabilities (Zheng et al., 2014). A sample of 45 per group for LBP participants and knee OA knee 
OA for the Pain Adaptability and MSK Study and the Acupuncture Response Study could be enough 
to detect the pain adaptability and response to acupuncture. 
 
 
Data analysis 
The Statistical Program for Social Science (SPSS, version 23.0; IBM corporation, USA) and Labchart8 
(Adinstruments, Australia) were used for data analyses. Baseline categorical data, such as gender 
and numerical data were analysed with chi square (χ2) tests and two-sample t-tests or analysis of 
variance (ANOVA) respectively, to determine comparability of the groups on these variables. For 
simple pre-and post-test comparison, paired t-tests were used. For a factorial design, ANOVA or 
mixed-method ANOVAs were used. Data for change in PPT, SUPRA and PIN were analysed using raw 
values and percentage changes; only data for the percentage changes were presented in the thesis. 
In general, a p value of <0.05 was considered to be of statistical significance. To avoid type-I error 
caused by multiple comparisons, Holm-Bonferroni correction (Holm, 1979) was applied. A p-value 
that was smaller than the Holm-Bonferroni adjusted significance was considered significant. Missing 
data were dealt with using the last value carried forward method or according to individual manual 
of questionnaires. The data in the text are reported as mean and standard deviation (SD) and in 
figures as mean and standard error of mean (SE).  
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Participant withdrawal criteria and participant withdrawal procedures 
Participants were informed that they may: 
a) Withdraw from the studies at any time without having to provide any reason. 
b) Terminate their involvement in the studies if their pain significantly worsened, if they could not 
tolerate the CPT or could not tolerate acupuncture. 
c) Remove their hand or foot immediately from the water bath if they could not tolerate the cold 
pressor. These participants would be provided with a towel to warm their foot. They had the 
right to continue or withdraw from the study even if they could not complete the CPT. 
 
 
Management of risks and adverse events  
QST 
For the thermal sensitivity tests safety cut off temperatures were set at 0°C and 50°C to ensure that 
there would not be any tissue damage. The participants were informed that they could take their 
foot out of the cold water at any time when they felt that the test was too painful for them to 
tolerate. After the CPT they were given towels to warm their foot. A bench and first aid facilities 
were available in the testing rooms. In case of fainting from the CPT, participants were taken to the 
bench to lie down, with the legs in an elevated position.  
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Acupuncture treatment 
For acupuncture treatment, a slight pain or no pain may be felt at the needle insertion site. There is 
a low risk of infection from acupuncture. The skin was disinfected with an alcohol swabs prior to 
insertion of needle. Only disposable single-use acupuncture needles were used. Acupuncture was 
delivered by registered acupuncturists who were trained to comply with infection control 
procedures. Mild bleeding occurred after the removal of the acupuncture needles. Sterilized cotton 
balls were used to stop the bleeding. Antiseptic swabs were used to clean the bleeding area. If 
needed, a band-aid was provided.  
 
Personal information  
All data collected were unidentifiable and were kept confidential. In this thesis, all personal 
information was removed. 
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Introduction 
Vibration has been used to reduce clinical pain (Ottoson et al., 1981, Lundeberg, 1983, Lundeberg, 
1984, Roy et al., 2003) and experimental pain (Yarnitsky et al., 1997, Hollins et al., 2014, Dahlin et al., 
2006). This analgesic effect was reflected by a decrease in pain intensity or an increase in pain 
threshold of a test stimulus. Vibratory stimulation is thought to activate SEG and to induce analgesia 
at segmental level, that is, the ipsilateral site and contralateral site to where vibration is applied 
(Salter and Henry, 1987, Bini et al., 1984, Yarnitsky et al., 1997).  
 
The analgesic effect of vibration seems to be inconsistent: some studies found that vibration induced 
analgesia whereas other did not. Dahlin and colleagues found that pain threshold from a non-
invasive electrocutaneous stimulation at the thumb and index finger increased in women after 20 
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minutes of vibratory stimulation at the forearm (Dahlin et al., 2006). Another study found that 
vibration significantly decreased the pain intensity from suprathreshold heat stimulus at an adjacent 
or similar dermatome (on the contralateral side) to the site of the heat stimulus (Yarnitsky et al., 
1997). Watanabe and colleagues, on the other hand, reported that vibration, at segmental and 
extra-segmental sites to the left arm (experiencing electrical stimulation), did not change the pain 
rating to an electrical stimulus at the left arm in healthy participants (Watanabe et al., 1999). Further, 
vibration did not affect laser pain or laser evoked potentials in healthy participants (Pazzaglia et al., 
2016). Thus, much consideration should be taken before choosing vibration to induce analgesia for 
pain management.  
 
These discrepancies among the studies might be attributable to the different methodologies used. 
Previous studies have used different parameters for vibration (frequency, duration of stimulation, 
area of probe) (Dahlin et al., 2006, Lundeberg et al., 1984, Tardy-Gervet et al., 1993). Those studies 
also used different procedures (outcome measures) to evaluate the analgesic effect of vibration with 
electrical (Watanabe et al., 1999, Dahlin et al., 2006), thermal (Staud et al., 2011, Yarnitsky et al., 
1997) or mechanical (Hollins et al., 2014) stimuli. The ideal protocol to induce vibration analgesia is 
still unclear. 
 
Vibration-induced analgesia may also be affected by individuals’ adaptability to pain. A previous 
study reported a weak positive correlation between SEG and pain adaptability (Zheng et al., 2014). 
Pain adaptability was based on their response to a CPT. In that study the healthy participants were 
categorised into two groups: the PA and PNA group (Zheng et al., 2014). At the start of the CPT both 
PA and PNA showed an increase in their pain intensity to the CPT. Then, at the end of the CPT, the 
PA showed a decrease in pain intensity from the CPT (≥2 from their maximum pain on a scale of 0-
10, 0 being no pain at all and 10 the worst pain possible) whereas the PNA showed no change in pain 
or an increase in pain intensity.  
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The aims of this study were: (1) to assess whether vibration could be used to induce analgesia; (2) to 
assess whether vibration-induced analgesia was segmentally or extra-segmentally distributed; and (3) 
to investigate whether PA and PNA differed in vibration analgesia, that is, if PA reported better 
vibration-induced analgesia than PNA did. 
 
 
Design and procedure 
Volunteers were recruited as part of a study investigating pain adaptability at the Aalborg University, 
Aalborg, Denmark (Zheng et al., 2014). The selection criteria for the healthy participants are 
described in Chapter 5 (Selection criteria section, pg 134). Participants aged 20-60 years old and free 
from ongoing or chronic pain were recruited. Pain adaptability of the included participants was 
determined previously in Zheng’s study by performing a CPT where they were asked to put their 
dominant hand in a cold water bath at 1-4°C for five minutes and simultaneously rate the pain from 
the cold water (Zheng et al., 2014). 
 
Design 
Each participant received one session of test. At the beginning of the session, demographics, hand 
dominance and BMI were recorded. The participants were also asked to report whether they had 
any caffeine intake, whether they did strenuous exercises and their quality of their sleep in the past 
24hr. They had to complete a questionnaire, the State-Trait Anxiety Inventory (STAI), about their 
level of stress and anxiety (Spielberger et al., 1983) (Chapter 5, Psychological factors section, pg 152-
154). These factors were measured as they were thought to affect pain (Sawynok, 2011, Kothari et 
al., 2015, Rio et al., 2015). The participants were seated comfortably with their arms on the armrests 
of a dental chair. The general procedure of the study is summarised in Figure 6.1. The participants 
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received a set of QSTs followed by vibration and a second and a third set of QSTs immediately after 
and 20 minutes after vibration respectively. There were two researchers: one was responsible for 
applying vibration (YD) and the other, the assessor, was responsible for delivering the QSTs (DW). 
Both researchers were blinded to the pain adaptability status of the participants. 
 
 
Figure 6.1: Procedure for SEG Study 
PA=pain adaptive; PNA=pain non-adaptive; BMI=body mass index; STAI=State-Trait Anxiety Inventory; PPT= pressure pain 
threshold; SUPRA= pain intensity from suprathreshold pressure stimulus; PIN= pain intensity to pinprick. 
 
 
Outcome measures 
The main outcome measure was the PPT; the average of three readings of PPT was recorded 
(Chapter 5, Pressure pain threshold section, pg 145). Secondary outcome measures included SUPRA 
using a numerical rating scale (Chapter 5, Suprathreshold stimulation section, pg 146), PIN using a 
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numerical rating scale (Chapter 5, Pin Prick section, pg 147) and rating to vibration measured using 
an electronic visual analogue scale (eVAS, Aalborg university, Aalborg, Denmark). The QST 
assessments were performed at sites on the dorsal aspect of the left and right forearms close to the 
elbow (about 3 cm from the lateral epicondyle on the brachioradialis muscle) and the medial aspect 
of the right tibia (on the right soleus at 8 cm proximal to the medial malleolus) (Figure 6.2). 
 
 
       
Figure 6.2: Testing sites at the forearms and right leg 
PPT=pressure pain threshold; SUPRA= pain intensity to suprathreshold pressure stimulus; PIN= pain intensity to pinprick 
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Vibration 
Participants received vibratory stimulation for 20 minutes on the left forearm (close to the site for 
PPT measurements). An electronic vibrometer, with a probe of diameter of 1cm, (Vibrameter type IV, 
Somedic AB, Sweden) was used to deliver the vibration stimulus at a frequency of 100 Hz (Figure 6.3). 
The amplitude of the stimulus ranged from 200 to 300µm (microns), and was determined 
individually. Prior to the vibration session, each participant was asked to rate the intensity of the 
sensation induced by vibration. The amplitude was adjusted so that the participants rated their 
sensation from the vibration to an intensity of 2-3 on a 0-10 scale eVAS (0 meaning no pain at all, 5 
just start to be painful and 10 the worst pain possible). During the 20 minutes of vibration the 
participants were asked to continuously rate their sensation to vibration, using the eVAS on the 
same scale. The maximum rating to vibration of each participant was recorded. During the vibration, 
the amplitude was adjusted and reduced if the participants felt that the vibration was too painful. 
 
 
Figure 6.3: Vibrameter type IV (Somedic AB, Sweden) 
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Data analysis 
The percentage PPT change after vibration at all sites was calculated such that a negative value 
indicated a decrease in PPT and a positive value indicated an increase in PPT. Similar methods were 
used to calculate the percentage change in SUPRA and PIN. To test whether vibration induced 
analgesia segmentally, the percentage PPT change immediately after and 20 minutes after vibration 
at the left and right arms were analysed using two-way (site by time) with two repeated measures 
(site, 2 levels and time, 2 levels) of ANOVA. To tests whether analgesia was induced extra-
segmentally, one way with one repeated measure (time, 2 levels) of ANOVA was used for the 
percentage PPT change at the leg after vibration. The baseline characteristics of PA and PNA were 
compared using independent t-tests and chi square tests. Three-way (group, time and site) mixed 
ANOVAs with repeated measures (time, 2 levels and sites, 3 levels) were used to analyse the 
percentage change in PPT, SUPRA and PIN before and after vibration at each site in PA and PNA. 
Post-hoc analyses were performed when necessary. Multiple comparisons were adjusted using the 
Holm-Bonferroni correction (Holm, 1979). The hypotheses were arranged in ascending order based 
on their p-value, and those p-values were compared with the Holm-Bonferroni adjusted significance. 
A p-value that was smaller than the Holm-Bonferroni adjusted significance was considered 
significant. The data in the text are reported as mean and standard deviation (SD) and in figures as 
mean and standard error of mean (SE). 
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Results  
Baseline characteristics 
From March to October 2013 a total of 21 healthy volunteers participated in this study, including 9 
PA and 12 PNA. The participants were aged 18 to 53 years old, with a mean age of 26.33 ± 7.75 years. 
Eight of them were males and 13 were females. The means and standard deviations of the 
participants’ baseline characteristics are shown in Table 6.1. 
 
Table 6.1: Baseline characteristics of participants 
Baseline 
characteristics Mean or frequency 
Standard deviation 
Age (yrs) 26.33 7.76 
Gender (M/F) 8/13 - 
BMI 22.33 2.81 
STAI (state score) 31.76 6.92 
Sleep quality (NRS*) 7.67 2.11 
Coffee/no coffee  15/6 - 
Exercise/ no exercise 5/16 - 
PA/ PNA 9/12 - 
PPT LA (KPa) 188.61 64.64 
PPT RA (KPa) 199.65 63.51 
PPT RL (KPa) 348.35 114.08 
SUPRA LA (NRS) 5.67 1.55 
SUPRA RA (NRS) 6.10 1.35 
SUPRA RL (NRS) 6.62 1.64 
PIN LA (NRS) 3.19 1.25 
PIN RA (NRS) 3.50 1.47 
PIN RL (NRS) 3.14 1.48 
Hand dominance L/R 2/19  
M=male; F=female; BMI= body mass index; STAI=State Trait Anxiety Inventory; NRS*=numerical rating scale 0-10, 0 being 
the worst sleep quality and 10 being the best sleep quality; PPT= pressure pain threshold; SUPRA= pain intensity to 
suprathreshold pressure stimulus; PIN= pain intensity to pin prick; LA=left arm; RA= right arm; RL= right leg; KPa=kilo Pascal; 
NRS= numerical scale 0-10, 0 being no sensation at all, 5 just painful and 10 the worst pain; L=left; R=right. 
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PPT, SUPRA and PIN changes after vibration 
The changes in PPT, SUPRA and PIN were analysed using both the raw values and percentage 
changes. There were no differences between the two sets of results. The data on the percentage 
change will be presented in the following sections. 
 
 Segmental effect of vibration 
A two–way (site by time) with two repeated measures (site, 2 levels and time, 2 levels) of ANOVA 
was performed to analyse the percentage change in PPT between the left and right arm after 
vibration (Figure 6.4). There was no time effect (F(1,20)=3.04, p=0.10), site effect (F(1,20)=3.01, p=0.10) 
or site by time interaction (F(1,20)=0.244, p=0.63). 
 
 
Figure 6.4: Percentage PPT change after vibration on the left and right arms (n=21, mean ± SE) 
Although not significant, an increase in PPT at the contralateral arm (right arm), and a decrease in PPT at the ipsilateral arm 
(left arm) were observed. PPT=pressure pain threshold; Imm= immediately after vibration; Post=20 minutes after vibration. 
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Two-way (site by time) with repeated measures (site, 2 levels and time 2 levels) of ANOVAs were 
also used to analyse the percentage change in SUPRA and PIN at the left arm and right arm. There 
was no statistically significant main effect of site or time for SUPRA and PIN at the left and right arms, 
and no site by time interaction either for SUPRA and PIN (Table 6.2). This indicates that ratings to 
suprathreshold pressure stimulus or pin prick did not change over time nor differ among the two 
sites. 
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Table 6.2: Percentage change in SUPRA and PIN after vibration at the left arm and right arm (n=21, mean ± SD) 
% changes Sites Imm Post 
Site effect Time effect Site by time 
F(1,20)-
value 
p-
value 
F(1,20)-
value 
p-
value 
F(1,20)-
value 
p-
value 
SUPRA Left arm 9.10 ± 26.97 16.64 ± 32.96 0.48 0.49 1.01 0.33 0.09 0.77 
Right arm 5.23 ± 11.76 11.03 ± 39.67 
PIN Left arm 19.84 ± 54.73 22.06 ± 62.90 1.59 0.22 0.02 0.88 0.08 0.78 
Right arm 12.79 ± 53.47 12.63 ± 57.34 
SUPRA=pain intensity to suprathreshold pressure stimulus; PIN=pain intensity to pin prick; Imm=immediately after vibration; Post= 20 minutes after vibration. 
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Extra-segmental effect of vibration 
The percentage change in PPT at the right leg was analysed using one-way repeated measures (time, 
2 levels) of ANOVA (Figure 6.5). No significant time effect was found in PPT at the right leg 
(F(1,20)=0.25, p=0.62). 
 
 
Figure 6.5: Percentage PPT change at the right leg after vibration (n=21, mean ± SE) 
PPT= pressure pain threshold; Imm= immediately after vibration; Post= 20minutes after vibration. 
 
 
The percentage change in SUPRA and PIN at the right leg were also analysed using one-way with 
repeated measure of ANOVAs (Table 6.3). SUPRA and PIN at the right leg seemed to increase 
immediately and 20 minutes after vibration. However, this change was not statistically significant. 
 
Table 6.3: Percentage change in SUPRA and PIN after vibration (n=21, mean ± SD) 
% changes Imm Post 
Time effect 
F(1,20)-
value p- value 
SUPRA 6.17 ± 18.09 8.94 ± 18.21 1.35 0.26 
PIN 21.64 ± 52.72 37.19 ± 72.35 3.00 0.10 
SUPRA=pain intensity to suprathreshold pressure stimulus; PIN=pain intensity to pin prick; Imm=immediately after 
vibration; Post= 20 minutes after vibration. 
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Rating to vibration 
The mean maximum rating to vibration of the 21 participants was 3.94 ± 1.96, ranging from 0.40 to 
7.60. Eight participants rated the vibration as being painful (mean rating of 5.86 ± 0.90) and 13 rated 
as non-painful (mean rating of 2.75 ± 1.39). 
 
To explore the possibility that the rating to vibration could have contributed to the lack of change in 
PPT after vibration, the effect of vibration in these two groups were compared. Those who rated 
vibration as being painful ( rating of ≥5) were categorised in the “Vib+” group and those who rated 
vibration as non-painful (rating of <5) were categorised in the “Vib-” group. 
 
The two groups were comparable in their age and gender (Table 6.4). Although the Vib+ were more 
sensitive to pressure and pin prick stimulation (that is they had lower PPT, higher SUPRA and higher 
PIN) than the Vib- at baseline, there was no statistically significant difference between the two 
groups. 
Table 6.4: Baseline characteristics of the Vib+ and the Vib- (mean ± SD) 
Baseline 
characteristics Vib+ (n=8) Vib- (n=13) 
X21/t19-
value 
P-
value 
Adjusted 
significance1 
Age (yrs) 26.63 ± 6.16 26.15 ± 8.83 0.13 0.90 0.03 
Gender (M/F) 3/5 5/8 <0.01 0.97 0.05 
PPT LA (KPa)  179.70 ± 65.81 194.10 ± 65.97 -0.49 0.63 0.01 
PPT RA (KPa) 185.05 ± 68.49 208.64 ± 61.29 -0.82 0.42 0.01 
PPT RL (KPa) 336.54 ± 145.77 355.62 ± 95.63 -0.36 0.72 0.01 
SUPRA LA (NRS) 6.06 ± 1.82 5.42 ± 1.38 0.91 0.37 0.01 
SUPRA RA (NRS) 6.50 ± 1.44 5.85 ± 1.28 1.09 0.29 <0.01 
SUPRA RL (NRS) 6.81 ± 1.81 6.50 ± 1.58 0.42 0.68 0.01 
PIN LA (NRS) 3.50 ± 1.31 3.00 ± 1.22 0.89 0.39 0.01 
PIN RA (NRS) 3.63 ± 1.60 3.42 ± 1.44 0.30 0.77 0.02 
PIN RL (NRS) 3.44 ± 1.64 2.96 ± 1.42 0.70 0.49 0.01 
Vib+= those who rated vibration as being painful; Vib-=those who rated vibration as being non-painful; M=male; F=female; 
PPT=pressure pain threshold; SUPRA= pain intensity to suprathreshold pressure stimulus; PIN pain intensity to pinprick; 
LA= left arm; RA= right arm; RL= right leg; NRS= numerical scale 0-10, 0 being no sensation at all, 5 just painful and 10 the 
worst pain possible; 1= Holm-Bonferroni adjusted criterion of statistical significance. 
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Other factors such as BMI, level of anxiety, sleep quality, level of exercise and caffeine intake were 
also compared between the two groups (Table 6.5). There was no significant difference in all those 
confounding factors between the two groups. However, a trend was identified in their state stress 
and anxiety score (t19=2.10, p=0.06). The Vib+ seemed to have a higher STAI (state) score than the 
Vib-, indicating that they were potentially more stressed than the Vib-. 
 
Table 6.5: Confounding factors in Vib+ and Vib- (mean ± SD) 
Confounding factors Vib+ (n=8) Vib- (n=13) X
2
1/t19-
value 
p-
value  
Adjusted 
significance1 
BMI 23.11 ± 2.91 21.85 ± 2.75 1.00 0.33 0.01 
STAI score (state) 35.88 ± 8.10 29.23 ± 4.83 2.10 0.06 0.01 
Sleep quality (NRS*) 7.25 ± 2.43 7.92 ± 1.93 -0.70 0.49 0.03 
Exercise/ no exercise  6/2 9/4 0.08 0.78 0.05 
Coffee / no coffee  1/7 4/9 0.91 0.34 0.02 
Vib+= those who rated vibration as being painful; Vib-=those who rated vibration as being non-painful; BMI=body mass 
index; STAI= state-trait anxiety inventory; NRS*=numerical rating scale of 0-10, 0 being worst sleep quality and 10 the best 
sleep quality; 1= Holm-Bonferroni adjusted criterion of statistical significance. 
 
 
Their percentage change in PPT was compared at the three sites, using three-way (site, time and 
group) with repeated measures (site 3 levels, time 2 levels) of mixed ANOVA (Table 6.6). A trend for 
time effect was found in percentage PPT change, with an increase in PPT at 20 minutes after 
vibration (F(1,19)=3.38, p=0.08). There was no main effect for groups, sites or significant interactions. 
The percentage change in SUPRA and PIN were also compared between those two groups using 
similar analysis (Table 6.6). No significant group, time or site effects was identified, neither 
significant interactions. 
 
 180 
 
Table 6.6: Percentage change in PPT, SUPRA, PIN after vibration in Vib+ and Vib- (mean ± SD) 
QST 
measures Sites 
Imm Post Group effect Time effect Group by time Site effect 
Group by 
site 
Vib+ (n=8) Vib- (n=13) Vib+ (n=8) Vib- (n=13) F(1,19)-value 
p-
value 
F(1,19)-
value 
p-
value 
F(1,19)-
value 
p-
value 
F(2,38)-
value 
p-
value 
F(2,38)-
value 
p-
value 
% PPT 
change 
Left 
arm -13.60 ± 29.38 -10.45 ± 24.74 -8.66 ± 42.28 -2.84 ± 27.03 
1.12 0.30 3.38 0.08 2.20 0.16 1.75 0.19 0.27 0.77 Right arm -7.00 ± 28.73 7.34 ± 13.82 8.53 ± 43.37 4.17 ± 16.50 
Right 
Leg -7.45 ± 20.22 6.94 ± 12.73 -7.07 ± 21.83 4.72 ± 11.67 
% SUPRA 
change 
Left 
arm 12.15 ± 37.81 7.23 ± 19.20 11.01 ± 38.56 20.10 ± 30.14 
0.67 0.42 0.84 0.37 0.74 0.40 0.52 0.60 0.16 0.86 Right arm 1.83 ± 9.56 7.32 ± 12.83 2.9 ± 16.89 16.02 ± 48.84 
Right 
Leg 3.44 ± 5.34 7.85 ± 22.82 4.32 ± 9.40 11.79 ± 21.86 
% PIN 
change 
Left 
arm 16.88 ± 66.44 21.67 ± 49.07 30.00 ± 90.51 17.18 ± 41.79 
0.44 0.52 0.94 0.35 0.06 0.81 1.67 0.21 0.71 0.50 Right arm 16.67 ± 57.04 10.40 ± 53.39 25.00 ± 73.46 5.02 ± 46.55 
Right 
Leg 45.75 ± 61.62 6.79 ± 42.33 47.84 ± 94.82 30.641 ± 57.95 
Vib+= those who rated vibration as being painful; Vib-=those who rated vibration as being non-painful; QST=quantitative sensory test; Imm=immediately after vibration; Post=20minutes post vibration; 
PPT=pressure pain threshold; SUPRA=pain intensity to suprathreshold stimulus; PIN=pain intensity to pin prick. 
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Effect of vibration in PA and PNA 
Baseline characteristics 
Table 6.7 shows the demographics and baseline characteristics of PA and PNA. No significant 
difference was found between PA and PNA in their baseline characteristics. 
 
Table 6.7: Demographic and baseline characteristics of PA and PNA (mean ± SD) 
Baseline 
characteristics PA (n=9) PNA (n=12) 
X21/t1-
value 
p-
value  
Adjusted 
significance1 
Age (yrs) 28.11 ± 9.97 25.00 ± 5.71 0.91 0.38 0.01 
Gender M/F 3/6 5/7 0.15 0.70 0.01 
PPT LA (KPa)  189.33 ± 55.20 188.08 ± 73.35 0.04 0.97 0.05 
PPT RA (KPa) 195.81 ± 61.81 202.53 ± 37.34 -0.23 0.82 0.02 
PPT RL (KPa) 321.30 ± 85.38 368.63 ± 131.58 -0.94 0.36 <0.01 
SUPRA LA (NRS) 5.44 ± 1.21 5.83 ± 1.80 -0.56 0.58 0.01 
SUPRA RA (NRS) 6.06 ± 1.47 6.13 ± 1.32 -0.11 0.91 0.03 
SUPRA RL (NRS) 7.00 ± 1.25 6.33 ± 1.89 0.92 0.37 0.01 
PIN LA (NRS) 3.11 ± 1.27 3.25 ± 1.29 -0.25 0.81 0.01 
PIN RA (NRS) 3.67 ± 1.58  3.38 ± 1.43 0.44 0.66 0.01 
PIN RL (NRS) 3.39 ± 1.69 2.96 ± 1.36 0.65 0.53 0.01 
PA=pain adaptive; PNA=pain non-adaptive; M=male; F=female; PPT=pressure pain threshold; SUPRA= pain intensity to 
suprathreshold pressure stimulus; PIN pain intensity to pinprick; LA= left arm; RA= right arm; RL= right leg; NRS= numerical 
scale 0-10, 0 being no sensation at all, 5 just painful and 10 the worst pain possible; 1= Holm-Bonferroni adjusted criterion 
of statistical significance. 
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Confounding factors 
Factors that could affect pain sensitivity such as BMI, psychological factors, sleep quality, exercise or 
caffeine intake were controlled. No significant difference was found in those confounding factors 
between PA and PNA (Table 6.8). 
 
Table 6.8: Confounding factors in PA and PNA (mean ± SD) 
Confounding factors PA (n=9) PNA (n=12) X
2
1/t1-
value 
p-
value 
Adjusted 
significance1 
BMI 22.46 ± 3.43 22.24 ± 2.39 0.17 0.81 0.02 
STAI score (state) 31.33 ± 6.70 32.08 ± 7.34 -0.24 0.81 0.03 
Sleep quality (NRS*) 7.67 ± 1.94 7.67± 2.31 <0.01 1.00 0.05 
Exercise/ no exercise  1/8 4/8 1.50 0.22 0.01 
Coffee / no coffee  6/3 9/3 0.18 0.68 0.01 
PA=pain adaptive; PNA=pain non-adaptive; BMI=body mass index; STAI= State-Trait Anxiety Inventory; NRS*=numerical 
rating scale of 0-10, 0 being worst sleep quality and 10 the best sleep quality; 1= Holm-Bonferroni adjusted criterion of 
statistical significance. 
 
 
Response to vibration in PA and PNA 
Three-way (group, time and site) with repeated measures (time, 2 levels and sites, 3 levels) were 
used to analyse the percentage change in PPT at the three sites in PA and PNA (Table 6.9). No 
significant main effects neither significant interactions were observed in percentage change in PPT. 
The percentage change in SUPRA and PIN was analysed using similar analysis (Tables 6.9). No 
significant main effects or significant interactions were identified in percentage change of SUPRA 
and PIN. This indicated that PA and PNA did not differ in their PPT, SUPRA and PIN response to 
vibration. 
 
 183 
 
Table 6.9: Percentage change in PPT, SUPRA, PIN after vibration in PA and PNA (mean ± SD) 
QST 
measures Sites 
Imm Post Group effect Time effect Group by time Site effect Group by site 
PA (n=9) PNA (n=12) PA (n=9) PNA (n=12) F(1,19)-value 
p-
value 
F(1,19)-
value 
p-
value 
F(1,19)-
value 
p-
value 
F(2,38)-
value 
p-
value 
F(2,38)-
value 
p-
value 
% PPT 
change 
Left 
arm -18.74 ± 25.74 -6.34 ± 25.84 -10.17 ± 37.18 -1.22 ± 30.11 
0.05 0.83 1.97 0.18 0.04 0.84 2.31 0.11 1.20 0.31 Right arm 2.35 ± 19.77 1.52 ± 23.27 2.09 ± 18.79 8.64 ± 35.01 
Right 
Leg 6.15 ± 14.44 -2.06 ± 18.63 5.66 ± 13.23 -3.84 ± 18.57 
% SUPRA 
change 
Left 
arm 4.71 ± 12.49 12.40 ± 34.37 19.73 ± 34.94 14.32 ± 32.76 
0.33 0.57 1.70 0.21 1.10 0.31 0.49 0.62 0.19 0.83 Right arm -0.44 ± 11.83 9.48 ± 10.17 13.89 ± 60.48 8.89 ± 13.73 
Right 
Leg 1.02 ± 13.61 10.03 ± 20.55 4.49 ± 14.16 12.28 ± 20.70 
% PIN 
change 
Left 
arm 26.48 ± 44.40 14.86 ± 62.85 16.11 ± 27.81 26.53 ± 81.11 
0.02 0.90 0.79 0.39 0.08 0.79 1.51 0.24 0.25 0.78 Right arm 10.00 ± 43.59 14.88 ± 61.69 2.96 ± 28.55 19.88 ± 72.47 
Right 
Leg 16.04 ± 56.46 25.83 ± 51.87 45.11 ± 70.04 31.25 ± 76.55 
PA=pain adaptive; PNA=pain non-adaptive; QST=quantitative sensory test; Imm=immediately after vibration; Post=20minutes post vibration; PPT=pressure pain threshold; SUPRA=pain intensity to 
suprathreshold stimulus; PIN=pain intensity to pin prick. 
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Discussion 
Summary of results 
Vibration neither significantly increased PPT, nor reduced ratings to SUPRA or PIN immediately after 
or 20 minutes after vibration at any of the three sites. In this study, vibration did not induce 
analgesia either segmentally or extra-segmentally, instead a decrease in percentage PPT was 
observed at the site of application, although not significant. No significant difference was found 
between PA and PNA in their response to vibration as assessed by the change in PPT, SUPRA and PIN. 
 
Vibration parameters 
The results are consistent with some studies. Watanabe and colleagues used a similar device as in 
the current study, with comparable frequency (120Hz) and amplitude (200µm), to stimulate the left 
brachioradialis muscle, which was also the site of stimulation in the present study (Watanabe et al., 
1999). They reported that vibration did not change pain intensity induced by painful electrical 
cutaneous stimulus in healthy participants. The duration of stimulation was not specified in their 
study, it was reported that the vibration was applied simultaneously with 30 consecutive electrical 
stimuli. 
 
On the other hand, the present study also contradicts the findings from other studies on vibration in 
healthy and pain participants. For instance, Yarnitsky and colleagues reported that vibration 
significantly decreased the pain rating to suprathreshold heat stimulus in healthy participants 
(Yarnitsky et al., 1997). Lundeberg and colleagues found that vibration reduced clinical pain in 
participants suffering from acute or chronic pain (Lundeberg et al., 1984). The analgesic effect of 
vibration is perhaps determined by a number of factors, such as, duration of stimulation, device 
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used to deliver vibration (surface area of stimulation), frequency of stimulation, types of stimulation 
or types of outcome measures. 
 
There are limited studies on the optimal duration of vibration. Lundeberg and colleagues found that 
the optimum analgesic response in participants with musculoskeletal pain from vibration can be 
detected after 20-25 minutes of stimulation; stimulation beyond 45 minutes did not increase the 
analgesic effect further (Lundeberg et al., 1984). The most efficient time of application of vibration 
may be different for individuals. In Dahlin’s study on healthy participants, after 20 minutes of 
vibration, the detection and pain thresholds from electrocutanenous stimulation increased in female 
participants but not in male participants (Dahlin et al., 2006). Dahlin discussed that women are more 
sensitive to pain than men, and perhaps might need less stimulation from vibration to induce 
analgesia. Those two studies mentioned above both showed that a 20-minute vibratory stimulation 
could induce analgesia. The same duration of stimulation was used in the present study. The 
discrepancy in the results could be due to another factor: the device used to deliver vibration, that is, 
the surface area being stimulated.  
 
Lundeberg and colleagues stimulated larger surfaces using probes of sizes 200cm2 and 6cm2 and 
found that the 200cm2 probe produced better analgesia than the 6cm2 in pain participants 
(Lundeberg, 1984). Dahlin and colleagues used a probe of size 13x20cm for 20 minutes and reported 
that vibration induced analgesia only in women and not in men (Dahlin et al., 2006). Another study 
used a plate of surface area of about 13cm2 for 10s and found that vibration decreased the pain 
rating from a noxious heat stimulus in healthy and pain participants (Staud et al., 2011). The 
stimulation of large surface areas seems to induce analgesia irrespective of the duration of 
stimulation. This could perhaps be attributable to the fact that stimulating larger surface areas 
activated more Aβ fibres to induce analgesia, which according to Melzack and Wall’s gate control 
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theory (Melzack and Wall, 1965) is the main contributor to pain inhibition. In Watanabe’s (Watanabe 
et al., 1999) and the current study, the probe used was smaller (diameter of 1cm, surface area of 
about 0.80cm2). Yarnitsky and colleagues used a probe of similar size (diameter of 1cm) for one 
minute and found that vibration decreased suprathreshold heat pain in healthy participants 
(Yarnitsky et al., 1997). The duration of stimulation could have been too long for such a smaller sized 
probe and instead of inducing analgesia, it seemed to have induced hyerpalgesia. 
 
A review on vibration studies reported that frequencies ranging from 50 to 200Hz have been used in 
previous studies in individuals with chronic pain to induce analgesia (Tardy-Gervet et al., 1993). The 
current study used a frequency of 100Hz. A number of studies also used a frequency of 100Hz in 
healthy participants with varied results; some showed an analgesic effect from vibration (Staud et al., 
2011, Yarnitsky et al., 1997) while others did not found any analgesic effect from vibration (Ertekin 
and Akçali, 1978, Pazzaglia et al., 2016). Again this disparity among the results could be due to the 
different procedures of vibration used, involving different duration of stimulation and different 
surface area being stimulated.  
 
The test stimuli used to assess vibration-induced analgesia in previous studies are diverse. This 
includes different types of stimulus applied or different methods of recording an outcome measure. 
Studies reported vibration induced analgesia typically used heat stimulation or transcutaneous 
electrical stimulation (Staud et al., 2011, Yarnitsky et al., 1997). The suprasthrehold heat and 
electrical stimulation activate nociceptors in the skin and could have been more easily felt by the 
participants. Conversely, in the current study mechanical pressure was used and likely stimulated 
the muscle (dull sensation). It is possible that vibration provided inhibition on the skin and not in the 
muscle, therefore the analgesic effect could be detected with a test stimulus at the skin rather than 
a test stimulus on the muscle. 
 187 
 
The type of outcome measure used to assess the extent of vibration-induced analgesia should also 
be considered. The change in clinical pain in temporomandibular disorders participants was assessed 
in three different ways: VAS rating before and after vibration, continuous VAS rating during vibration 
and pain mapping before and after vibration (Roy et al., 2003). Continuous VAS rating and pain 
mapping showed significant decrease in pain whereas the VAS rating before and after vibration did 
not (Roy et al., 2003). Another study also reported that continuous rating of pain intensity from a 
constant pressure stimulation decreased during vibration (Hollins et al., 2014). Among those studies 
mentioned above, those using continuous pain rating have reported analgesic effects of vibration. 
Since the rating was made by the participants, their attention, understanding and memory 
recollection could be very important. Perhaps because the participants were focussing on their 
rating, they were able to notice any changes more easily. Another explanation could be because 
continuous rating enables the detection of small changes. Roy and colleagues discussed that when 
the ratings are averaged over numerous time points, they become less variable and can easily detect 
small changes (Roy et al., 2003). Therefore, future studies should carefully choose their outcome 
measures for pain rating. 
 
There is no standard protocol for vibration analgesia. More studies are needed to explore and 
determine the vibration parameters necessary to induce analgesia in healthy and pain participants. 
It is important that future research report the parameters that they used (frequency, duration, and 
contact surface area) to enable comparisons among studies. 
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Vibration may induce hyperalgesia 
Vibration may induce hyperalgesia. It has been shown that long-term exposure to vibration may 
cause pain or injury (Heaver et al., 2011). Experimental settings have also shown that short exposure 
to vibration may cause hyperalgesia in some individuals (Ayles et al., 2011, Fillingim et al., 1998, 
Hollins et al., 2014). 
 
In a study of 18 healthy participants, two participants showed an increase in their pain (hyperalgesia) 
from a constant pressure stimulus during vibration (Hollins et al., 2014). One of the two participants 
who presented with hyperalgesia from vibration also reported vibration as being painful. Hollins 
suggested that the increase in pain could have been the results of cortical dynamics, with the 
simultaneous activation of different areas, resulting in summation of pain (Hollins et al., 2014). Pain 
intensity from vibration could have been a factor contributing to the extent of analgesia experienced. 
In this study eight participants rated vibration as being painful, although this intervention was non-
painful at the start. Those eight participants showed a decrease in their percentage PPT after 
vibration and the remaining 13 participants who rated vibration as non-painful showed an increase 
in their percentage PPT. However, the percentage PPT change did not differ between the two groups. 
Thus, the rating to vibration did not contribute to these results. 
 
Vibration response in PA and PNA 
No significant difference was found between PA and PNA in either their PPT, SUPRA or PIN response 
before and after vibration at any site. Zheng and colleagues found that pain adaptability and SEG 
were positively correlated in healthy humans (Zheng et al., 2014). Since, no analgesia was produced 
by vibration in this study, hence no difference between PA and PNA in their PPT, SUPRA or PIN after 
vibration was expected. 
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Strengths and Limitations 
In this study, all the participants were assessed in the same room under similar experimental 
conditions. Both researchers were blinded from the pain adaptability status of the participants. Also, 
confounding factors such as BMI, anxiety, sleep quality, level of exercise and caffeine intake were 
taken into consideration.  
 
This study also has some limitations. Firstly, the current design does not allow the measurement of 
PPT during vibration. It is unclear if analgesia was induced earlier, during the stimulation. Secondly 
the vibrator probe size might have been too small, and the duration of the stimulation with this 
probe might have been long to induce analgesia.  
 
  Conclusion
Vibration in this study did not induce analgesia, hence it could not be determined whether vibration 
analgesia is a segmental effect or extra-segmental effect. PPT seemed to decrease at the site of 
vibration (left forearm) and slightly increased at the segmental site (right forearm). There was no 
significant difference between PA and PNA in their response to vibration. The surface area 
stimulated and duration of stimulation might be important contributors to vibration induced 
analgesia. More studies are needed to determine the parameters of vibration to induce analgesia. 
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Introduction  
Acupuncture is increasingly used for pain relief. Many clinical trials have been conducted to assess 
the efficacy of acupuncture for various clinical pains, including headache (Linde et al., 2009), LBP 
(Furlan et al., 2005), OA (Ezzo et al., 2001), neck pain (Fu et al., 2009) and shoulder pain (Molsberger 
et al., 2010, Zhang et al., 2016). The commonly used control is sham acupuncture (SA), where 
needles are inserted shallowly into sites that are non-acupoints, but are close to the site of real 
acupoints, and Deqi sensation is avoided. Deqi is a complex sensation of aching, soreness, heaviness, 
and others (Kong et al., 2007), and indicates that the appropriate dose has been achieved. This form 
of invasive SA has been criticized for being non-inert as it has real physiological effects (Lund et al., 
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2009, Carlsson, 2002, Kenjil and White) therefore contributes to the small differences between real 
acupuncture (RA) and SA observed in many clinical trials (Vickers et al., 2012). 
It is well known that acupuncture exerts its analgesia through activating endogenous pain inhibitory 
systems. The systems include SEG, where analgesia is exhibited at the bilateral nerve segmental 
distributions around the site of the needling (Bekking and van Byssel, 1998); CPM, where analgesia is 
exhibited at multiple sites all over the body away from the needling site (Bekking and van Byssel, 
1998, Le Bars and Willer, 2002). For instance, needling LI4, a point in the web between the thumb 
and index finger, increases PPT in healthy volunteers on multiple parts of the body, such as the 
contralateral arm, legs and abdomen (Zaslawski et al., 2003). Electro-acupuncture on one of the legs 
increases pain threshold on the same and opposite legs, but has little effect on pain threshold on the 
arm (Zheng et al., 2010b). Those studies support the view that acupuncture analgesia relies on the 
functionality of the endogenous controls. 
 
In addition to inhibition, a recent study identifies the dichotomy of pain adaptability, that is, PA and 
PNA individuals (Zheng et al., 2014). When undergoing a 5-minute CPT, PA individuals reported a fast 
increase in pain, then a significant reduction of pain intensity of at least 2 out of 10 by the end of the 
test; whereas PNA had a slower increase of pain to cold pressor, and the pain then remained high 
throughout the test. In addition, being adaptive to pain was associated with the potency of local pain 
inhibition (SEG), but was not correlated with the potency of CPM. Pain adaptability could be a 
representation of a facilitation-inhibition circuitry that has rarely been explored before. 
 
This exploratory, cross-over study involving healthy participants aimed to examine: (1) if pain 
adaptability impacted on individual responses to RA and SA; and (2) the spatial distribution of 
acupuncture analgesia in PA and PNA individuals. 
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Design and procedure  
This randomised, practitioner-assessor blind, cross-over study was conducted at the Aalborg 
University, Denmark. Twenty-two healthy volunteers who had previously undergone a five-minute 
CPT (Zheng et al., 2014) took part in the study. The selection criteria are described in Chapter 5 in 
the Selection criteria section (pg 134). Nine participants were classified as PA and 13 as PNA. In the 
present study they were randomly allocated to receive RA and SA in separate sessions with half 
receiving RA first then SA, the other SA first then RA. Figure 7.1 illustrates the study procedure. 
During the tests and interventions, subjects were positioned comfortably in a reclining position with 
arms resting on arm rests and legs elevated to just below hip level. One researcher was responsible 
for the QSTs (DW) and was blinded from the group allocation, and another researcher was 
responsible for delivering the acupuncture interventions (GI). Both researchers were blinded from 
the status of pain adaptability of the participants. 
 
At baseline participants were asked to complete questionnaires about their demographics, mental 
and physical health (Ware et al., 2008) and level of anxiety as measured with State Trait and Anxiety 
Inventory (Spielberger et al., 1983). Before each acupuncture session, participants were asked about 
their sleep quality from the night before on a numerical scale of 0-10 where 0 means the worst sleep 
and 10 the best sleep quality, whether or not they had done any strenuous exercise or taken coffee 
in the 24 hours. Female participants were asked about their menstrual cycle. 
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Figure 7.1: a. study procedure; b. assessment during each session 
PA= pain adaptive; PNA= pain non-adaptive; RA= real acupuncture; SA=sham acupuncture; Pre=pre-acupuncture; 
Imm=immediately after acupuncture; Post=20 minutes after end of acupuncture; Assessment includes pressure pain 
threshold (PPT), pain intensity to suprathreshold pressure stimulus (SUPRA) and pinprick (PIN), and VAS rating to real or 
sham acupuncture stimulation during the treatment  
 
 
 
 
a. 
b. 
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Acupuncture 
Acupuncture procedures followed those described previously in a study by Zheng (Zheng et al., 
2010b). Such RA and SA protocols were found to be credible. Table 7.1 compares the two 
acupuncture interventions. Disposable stainless steel needles of size 0.25 x 25mm were used 
(Phoenix medical direct LTD UK). A pillow was used to block the view of the participants so that they 
could not see the needling procedure. The acupuncturist, with over one year of experience in clinical 
practice, needled the points LI4 and LI10 on the left arm for the RA and off site points for SA. LI4 and 
LI10 were chosen because of their pain-reduction effect. After insertion, needles were manipulated 
for one minute to achieve Deqi in RA. This procedure was repeated another two times, every 10 
minutes during the 20 minute needle retention time. In SA, sham points were used. Although Deqi 
cannot be completely hindered, needles were shallowly inserted to avoid Deqi in the SA. The 
acupuncturist moved the needles gently and briefly every 10 minutes. Again needle retention was 20 
minutes. 
 
Sensation to needling was recorded using a modified numerical rating scale on an eVAS (0 being no 
sensation at all, 5 just painful, 10 the worst pain possible) and the Massachusetts General Hospital 
acupuncture sensation scales (MASS) (Kong et al., 2007). Side effects of acupuncture treatment were 
also recorded. The acupuncturist’s interaction with subjects was minimal to reduce potential bias. 
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Table 7.1: Comparison of the two acupuncture interventions 
 RA SA 
Needle 
placement  
LI4 and LI10 left side of the forearm   Sham LI4 and LI10 (see end of the 
table for explanation), avoid any 
known acupuncture points and 
meridians.  
Insertion 10–20 mm 2–3 mm 
Duration 20 min 20 min  
Manipulation Needles were manipulated in a bi-
directional manner for 1 min after 
insertion. The manipulation was 
repeated every 10 min for a total of 
three times. 
 
The needles were touch and moved 
gently after insertion for 5 seconds. 
This procedure was repeated every 10 
min for a total of three times. 
 
But the acupuncturist then sat with 
the participants for the remaining one 
minute to match the contact time in 
the RA session.   
Deqi Yes Deqi avoided 
RA= real acupuncture; SA= sham acupuncture;LI4: On the dorsum of the hand, between the 1st and 2nd metacarpal bones, 
approximately in the middle of the 2nd metacarpal bone on the radial side; LI10: About four finger width below the lateral 
epicondyle of the humerus. On the radial side of the radius, the extensor carpi radialis brevis and longus muscles; Location 
of sham LI4: On the dorsal part of the wrist, about 1 finger breath above the wrist crease and between the styloid process 
of the radius and midline of the dorsal aspect of the forearm. Location of sham LI 10: On the medial aspect of the forearm, 
between the midline and the lateral edge of the radius, four finger breadth distal to the cubital fossa. Deqi: described as a 
numb, distended and aching sensation, and indicates the desired effect of acupuncture stimulation being achieved. 
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Outcome measures 
The primary outcome measure was PPT measured using an algometer (Somedic, Sweden) as 
described in Chapter 5 (Pressure pain threshold section, pg 145) at three locations (see below). The 
mean of three PPT measurements at each site was recorded. Secondary outcome measures included 
PIN (Chapter 5, Pin prick section, pg 147) and SUPRA (Chapter 5, Suprathreshold stimulation section, 
pg 146) on a modified numerical rating scale (0 being no sensation, 5 being just painful and 10 being 
the worst possible pain). All the QSTs were performed before, immediately after and 20 minutes 
after the acupuncture session, at bilateral extensor carpi radialis (testing SEG), and on the right 
soleus (testing CPM) in a randomised order. The skin temperature at the acupuncture points was 
measured using an infrared camera (SATIR SAT-S280 Guangzhou) before acupuncture. 
 
Blinding and assessment of expectancy and blinding 
Participants were blinded from the type of acupuncture they were receiving. One researcher was 
responsible for the QSTs (DW) and was blinded from the group allocation, and another researcher 
was responsible for delivering the acupuncture interventions (GI). Both of them were blinded from 
the status of pain adaptability of the participants.  
 
Prior to each intervention, participants were asked about their expectation from the acupuncture 
sessions (Mao et al., 2007). At the end of each intervention, participants were asked to guess if they 
received real or sham acupuncture and based on what they made the decision using a validated 
credibility scale (Zheng et al., 2010b). 
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Data analysis 
Independent t-tests and chi square tests were used to analyse the baseline data. Three-way (site, 
acupuncture session and pain adaptability) with two repeated measures (site, acupuncture session) 
ANOVAs were used to assess the main effect of mode (RA and SA), site and pain adaptability status 
(PA and PNA) and their interactions in the percentage changes of PPT, SUPRA and PIN. Appropriate 
post-hoc analyses, such as two-way ANOVA or independent t-tests, were used when necessary. Data 
were presented as mean and SD in the texts and as mean and SE in the figures. P values of less than 
0.05 were considered significant. The Holm-Bonferroni correction was used for multiple comparisons. 
A p-value that was smaller than the Holm-Bonferroni adjusted significance was considered 
significant. 
 
 
Results  
Baseline data 
All 22 participants completed the two-session experiment. The two groups (PA and PNA) were 
comparable in their demographic data and key baseline data, including quality of life, anxiety, sleep 
quality the night before the test, level of exercise, and coffee intake (Table 7.2). For female 
participants, there were no differences in their menstrual cycle phases (Table 7.3). 
 
The two groups were also comparable on their pain sensitivity prior to either real or sham session of 
acupuncture as measured with PPT at the three sites, SUPRA and PIN (Table 7.4). The skin 
temperature at the needling site prior to acupuncture were also comparable between the two pain 
adaptability groups (Table 7.4). 
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Table 7.2: Baseline characteristics of PA and PNA (mean ± SD) 
Baseline characteristics PA (n = 9) PNA (n = 13) x
2
1/t20 
tests p-value 
Adjusted 
significance1 
Age 28.11 ± 9.97 25.92 ± 6.40 0.63 0.54 0.01 
Gender M/F 3/6 5/8 0.06 0.81 0.03 
SF-36 physical 
component summary 85.22 ± 6.53 86.69 ± 7.02 -0.50 0.63 0.02 
SF-36 mental 
component summary 75.00 ± 15.86 81.31 ± 12.45 -1.05 0.31 0.01 
SF-36 total 81.22 ± 10.59 85.23 ± 9.39 -0.94 0.36 0.01 
RA-STAI (State) 31.44 ± 7.83 38.85 ± 10.57 -1.78 0.09 <0.01 
RA-sleep Quality 8.39 ± 0.70 7.85 ± 1.41 1.20 0.25 <0.01 
RA-coffee intake Y/N 7/2 8/5 0.65 0.42 0.01 
RA-exercise Y/N 2/7 3/10 <0.01 0.96 0.05 
SA-STAI (State) 32.56 ± 8.53 37.46 ± 8.10 -1.37 0.19 <0.01 
SA-Sleep Quality 8.39 ± 0.86 7.23 ± 1.83 1.99 0.06 <0.01 
SA-coffee Y/N 8/1 10/3 0.51 0.47 0.01 
SA-exercise Y/N 3/6 3/10 0.28 0.60 0.01 
PA= pain adaptive; PNA= pain non-adaptive; SF-36= short form 36 items survey, to measure quality of life; RA=real 
acupuncture; SA= sham acupuncture; Y/N= yes or no; 1= Holm-Bonferroni adjusted significance. 
 
 
Table 7.3: Contraceptive pills and menstrual cycle (female participants n=14) 
 
PA (n = 6/9) PNA n=(8/13) x
2 
tests 
p-
value 
Adjusted p 
significance1 
RA-contraceptive Y/N 0/6 2/6 1.75 0.19 0.27 
RA-menstrual cycle 
(MP/FP/LP) 1/3/2 0/4/4 1.56 0.46 0.11 
SA-contraceptive Y/N 0/6 2/6 1.75 0.19 0.27 
SA-menstrual cycle 
(MP/FP/LP) 1/0/5 0/3/5 3.79 0.15 0.33 
RA=real acupuncture; SA= sham acupuncture; Y/N= yes or no; MP=menstrual phase; FP=follicular phase; LP=luteal phase; 
1= Holm-Bonferroni adjusted significance. 
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Table 7.4: Pain sensitivity measured prior to acupuncture (mean ± SD) 
Sessions Outcome measures prior to acupuncture Sites PA (n = 9) PNA (n = 13) t20 p value 
Adjusted 
significance1 
Prior to real 
acupuncture 
PPT (KPa) 
Left arm 231.30 ± 81.11 189.06 ± 79.15 1.22 0.24 0.03 
Right arm 266.78 ± 82.40 198.85 ± 75.66 2.00 0.06 0.02 
Right leg 389.26 ± 150.68 347.38 ± 135.11 0.68 0.50 0.05 
SUPRA (NRS) 
Left arm 6.56 ± 1.57 5.96 ± 1.38 0.94 0.36 0.03 
Right arm 6.78 ± 1.33 5.58 ± 1.59 1.86 0.08 0.02 
Right leg 6.94 ± 1.42 6.31 ± 1.69 0.92 0.37 0.05 
PIN (NRS) 
Left arm 4.17 ± 1.97 3.46 ± 1.45 0.97 0.34 0.02 
Right arm 3.83 ± 2.18 3.77 ± 1.48 0.08 0.94 0.05 
Right leg 3.67 ± 2.18 3.58 ± 1.19 0.11 0.91 0.03 
skin temperature (°C) 
point LI 10 33.58 ± 1.71 32.49 ± 1.52 1.54 0.14 0.02 
point LI 4 31.81 ± 2.98 31.86 ± 2.71 -0.04 0.97 0.05 
thumb 30.90 ± 4.02 29.91 ± 4.39 0.53 0.60 0.03 
Prior to sham 
acupuncture 
PPT (KPa) 
Left arm 205.48 ± 74.02 216.51 ± 97.55 -0.29 0.78 0.02 
Right arm 236.59 ± 84.83 241.21 ± 96.81 -0.12 0.91 0.05 
Right leg 348.96 ± 142.84 361.09 ± 134.77 -0.20 0.84 0.03 
SUPRA (NRS) 
Left arm 6.06 ± 1.18 6.19 ± 1.20 -0.26 0.79 0.05 
Right arm 6.67 ± 0.97 6.23 ± 1.26 0.88 0.39 0.03 
Right leg 6.89 ± 1.52 6.31 ± 1.38 0.93 0.36 0.02 
PIN (NRS) 
Left arm 4.06 ± 1.91 3.35 ± 1.82 0.88 0.39 0.02 
Right arm 3.33 ± 2.00 3.62 ± 1.70 -0.36 0.73 0.03 
Right leg 3.39 ± 2.26 3.35 ± 1.77 0.05 0.96 0.05 
skin temperature (°C) 
point LI 10 33.38 ± 1.15 33.68 ± 1.45 -0.53 0.60 0.03 
point LI 4 32.43 ± 2.25 32.65 ± 1.51 -0.28 0.79 0.05 
thumb 32.59 ± 1.99 31.91 ± 2.73 0.64 0.53 0.02 
PA=pain adaptive; PNA= pain non-adaptive; RA= real acupuncture; SA=sham acupuncture PPT= pressure pain threshold; SUPRA = pain rating to suprathreshold pressure stimulus; PIN= pain 
rating to pinprick; NRS= numerical rating scale 0-5-10, 0 meaning no sensation at all, 5 being just painful and 10 the worst pain possible; 1=Holm-Bonferroni adjusted criterion of statistical 
significance. 
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Needling sensation perceived by PA and PNA groups  
Both PA and PNA groups rated the peak sensation induced by RA as mild pain (5.21 ± 2.08), and 
significantly stronger than that induced by SA (2.29 ±2.45), which was considered not painful. The 
two PA and PNA groups did not differ on this measure (Table 7.5). Consistently, there were no 
differences between PA and PNA in their rating to the needling sensation at the end of the session.  
 
Deqi sensation as assessed with MASS was considered to be stronger during the acupuncture session 
with no differences between PA and PNA groups (Table 7.6). Sensations induced by RA were 
consistently rated stronger than SA on aching, soreness, deep pressure, heaviness, fullness, 
numbness, sharp pain and dull pain, but not on cold, warmth, tingling or throbbing. 
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Table 7.5: Needling sensation in PA and PNA during real and sham acupuncture (mean ± SD) 
Needling sensation 
Real acupuncture  Sham acupuncture Session effect (RA vs SA session) 
Group effect (pain 
adaptability)  
Group by Session 
effect 
PA (n=9) PNA (n=13)  PA (n=9) PNA (n=13)  F(1,20)-value p-value F(1,20)-value p-value F(1,20)-value p-value 
VAS peak sensation 
(0,5,10)# 4.31 ± 2.22 5.80 ± 1.84 2.06 ± 2.91 2.47 ± 2.16 29.40 <0.01* 0.96 0.34 1.33 0.26 
VAS end sensation 
(0,5,10)# 2.97 ± 2.27 4.78 ± 2.58 1.36 ± 2.01 1.89 ± 1.92 17.35 <0.01* 1.70 0.21 1.59 0.22 
PA= pain adaptive; PNA= pain non-adaptive; RA=real acupuncture; SA=sham acupuncture; #=VAS 0-5-10scale, 0 is no sensation at all, 5, just painful and 10 the worst pain possible; *=significant p value. 
 
Table 7.6: Deqi sensation in PA and PNA during real and sham acupuncture (mean ± SD) 
Deqi sensation 
Real acupuncture  Sham acupuncture Session effect (RA vs SA session) 
Group effect (pain 
adaptability)  
Group by Session 
effect 
PA (n=9) PNA (n=13) PA (n=9) PNA (n=13) 
F(1,20)-
value p-value 
F(1,20)-
value p-value 
F(1,20)-
value 
p-
value 
Soreness 2.22 ± 1.56 2.38 ± 1.71 1.11 ± 1.69 1.12 ± 1.21 14.63 <0.01* 0.02 0.89 0.07 0.80 
Aching 3.22 ± 2.33 2.73 ± 1.59 1.83 ± 2.47 1.19 ± 1.22 11.45 <0.01* 0.68 0.42 0.03 0.86 
Deep pressure 2.33 ± 2.60 2.15 ± 1.95 0.89 ± 1.29 1.27 ± 1.33 5.21 0.03* 0.03 0.87 0.30 0.59 
Heaviness 1.89 ± 1.76 1.88 ± 1.88 0.72 ± 1.35 0.81 ± 0.83 8.25 0.01* 0.01 0.94 0.01 0.91 
Fullness 1.67 ± 1.66 1.81 ± 2.01 0.28 ± 0.57 0.96 ± 1.03 8.10 0.01* 0.69 0.42 0.48 0.50 
Tingling 2.00 ± 2.74 2.31 ± 1.91 2.00 ± 2.28 1.31 ± 1.60 1.47 0.24* 0.06 0.82 1.47 0.24 
Numbness 3.39 ± 3.02 2.85 ± 2.75 1.50 ± 1.58 1.77 ± 1.64 6.02 0.02* 0.03 0.87 0.45 0.51 
Sharp pain 4.22 ± 3.11 2.73 ± 1.52 2.39 ± 3.97 0.96 ± 1.65 10.05 0.01* 2.32 0.14 <0.01 0.96 
Dull pain 1.17 ± 1.22 2.31 ± 1.91 0.50 ± 0.79 1.12 ± 1.43 7.94 0.01* 2.64 0.12 0.64 0.44 
Warmth 1.11 ± 1.76 1.35 ± 1.64 1.50 ± 2.15 1.54 ± 1.66 1.04 0.32 0.04 0.85 0.12 0.73 
Cold 1.11 ± 2.09 1.88 ± 2.05 0.39 ± 0.99 0.88 ± 1.49 3.08 0.10 1.25 0.28 0.08 0.78 
Throbbing 1.11 ± 1.54 2.35 ± 2.49 1.17 ± 2.35 1.04 ± 1.22 1.81 0.19 0.60 0.45 2.15 0.16 
Total Deqi 26.56 ± 16.39 27.62 ± 14.14 14.61 ± 18.42 14.54 ± 12.42 16.85 <0.01* 0.01 0.93 0.04 0.85 
PA= pain adaptive; PNA= pain non-adaptive; RA=real acupuncture; SA=sham acupuncture; *=significant p value. 
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PPT changes after real and sham acupuncture between PA and PNA 
The changes in PPT after RA and SA were analysed using raw values and percentage changes. No 
difference was observed between the two sets of results. This section will present the results of the 
percentage changes of PPT. 
 
Immediately after acupuncture, there were no statistically significant changes to PPT between the 
two acupuncture sessions (F(1,20)=0.05, p=0.82), at all three sites (left arm, right arm and right leg) 
(F(1,20)=0.56, p=0.58) or between pain adaptability groups (F(1,20)=0.37, p=0.55). There was no 
interaction of acupuncture session by pain adaptability group. 
 
Twenty minutes after acupuncture, the perchance PPT changes did not differ between RA and SA, 
but differed statistically significantly between PA and PNA (Figure 7.2) indicated by an acupuncture 
session by pain adaptability interaction (F(1,40) =4.81, p=0.04). Two-way ANOVA was used to for post-
hoc analysis and showed that there was a trend that PA responded to SA (20.3% increase) better 
than PNA did (2.1%) (F(1,40) =4.06, p =0.06). The PA’s response to RA (5.9% increase) was similarly to 
the PNA  (5.8%). 
 
The two groups also tended to respond differently among the three sites (Figure 7.3) at 20 minutes 
after acupuncture, site by pain adaptability interaction (F(2,40) =2.800, p=0.07). As shown in Figure 7.3, 
the PPT increase was higher at the right leg (19.7%) and right arm (13.5%) than on the left arm 
(6.2%), that is, the site of acupuncture. PA reported a stronger analgesia induced by either real or 
sham acupuncture on the right arm and right leg whereas PNA had the strongest analgesia on the 
left arm, that is, the needling site (6.5%). 
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Figure 7.2: Percentage PPT change 20 minutes post real and sham acupuncture in PA and PNA at all sites (n=22, mean ± 
SE). Significant acupuncture session by group interaction (p=0.04). PA seemed to respond to sham acupuncture better 
than PNA 
PPT=pressure pain threshold; PA=pain adaptive; PNA=pain non-adaptive; Real= real acupuncture; Sham=sham acupuncture. 
 
 
 
Figure 7.3: Percentage PPT changes at all three sites 20 min post acupuncture in the PA and PNA groups (n=22, mean 
±SE). A trend for site by pain adaptability interaction (p=0.07) 
PA=pain adaptive; PNA=pain non-adaptive 
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Changes in ratings to SUPRA or PIN after real and sham acupuncture between PA and PNA 
groups  
Raw values and percentage changes in SUPRA and PIN were used to analyse the change in SUPRA 
and PIN in PA and PNA. The results of the analyses with raw values did not differ from those with 
percentage changes. This section will present the data on percentage changes in SUPRA and PIN. 
 
Immediately after either session of acupuncture, SUPRA did not differ between the PA and PNA 
groups. However there was acupuncture session by site interaction (F(2,40) =4.18, p=0.02). Post hoc 
analysis with two-related sample test indicated that SUPRA increased during RA session and reduced 
in the SA session on the left or right arm, but did not differ between acupuncture sessions (RA: 5%, 
11%, 6%; SA: -2%, -3% and 9%, for left arm, right arm and right leg respectively). This indicates an 
overall pain enhancing effect to RA intervention at the segmental level immediately after 
acupuncture. 
 
Twenty minutes after either session of acupuncture, the PA and PNA groups differed in their SUPRA 
(group effect F(1,20) =6.51, p=0.02). The PA group reported consistently reduced pain rating to 
suprathreshold pressure at all three sites, whereas the PNA group reported increased pain rating (-4% 
vs 5.4%). There was no other difference between either PA and PNA groups or RA and SA sessions 
(Table 7.7). 
 
There was no PA and PNA group difference in PIN either immediately or 20 minutes after either 
session of acupuncture (F(1,20)=0.95, p=0.34) (Table 7.8). 
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Table 7.7: Percentage SUPRA change 20 minutes post real and sham acupuncture in PA and PNA (mean ± SD) 
Session Sites PA (n=9) PNA (n=13) 
Group effect Session effect Site effect 
F(1,20) value p value F(1,20) value 
p 
value F(2,40) value 
p 
value 
Real acupuncture 
left arm -1.55 ± 25.56 6.58 ± 16.48 
6.51 0.02* 1.19 0.29 0.44 0.65 
right arm -0.59 ± 13.82 6.38 ± 24.38 
right leg -5.03 ± 14.56 9.88 ± 17.34 
Sham 
acupuncture 
left arm -4.36 ± 16.83 4.72 ± 16.49 
right arm -11.68 ± 8.47 1.74 ± 8.65 
right leg -0.50 ± 9.33 3.00 ± 16.98 
SUPRA= rating to suprathreshold pressure stimulus; PA=pain adaptive; PNA=pain non-adaptive; a negative score indicates a reduction in pain rating and a positive score indicates an increase in pain rating; 
*=significant p value.  
 
 
Table 7.8: Percentage PIN change 20 minutes post real and sham acupuncture in PA and PNA (mean ± SD) 
Session Sites PA (n=9) PNA (n=13) 
Group effect Session effect Site effect 
F(1,20) 
value p value 
F(1,20) 
value p value 
F(2,40) 
value p value 
Real acupuncture 
left arm -2.44 ± 11.23 18.97 ± 58.41 
0.95 0.34 0.65 0.43 0.11 0.90 
right arm -1.69 ± 23.66 -0.13 ± 20.49 
right leg 15.56 ± 51.21 10.83 ± 22.54 
Sham acupuncture 
left arm -6.40 ± 13.14 35.00 ± 85.68 
right arm 2.41 ± 32.54 37.35 ± 143.04 
right leg 20.58 ± 53.18 14.10 ± 30.31 
PIN= rating to pinprick; PA=pain adaptive; PNA=pain non-adaptive; a negative score indicates a reduction in pain rating and a positive score indicates an increase in pain rating.  
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Expectation of acupuncture and Blinding 
Before SA and RA sessions, expectancy of acupuncture was assessed. Chi square analyses showed 
there were no differences between PA and PNA in expectancy at either session (Table 7.9). 
 
After each acupuncture sessions, participants were asked if they had RA or SA. After the RA 
session, eight out of nine PA participant thought they had RA (Table 7.10), a higher proportion 
than in the PNA group (thought had RA, 7/13; do not know 6/13) (χ2=6.56, p=0.04). This is largely 
due to the needling sensation perceived by the PA group (χ2=5.16, p =0.08) (Table 7.11). After the 
SA session, there was no difference between PA and PNA groups in their estimation of the type of 
acupuncture they had (χ2=1.04, p 0.59) (Table 7.10). 
 
 
Table 7.9: Acupuncture expectancy in PA and PNA prior to real and sham acupuncture 
Acupuncture 
sessions Expectancy of acu 
PA 
(n=9) 
PNA 
(n=13) 
X23 
 value p value 
Real 
lower pain 
threshold 2 1 
1.67 0.65 no change 3 6 higher pain 
threshold 1 3 
do not know 3 3 
Sham 
lower pain 
threshold 1 2 
1.56 0.82 no change 3 5 higher pain 
threshold 2 3 
do not know 3 2 
PA=pain adaptive; PNA=pain non-adaptive; acu=acupuncture. 
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Table 7.10: Credibility of acupuncture in PA and PNA for real and sham acupuncture 
Acupuncture 
sessions Credibility PA (n=9) 
PNA 
(n=13) X
2
2 value p value 
Real 
real  8 7 
6.56 0.04* sham  1 0 
do not know 0 6 
Sham 
real  4 8 
1.04 0.59 sham  3 2 
do not know 2 3 
PA=pain adaptive; PNA=pain non-adaptive; *=significant p value. 
 
Table 7.11: Credibility of acupuncture in PA and PNA  
Acupuncture 
sessions Credibility PA (n=9) PNA (n=13) 
X22 
value 
p 
value 
Real 
manner, attitude or words of 
the acupuncturist 0 3 
5.16 0.08 sensation of the stimulation 8 4 
experience of the procedure 1 0 
Sham 
manner, attitude or words of 
the acupuncturist 4 8 
1.03 0.60 sensation of the stimulation 3 2 
experience of the procedure 2 3 
PA=pain adaptive; PNA=pain non-adaptive. 
 
Internal consistency and session effect  
To examine if participants were internally consistent with respect to PPT measures, PPTs 
measured before each session of acupuncture were analysed using Pearson r correlation. PPTs 
measured at three sites over the two sessions prior to intervention were highly correlated (left 
arm r=0.81, p<0.01; right arm r=0.80, p<0.01; right leg r=0.708, p<0.01). 
 
To examine if there was session effect, PPTs before acupuncture were compared between the 
first and second sessions using two-way repeated ANOVA. There were significant main effects of 
time (F(1,40)= 13.3, p<0.01) and site (F(2,40)=58.4, p<0.01) without site by time interaction(F(2,40)=0.94, 
p=0.40). This is due to the PPTs measured prior to acupuncture at the second session was being 
consistently higher than those prior to acupuncture at the first session. 
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Discussion  
Summary of results 
In this cross-over study, RA and SA induced a similar magnitude of analgesia. PA individuals 
reported statistically significantly high PPT changes (20%) to SA 20 minutes after acupuncture, 
whereas PNA individuals had a small increase in PPT after either RA (6%) or SA (2%). Furthermore, 
the enhanced PPT in the PA group was better on the sites away from the needling site. This 
observation that pain adaptability, but not types of acupuncture, determined the analgesia effect 
of acupuncture was also supported by the changes in SUPRA. For the first time it is demonstrated 
that pain adaptability could determine how individuals responded to acupuncture.  
 
Strengths of the study: controlling of confounding factors  
This study controlled a number of confounding factors that could impact on QSTs, effect of 
acupuncture, and outcome measures. Age, gender, BMI, anxiety, quality of life, and coffee and 
tea intake and sleep quality the night prior to both sessions of acupuncture were found to impact 
on pain threshold (Kothari et al., 2015, Laursen et al., 2005, Neumann et al., 2008, Sawynok, 
2011). No difference between PA and PNA was found in those measures prior to acupuncture. 
Also importantly, the level of expectancy of acupuncture, a factor considered to modulate the 
analgesic effect of acupuncture, was assessed (Linde et al., 2007). Again there was no difference 
between PA and PNA in their expectancy levels. To control the performance bias, a SA session 
was included, which was credible as it induced Deqi sensation in all participants. Blinding was 
successful during SA session, but was not in the RA session. A higher proportion of the PA groups 
guessed their group allocation correctly during RA session when compared with the PNA. This did 
not seem to impact on their response to acupuncture. Indeed the PA group reported better 
analgesia to SA than RA. It is possible the random allocation might have eliminated the impact of 
expectation. In addition to controlling the performance bias of participants, the researchers were 
 209 
 
blinded. Studies showed that a high expectancy of trial acupuncturists led to a better pain 
reduction (Witt et al., 2012). In the present study, both the independent outcome assessor and 
the acupuncturist were unaware of the status of PA and PNA; and the assessor was blinded also 
to acupuncture allocation. 
 
PPTs measured at the second session were consistently higher than the first session. This could 
not be the effect of acupuncture as single session acupuncture analgesia usually does not last 
more than one week (Irnich et al., 2002). This is likely to be a training effect. It is well-established 
that in studies involving repeated tests, participants tended to have a high pain threshold on the 
second or later session (Brooks et al., 2007, Stening et al., 2007). This order effect could not 
impact on the finding from the current study as percentage changes in relation to the session 
baseline were used for data analysis. 
 
The debate over real and sham acupuncture  
The key controversy in acupuncture pain research is the application of SA. A number of clinical 
trials showed no difference between RA and SA in pain reduction in low back pain, headache, 
knee pain (Madsen et al., 2009, Ezzo et al., 2000). A recent meta-analysis including 29 high-quality 
randomised controlled trials with 17,922 patients found a small but statistically significant 
difference between RA and SA (placebo) (Vickers et al., 2012). The difference in pain reduction 
between the two forms of acupuncture was on average SMD 0.18, being clinically not significant. 
The difference between acupuncture and no acupuncture was however nearly three times better 
at SMD 0.51. The meta-analysis supports that RA is better than SA. The small difference between 
the two forms of acupuncture could only be detectable when the sample size is sufficiently large. 
This could explain the negative results of a number of SA controlled trials, as well as the findings 
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in the current study. However those findings have not lent any help to researchers and 
practitioners on why the differences are so small. 
 
Acupuncture analgesia, sham acupuncture and the status of the nervous system   
The effect of acupuncture is considered to be dependent on the status, or the plasticity, of the 
nervous system (Carlsson, 2002, Lund et al., 2009). It is hypothesized that under central 
sensitization, the receptive fields of the central neurons are expanded and the neurons are highly 
sensitized and responsive, therefore gentle stimulation as the in sham acupuncture procedure 
could induce adequate analgesic effect (Carlsson, 2002). Indeed, a study involving healthy 
humans examined exactly this question. The researchers induced primary heat and secondary 
mechanical hyperalgesia using a well-established and validated heat-capsaicin model. They found 
that real and sham electro-acupuncture were equally effective in reducing secondary mechanical 
hyperalgesia (Zheng et al., 2010a). The existence of central sensitization might have enhanced the 
effect of sham acupuncture. It is well known that central sensitization exists in many type of 
chronic pain, such as low back pain (Correa et al., 2015), headache and fibromyalgia (Staud et al., 
2014). These might explain the findings of little or no difference between RA and SA observed in 
many clinical trials (Deare et al., 2013). 
 
The current study demonstrates that whether one is adaptive to pain could be another important 
factor determining not only the response to acupuncture, but also to which form of acupuncture 
that individual might respond. The findings from this study provide an initial step to link the 
individual variations in their response to pain, with how they respond to acupuncture. Clinically 
gentle and shallow needling as a form of acupuncture is practised widely for a sub-set of patients. 
Those patients are classified as hyper-strong reactors and strong reactors, who often respond to 
 211 
 
gentle needling and the results can be long-lasting (Mann, 2000). It is unknown what could 
mediate such an effect. 
 
In their study, Zheng and colleagues found that PA did not differ from PNA on many measures, 
including the intensity of pain rating to cold pressor, PPT, and potency of CPM, that is percentage 
increase of PPT after cold pressor (Zheng et al., 2014). They differed however on time to 
maximum pain. PA reached their maximum pain within two minutes of a CPT; whereas PNA took 
much longer to reach their maximum pain. It is possible that PA has a robust nervous system so 
that a fast ascending facilitation induces a fast descending inhibition; whereas PNA has a slower 
ascending facilitation therefore the inhibition system might be activated too slowly to show an 
effect. As a result while the pain rating to cold pressor reduces in PA, it is maintained in PNA. Such 
a robust pain inhibition could be activated with gentle stimulation, such as that in sham 
acupuncture, in certain individuals, like PA individuals. How this mechanism is related to 
acupuncture analgesia is yet to be explored. This study demonstrates a fast acting nervous system 
is perhaps responsible for the analgesia induced by SA in PA. This effect is less likely to be due to 
placebo as PA did not have the same response to RA. 
 
Spatial distribution of acupuncture analgesia  
In the current study, the PA showed 5% increase of PPT at the site of needling and 14% to 20% 
increase of PPT at the contralateral and distant site respectively, reflecting stronger SEG and CPM 
in this group. This observation is consistent with a previous study, in which manual acupuncture 
on the hand increased PPT at a number of areas spreading over the body (Zaslawski et al., 2003). 
However, that study did not report individual variations to acupuncture. This observation is not 
consistent with an electro-acupuncture study where real acupuncture induced segmentally 
distributed analgesia with analgesia on the distant part of the body (Zheng et al., 2010b). 
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Nevertheless, the mode of acupuncture differs, with manual acupuncture in the current study 
and electro-acupuncture in the previous one; and the other study did not report individual 
variations either. This discrepancy suggests it is necessary to replicate the current study with 
different modes of acupuncture, such as electro-acupuncture and / or laser acupuncture. 
 
In addition, the current findings seem to be contradictory to previous findings that PA presented 
a stronger “local inhibition” (SEG) than PNA, but did not differ on CPM. This could be because 
acupuncture analgesia is not the same as cold pressor. Indeed, cold pressor induced strong pain 
(8.2/10, with 0 being just painful) (Zheng et al., 2014), whereas the rating to RA in the current 
study was around just painful (5/10, with 5 being just painful). Two recent studies also showed 
that acupuncture analgesia is not equal to CPM (Schliessbach et al., 2012, Tobbackx et al., 2013). 
It is possible that the way pain inhibition manifests in PA individuals depends on the strength of 
stimulation. 
 
 
Limitations  
This study included 22 healthy participants. The sample size is relatively small. Although the cross-
over design enhances the power of the study, it is preferable to repeat this study in a large 
sample. Healthy participants were tested, and it is unknown if those findings are applicable to 
those who have chronic pain. 
 
 
 213 
 
Implications of this study  
About 40% of the healthy population could be PA. If gentle stimulation such as that in SA can 
induce potent analgesia in this group of people, its implication for current trial design and clinical 
practice is significant. It is yet to be tested if the dichotomy of PA and PNA also exists in people 
with chronic pain. If it does, it is necessary to replicate the current study in a clinical sample. The 
results of this current study and future studies may shed light on individual variations to 
acupuncture and the powerful effect of SA. 
 
Conclusions  
Individuals who are adaptive to pain are more likely to benefit from sham acupuncture analgesia. 
The effects are likely to be segmentally and distally distributed. Those who are non-adaptive to 
pain had limited analgesia after real acupuncture only. Pain adaptability may determine 
individual’s response to real and sham acupuncture. This finding might partly explain varied 
potency of acupuncture analgesia in clinical practice and trials.  
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Introduction 
The body has its own way to process and inhibit pain. CPM is one of the well-studied endogenous 
pain controls. It involves the reduction of pain from a painful stimulus when a second painful 
stimulus is applied distantly or heterotopically (Yarnitsky et al., 2010). Pain adaptability is a 
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another type of pain modulation, which has been studied in healthy humans, with a group 
experiencing reduced pain induced by cold water (PA) during a CPT while the other group 
experienced no changes or an increase in pain (PNA) (Zheng et al., 2014, Devoize et al., 2015). 
 
The relationship between pain adaptability and endogenous pain controls, pain adaptability and 
change in blood pressure and pain adaptability and acupuncture response has been investigated 
in healthy participants. Zheng and colleagues have examined the relationship between 
endogenous pain controls and pain adaptability (Zheng et al., 2014). They found a positive 
correlation between pain adaptability and the potency of “local inhibition” (SEG), but found no 
correlation between pain adaptability and potency of CPM (Zheng et al., 2014). Devoize and 
colleagues investigated the relationship between pain adaptability and cardiovascular responses, 
such as change in blood pressure, to thermal conditioning stimuli (Devoize et al., 2015). They 
found that pain adaptability was not related to the change in blood pressure. 
 
It is unclear if this dichotomy in pain adaptability also exists among individuals with MSK, and if 
pain adaptability is related to endogenous pain controls or blood pressure change in those 
individuals. 
 
An appropriate protocol that is adequate to determine pain adaptability as well as CPM in 
individuals with MSK requires further development. Previous studies used five-minute CPTs at 
temperatures of 1-4°C (Zheng et al., 2014) and 7°C (Devoize et al., 2015) to determine the pain 
adaptability of healthy humans. Such temperatures have also been used in other studies to test 
CPM or cold pain tolerance in chronic pain participants without any adverse events (Nouwen et 
al., 2006, Neziri et al., 2012a, Finan et al., 2013, Wilder-Smith and Robert-Yap, 2007, Pickering et 
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al., 2014). It is known that for cold stimuli, lower temperatures are perceived as more painful 
than higher temperatures (Wolf and Hardy, 1941). In the healthy volunteer study, one participant 
could not complete the CPT at 1-4°C (Zheng et al., 2014). It was speculated that a CPT at 2°C could 
be too painful for MSK participants. On the other hand, a CPT at 7°C might not be strong enough 
to identify PA and PNA and to induce CPM. Indeed, CPT at 8°C could not induce CPM (King et al., 
2013). Thus, a comparison of both temperatures should be explored. The ideal protocol to 
identify PA and PNA in individuals with MSK would be one being responsive, that is able to 
distinguish between PA and PNA, and practical, that is able to identify PA and PNA and measure 
CPM, while being safe and tolerable by all participants so as to increase completion rate. 
 
This study examined the pain adaptability, thermal sensitivity and potency of endogenous pain 
controls in participants with knee OA or LBP. It aimed: (1) to develop a feasible protocol to 
determine whether pain adaptability existed in MSK participants. Feasibility was assessed based 
on whether the protocol could be used to assess pain adaptability and potency of CPM, had a 
high rate of completion for the CPT and be tolerable by the MSK participants; (2) to investigate if 
there was any differences in demographics, thermal sensitivity, clinical pain, endogenous pain 
controls and the autonomic nervous system response between PA and PNA; and (3) to compare 
pain adaptability and potency of CPM between healthy and MSK participants. 
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Methods 
Design and procedure 
Participants were screened against the selection criteria described in Chapter 5 (Selection criteria 
section, pg 133-136). The steps of this study are shown in Figure 8.1. All participants had three 
sessions of tests over three weeks to assess their thermal and mechanical sensitivity, pain 
adaptability and potency of CPM. Baseline data such as demographics, BMI and pain history were 
collected at week 1. At weeks 2 and 3, participants were randomly allocated to receive a CPT at 
2°C followed by another one at 7°C or a CPT at 7°C followed by a 2°C one. Blood pressure was 
measured before and during CPTs to monitor their autonomic nervous system activity. Skin 
temperature of the foot was measured before the CPT (Chapter 5, Skin temperature section, pg 
156). Any adverse event due to the tests was recorded. During all the testing the participants 
were in the seated position. 
 
 
Figure 8.1: Procedure for the Pain Adaptability and MSK Study 
HH=healthy participants; LBP= chronic non-specific low back pain participants; OA=knee osteoarthritis participants; 
Psychophysics testing= psychophysics test including cold pressor test, pressure pain threshold and pain intensity to 
suprathreshold stimulus; Wk=week. 
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Test sites 
Participants were assessed bilaterally for their thermal sensitivity at the knees, wrists and lower 
back (Figure 8.2). PPT and SUPRA were also assessed bilaterally at these sites before the CPTs. 
During and after the CPTs only unilateral sites were tested (Table 8.1). 
 
 
 
Figure 8.2: Test sites 
(a)=knee site, 3cm medial to the mid-point on the medial edge of patella (Wylde et al., 2012, Graven-Nielsen et al., 
2012); (b)=lower back site, 2-3cm lateral to L4 spinous process (Imamura et al., 2013, O'Neill et al., 2011); (c)= wrist site, 
midpoint of dorsal aspect of the wrist joint line (O'Sullivan et al., 2014). 
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Table 8.1: Sites for PPT measurement during and after CPTs 
Type of 
participants 
Unilateral sites for PPT measurement during and after CPTs 
Knee OA 1. most painful knee 
2. side of the lower back ipsilateral to the most painful knee 
3. contralateral wrist to the most painful knee 
LBP 1. knee ipsilateral to the most painful side of the lower back 
2. most painful side of the lower back 
3.  the contralateral wrist to the most painful side of the lower back 
Healthy  1. right knee  
2. right side of the lower back  
3. left wrist 
CPT=cold pressor test; OA=osteoarthritis; LBP=chronic non-specific low back pain. 
 
 
Outcome measures 
Pain intensity from the cold water assessed during the CPTs and PPT measured before, during and 
after the CPTs were the primary outcomes (Chapter 5, Cold pressor test section, pg 148 and 
Pressure pain threshold section, pg 145). The secondary outcome measures included: (1) thermal 
sensory thresholds (Chapter 5, Thermal sensitivity section, pg 144); (2) SUPRA (Chapter 5, 
Suprathreshold stimulation section, pg 146); (3) psychological factors including level of depression, 
anxiety and stress as described in Chapter 5 section on “psychological factors” (pg 152-154); (4) 
functional status and quality of life (Chapter 5, Quality of life and functionality section, pg 154); (5) 
activity of the autonomic nervous system (Chapter 5, Measurements of the outputs of the 
autonomic nervous system section, pg 155); (6) skin and water temperatures and (7) adverse 
event from QSTs. 
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Data analysis 
Pain adaptability was determined following the protocol from Zheng’s study (Zheng et al., 2014). 
A decrease of two or more on a 0-10 pain scale between the maximum pain and pain at the end 
of CPT was categorised as PA; a decrease of less than two or no change in pain was categorised as 
PNA. McNemar’s chi square test was used to compare the proportions of PA and PNA, and the 
proportions of participants who completed and those who could not complete the CPTs at 2°C 
and 7°C. Paired t-tests were used to compare the characteristics of the participants at the CPTs at 
2°C and at 7°C. The correlation of experimental pain characteristics of the two CPTs was 
investigated using Pearson correlation to assess the consistency of the QST measurements across 
the two CPT sessions. The baseline characteristics were compared using independent t-tests and 
chi square tests. The Holm-Bonferroni adjustment was used for multiple comparisons (Holm, 
1979). The hypotheses were arranged in ascending order according to their p-value, and the p-
values are compared with the Holm-Bonferroni adjusted significance. A p-value that is smaller 
than the Holm-Bonferroni adjusted significance is considered significant. Thermal sensitivity, PPT 
and SUPRA of the participants between the subgroups (PA vs PNA; MSK participants vs healthy 
participants) were analysed using mixed ANOVA. The average blood pressure for every 30s was 
calculated. Mixed ANOVAs with repeated measures were used to analyse the change in blood 
pressure during the CPTs between PA and PNA. When needed post hoc analyses were carried out 
using Bonferroni adjustment. The data in the text are reported as mean and SD and in figures as 
mean and SE. 
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Results  
Recruitment of MSK participants 
Recruitment was between February 2015 and February 2016. A total of 138 enquiries were 
received via emails and phone (Appendix 29). Most enquiries reported learning about the study 
from the local newspapers: Whittlesea Leader (n=60) and Diamond Valley Leader (n=32) 
(Appendix 30). After screening, 49 enquiries were found to be eligible and were included in the 
study; 89 enquiries were not eligible and thus excluded. 
 
The main reasons for exclusion were that low back pain were due to specific conditions such as 
spinal stenosis or herniated disc; inability to commit for the duration of the study, and suffering 
from both LBP and OA in the knee (Table 8.2). Eleven individuals declined their interest in 
participating in the study after having read the Participant Information and Consent Form. 
 
Table 8.2: Reasons for exclusion 
Reasons for exclusion No of enquiries 
Low back pain due to specific conditions 26 
Unable to commit 12 
Knee OA +LBP 11 
Declined after reading PICF 11 
Regular anti-convulsant, anti-depressant or opioid use for pain 10 
Major disease 4 
Recently had surgery 4 
Not within age range 2 
Injury/ skin diseases in areas to be tested 2 
Unable to communicate in English 2 
High blood glucose 2 
Not LBP just tightness 1 
Declined because location of study site being too far 1 
Declined after patient consulting with their doctor 1 
Total 89 
Knee OA+LBP= suffering from knee osteoarthritis and severe low back pain; PICF= participant information and consent 
form. 
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Out of the 49 included participants, 25 participants were LBP participants and 24 knee OA 
participants (Figure 8.3). After the first session, the baseline measurements and thermal 
sensitivity tests, six participants (five LBP and one knee OA) dropped out: four because of work or 
study commitment, one because of medical reasons and one for unknown reasons. Their data 
were excluded from the analysis. All analyses were performed for a sample of 43 MSK 
participants: 20 LBP and 23 knee OA participants. 
 
 
Figure 8.3: Flow chart of included participants 
LBP= chronic non-specific low back pain; OA= knee osteoarthritis; Wk= week. 
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CPT 2°C vs CPT 7°C in MSK participants 
Pain adaptability in MSK participants 
All 43 pain participants were tested with both CPTs (2°C and 7°C) in a random order. PA and PNA 
were identified during both tests. A McNemar’s chi square test revealed that the proportions of 
PA (n=18) and PNA (n=25) identified using the CPT at 2°C was not different (p=1.00) from the 
proportion of PA (n=17) and PNA (n=26) identified using the CPT at 7°C (Table 8.3). More 
participants completed the CPT at 7°C (n=35) than those who completed at 2°C (n=32) (Table 8.4); 
however there was no statistically significant difference in the proportion of those who 
completed the CPT (p=0.45). Although not all of them could successfully complete the five 
minutes at 2°C (n=11, 25.58% could not complete) or seven minutes at 7°C (n=8, 18.60% could 
not complete), no adverse events were reported. 
 
Table 8.3: Pain adaptive and pain non-adaptive identified using cold pressor tests at 2°C and 7°C. 
 PA 7°C PNA 7°C Total 
PA 2°C 13 5 18 
PNA 2°C 4 21 25 
Total 17 26 43 
PA=pain adaptive; PNA= pain non-adaptive. 
 
Table 8.4: Number of participants who completed the CPTs at 2°C and 7°C 
 
Completed Did not complete Total 
CPT 2°C 32 11 43 
CPT 7°C 35 8 43 
CPT=cold pressor test. 
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Correlation of experimental pain characteristics of the two CPTs was investigated. Moderate to 
strong positive correlations were found between the two CPT sessions in the participants’ 
severity of average pain, maximum pain, time to reach maximum pain and difference between 
their maximum experimental pain and pain at the end of the CPT (Table 8.5). 
 
Paired t-tests showed that the maximum pain from the CPT at 2°C was more intense than that 
from the CPT at 7°C and that the time to reach maximum pain was shorter during the 2°C CPT 
than the 7°C CPT (Table 8.5). No difference was found in either the average pain or the difference 
between the maximum pain and pain at the end (pain adaptability) between the two CPT sessions. 
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Table 8.5: CPT pain parameters of the MSK participants during the two CPTs (mean ± SD) 
CPT pain parameters CPT 2°C (n=43) CPT 7°C (n=43) Pearson correlation , r p-value t42-value p-value 
Adjusted 
significance1 
Average pain from CPT (VAS) 6.08 ± 1.97 5.76 ± 1.83 0.53 <0.01* 1.14 0.26 0.03 
Maximum Pain from CPT (VAS) 8.88 ± 1.77 8.34 ± 1.60 0.70 <0.01* 2.72 0.01* 0.02 
Time to reach Maximum Pain (s) 110.27 ± 109.832 153.68 ± 143.478 0.77 <0.01* -3.08 <0.01* 0.01 
Pain difference (Max-End) 2.34 ± 2.87 2.27 ± 2.81 0.74 <0.01* 0.22 0.83 0.05 
CPT= cold pressor test; VAS= visual analogue scale 0-10, 0 being no pain at all and 10 the worst pain possible; Max-End= difference between maximum pain and pain at the end during the cold pressor test; 
*=significant p values; 1= Holm-Bonferroni adjusted criterion of statistical significance. 
 
 226 
 
Baseline PPT in MSK participants across the two sessions  
PPT was measured before the CPTs at six sites (Table 8.6). Moderate to strong correlations between 
PPTs measured prior to the two CPTs were found at the six testing sites. Further, paired t-tests 
resulted in no statistically significant difference between PPTs measured prior to the two CPT 
sessions. 
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Table 8.6: Correlation and differences of PPT pre CPT 2°C and CPT 7°C in the MSK participants (mean ± SD) 
QST 
measures Sites CPT 2°C (n=43) CPT 7°C (n=43) 
Pearson 
correlation, r p-value t42-value p-value 
Adjusted 
significance1 
PPT pre CPT 
right knee 3.35 ± 1.32 3.20 ± 1.30 0.73 <0.01* 1.05 0.30 0.01 
left knee 3.09 ± 1.08 3.13 ± 1.22 0.77 <0.01* -0.33 0.74 0.01 
right wrist 3.04 ± 1.02 2.91 ± 1.09 0.52 <0.01* 0.83 0.41 0.01 
left wrist 2.88 ± 0.98 2.90 ± 1.04 0.41 0.01* -0.12 0.91 0.03 
right lower back 3.78 ± 1.66 3.56 ± 1.61 0.66 <0.01* 1.09 0.28 0.01 
left lower back 3.55 ± 1.50 3.49 ± 1.48 0.67 <0.01* 0.33 0.75 0.01 
QST=quantitative sensory tests; CPT=cold pressor test; PPT=pressure pain threshold; *= significant p-values; 1= Holm-Bonferroni adjusted criterion of statistical significance. 
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Endogenous pain controls in MSK participants 
The analyses of the potency of endogenous pain controls were conducted using raw values and 
percentage changes in PPT. No difference was observed between the two sets of results. This section 
will present the data on percentage changes in PPT. 
 
The potency of CPM was measured using the percentage change in PPT at the wrist and the lower 
back during the CPTs. There was no correlation between the two sessions of CPTs. No session effect 
was observed between the two CPTs. A trend in site effect (F(1,42)=4.24, p=0.05) showed that the 
increase in percentage PPT was higher in the lower back compared with the wrist (Table 8.7). The 
potency of SEG was measured using the percentage change in PPT at the knee during the CPTs. 
There was a moderate correlation in the percentage change of PPT at the knee between the two 
CPTs (r=0.42, p=0.01). But no difference was observed between the CPT at 2°C (9.05 ± 28.56%) and 
at 7°C (9.91 ± 32.64%) in percentage change of PPT at the knee (t42=-0.17, p=0.87). 
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Table 8.7: CPM in MSK participants during the two CPTs (mean ± SD) 
%PPT 
change 
during CPT 
CPT 2°C (n=43) CPT 7°C (n=43) 
Pearson 
correlation , 
r 
p-
value 
Adjusted 
significance1 
Session 
effect F(1,42) 
Site effect 
F(1,42) 
Session x site 
effect F(1,42) 
F 
value 
p 
value 
F 
value 
p 
value 
F 
value 
p 
value 
wrist 4.99 ± 27.52 4.34 ± 28.36 0.11 0.48 0.05 0.59 0.45 4.24 0.05 0.43 0.51 
lower back 13.32 ± 32.69 20.74 ± 59.30 0.28 0.08 0.03 
PPT=pressure pain threshold; CPT=cold pressor test; 1= Holm-Bonferroni adjusted criterion of statistical significance. Two-way with two repeated measure of ANOVA was used to analyse the 
data.  
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Characteristics of PA and PNA in MSK participants 
Since the proportion of PA and PNA between the two CPTS were similar, with strong correlations 
between the CPTs in the experimental pain characteristics and pain adaptability, this section will 
present the data of the PA and PNA identified using the CPT at 2°C. 
 
Baseline characteristics 
Among the 43 participants, 18 PA and 25 PNA were identified using a CPT at 2°C. No significant 
difference was found between PA and PNA in their demographics, pain history, sleep quality and 
quality of life (Table 8.8). There was a trend that PNA had more comorbidity than PA did (t41=-2.16, 
p=0.02), there was however no statistically significant difference between the two groups (Table 8.8). 
The baseline data of PA and PNA identified using the CPT at 7°C is presented in Appendices 31 -32. 
 
Table 8.8: Baseline characteristics of the PA and PNA identified at 2°C (mean ± SD) 
Baseline characteristics PA (n=18) PNA (n=25) 
X21/ 
t41-test 
p 
value 
Adjusted 
significance1 
Age (yrs) 55.67 ± 14.07 56.92 ± 12.93 -0.30 0.76 0.02 
BMI 28.01 ± 3.58 28.77 ± 8.21 -0.37 0.72 0.01 
Gender M/F 12/6 14/11 0.50 0.48 0.01 
History of pain (yrs) 5.51 ± 6.72 8.37 ± 9.01 -1.14 0.26 0.01 
Maximum Pain in the 
past week (NRS) 6.00 ± 2.25 5.54 ± 2.43 0.63 0.53 0.01 
No. of painful areas 2.33 ± 1.41 2.72 ± 1.37 -0.90 0.37 0.01 
No. of comorbidities 0.39 ± 0.50 1.08 ± 1.29 -2.16 0.02 <0.01 
Sleep quality (PSQI) 6.67 ± 3.87 6.56 ± 3.49 0.09 0.93 0.05 
Pain catastrophizing 13.67 ± 10.37 16.24 ± 10.88 -0.78 0.44 0.01 
Physical health (SF-36) 45.79 ± 5.33 42.71 ± 8.27 1.48 0.15 <0.01 
Mental health (SF-36) 53.70 ± 6.63 53.15 ± 7.53 0.25 0.81 0.03 
Medication/ no 
medication 7/11 16/9 2.69 0.10 <0.01 
LBP/knee OA 7/11 13/12 0.29 0.59 0.01 
PA=pain adaptive; PNA=pain non-adaptive; BMI=body mass index; M=male; F=female; NRS=numerical rating scale 0-10, 
0being no pain at all and 10 the worst pain possible; PSQI=Pittsburgh Sleep Quality index; SF-36= short form 36 items 
survey, to measure quality of life; 1= Holm-Bonferroni adjusted criterion of statistical significance; significant p values are 
less than these values. 
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The thermal sensitivity of PA and PNA at the knees, wrists and lower back, tested at baseline, were 
compared. Three-way (group, site and sides) mixed ANOVAs with two repeated measures (sites, 3 
levels and sides 2 levels) were used to analyse their cold detection threshold, warm detection 
threshold, cold pain threshold and heat pain threshold (Table 8.9). There was no main effect for 
groups or sides, and no group by site or group by side interaction for their cold and warm detection 
thresholds and their cold and heat pain thresholds at all sites.  
 
Site effects were observed in warm detection threshold (F(2,82)=29.03, p<0.01), cold pain threshold 
(F(2,82)=8.68, p<0.01) and heat pain threshold (F(2,82)=43.84, p<0.01). Warm detection and heat pain 
thresholds were higher at the wrist compared with the knee (p<0.01, p<0.01 respectively) and the 
lower back (p<0.01, p<0.01 respectively), and higher at the knee compared with the back (p=0.01, 
p<0.01 respectively) (Figure 8.4). Further, cold pain thresholds were lower at the wrists compared 
with the knees (p<0.01) and lower back (p<0.01) (Figure 8.5). Those findings indicate that low back 
was the most sensitive site to both cold and heat changes; and the wrists were the least sensitive 
site among the three anatomic locations. 
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Figure 8.4: Warm detection and heat pain thresholds was higher at the wrist compared with the knee and lower back, 
and higher in the knee compared with the lower back 
SE=standard error of mean; WD=warm detection threshold; HP=heat pain threshold. 
 
                  
Figure 8.5: Cold pain threshold was lower at the wrist compared with the knee and lower back 
SE=standard error of mean; CP=cold pain threshold. 
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Table 8.9: Thermal sensitivities at the knees, wrists and lower back in PA and PNA identified using a CPT at 2°C (mean ± SD) 
Thermal sensitivity 
tests (°C) Sites Sides PA (n=18) PNA (n=25) 
Group effect Site effect  Group x site effect 
F(1,41) 
value p value 
F(2,82) 
value p value 
F(2,82) 
value p value 
Cold detection 
threshold 
knees R 27.03 ± 2.07 27.59± 1.93 
1.34 0.25 0.94 0.40 0.18 0.84 
L 26.86 ± 2.09 27.39 ± 2.20 
wrist R 26.29 ± 5.33 26.78 ± 2.15 
L 28.00 ± 2.64 27.87 ± 2.30 
Lower back R 27.11 ± 2.76 27.91 ± 2.01 L 27.29 ± 4.35 28.38 ± 1.66 
Warm detection 
threshold 
knees R 37.03 ± 2.49 35.87 ± 1.30 
0.10 0.92 29.03 <0.01* 0.18 0.84 
L 36.31 ± 2.09 36.72 ± 2.62 
wrist R 39.10 ± 5.02 39.66 ± 4.82 L 38.89 ± 4.31 38.44 ± 3.66 
Lower back R 35.30 ± 1.43 35.76 ± 1.62 L 35.80 ± 1.89 35.61 ± 1.69 
Cold pain threshold 
knees R 10.75 ± 9.33 11.80± 9.33 
0.12 0.92 8.68 <0.01* 0.24 0.79 
L 12.81 ± 10.64 13.16 ± 11.98 
wrist R 9.34 ± 8.95 10.29 ± 10.96 L 9.27 ± 9.71 9.77 ± 10.13 
Lower back R 14.01 ± 11.53 12.73 ± 12.03 L 14.32 ± 11.21 14.57 ± 10.67 
Heat pain threshold 
knees R 46.76 ± 3.13 45.37 ± 3.53 
2.09 0.16 43.84 <0.01* 1.54 0.22 
L 45.78 ± 3.11 45.96 ± 3.11 
wrist R 48.85 ± 1.76 47.48 ± 2.88 L 49.64 ± 2.93 47.18 ± 3.04 
Lower back R 44.74 ± 3.82 43.95 ± 3.99 L 44.31 ± 3.04 43.94 ± 3.37 
PA=pain adaptive; PNA=pain non-adaptive; R=right; L=left; *=significant p values. 
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The baseline PPT and SUPRA of PA and PNA at the knees, wrists and lower back before the CPT at 
2°C and 7°C were analysed using three-way (group, site and session) mixed ANOVAs with repeated 
measures (sites, 3 levels and sessions 2 levels). No group effect or session effect was observed for 
PPT and SUPRA (Table 8.10). Significant site effects were found for PPT (F(2,82)=12.57, p<0.01) and 
SUPRA (F(2,82)=7.48, p<0.01). PPT was found to be higher at the lower back compared with the wrist 
(p<0.01) and the knee (p=0.03); there was no difference in PPT between the wrist and the knee. 
SUPRA was higher at the knee compared with the wrist (p=0.01) and the lower back (p=0.01); no 
difference was found in SUPRA at the wrist and the lower back. 
 
                     
Figure 8.6: Higher PPT at the lower back compared with the wrists and knees 
SE=standard error of mean; PPT=pressure pain threshold. 
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Figure 8.7: Higher SUPRA at the knees compared with the lower back and wrists 
SE=standard error of mean; SUPRA=pain intensity to suprathreshold stimulus. 
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Table 8.10: PPT and SUPRA at the knees, wrists and lower back in PA and PNA before CPT at 2°C and 7°C (mean ± SD) 
QST 
measures Sites Sides 
CPT 2°C CPT 7°C Group effect Site effect Session effect 
Group x site 
effect 
Group x 
session 
effect 
PA (n=18) PNA (n=25) PA (n=18) PNA (n=25) F(1,41) value 
p 
value 
F(2,82) 
value 
p 
value 
F(1,41)  
value 
p 
value 
F(2,82) 
value 
p 
value 
F(1,41) 
value 
p 
value 
PPT 
(Kgf/cm2) 
knees 
R 3.83 ± 1.32 3.01 ± 1.23 3.47 ± 1.40  3.01 ± 1.21 
2.92 0.10 12.57 <0.01* 0.62 0.44 0.80 0.45 0.03 0.88 
L 3.51 ± 1.13 2.79 ± 0.95 3.51 ± 1.16 2.85 ± 1.21 
wrist 
R 3.22 ± 1.10 2.92 ± 0.96 3.15 ± 1.08 2.74 ± 1.09 
L 2.9 8 ± 1.03 2.81 ± 0.97 3.15 ± 1.23 2.72 ± 0.87 
Lower 
back 
R 4.28 ± 1.91 3.42 ± 1.39 3.91 ± 1.96 3.31 ± 1.29 
L 4.28 ± 1.91 3.42 ± 1.39 3.74 ± 1.48 3.31 ± 1.48 
SUPRA 
(NRS) 
knees 
R 4.42 ± 1.95 3.82 ± 2.24 3.97 ± 1.68 3.98 ± 2.14 
0.08 0.78 7.48 <0.01* 1.18 0.29 2.10 0.15 0.26 0.61 
L 3.92 ± 1.80 3.80 ± 2.30 3.97 ± 1.68 4.24 ± 2.07 
wrist 
R 3.67 ± 2.40 3.74 ± 2.12 3.36 ± 1.89 3.66 ± 1.97 
L 3.22 ± 1.82 3.12 ± 2.45 3.80 ± 1.52 3.14 ± 1.71 
Lower 
back 
R 3.50 ± 2.36 3.58 ± 2.35 3.39 ± 1.91 3.92 ± 1.55 
L 3.11 ± 2.19 3.68 ± 2.53 3.53 ± 1.75 3.70 ± 1.67 
QST=quantitative sensory tests; R=right; L=left; CPT=cold pressor test; PA=pain adaptive; PNA=pain non-adaptive; NRS=numerical rating scale 0-10, 0 meaning no sensation at all, 5 just painful and 10 the worst 
pain possible; *=significant p values. 
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Confounding factors measured before each CPT 
The psychological characteristics (level of depression, anxiety and stress), physical function, sleep 
quality from the previous night, room temperature, water temperature and foot temperature were 
recorded before each CPT. No group effect or interaction was observed for all these factors (Tables 
8.11 and 8.12). Main effect for sessions were found for the water temperature at the start of CPT 
(F(1,41)= 5805.41, p<0.01) and the difference in temperature between the foot to be immersed and 
the water at the start of the CPTs (F(1,26)= 517.98, p<0.01). The water temperature was obviously 
higher at the CPT at 7°C and this has led to a smaller difference in temperature between the foot 
and the water at the CPT at 7°C and a larger temperature difference at the CPT at 2°C. This 
difference was expected. 
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Table 8.11: Psychological characteristics, function and sleep quality of PA and PNA before the CPT at 2°C and 7°C (mean ± SD) 
Confounding factors 
CPT 2°C CPT 7°C Group effect Session effect Group x session effect 
PA (n=18) PNA (n=25) PA (n=18) PNA (n=25) F(1,41) value 
p 
value 
F(1,41) 
value 
p 
value 
F(1,41) 
value 
p 
value 
Depression (DASS21) 2.17 ± 2.62 2.64 ± 3.90 1.78 ± 2.21 3.20 ± 4.14 0.85 0.36 0.15 0.76 2.96 0.09 
Anxiety (DASS21) 1.44 ± 1.65  2.00 ± 2.16 1.33 ± 1.94 2.24 ± 2.33 1.52 0.23 0.07 0.79 0.52 0.48 
Stress (DASS21) 4.06 ± 3.96 4.00 ± 4.12 3.83 ± 4.40 4.08 ± 3.94 0.01 0.94 0.04 0.84 0.18 0.67 
Function (RMQ) 6.72 ± 4.73 6.96 ± 4.35 5.56 ± 3.26 7.40 ± 4.29 0.75 0.39 0.51 0.48 2.51 0.12 
Sleep quality (NRS1) 6.94 ± 1.83 6.98 ± 1.87 6.74 ± 1.84 6.92 ± 1.56 0.02 0.90 0.27 0.61 0.27 0.61 
CPT=cold pressor test; PA= pain adaptive; PNA=pain non-adaptive; DASS21=Depression, Anxiety and Stress Scale 21 items; RMQ= modified Roland Morris Questionnaire; NRS1=numerical rating scale 0-10, 0 
being worst sleep quality and 10 the best sleep quality. 
 
 
Table 8.12: Room temperature, water temperature and foot temperature in PA and PNA before CPTs at 2°C and 7°C (mean ± SD) 
Temperature/°C 
CPT 2°C CPT 7°C Group effect Session effect Group x session effect 
PA (n=18) PNA (n=25) PA (n=18) PNA (n=25) F(1,41) value 
p 
value 
F(1,41) 
value 
p 
value 
F(1,41) 
value 
p 
value 
Room temperature 22.61 ± 0.40 22.83 ± 0.45 22.76 ± 0.39 22.86 ± 0.42 2.08 0.16 1.70 0.20 0.77 0.39 
Water temperature at start of 
CPT 2.69 ± 0.32 2.58 ± 0.27 7.35 ± 0.42 7.48 ± 0.45 0.01 0.93 5805.41 <0.01* 3.63 0.64 
Temperature of foot before CPT 21.95 ± 0.80^ 22.00 ± 0.71$ 22.19 ± 0.71^ 21.92 ± 0.54$ 0.71# 0.41 0.39# 0.54 0.01# 0.92 
Temperature difference (foot- 
CPT) 19.28 ± 0.90
^ 19.39 ± 0.83$ 14.82 ± 0.78^ 14.44 ± 0.60$ 1.31# 0.26 517.98# <0.01* 0.29# 0.60 
CPT= cold pressor test; PA= pain adaptive; PNA= pain non-adaptive; foot-CPT=temperature difference between foot temperature and water temperature before the cold pressor test; ^= sample size is 13; $= 
sample size is 15; #= degree of freedom is F(1,26); *=significant p-values. 
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Clinical and experimental pain 
Before each CPT, the intensity of clinical pain was recorded (Table 8.13). A trend in group difference 
was observed between PA and PNA in their maximum pain 24 hours before the CPTs (F(1,41)= 4.15, 
p=0.05), with the PNA having greater pain than PA. No other main effects or interaction was found in 
their clinical pain: average pain in the last week and maximum pain in the last 24 hour. 
 
Two-ways (group x session) mixed ANOVAs with repeated measures (session, 2 levels) were used to 
analyse the experimental pain parameters during the CPTs at 2°C and 7°C. There was no difference 
in the average experimental pain during the CPTs between PA and PNA or between the two CPT 
sessions (Table 8.14). A significant session effect was found for the maximum experimental pain, 
with a higher maximum pain during the CPT at 2°C than at the CPT at 7°C (Table 8.14). Group (F(1,41)= 
4.88, p=0.03) and session (F(1,41)=8.93, p=0.01) effects were found for the time to reach their 
maximum experimental pain (Figure 8.8). PA (86.73 ± 60.66s) had a shorter time to reach maximum 
pain than PNA (164.55 ± 139.94s). The time to reach maximum pain was shorter at the 2°C (110.27 ± 
109.83s) than at the 7°C (153.68 ± 143.48s) CPT. A main effect of groups (F(1,41)= 100.64, p<0.01) was 
also found in the pain difference between the maximum experimental pain and the experimental 
pain at the end of the CPT (Figures 8.9). PA had a higher pain difference (4.91 ± 2.11) than PNA (0.43 
± 0.64), which is expected as it was based on this outcome measure that PA and PNA were 
categorised. There was a significant group by session interaction (F(1,41)= 4.47, p=0.04); PNA showed 
a greater pain difference between the maximum pain and pain at the end of CPT at 7°C than at 2°C 
(t24=-2.17, p=0.04), whereas PA did not show any significant difference between the two CPTs 
(t17=1.26, p=0.22). 
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Table 8.13: Clinical pain of PA and PNA before the CPT at 2°C and 7°C (mean ± SD) 
Clinical pain 
CPT 2°C CPT 7°C Group effect Session effect Group x session effect 
PA (n=18) PNA (n=25) PA (n=18) PNA (n=25) F(1,41) value 
p 
value 
F(1,41) 
value 
p 
value 
F(1,41) 
value 
p 
value 
Average Pain in the last week (NRS) 4.22 ± 1.46 4.58 ± 1.62 4.11 ± 1.69 4.31 ± 1.50 0.41 0.53 0.75 0.39 0.13 0.72 
Maximum Pain in the last 24Hr (NRS) 3.76 ± 2.13 4.84 ± 2.11 3.72 ± 1.82 4.84 ± 1.77 4.15 0.05 0.01 0.94 0.01 0.94 
CPT=cold pressor test; PA= pain adaptive; PNA=pain non-adaptive; NRS=numerical rating scale 0-10, 0 being no pain at all and 10 the worst pain possible. 
 
 
Table 8.14: Experimental pain parameters of PA and PNA during the CPT at 2°C and 7°C (mean ± SD) 
CPT Pain parameters 
CPT 2°C CPT 7°C Group effect Session effect Group x session effect 
PA (n=18) PNA (n=25) PA (n=18) PNA (n=25) F(1,41) value 
p 
value 
F(1,41)  
value 
p 
value 
F(1,41)  
value 
p 
value 
Average pain from CPT (VAS) 6.37 ± 1.53  5.88 ± 2.24 5.61 ± 1.74 5.87 ± 1.93 0.05 0.83 1.84 0.18 1.76 0.19 
Maximum Pain from CPT (VAS) 9.05 ± 1.15 8.76 ± 2.12 8.38 ± 1.42 8.32 ± 1.75 0.13 0.72 7.55 0.01* 0.31 0.58 
CPT=cold pressor test; VAS= visual analogue scale 0-10, 0 being no pain at all and 10 the worst pain possible; PA=pain adaptive; PNA=pain non-adaptive; *=significant p values. 
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Figure 8.8: Time to reach maximum experimental pain during the CPT at 2°C and 7°C for PA (n=18) and PNA (n=25) 
(mean ± SE) 
CPT= cold pressor test; #=significant group effect (F(1,41)= 4.88, p=0.03), with PNA taking longer to reach their maximum 
pain compared with PA; *= significant session effect (F(1,41)= 8.93, p=0.01), with a longer time to reach maximum pain 
during the CPT at 7°C compared with the CPT at 2°C. 
 
 
 
Figure 8.9: Pain difference during the CPT at 2°C and 7°C for PA (n=18) and PNA (n=25) (mean ± SE) 
Max-End= difference between maximum pain and pain at the end during the cold pressor test. *= significant group x 
session interaction (F(1,41)= 8.93, p=0.01), with PNA having a smaller pain difference during the CPT at 2°C than the CPT at 
7°C (t24=-2.17, p=0.04), and PA showing no significant difference between the two CPTs. 
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Pain adaptability and endogenous controls 
Percentage changes and raw values of PPT were used to analyse the potency of endogenous pain 
control in PA and PNA. No difference was found between the results of the two types of analyses. 
This section will present the results from the analyses of percentage PPT changes.  
 
The potency of endogenous pain controls between PA and PNA were compared by analysing the 
percentage PPT during, immediately after and 15 minutes after the completion of the CPTs at each 
site using three-way (group, session and time) repeated measures (sessions, 2 levels and time, 3 
levels) of ANOVAs. No main effect for groups or sessions, and no group by session interactions were 
observed at all the sites. A significant time effect was observed at the knee (F(2,82)=3.44, p=0.04) and 
wrist (F(2,82)=5.80, p<0.01) but not at the lower back (Figures 8.10). The percentage of PPT change at 
the knee or wrist was higher during the CPTs than immediately after or 15 minutes after. There was 
no significant group by time interaction. 
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Figure 8.10: Graphs of percentage PPT changes (mean ± SE). a.= %PPT change at the knee during a CPT at 2°C; b.= %PPT change at the knee during a CPT at 7°C; c.= %PPT change at the wrist during a CPT at 
2°C; b.= %PPT change at the wrist during a CPT at 7°C; e.= %PPT change at the lower back during a CPT at 2°C; f.= %PPT change at the lower back during a CPT at 7°C 
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Pain adaptability and blood pressure 
The activity of the autonomic nervous system in PA and PNA was compared using their mean blood 
pressure before and during the CPTs. The analysis was carried out in 32 participants only as the beat 
to beat blood pressure of 11 participants could not be measured due to a technical fault. Mean 
blood pressure data were analysed in the following manner : (1) two-way (group by time) mixed 
ANOVA with repeated measures were used to analyse the mean blood pressure of all the PA and 
PNA; (2) two-way mixed (group by time) ANOVA with repeated measures were used to analyse the 
mean blood pressure of only those PA and PNA who completed their CPTs; (3) independent t-tests 
were used to compare the mean blood pressure at baseline and during the CPTs for all the PA and 
PNA, (4) independent t-tests were used to compare the mean blood pressure at baseline and during 
the CPTs for those PA and PNA who completed their CPTs. 
 
ANOVA analysis for all PA and PNA during CPTs at 2°C and 7°C 
There was a significant time effect (F(13,390)= 9.62, p<0.01) for these 32 participants for the CPT at 2°C. 
The mean blood pressure of both PA and PNA increased to their maximum at about 210s 
(approximately 60s after the start of the CPT and then decreased). There were neither group effect 
(F(1, 30)=0.11, p=0.74) nor group by time interaction (F(13, 390)=1.80, p=0.16) in their mean blood 
pressure. 
 
Similar analysis was carried out for the change in blood pressure of PA and PNA during the CPT at 
7°C. The analysis of the 32 participants, for whom data were available, also resulted in a significant 
time effect (F(17, 442)=8.97, p<0.01), and no group effect (F(1,26)= 1.54, p=0.23) or group by time 
interaction (F(17, 442)= 1.14, p=0.37). 
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ANOVA analysis for those PA and PNA who completed the CPTs at 2°C and 7°C 
Among these 32 participants, 9 participants did not complete the CPT at 2°C and the remaining 23 
participants completed the 5-minutes test. The same analysis was carried out for only those 
participants who completed the 5-minutes test (Figure 8.11). Again a time effect (F(13,273)=10.63, 
p<0.01) was observed but no group effect (F(1, 21)=0.49, p=0.49) or group by time interaction (F(13, 
273)=0.40, p= 0.97). 
 
 
Figure 8.11: Graph of blood pressure before and during the CPT, and pain intensity from the CPT at 2°C for the PA (n=11) 
and PNA (n=12) who completed the CPT 
BP= mean blood pressure; CPT=cold pressure test; PA=pain adaptive; PNA=pain non-adaptive; VAS=visual analogue scale 0-
10, 0 meaning no pain at all and 10 the worst pain possible; pain= pain intensity to cold pressor. 
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Further, the analysis of only those who completed the CPT at 7°C (n=27) had similar findings: a 
significant time effect (F(17, 425)=9.24, p<0.01), and no group effect (F(1, 25)=1.57, p=0.22) or group by 
time interaction (F(17, 425)=1.31, p=0.28) (Figure 8.12). 
 
 
Figure 8.12: Graph of blood pressure before and during the CPT, and pain intensity from the CPT at 7°C for the PA (n=11) 
and PNA (n=16) who completed the CPT 
BP=blood pressure; CPT=cold pressure test; PA=pain adaptive; PNA=pain non-adaptive; VAS=visual analogue scale 0-10 (0 
meaning no pain at all, 10 the worst pain possible); pain= pain intensity to cold pressor. 
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T-tests for all PA and PNA during CPTs at 2°C and 7°C 
PA and PNA did not differ in their baseline mean blood pressure, average mean blood pressure, 
maximum mean blood pressure and time to reach their maximum mean blood pressure at both CPTs 
(Table 8.15). 
 
Table 8.15: Autonomic nervous system response in all PA and PNA during the CPTs at 2°C and 7°C (mean ± SD) 
CPTs 
Autonomic 
response 
parameters 
PA (n=11) PNA (n=21) t30-test 
p 
value 
Adjusted 
significance1 
2°C 
Baseline BP 
pre CPT 79.07 ± 14.06 84.71 ± 12.74 -1.15 0.26 0.01 
Average BP 
during CPT 87.32 ± 15.20 90.02 ± 16.47 -0.45 0.66 0.02 
MaxBP during 
CPT 95.14 ± 16.06 97.24 ± 19.00 -0.31 0.76 0.03 
Time to 
MaxBP during 
CPT 
100.91 ± 75.03 97.14 ± 105.17 0.11 0.92 0.05 
7°C 
Baseline BP 
pre CPT 76.40 ± 11.10 81.24 ± 10.75 -1.20 0.24 0.01 
Average BP 
during CPT 82.43 ± 15.22 87.45 ± 12.82 -0.99 0.33 0.03 
MaxBP during 
CPT 91.54 ± 14.21 95.54 ± 16.26 -0.69 0.50 0.05 
Time to 
MaxBP during 
CPT 
190.91 ± 135.68 141.43 ± 132.53 1.00 0.33 0.02 
CPT=cold pressor test; PA=pain adaptive; PNA=pain non-adaptive; BP= mean blood pressure; MaxBP=maximum blood 
pressure; 1= Holm-Bonferroni adjusted criterion of statistical significance. 
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T-tests for those PA and PNA who completed the CPTs at 2°C and 7°C 
Independent t-tests were also used to compare the autonomic nervous response of the PA and PNA 
who completed the CPTs. Similar results were found. There was no difference in their baseline mean 
blood pressure, average mean blood pressure, maximum mean blood pressure and time to reach 
their maximum mean blood pressure at both temperatures (Table 8.16). 
 
Table 8.16: Autonomic nervous system response in those PA and PNA who completed the CPTs at 2°C and 7°C (mean ± 
SD) 
CPTs 
Autonomic 
response 
parameters 
PA (n=11) PNA (n=16) t30-test 
p 
value 
Adjusted 
significance1 
2°C 
Baseline BP 
pre CPT 79.07 ± 14.06 85.45 ± 13.80 -1.10 0.28 0.01 
Average BP 
during CPT 87.32 ± 15.20 91.71 ± 20.29 -0.58 0.57 0.03 
MaxBP during 
CPT 95.14 ± 16.06 100.08 ± 23.63 -0.58 0.57 0.05 
Time to 
MaxBP during 
CPT 
100.91 ± 75.03 140 ± 120.23 -0.93 0.37 0.02 
7°C 
Baseline BP 
pre CPT 76.40 ± 11.10 82.41 ± 11.49 -1.35 0.19 0.01 
Average BP 
during CPT 82.43 ± 15.22 89.13 ± 13.73 -1.19 0.24 0.02 
MaxBP during 
CPT 91.54 ± 14.21 98.86 ± 16.73 -1.18 0.25 0.03 
Time to 
MaxBP during 
CPT 
190.91 ± 135.68 172.50 ± 135.72 0.35 0.73 0.05 
CPT=cold pressor test; PA=pain adaptive; PNA=pain non-adaptive; BP=mean blood pressure; MaxBP=maximum blood 
pressure,1= Holm-Bonferroni adjusted significance. 
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Healthy vs MSK participants 
This section will present the comparison between MSK participants and healthy humans in their pain 
adaptability and CPM.  
 
Baseline characteristics  
The two groups (healthy and MSK participants) were comparable in their age, body mass index, 
gender, number of comorbidities and mental health (Table 8.17). A significant difference was found 
in the clinical pain. The MSK participants had a longer history of pain (t64=-5.76, p<0.01), more pain 
in the previous week (t64=-16.06, p<0.01) and more areas in pain (t64=-11.25, p<0.01) than the 
healthy participants. Compared with the healthy participants, the pain participants presented with a 
higher pain catastrophizing level (t64=-6.23, p<0.01), and a poorer physical health (t64=7.95, p<0.01) 
(indicated by a lower score in the physical health component of the quality of life questionnaire). A 
trend was observed in their sleep quality (t64=-2.07, p=0.04), with the healthy participants having a 
better sleep quality than the MSK participants. 
 
Table 8.17: Baseline characteristics of the healthy and MSK participants (mean ± SD) 
Baseline characteristics 
Healthy 
participants 
(n=23) 
MSK 
participants 
(n=43) 
x21/t64-
value 
p-
value 
Adjusted 
significance1 
Age (yrs) 52.83 ± 12.78 56.40 ± 13.27 -1.05 0.30 0.01 
BMI 11/12 26/17 0.97 0.32 0.02 
Gender M/F 26.51 ± 4.90 28.45 ± 6.62 -1.24 0.22 0.01 
History of pain (yrs) 0 7.17 ± 8.17 -5.76 <0.01* <0.01 
Maximum Pain in the 
past week (NRS) 0 5.73 ± 2.34 -16.06 <0.01* 0.01 
No. of painful areas 0.09 ± 0.29 2.56 ± 1.39 -11.25 <0.01* 0.01 
No. of comorbidities 0.65 ± 1.03 0.79 ± 1.08 -0.50 0.62 0.05 
Sleep quality (PSQI) 4.83 ± 2.74 6.60 ± 3.61 -2.07 0.04 0.01 
Pain catastrophizing 3.35 ± 4.73 15.16 ± 10.62 -6.23 <0.01* 0.01 
Physical healthy (SF-36) 55.45 ± 4.52 43.84 ± 7.32 7.95 <0.01* 0.01 
Mental health (SF-36) 53.46 ± 7.59 52.31 ± 8.29 0.56 0.58 0.03 
MSK=chronic musculoskeletal pain; BMI=body mass index; M=male; F=female; NRS=numerical rating scale 0-10, 0being no 
pain at all and 10 the worst pain possible; PSQI=Pittsburgh Sleep Quality index; SF-36= short form 36 items survey, to 
measure quality of life; 1= Holm-Bonferroni adjusted criterion of statistical significance; *=significant p-values. 
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Comparison of their thermal sensitivity showed group differences in cold (F(1,64)=8.31, p=0.01) and 
warm (F(1,64)=4.44, p=0.04) detection thresholds (Table 8.18). The healthy participants showed a 
higher cold detection threshold (Figure 8.13) and a lower warm detection threshold (Figure 8.14) 
than the pain participants, indicating that the healthy participants were more sensitive to those 
thermal stimulations than the pain participants. 
 
Statistically Significant site effects were observed in warm detection threshold (F(2,128)= 21.37, p<0.01) 
and cold (F(2,128)= 9.89, p<0.01) and heat pain thresholds (F(2,128)= 8.31, p<0.01) (Table 8.18). The 
results were similar with that from the analysis of thermal sensitivity of the MSK participants only 
(Baseline characteristics section, pg 233-235). The warm detection threshold and the heat pain 
threshold of both groups were higher at the wrist compared with the knee (p<0.01, p<0.01 
respectively) and the lower back (p<0.01, p<0.01 respectively). The cold pain threshold was lower at 
the wrist than at the lower back (p<0.01). 
 
Statistically significant group by site interaction was found in warm detection thresholds (F(2,128)=5.91, 
p<0.01). The healthy participants presented with a lower warm detection threshold than the MSK 
participants at the wrist (F(1,64)=6.96, p=0.01). No difference was found in their warm detection 
thresholds at the knee or the lower back. 
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Figure 8.13: Cold detection thresholds at the knees, wrists and lower back in healthy and MSK participants 
Significant group effect for cold detection threshold, with a higher threshold in healthy than MSK participants. HH=healthy 
participants; MSK=chronic musculoskeletal pain participants; SE= standard error of mean. 
 
 
 
Figure 8.14: Warm detection thresholds at the knees, wrists and lower back in healthy and MSK participants 
Warm detection threshold at the wrist was lower in healthy than MSK participants. HH=healthy participants; MSK=chronic 
musculoskeletal pain participants; SE= standard error of mean. 
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Table 8.18: Thermal sensitivities at the knees, wrists and lower back in healthy and MSK participants identified using a CPT at 2°C (mean ± SD) 
Thermal 
sensitivity 
tests(°C) 
Sites Sides Healthy participants (n=23) 
MSK participants 
(n=43) 
Group effect Site effect Group x site effect 
F(1,64) 
value 
p 
value 
F(2,128) 
value 
p 
value 
F(2,128) 
value 
p 
value 
Cold 
detection 
threshold 
knees R 28.54 ± 1.71 27.36 ± 1.99 
8.31 0.01* 1.94 0.15 0.63 0.54 
L 28.61 ± 1.60 27.17 ± 2.15 
wrist R 28.93 ± 1.90 27.16 ± 3.83 L 29.39 ± 1.29 27.93 ± 2.42 
Lower 
back 
R 28.86 ± 1.41 27.59 ± 2.35 
L 28.82 ± 1.56 27.93 ± 3.09 
Warm 
detection 
threshold 
knees R 35.82 ± 1.30 36.36 ± 1.95 
4.44 0.04* 21.37 <0.01* 5.91 <0.01* 
L 36.48 ± 2.45 36.55 ± 2.40 
wrist R 36.45 ± 2.62 39.43 ± 4.85 L 36.84 ± 3.48 38.63 ± 3.90 
Lower 
back 
R 35.27 ± 1.31 35.57 ± 1.54 
L 35.60 ± 1.33 35.69 ± 1.76 
Cold Pain 
threshold 
knees R 10.92 ± 11.48 11.36 ± 10.57 
0.14 0.71 9.89 <0.01* 0.50 0.61 
L 9.75 ± 10.56 13.01 ± 11.31 
wrist R 7.57 ± 10.62 9.89 ± 10.06 L 11.59 ± 11.05 9.56 ± 9.84 
Lower 
back 
R 13.40 ± 10.59 13.26 ± 11.70 
L 12.94 ± 12.25 14.47 ± 10.77 
Heat Pain 
threshold 
knees R 47.55 ± 2.22 45.95 ± 3.40 
1.42 0.24 47.32 <0.01* 3.69 0.27 
L 47.27 ± 2.45 45.88 ± 3.06 
wrist R 48.12 ± 1.96 48.05 ± 2.54 L 47.44 ± 2.60 48.21 ± 3.20 
Lower 
back 
R 45.15 ± 3.32 44.28 ± 3.89 
L 44.97 ± 2.73 44.10 ± 3.21 
MSK=chronic musculoskeletal pain; *=significant p values. 
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The baseline PPT and SUPRA were compared between the healthy and MSK participants. A main 
group effect was observed in SUPRA (F(1,64)=4.84, p=0.03) before the two CPTs (Table 8.19) but not in 
PPT (F(1,64)=2.68, p=0.11). The healthy participants presented with higher SUPRA at all sites compared 
with the MSK participants. Main effects for sites were found in both PPT (F(2,128)=14.22, p<0.01) and 
SUPRA (F(2,128)=5.61, p=0.01). PPT was higher at the lower back compared with the knee (p<0.01) and 
wrist (p<0.01) (Figure 8.15). SUPRA was higher at the knee than at the lower back (p<0.01) (Figure 
8.16). No main effect of session nor significant group by site or group by session interaction was 
found for PPT or SUPRA.  
 
 
Figure 8.15: Graph of PPT at the knee, wrist and lower back in the healthy (n=23) and MSK (n=43) participants (mean ± 
SE). A main effect for site was identified with a higher PPT at the lower back compared with the knee and wrist 
(F(2,128)=14.22, p<0.01) (mean ± SE) 
PPT=pressure pain threshold; MSK=chronic musculoskeletal pain participants; SE=standard error of mean; CPT=cold 
pressor test. 
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Figure 8.16: Graph of SUPRA at the knee, wrist and lower back in the healthy (n=23) and MSK (n=43) participants (mean 
± SE). A main effect for site was identified with a higher SUPRA at the knee compared with the lower back (F(2,128)=5.61, 
p=0.01) (mean ± SE) 
MSK=chronic musculoskeletal pain participants; SE=standard error of mean; SUPRA=pain intensity to suprathreshold 
stimulus; NRS=numerical rating scale, 0 meaning no pain at all and 10 the worst pain possible. 
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Table 8.19: PPT and SUPRA at the knees, wrists and lower back in healthy and MSK participants before CPT at 2°C and 7°C (mean ± SD) 
QST measures Sites Sides 
CPT 2°C CPT 7°C Group effect Group x site effect 
Group x session 
effect 
Healthy (n=23) MSK (n=43) Healthy (n=23) MSK (n=43) F(1,64) value p value 
F(2,128) 
value p value 
F(1,64) 
value p value 
PPT (Kgf/cm2) 
knees 
R 3.63 ± 1.27 3.35 ± 1.32 3.55 ± 1.14 3.20 ± 1.30 
2.68 0.11 0.32 0.72 1.15 0.29 
L 3.46 ± 1.17 3.09 ± 1.08 3.47 ± 1.05 3.13 ± 1.22 
wrist 
R 3.64 ± 1.30 3.04 ± 1.02 3.24 ± 0.93 2.91 ± 1.09 
L 3.53 ± 1.35 2.88 ± 0.98 3.44 ± 1.27 2.90 ± 1.04 
Lower 
back 
R 4.37 ± 1.74 3.78 ± 1.66 3.74 ± 1.37 3.56 ± 1.61 
L 4.24 ± 2.03 3.55 ± 1.50 3.79 ± 1.30 3.49 ± 1.48 
SUPRA (NRS) 
knees 
R 4.74 ± 1.78 4.07 ± 2.12 4.65 ± 2.01 3.98 ± 1.88 
4.84 0.03* 2.31 0.10 0.02 0.90 
L 4.57 ± 2.41 3.85 ± 2.09 4.91 ± 1.95 4.13 ± 1.90 
wrist 
R 4.48 ± 1.59 3.71 ± 2.21 4.52 ± 2.15 3.54 ± 1.92 
L 4.80 ± 1.83 3.16 ± 2.19 4.85 ± 1.58 3.45 ± 1.66 
Lower 
back 
R 4.39 ± 2.02 3.55 ± 2.33 4.41 ± 2.12 3.70 ± 1.71 
L 4.26 ± 1.84 3.44 ± 2.39 4.28 ± 2.09 3.63 ± 1.68 
Healthy= healthy participants; MSK=chronic musculoskeletal pain participants; SUPRA=pain intensity to suprathreshold stimulus; NRS=numerical rating scale, 0 meaning no sensation at all, 5 just painful and 10 
the worst pain possible; CPT=cold pressor test; R=right; L=left; *=significant p values. 
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Pain adaptability in healthy and MSK participants 
No difference was found between the healthy and MSK participants in their average and maximum 
experimental pain, time to reach their maximum experimental pain and pain difference between the 
maximum pain and pain at the end of the CPTs (Table 8.20). There were significant session effects in 
the average experimental pain (F(1,64)=8.75, p<0.01), maximum experimental pain (F(1,64)=18.17, 
p<0.01) and time to reach maximum pain (F(1,64)=20.75, p<0.01). Both the average and maximum 
experimental pain was higher during the CPT at 2°C. The time to reach maximum pain was shorter 
during the CPT at 2°C than at the 7°C one. 
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Table 8.20: Experimental pain parameters of healthy and MSK participants during the CPT at 2°C and 7°C (mean ± SD) 
CPT Pain parameters 
CPT 2°C CPT 7°C Group effect Session effect Group x session effect 
Healthy (n=23) MSK (n=43) Healthy (n=23) MSK (n=43) F(1,64) value 
p 
value 
F(1,64)  
value 
p 
value 
F(1,64)  
value 
p 
value 
Average pain from CPT (VAS) 6.36 ± 2.06 6.08 ± 1.97 5.40 ± 2.40 5.76 ± 1.83 <0.01 0.98 8.75 <0.01* 2.37 0.13 
Maximum Pain from CPT (VAS) 8.26 ± 2.13 8.88 ± 1.77 7.34 ± 2.80 8.34 ± 1.60 2.59 0.11 18.17 <0.01* 1.60 0.21 
Time to reach Maximum Pain (s) 91.98 ± 98.14 110.27 ± 109.83 184.61 ± 148.56 153.68 ± 143.48 0.47 8.30 20.75 <0.01* 2.72 0.10 
Pain difference (Max-End) 1.12 ± 1.46 2.34 ± 2.87 2.00 ± 2.62 2.27 ± 2.81 1.45 0.23 2.17 0.15 2.96 0.09 
CPT=cold pressor test; VAS= visual analogue scale 0-10, 0 being no pain at all and 10 the worst pain possible; Healthy= healthy participants; MSK=chronic musculoskeletal pain participants; *=significant p values. 
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Endogenous pain controls in healthy and MSK participants 
The potency of endogenous pain controls was analysed using raw values and percentage changes in 
PPT. There was no difference between the two sets of results. This section will present the results of 
the percentage changes in PPT. 
 
No group effect was found in the percentage PPT change at any of the sites, however mean PPT 
change during cold pressor was consistently higher in the healthy controls than in the pain 
participants at all sites (Table 8.21). Main effect of session was observed in the percentage PPT 
change at the lower back (F(1,64)=4.24, p=0.04); the participants showed a greater increase in PPT at 
the CPT at 7°C (p=0.04). Main effect for time was found at the wrist only (F(1,64)=5.57, p=0.01), with a 
greater change in PPT during the CPTs compared with immediately after (p =0.01) and 15 min post 
the CPTs (p=0.02). A trend in group by time interaction was observed at the knee (F(1,64)=3.18, 
p=0.05). The MSK participants showed a significant decrease in their percentage PPT change from 
during the CPT to post CPT, whereas the healthy participants showed no significant change in their 
percentage PPT change from during the CPT to post CPT. 
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Table 8.21: Percentage PPT change at the knee, wrist and lower back for healthy and MSK participants at the CPTs at 2°C and 7 °C (mean ± SD) 
Sites Time 
CPT 2°C CPT 7°C Group effect Session effect Time effect 
Group x 
session effect 
Group x Time 
effect 
Healthy 
(n=23) MSK (n=43) 
Healthy 
(n=23) MSK (n=43) 
F(1,64) 
value 
p 
value 
F(1,64) 
value 
p 
value 
F(2,128) 
value 
p 
value 
F(1,64)  
value 
p 
value 
F(2,128) 
value 
p 
value 
Knee 
Dur 
(2min) 17.02 ± 30.15 9.05 ± 28.56 9.17 ± 19.67 9.91 ± 32.64 
1.97 0.17 0.71 0.40 0.56 0.58 0.16 0.69 3.18 0.05 Imm (5min) 14.88 ± 36.81 9.12 ± 29.91 7.99 ± 31.07 3.02 ± 28.29 
Post 
(15min) 17.16 ± 30.29 1.77 ± 33.63 16.97 ± 32.72 1.74 ± 32.58 
Wrist 
Dur 
(2min) 5.00 ± 27.92 4.99 ± 27.52 7.59 ± 35.13 4.34 ± 28.36 
0.57 0.45 0.03 0.87 5.57 0.01* <0.01 0.95 0.40 0.67 Imm (5min) -1.04 ± 26.69 -4.82 ± 23.04 -1.03 ± 26.01 -2.53 ± 33.48 
Post 
(15min) 1.88 ± 32.20 -5.38 ± 22.35 0.51 ± 28.32 -4.40 ± 24.89 
Lower 
back 
Dur 
(2min) 15.82 ± 22.91 13.32 ± 32.69 31.94 ± 35.23 20.74 ± 59.30 
1.23 0.27 4.34 0.04* 2.18 0.13 0.01 0.92 2.66 0.74 Imm (5min) 12.61 ± 27.47 7.72 ± 27.79 30.79 ± 32.52 12.71 ± 52.96 
Post 
(15min) 9.82 ± 27.99 0.44 ± 42.56 28.03 ± 40.20 15.15 ± 80.18 
CPT= cold pressor test; Healthy= healthy participants; MSK=chronic musculoskeletal pain participants; Dur=2minutes after the start of the CPT; Imm=immediately after the CPT; Post=15minuntes after the end of 
the CPT; *=significant p values. 
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Discussion 
Summary of results 
The dichotomy of PA and PNA exists in MSK participants. Both the CPT at 2°C and at 7°C could be 
used to identify PA and PNA and induce CPM in patient participants. The number of PA and PNA 
identified using the CPT at 2°C (42% and 58% respectively) was comparable to those identified using 
the CPT at 7°C (40% and 60% respectively). Further, the completion rate of both CPTs did not differ: 
74% at 2°C and 81% at 7°C. The maximum pain from the CPT at 2°C (8.88 ± 1.77) was rated higher 
than that at 7°C (8.34 ± 1.60). However, there was no difference in pain adaptability (difference in 
their maximum experimental pain and pain at the end of the CPT) and potency of CPM between the 
two CPTs. No adverse events were observed at either CPT session. 
 
PA and PNA in MSK participants were found to be consistent across the two CPTs in their baseline 
PPT and SUPRA and in all their experimental pain rating (average and maximum pain rating). The 
time to reach the maximum experimental pain was shorter in PA than PNA. There was a trend that 
PNA had more comorbidities and higher clinical pain 24 hour before the CPTs. PA and PNA did not 
differ in their demographics, thermal sensitivity, experimental pain, potencies of endogenous pain 
controls and blood pressure changes. 
 
No difference was found between the healthy (n=23) and the MSK (n=43) participants in their pain 
adaptability and potency of endogenous pain controls, possibly due to a small sample size of the 
healthy controls. 
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CPT at either 2°C and 7°C can be reliably used to identify PA and PNA 
In terms of responsiveness, practicality and safety, both CPTs at 2°C or 7°C could be suitable to 
distinguish between PA and PNA in MSK participants. This is the first study to investigate pain 
adaptability in MSK participants. Eighteen (42%) PA and 25 (58%) PNA were identified at the CPT at 
2°C and 17 (40%) PA and 26 (60%) PNA were identified using the CPT at 7°C. The proportion of PA 
and PNA identified at the two CPTs was not statistically different. This proportion of PA and PNA was 
also comparable with previous studies in healthy participants, with the proportions of PA and PNA 
being 39% and 61% respectively in one study (Zheng et al., 2014) and 35% and 65% respectively in 
another study (Devoize et al., 2015). This shows that pain adaptability does not seem to be 
temperature dependent. Further, this hypothesis is supported by Devoize’s study where they also 
used hot water immersion at 47.5°C for five minutes to subgroup PA and PNA in healthy participants 
(Devoize et al., 2015); 31% of the participants were PA and 69% were PNA. 
 
Both CPTs could also be used to induce CPM. The CPM measured at the wrist was less potent than 
that measured at the lower back. The wrist or hand is more often used to measure CPM than the 
lower back, and poor or no CPM at the wrist or hand is supported by the findings from previous 
studies in MSK participants (Arendt-Nielsen et al., 2010, Cruz-Almeida et al., 2013, King et al., 2009). 
A study in temporomandibular disorder participants, which also used CPT (8-16°C) at the foot, 
reported that the CPT did not change the rating of heat pain at the left palm (King et al., 2009). Thus, 
the finding from the present study is consistent with previous studies. 
 
The maximum pain from the CPT at 2°C was slightly higher (0.54 ± 1.31) than that at 7°C, however 
there was no difference in the average pain. There was no significant statistical difference between 
the completion rates of the two CPTs. No adverse events were observed at both CPTs, which is in 
line with previous studies using those temperatures in MSK participants (Nouwen et al., 2006, 
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Devoize et al., 2015, Zheng et al., 2014). Thus it can be concluded that both CPTs tests are equally 
responsive, practical and safe procedures to detect PA and PNA in MSK populations. For a lesser 
painful procedure, 7°C is preferable. Future, studies are needed to investigate whether pain 
adaptability could be determine using other forms of stimulation and whether the duration of 
stimulation could be reduced to determine pain adaptability so as to reduce the level of discomfort 
for the participants. 
 
Characteristics of PA and PNA in MSK participants 
PA and PNA did not differ in their baseline characteristics, which is in line with a previous pain 
adaptability study in healthy participants (Zheng et al., 2014). There was also no difference in their 
autonomic response which agrees with the Devoize’s study (Devoize et al., 2015). The current study 
also showed that there is no difference in thermal sensitivity between PA and PNA. No relationship 
was found between pain adaptability and potency of endogenous pain controls. This contradicts the 
findings of a previous study, where the researchers found a weak positive correlation between SEG 
and pain adaptability in healthy participants (Zheng et al., 2014). It is well known that CPM is 
impaired in MSK participants compared with healthy participants (King et al., 2009, Arendt-Nielsen 
et al., 2010). It could be that the SEG was also impaired in some the participants of the current study. 
Further, SEG was measured using the change in PPT at the knee, which was an affected and sensitive 
area in some of the participants (knee OA) and thus may have failed to show any inhibitory effect. 
 
The only significant difference found between PA and PNA was in their time to reach maximum pain, 
with PA reaching their maximum pain quicker at both CPTs. This is also in line with previous studies 
on pain adaptability in healthy participants (Devoize et al., 2015, Zheng et al., 2014) where the PA 
and PNA differed time to reach the maximum experimental pain. 
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It is to be noted that PA and PNA received the CPTs under identical experimental conditions, and had 
the similar thermal sensitivity (even to cold stimulus), sleep quality and psychological status. 
Therefore, the association between pain adaptability and time to reach maximum pain could be due 
the time to process the nociceptive input from the noxious CPT and to activate the descending 
inhibition. A previous study also found a delayed report of maximum experimental pain in one group 
of participants (Zheng et al., 2009). In that study, the researchers compared capsaicin-induced 
hyperalgesia between younger and older healthy participants. They found that both groups were 
similar in their pain intensity and flare response to the application of topical capsaicin. However, 
there was a trend that the older participants presented with a longer time to reach their maximum 
pain from the capsaicin. Further, the secondary hyperalgesia induced by capsaicin (area of punctate 
hyperalgesia) was maintained for a significantly longer duration in the older participants than in the 
younger participants. This means that the younger participants reached their maximum pain faster 
than the older participants and also presented with pain reduction sooner than the older 
participants. It was proposed that those differences in the latency of reporting maximum pain and 
maintained hyperalgesia might be due to reduced capacity of the central nervous system to activate 
the inhibition systems in the older participants (Zheng et al., 2009). Similarly, the PNA could have a 
reduced capacity to activate the inhibition systems and hence the longer time to reach the 
maximum pain and the lack of pain inhibition during the CPT. This hypothesis remains to be tested. 
 
An important question is whether pain adaptability is a “state” characteristic or a “trait” 
characteristic. Given no group difference in the demographic, baseline pain or psychological data, 
pain adaptability could be a state feature rather than a trait feature. The severer clinical pain in PNA 
24 hours before but not the week before when compared with PA individuals supports this 
hypothesis. An explanation for this possible association is that clinical pain may impact on 
experimental pain. A study in knee OA participants reported that the sub-set of participants with 
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more pain 24 hours prior to the test presented with significantly lower PPT at the knee than those 
with less pain (Arendt-Nielsen et al., 2010). It is speculated that those with more pain were more 
sensitized and thus showed a lower PPT than those with less pain. It is possible that their pain 
inhibition was also impacted. 
 
A trend was also observed that PNA had more comorbidities than PA. Perhaps the central nervous 
system of PNA is already burdened with the comorbid diseases and pain, and is slow in reacting to 
the CPT stimulation. However, the interference of clinical pain and comorbidities cannot fully 
support or explain the dichotomy in pain adaptability in the present study, since PA and PNA can 
also be identified in healthy participants, and also, no difference in pain adaptability was observed 
between healthy participants and MSK participants. Given there was a high correlation in pain 
adaptability between two CPT sessions, it is also possible that pain adaptability is a “trait” feature. 
 
It is possible that pain adaptability is a physiological response which could be enhanced by 
psychological behaviours. Previous studies have found that different coping strategies could impact 
on cold pain tolerance time from a CPT test. Ahles and colleagues (Ahles et al., 1983) reported that 
attention (monitoring pain sensations) increased pain tolerance time. It is unknown if pain 
adaptability could have been affected by cognitive coping strategies. Although all the participants in 
the current study received the same information and the same tests, the way they “coped” with the 
cold pain could have been different and contributed to this dichotomy. Unfortunately, this could not 
be determined because the coping strategies of the participants were not monitored. 
 
In summary the dichotomy of PA and PNA exists in MSK population, and being PNA may be 
associated with poor health and higher 24 hours pain prior to the test. The current results show that 
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pain adaptability is perhaps a physical response that could possibly be enhanced by a state event, 
that is given the right environment or instructions, PNA could be turned into PA or vice versa. It is 
important to identify the conditions that may change pain adaptability. 
 
Healthy vs MSK participants 
Healthy participants were found to be more sensitive to thermal sensory stimuli (cold and warm 
detection thresholds) compared with the MSK participants. This is supported by previous studies 
where healthy participants were reported to have lower warm detection and higher cold detection 
thresholds than the MSK participants (Wylde et al., 2012, Harden et al., 2013). This could be due to 
decreased sensitivity from neuropathic changes or inflammatory damages in MSK participants 
(Harden et al., 2013). 
 
This is the first study to compare pain adaptability between healthy and MSK participants. The two 
groups did not differ in their rating of experimental pain from the CPTs neither in their time to reach 
maximum pain nor in their pain adaptability. It is interesting to see a lack of difference. Given the 
chronic pain status, it is nature to think there might be more PNA in chronic pain patients. Results of 
this study do not support this hypothesis. Why there is a lack of difference is beyond the scope of 
this thesis and should be further investigated in future studies. 
 
CPM was induced in both the healthy and MSK participants at the wrist and at the lower back; no 
difference was found between the groups in the potency of CPM. This contradicts the results of 
previous studies where healthy humans were reported to have a better potency of CPM than the 
MSK participants (Correa et al., 2015, Arendt-Nielsen et al., 2010). On the other hand, the healthy 
participants seemed to have a better SEG than the MSK participants. This was indicated by a trend in 
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a sustained inhibition at the knee at 15 minutes after the CPT in the healthy participants compared 
with the MSK participants. 
 
It is possible that the different methodologies used in the studies, the age group and the small 
sample of the healthy controls have led to these varied results on CPM. Not many studies used cold 
pressor at the foot as the conditioning stimulus to measure CPM in MSK participants, or used the 
lower back as site for the test stimulus. The present study used CPTs at 2°C and 7°C at the foot for 
durations of five minutes and seven minutes respectively, and measured the change in PPT at the 
lower back at two minutes after the immersion of the foot. Correa and colleagues, similar with the 
present study, used CPT (4°C) at the foot as the conditioning stimulus and PPT at the lower back as 
the testing stimulus (Correa et al., 2015). They measured the change in PPT at the lower back at 30s 
after immersion of the foot (Correa et al., 2015). There was a significant difference in the potency of 
CPM between the healthy and LBP participants during the CPT, with an increase in PPT at the lower 
back of about 21% in the healthy participants and no CPM activation in the LBP participants, instead 
a significant decrease in PPT was found (about 19%, a decrease of 47.17 KPa from 253 KPa) (Correa 
et al., 2015). It is unknown which is the best time to measure CPM when using these sites. It is 
possible that 30s after the immersion of the foot was too soon to capture an increase in PPT at the 
lower back and two minutes was more appropriate in this case. The time at which the test stimulus 
is measured could be important when assessing the potency of CPM. It is to be noted that a shorter 
time point than 30s has been previously used to measure CPM but at a different site. Campbell and 
colleagues used a CPT at 4°C, at the non-dominant hand of their participants and found that PPT at 
the contralateral trapezius increased in knee OA participants at 20 s during the CPT (Campbell et al., 
2015). 
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In the current study both the healthy participants and MSK participants showed an increase in their 
PPT at the lower back during the CPTs, about 24% and 17% respectively. The healthy participants 
constantly presented with better CPM than the MSK participants in the current study, however, no 
statistically significant difference was detected. This could have been due to the small sample size. 
The sample size required to show a difference between the healthy and MSK participants in their 
percentage PPT change at the lower back in the present study was calculated using the program 
G*Power 3.1.9.2. The means and standard deviation of the percentage PPT change at the lower back 
at both CPTs for the healthy and MSK participants respectively were used with significance α level of 
0.05 (two-tailed) and power of 0.80. The required total sample size revealed to be 786, which is 
much larger than the current sample size. Further, some studies showed that subgroups of MSK 
participants had CPM that was equally potent with the healthy participants (Egsgaard et al., 2015), 
which could have been the case in the present study. The fact that some MSK participants could 
have equally potent endogenous pain controls with the healthy participants could have diluted the 
results to show the lack of disparity between the healthy and MSK participants in their potency of 
CPM. 
 
Another explanation for a lack of disparity in potency of CPM between the healthy (age range 30-78 
years) and MSK (age range 30-79 years) participants might be due to the reduced CPM in both the 
group of participants due to aging. Previous studies have showed that CPM is either poor (Riley et al., 
2010, Washington et al., 2000) or not induced (Edwards et al., 2003) in older healthy participants, 
and that this impairment in CPM may start as from middle age (aged 40-55 years) (Lariviere et al., 
2007). 
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What determines PA and PNA  
Many confounding factors were taken into consideration in this study. Confounding factors such as 
psychological characteristics (level of depression, stress and anxiety), sleep quality, functional status 
and room and water temperatures were controlled. There was no significant difference in any of 
these factors between the CPT sessions and between the two groups (PA and PNA). Thus, it is less 
likely that these factors contributed to the dichotomy of pain adaptability. 
 
These results also suggested that pain adaptability may not be CPT temperature dependent as the 
proportion of PA and PNA was not different at the two CPTs with different water temperatures. 
 
Thermal sensitivity to cold or heat does not contribute to pain adaptability since PA and PNA did not 
differ in any of their thermal sensitivity tests. PA participants consistently had a shorter time to 
maximal pain. This implies that the time needed for the central nervous system to process pain 
sensitivity and in turn activate descending pain inhibition may be crucial in determining if the 
subsequent pain inhibition may occur. The trend for more comorbidities and higher clinical pain in 
the last 24 hours in PNA than PA (MSK participants) may interfere with the activation-inhibition loop, 
therefore leading to pain non-adaptive. However, pain adaptability was also identified in healthy 
participants with neither comorbidities nor pain in the last 24 hours. Nevertheless, there might be 
other factors interfering with the system that have not been captured in the current study among 
the healthy controls, such as coping strategies. 
 
The dissociation between pain adaptability and endogenous pain controls indicates that these two 
pain modulations do not share the same mechanisms in the current study model. 
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Future studies need to explore the possible factors contributing to pain adaptability such as age or 
coping strategies and whether pain adaptability could be identified using other forms of stimuli. 
Since pain adaptability is related to the time to perceive the highest pain from the CPTs, future 
studies could also investigate whether PA and PNA differ in other time bound responses such as 
withdrawal reflexes. 
 
Significance of identifying PA and PNA  
Previous studies have shown that psychophysical characteristics have potentials to predict 
treatment prognosis. Potency of CPM has been found to predict treatment effect in chronic pain 
participants (Petersen et al., 2015, Yarnitsky et al., 2012). A post hoc analysis of participants with 
lateral epycondylalgia showed that participants with cold hyperalgesia had poorer prognostic 
(Coombes et al., 2015). In Petersen’s recent study, participants with less knee pain 24 hours before 
total knee replacement surgery reported less post-operative pain at 2 months and 12 months after 
surgery than those with a higher knee pain pre-surgery (Petersen et al., 2015). Pain adaptability 
could be used in a similar way to predict the prognostic from an acute noxious stressful event such 
as surgery. PNA individuals might have severer and long-lasting post-operative pain. It is yet to be 
explored if pain adaptability could also impact on other treatment response for pain, whether being 
PA would have a better prognostic than the PNA. For instance, acupuncture has been shown to have 
different effect in PA and PNA in healthy humans (Chapter 7). It is necessary to investigate whether 
there the PA and PNA in MSK participants also differ in their response to acupuncture. This could 
lead to an improvement of treatment choice.  
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Limitations 
This study has a few limitations. Firstly, the sample size of the healthy participants of this study 
might not be large enough to achieve statistical differences in some outcome measures. Secondly, 
coping strategies were not monitored during the CPT. It is possible that they could have contributed 
to pain adaptability. Thirdly, some participants could not complete the CPTs and did not have a PPT 
measurement at the two minutes time point. Their PPT was considered unchanged at the two 
minutes time point and thus the potency of their CPM could have been underestimated. 
 
Conclusion and future directions  
Both CPTs at 2°C and 7°C are suitable to measure pain adaptability. The only difference between PA 
and PNA was in their time to reach maximum experimental pain, which could have been influenced 
by comorbidities or maximum clinical pain in the last 24 hours. Pain adaptability is dissociated with 
the potency of CPM and SEG in this sample of participants. Healthy participants and MSK 
participants did not differ in their pain adaptability. Pain adaptability may reflect the resilience of the 
system in response to strong and long-lasting pain. Future studies should explore the meaning of 
pain adaptability. It is also necessary to explore the implications for pain adaptability in pain 
treatment. 
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Introduction  
Individuals respond to pain treatment differently; some have satisfactory pain reduction while 
others have modest or no pain reduction (Beswick et al., 2012, Lee et al., 2014, Yarnitsky et al., 
2012). For instance, neuropathic pain participants with less potent CPM, a type of endogenous pain 
control, respond better to duloxetine compared to those with more potent CPM (Yarnitsky et al., 
2012). In order to improve the putative treatment outcomes, it is important to examine the possible 
factors that could affect these outcomes. In the case of acupuncture, different approaches have 
been used to gather more knowledge about the treatment outcomes. Studies on acupuncture have 
focussed on needling techniques (depth of needling, duration of needling, point selection, number 
of points, and frequency of treatment) (Hao et al., 2013, Itoh et al., 2011, Leung et al., 2008, Paley 
and Johnson, 2015), practitioners’ characteristics (Witt et al., 2012) and patients’ characteristics 
(Linde et al., 2007, Witt et al., 2011) to examine treatment response. Studies on acupuncture have 
found that a group of individuals may get a better pain reduction than others depending on their 
pain and disability history (Glazov, 2010, Witt et al., 2011) or expectation from acupuncture (Linde et 
al., 2007). 
 
No study has yet examined treatment response to acupuncture based on their psychophysical 
characteristics in a clinical sample. The current study aimed to address this gap. Previous studies 
have shown that acupuncture analgesia is related to endogenous pain controls (Bing et al., 1990, 
Han, 2004, Mayer et al., 1977). Thus, Individuals with different psychophysical characteristics such as 
pain adaptability and potency of endogenous pain controls may have different responses to 
acupuncture. For instance, in Chapter 7 (Pain Adaptability and Acupuncture Analgesia Study) healthy 
participants who were PA showed a greater PPT increase (analgesia) to sham acupuncture (shallow 
needling without manipulation at points off the classical point locations) compared with the PNA 
participants. 
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Subgrouping, based on psychophysical characteristics, may help in predicting the prognostic or 
treatment response which may guide practitioners to choose the most appropriate therapies. To the 
author’s knowledge, there has not been any report on whether PA and PNA MSK participants or MSK 
participants with different potencies of CPM respond differently to acupuncture treatment. 
 
This study investigated the response to local acupuncture from the MSK participants by monitoring 
the change in clinical pain using pain diaries. The local acupuncture point treatment was selected to 
treat the MSK participants in the present study for the following reasons. Firstly, based on the 
results of Chapter 3 (systematic review on local and distant point in the treatment of MSK), local 
points (points at or near the site in pain) were found to be more effective than distant points (points 
away from the site in pain) in reducing pain in the short-term (Wong Lit Wan et al., 2015). Secondly, 
there is currently a lack of consensus on when and how to select distant points for painful conditions 
even though clinically local and distant points are often used together. Therefore no distant points 
were selected for the treatment. Thirdly, Chapter 3 also reported that local acupuncture was more 
effective than their controls (sham needles, placebo needles and no treatment). 
 
Considering the conflicting opinions over using appropriate controls for acupuncture (Langevin et al., 
2011, Lund et al., 2009, Sanchez Aranjo, 1998), the results from Chapter 3 and a large sample size 
needed for a full factorial design, in this exploratory study, local acupuncture was chosen without a 
sham control group. This design is consistent with one form of clinical practice, and evidence, and 
would allow the comparison of pain reduction between subgroups. Further, to reflect clinical 
practice, an experienced clinician’s opinion and advice was also sought (DL) to ensure the local 
acupuncture procedure conformed to clinical practice. 
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The aims of this study were: (1) to examine the effects of local acupuncture on the clinical 
characteristics, pain adaptability and endogenous pain controls, (2) to investigate the relationship 
between baseline characteristics (clinical pain, pain adaptability and potency of CPM) and changes in 
clinical (average daily pain intensity, daily duration of pain in hours and daily medication intake) and 
psychophysical (pain adaptability and potency of CPM) outcomes after local acupuncture; 3) to 
compare the effect of local acupuncture between PA and PNA individuals. 
 
 
Methods 
Design and procedure 
All the MSK participants of the Pain Adaptability and MSK Study participated in the present study to 
receive a four-week acupuncture treatment. The inclusion criteria are described in Chapter 5 
(Selection criteria section, pg 135-136). Figure 9.1 illustrates the procedure of the study. At week 1, 
participants were asked to complete a pain and medication diary for one week, to take a CPT and to 
answer questionnaires on their level of depression, anxiety and stress, sleep quality, physical 
function and quality of life. Then, starting from week 2 to week 5, participants received the 
acupuncture treatment. The participants received a second CPT, and were asked to answer the same 
questionnaires at the end of the last acupuncture treatment (week 5). At week 6, the participants 
were given a second pain and medication diary for one week. Two researchers were involved in this 
study, one of them (YW) was the acupuncturist (registered acupuncturist with 14 years of clinical 
experience) and the other was responsible for delivering the CPT (DW). The acupuncturist was 
blinded from the psychophysical characteristics of the participants (pain adaptability and potency of 
endogenous pain controls) and the other researcher was blinded from the participants’ pain history. 
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Figure 9.1: Procedure for Acupuncture Response Study 
LBP= chronic non-specific low back pain; OA= knee OA; Wk= week; CPT= cold pressor test; Assessment= assessment of 
psychological factors (depression, anxiety and stress), physical function, sleep quality and quality of life; Acu= local 
acupuncture treatment. 
 
 
Acupuncture procedure 
Participants were given eight sessions of acupuncture twice a week from week 2 to week 5 (Figure 
9.2). A session consisted of greeting the participants, enquiring about any adverse events from the 
previous session and the current one, delivering the acupuncture treatment and confirming for the 
next appointment. The treatment duration included time for point selection and needle insertion, 
retention and removal. At the first session, the acupuncturist also enquired about the pain history of 
the participants, and explained the treatment procedure. Before the first treatment, participants 
were asked to complete a questionnaire about their expectancy to the acupuncture treatment (Mao 
et al., 2010). The duration of each session and treatment was recorded. 
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Four to eight Ashi points around the painful area (knee or lower back) were used, this was based on 
a systematic review (Wong Lit Wan et al., 2015) and the advice of an experienced practitioner who 
specialised in using local Ashi points for knee pain (DL). The acupuncturist in the present study was 
trained to palpate the affected area to identify the Ashi points (tender spots). A force of about 1KPa 
was delivered at each spot (including classical acupuncture points), an Ashi point was identified 
where the participants found painful when the acupuncturist applied the pressure. 
 
Acupuncture needles of size 0.25x 40mm (Hwato, Suzhou Medical Instrument Factory, China) were 
used and retained for 20 minutes. The needles were inserted to a depth of 10-20mm with manual 
manipulation in a bi-directional manner to elicit the Deqi sensation every 10 minutes. More 
information about the acupuncture procedure can be found in Appendix 28.  
 
 
Figure 9.2: Acupuncture procedure 
A1= acupuncture session 1; AE= recording of adverse events; A exp= acupuncture expectancy, Wk= week.  
 
 
Outcome measures 
The main outcome measures were the daily pain intensity, pain duration in hours and analgesic 
intake recorded by the MSK participants in the pain and medication diaries (Appendix 27) one week 
before (week 1) and one week after the acupuncture treatment (week 6). Participants were asked to 
complete the diary at the end of the day, rating their daily pain from the lower back or the knee on 
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different scales and recording their duration of daily pain and daily medication intake. They were 
asked about their “pain at the moment”, “highest pain during the day”, “average pain during the 
day”, “how strong is the average pain” (pain intensity), “level of unpleasantness”, the duration of 
pain during the day (in hours) and the types and doses of the pain medications taken. Participants 
were required to send the diaries to the acupuncturist, so that the researcher delivering the CPTs 
was blinded from their pain history. 
 
The secondary outcome measures were (1) psychophysical characteristics, percentage PPT change 
during CPTs (potency of CPM) as described in Chapter 5, Endogenous pain controls and analgesia 
section (pg 151-152), (2) difference between maximum pain and pain at the end of the CPT (pain 
adaptability) as described in Chapter 5, section on CPT (pg 148-150), (3) psychological factors, such 
as level of depression, anxiety and stress (Chapter 5, Psychological factors section, pg 152-154), (4) 
physical function (Chapter 5, Quality of life and functionality section, pg 154), (5) sleep quality 
(Chapter 5, Quality of life and functionality section, pg 154), (6) quality of life (Chapter 5, Quality of 
life and functionality section, pg 154), (7) expectancy from acupuncture (Chapter 5, Psychological 
factors section, pg 152-154), (8) adverse events associated with acupuncture and (9) average clinical 
pain since last session (verbal rating scale 0-10 where 0 is no pain at all and 10 the worst pain 
possible). 
 
 
Data analysis  
Per protocol analysis was carried out. Only participants with a complete data set were included in 
the analysis; such participant must complete at least 50% (4 sessions) of treatment, both sessions of 
CPT and both pain and medication diaries. Medication consumption of the participant was 
calculated based on their pill count and the Medication Quantification Scale (MQS) (Harden et al., 
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2005). The effect of acupuncture on clinical and psychophysical characteristics was analysed using 
paired t-tests to compare the outcome measures pre and post acupuncture treatment for all 
participants. Changes from pre and post acupuncture were calculated such that a negative value 
reflects a decrease and a positive value reflects an increase in the outcome measures. Bivariate 
Pearson correlation analyses were adopted to investigate the relationship between the changes in 
clinical and psychophysical characteristics and baseline characteristics of the participants (clinical 
pain, psychological factors, physical function, sleep quality, physical and mental health, potency of 
CPM and pain adaptability). The baseline characteristics of the participants in each group (PA vs PNA) 
were compared using independent t-tests and chi square tests. The Holm-Bonferroni correction was 
used for multiple comparisons (Holm, 1979) which involved ordering the hypotheses according to 
their p-value in an ascending order, and comparing the p-values to the Holm-Bonferroni adjusted 
significance. A significant p-value should be smaller than the Holm-Bonferroni adjusted significance. 
Two-way (group by time) with one (time) repeated measure mixed ANOVA was used to analyse the 
change in outcome measures between the subgroups. If there was a significant interaction between 
groups and time, appropriate post hoc analysis was performed. The data in the text are reported as 
mean and SD and in figures as mean and SE. 
 
 
Results 
Recruitment 
The 43 participants who were included in the Pain Adaptability and MSK Study (Chapter 8) were also 
included in this study. Twenty of them were LBP participants and 23 were knee OA participants. 
Three participants dropped out during the treatment (Figure 9.3): one participant dropped out at 
her second session because she could not bear the needling sensation; another participant dropped 
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out at his sixth session because of worsening of his pain and one participant dropped out at her 
eighth session for unknown reason. Of those three participants, the first two were identified as PA 
and the last one as PNA. One participant started to take valium and Lexapro during the treatment 
phase. Those medications are anticonvulsant and antidepressant medications listed in the exclusion 
criteria for the study. Although this participant completed the treatment and the CPTs, his data was 
excluded. This participant was identified as PNA. The remaining 39 participants completed at least 
50% of their treatments (36 of them completed all the eight acupuncture sessions). Two participants 
missed one session and one participant missed two sessions. Although those three participants 
missed their acupuncture sessions, they all completed the CPTs and pain diaries, and none of them 
missed more than 50% of the treatment (4 sessions). Therefore, their data were included in the 
analysis. 
 
After the treatment four participants did not return their second pain and medication diary. The 
remaining 35 participants returned their second pain and medication diary at end of treatment. Per 
protocol analysis was carried out on the 35 participants who completed at least 50% of the 
treatment, the two CPTs and returned their two pain and medication diaries. Missing data were 
replaced with the last known observation. 
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Figure 9.3: Flow chart of study procedure 
LPB= chronic non-specific low back pain participants; OA= knee osteoarthritis participants; Wk= week; Acu=acupuncture 
session; CPT = cold pressor test; assessment= assessment of psychological factors (depression, anxiety and stress), physical 
function, sleep quality and quality of life. 
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Effect of local acupuncture 
Baseline characteristics 
The baseline characteristics of the 35 participants are presented in Table 9.1. 
Table 9.1: Baseline characteristics of the participants 
Baseline characteristics Mean or Frequency Standard Deviation 
Age 57.71 13.25 
BMI 28.98 7.04 
Gender M/F 20/15 - 
Duration of pain (yrs) 7.95 8.71 
No. of painful areas across the body 2.63 1.26 
No. of comorbidities 0.89 1.16 
Medication/ no medication 20/15 - 
LBP/knee OA 15/20 - 
Acu expectancy (AES) 12.94 3.99 
BMI=body mass index; M=male; F=female; yrs= years; Medication=taking pain medication; no medication= not taking pain 
medication; LBP= suffering from chronic non-specific low back pain; OA= suffering from osteoarthritis; Acu=acupuncture; 
AES=Acupuncture Expectancy Scale. 
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The medication taken by the participants during treatment are listed in Table 9.2. The participants 
took simple analgesics and anti-inflammatory medication during the treatment. 
 
Table 9.2: List of medications taken by participants during treatment 
Medications Type 
Aspirin Simple analgesics and antipyretics 
Diclofenac Nonsteroidal anti-inflammatory agents 
Ibuprofen Nonsteroidal anti-inflammatory agents 
Mobic Nonsteroidal anti-inflammatory agents 
Movalis Nonsteroidal anti-inflammatory agents 
Nurofen Nonsteroidal anti-inflammatory agents 
Nurofen plus Opioid schedule 2 and Nonsteroidal anti-inflammatory agents 
Osteomol Simple analgesics and antipyretics 
Panadeine Opioid schedule 2 and Simple analgesics and antipyretics 
Panadol Simple analgesics and antipyretics 
Panadol 
Osteo Simple analgesics and antipyretics 
Panamax Simple analgesics and antipyretics 
Tramadol Analgesic miscellaneous 
Voltaren Nonsteroidal anti-inflammatory agents 
 
 
Effects of local acupuncture on clinical characteristics 
Paired t-tests were used to compare the clinical outcome measures (pain, medication intake, 
psychological factors, function, sleep quality and quality of life) pre and post the local acupuncture 
treatment. 
 
Statistically significant changes were observed in clinical pain measured using the pain diaries for 
one week before and one week after the local acupuncture treatment (Table 9.3). The intensity and 
unpleasantness of clinical pain were statistically significantly reduced. A trend was found that the 
duration of pain (in hours) and medication intake (measured using MQS) also decreased. 
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Table 9.3: Clinical pain measured using pain and medication diaries pre and post acupuncture treatment (n=35, mean ± 
SD) 
Pain diary outcome 
measures Pre Acu Post Acu ∆ post-pre 
t34 
value p value 
Adjusted 
significance1 
Pain at moment (0-
10 NRS1) 3.52 ± 2.18 2.79 ± 1.85 -0.73 ± 1.52 2.85 0.01 0.01 
Highest pain (0-10 
NRS1) 4.70 ± 2.07 3.73 ± 1.83 -0.97 ± 1.11 5.16 <0.01* 0.01 
Average pain (0-10 
NRS1) 3.70 ± 2.10 2.92 ± 1.70 -0.79 ± 1.09 4.27 <0.01* 0.01 
Pain Intensity (0-20 
NRS2) 8.51 ± 3.83 6.93 ± 3.98 -1.57 ± 2.31 4.03 <0.01* 0.01 
Level of 
unpleasantness (0-20 
NRS2) 
7.58 ± 3.69 6.24 ± 3.70 -1.34 ± 1.96 4.04 <0.01* 0.01 
Duration of daily 
pain (hr) 7.24 ± 5.95 5.79 ± 5.72 -1.45 ± 3.77 2.28 0.03 0.02 
Analgesic intake (Pill 
count) 10.11 ± 13.98 8.60 ± 14.54 -1.51 ± 6.95 1.29 0.21 0.05 
Analgesic intake 
(MQS) 3.70 ± 5.04 2.29 ± 3.71 -1.41 ± 3.96 2.10 0.04 0.03 
Acu=acupuncture; NRS1= numerical scale of 0-10, 0 being no pain at all and 10 the worst pain possible; NRS2= numerical 
scale 0-20, 0 being no sensation/ neutral, 20 being extremely intense/ extremely intolerable; hr=hour; MQS=Medication 
Quantification Scale; ∆ post-pre= change between pre and post acupuncture treatment, a negative value indicating a 
decrease and a positive value indicating an increase; *=significant p values; 1= Holm-Bonferroni adjusted criterion of 
statistical significance. 
 
 
Significant improvement was found in the participants’ physical health (increase of 2.57 ± 4.68, t34=-
3.25, p<0.01) after the treatment (Table 9.4). No change was found in their mental health, physical 
function, psychological characteristics and their sleep quality. 
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Table 9.4: Clinical characteristics pre and post the acupuncture treatment (n=35, mean ± SD) 
Clinical characteristics Pre Acu Post Acu ∆ post-pre t34 value p value 
Adjusted 
significance1 
Depression (DASS21) 2.31 ± 2.26 2.71 ± 3.22 0.40 ± 2.29 -1.03 0.31 0.01 
Anxiety (DASS21) 1.63 ± 1.77 1.60 ± 1.61 -0.03 ± 1.65 0.10 0.92 0.03 
Stress (DASS21) 3.89 ± 4.09 3.91 ± 4.53 0.03 ± 3.29 -0.05 0.96 0.05 
Function (RMQ) 6.63 ± 4.03 5.60 ± 3.81 -1.03 ± 4.03 1.51 0.14 0.01 
Sleep quality (PSQI) 6.46 ± 3.21 6.23 ± 3.13 -0.23 ± 1.85 0.73 0.47 0.01 
Physical health (SF-36) 43.14 ± 7.27 45.72 ± 6.13 2.57 ± 4.68 -3.25 <0.01* 0.01 
Mental health (SF-36) 52.66 ± 8.33 52.86 ± 7.41 0.19 ± 8.22 -0.14 0.89 0.02 
DASS21=Depression Anxiety and Stress Scale 21 items; RMQ= modified Roland Morris Questionnaire; PSQI= Pittsburgh Sleep Quality Index; SF-36= Short Form 36 items survey, to measure 
quality of life; Acu=acupuncture; ∆ post-pre= change between pre and post acupuncture treatment, a negative value indicating a decrease and a positive value indicating an increase; 1= 
Holm-Bonferroni adjusted criterion of statistical significance; *=significant p value. 
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Effects of local acupuncture on psychophysical characteristics 
The percentage PPT change at the knee during the CPTs was used to measure the potency of SEG, 
and the percentage PPT change at the lower back and the wrist were measured to determine the 
participants’ potency of CPM. A Trend was observed for an increase in the percentage PPT change at 
the wrist, reflecting an increased potency of CPM after the acupuncture treatment (t34=-2.61, p=0.04) 
(Table 9.5). No significant change was found in their percentage PPT change at the knee and lower 
back after acupuncture. 
 
Table 9.5: Percentage PPT change during CPTs pre and post acupuncture treatment (n=35, mean ± SD) 
Sites 
for %PPT 
change 
Pre Acu Post Acu ∆ post-pre t34 value 
p 
value 
Adjusted 
significance1 
Knee 14.13 ± 33.35 13.12 ± 30.83 -1.01 ± 43.57 0.14 0.89 0.05 
Wrist 1.63 ± 29.85 19.84 ± 39.85 18.21 ± 49.94 -2.16 0.04* 0.02 
Lower back 21.98 ± 65.34 18.54 ± 35.58 -3.44 ± 72.54 0.28 0.78 0.03 
PPT=pressure pain threshold; Pre= pre acupuncture treatment; Post = post acupuncture treatment; ∆ post-pre= change 
between pre and post acupuncture treatment, a negative value indicating a decrease and a positive value indicating an 
increase; 1= Holm-Bonferroni adjusted criterion of statistical significance; *=significant p value.. 
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The experimental pain parameters during the CPTs pre and post the local acupuncture treatment 
were also compared. The difference between the maximum pain and pain at the end of the CPTs 
was used to indicate the pain adaptability of the participants. No significant change was observed in 
any pain related parameters (Table 9.6). 
 
Table 9.6: Pain parameters during CPTs pre and post acupuncture treatment (n=35, mean ± SD) 
CPT Pain 
parameters Pre Acu Post Acu ∆ post-pre 
t34 
value 
p 
value 
Adjusted 
significance1 
Average pain 
(VAS) 5.52 ± 1.82 5.36 ± 1.76 -0.16 ± 1.24 0.75 0.46 0.03 
Maximum pain 
(VAS) 8.30 ± 1.56 7.99 ± 1.83 -0.31 ± 1.06 1.75 0.09 0.02 
Pain difference 
(Max-End) 2.07 ± 2.99 2.11 ± 2.56 0.05 ± 1.71 -0.16 0.87 0.05 
CPT= cold pressor test; VAS= visual analogue scale 0-10, 0 being no pain at all and 10 the worst pain possible; Max-End= 
difference between maximum pain and pain at the end during the cold pressor test; Pre Acu= pre acupuncture treatment; 
Post Acu= post acupuncture treatment; ∆ post-pre= change between pre and post acupuncture treatment, a negative value 
indicating a decrease and a positive value indicating an increase; 1= Holm-Bonferroni adjusted criterion of statistical 
significance. 
 
 
Relationship between baseline characteristics and the change in clinical and 
experimental outcome measures  
 
Baseline characteristics and clinical outcomes measures 
Bivariate correlation analyses were performed to determine whether baseline characteristics were 
associated with any changes in clinical pain, daily duration of pain and analgesic intake (MQS) (Table 
9.7). 
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Baseline characteristics and changes pain intensity 
Moderate to strong negative correlations were found between clinical pain reduction (indicated by a 
negative score in the change in average clinical pain) and baseline clinical pain (Table 9.7). Those 
presenting with higher clinical pain before acupuncture experienced a greater clinical pain reduction 
after acupuncture (Figure 9.4). A trend was found for a weak negative correlation between clinical 
pain reduction and daily pain duration; those with a longer daily pain duration tended to experience 
better pain reduction (r=-0.31, p=0.07). 
 
 
Figure 9.4: Scatter plot of change in clinical pain after acupuncture and baseline average clinical pain indicating a strong 
correlation between clinical pain reduction and baseline clinical pain intensity (r=-0.56, p<0.01) 
 
 
There was a moderate correlation between clinical pain reduction and baseline percentage PPT 
change during the CPT at the wrist (r=0.41, p=0.01). Those who had greater pain reduction after 
acupuncture treatment also presented a greater decrease in percentage PPT change at the wrist 
during the CPT at baseline, reflecting those with poorer CPM before the acupuncture experienced 
better pain reduction after acupuncture (Figure 9.5). No other significant correlations were 
identified. 
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Figure 9.5: Scatter plot of change in clinical pain after acupuncture and baseline percentage PPT change at the wrist 
indicating a moderate correlation between clinical pain reduction and baseline potency of CPM (r=0.41, p=0.01) 
PPT=pressure pain threshold; CPM=conditioned pain modulation; CPT=cold pressor test. 
 
 
Baseline characteristics and changes in daily duration of pain 
No significant correlations were found between the baseline characteristics and change in daily 
duration of pain (Table 9.7). However, a trend was observed for a negative correlation between 
baseline pain adaptability and change in daily duration of pain (r=-0.32, p=0.06). 
 
Baseline characteristics and changes in pain medication intake 
Statistically significant negative correlations (Table 9.7) were found between the reduction in 
medication intake (indicated by a negative value in the change in MQS scores) and the baseline 
medication intake (measured using pill count and MQS; r=-0.44, p=0.01 and r=-0.69, p<0.01 
respectively) and sleep quality (r=-0.39, p=0.02). Those with greater medication intake and those 
with poor sleep had a better reduction in medication intake. 
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In summary, 
• those who had better reduction in pain intensity were those who had more severe and more 
unpleasant pain at the baseline; and those who had poor CPM; 
• those who had more reduction in intake of pain medications were those who took more 
pain killers and had poorer sleep at the baseline. 
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Table 9.7: Relationship between baseline characteristics and clinical outcomes 
Baseline characteristics 
change in average 
clinical pain (NRS1) Adjusted 
significance1 
change in duration of 
pain (hr) Adjusted 
significance1 
Chang in MQS 
Adjusted 
significance1 Pearson 
Correlation, r 
p-
value 
Pearson 
Correlation, r 
p-
value 
Pearson 
Correlation, r 
p-
value 
Acu expectancy -0.05 0.79 0.05 -0.21 0.22 0.05 -0.09 0.62 0.05 
Pain at moment (NRS1) -0.56 <0.01* 0.01 0.09 0.60 0.01 -0.02 0.92 0.03 
Highest pain (NRS1) -0.47 <0.01* 0.01 0.10 0.59 0.01 -0.16 0.36 0.01 
Average pain (NRS1) -0.59 <0.01* 0.02 0.06 0.73 0.03 -0.08 0.63 0.02 
Pain Intensity (NRS2) -0.58 <0.01* 0.03 0.07 0.71 0.02 0.00 0.99 0.05 
Level of unpleasantness (NRS2) -0.34 0.04* 0.05 0.02 0.89 0.05 -0.11 0.53 0.01 
Duration of pain (hr) -0.31 0.07 0.05 -0.23 0.18 0.05 0.03 0.86 0.05 
Analgesic intake (Pill count) -0.24 0.17 0.03 0.13 0.44 0.05 -0.49 <0.01* 0.05 
Analgesic intake (MQS) -0.16 0.37 0.05 0.14 0.41 0.03 -0.60 <0.01* 0.03 
Sleep quality (PSQI) 0.03 0.88 0.05 -0.02 0.90 0.05 -0.39 0.02* 0.05 
Depression (DASS21) 0.02 0.93 0.05 -0.13 0.46 0.03 0.03 0.88 0.05 
Anxiety (DASS21) 0.02 0.93 0.03 -0.14 0.44 0.02 0.03 0.88 0.03 
Stress (DASS21) -0.04 0.82 0.02 -0.04 0.84 0.05 -0.24 0.17 0.02 
Function (RMQ) -0.28 0.11 0.05 -0.28 0.11 0.05 0.15 0.41 0.05 
Physical health (SF-36) 0.24 0.17 0.03 0.09 0.60 0.05 -0.05 0.79 0.03 
Mental health (SF-36) 0.01 0.95 0.05 0.14 0.44 0.03 0.01 0.98 0.05 
Pain difference (Max-End)  -0.1 0.57 0.05 -0.32 0.06 0.05 -0.14 0.43 0.05 
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%PPT change at knee -0.01 0.97 0.05 0.14 0.43 0.05 0.11 0.52 0.02 
%PPT change at wrist 0.47 0.01* 0.02 0.29 0.19 0.02 0.05 0.77 0.03 
%PPT change at lower back 0.15 0.39 0.03 0.13 0.27 0.03 0.05 0.77 0.05 
NRS1= numerical scale of 0-10, 0 being no pain at all and 10 the worst pain possible; NRS2= numerical scale 0-20, 0 being no sensation/ neutral, 20 being extremely intense/ extremely intolerable; hr=hour; 
MQS=Medication Quantification Scale; post-pre= difference in outcome measure between pre and post acupuncture treatment; DASS21=Depression, Anxiety and Stress Scale 21 items; RMQ= modified Roland 
Morris Questionnaire; PSQI= Pittsburgh Sleep Quality Index; SF-36= Short Form 36 items health survey, to measure quality of life; Max-End= Difference between maximum pain and pain at the end of the cold 
pressor test; PPT=pressure pain threshold; 1= Holm-Bonferroni adjusted criterion of statistical significance; *=significant p- values. 
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Baseline characteristics and psychophysical outcome measures 
This set of correlation analyses explored whether changes in pain adaptability (measured by the 
difference between the maximum pain and pain at the end of the CPT) or potency of CPM 
(measured at the wrist and at the lower back) after acupuncture treatment are related to 
participants’ baseline clinical and psychophysical characteristics (Table 9.8). 
 Baseline characteristics and pain adaptability changes after treatment 
A weak negative correlation was found between the baseline daily pain duration and change in pain 
adaptability (r=-0.34, p=0.04). Those with shorter daily pain duration become more pain adaptive 
(reflected by a positive score). The baseline pain adaptability moderately correlated with the change 
in pain adaptability (r=-0.52, p<0.01). Those with a lower pain adaptability scores (those who tend to 
be PNA) showed a better increase in their pain adaptability, meaning that they tend to become more 
PA (Figure 9.6). No other statistically significant correlations were found between the other baseline 
characteristics (clinical pain intensity, analgesic intake , sleep quality, psychological characteristics, 
physical function, quality of life and potency of endogenous pain controls) and change in pain 
adaptability (Table 9.8). 
 
 
Figure 9.6: Scatter plot of change in pain adaptability after acupuncture and baseline pain adaptability indicating a 
moderate correlation between change in pain adaptability after acupuncture and baseline pain adaptability (r=-0.52, 
p<0.01) . Max-End=difference between maximum and pain at the end of cold pressor test. 
-8
-3
2
7
0 2 4 6 8 10
Ch
an
ge
 in
 p
ai
n 
ad
ap
ta
bi
lit
y 
(M
ax
-E
nd
) 
Baseline pain adaptability (Max-End) 
Relationship between change in pain adatptability after 
acupucture and baseline pain adaptability 
 293 
 
Baseline characteristics and CPM changes after treatment 
A moderate negative correlation was also found between the baseline potency of CPM (wrist) and 
the change in potency of CPM (wrist, r=-0.55, p<0.01). This indicates that those with a less potent 
CPM at the wrist at baseline improved more in their CPM at the wrist after the treatment (Figure 
9.7). 
 
 
Figure 9.7: Scatter plot of changes in percentage PPT change at the wrist after acupuncture and baseline percentage PPT 
change at the wrist indicating a moderate correlation between the change in potency of CPM at the wrist after 
acupuncture and baseline potency of CPM (r=-0.60, p<0.01) 
PPT=pressure pain threshold; CPM=conditioned pain modulation; CPT=cold pressor test. 
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The baseline potency of CPM at the lower back strongly correlated with the change in potency of 
CPM at the lower back (r=-0.62, p<0.01). Those with poor CPM at the lower back at baseline showed 
a greater improvement in their potency of CPM (indicated by a positive score) at the lower back 
(Figure 9.8). No other statistically significant correlations were found (Table 9.8)  
 
 
Figure 9.8: Scatter plot of changes in percentage PPT change at the lower back after acupuncture and baseline 
percentage PPT change at the lower back indicating a strong correlation between the change in potency of CPM after 
acupuncture and baseline potency of CPM at the lower back (r=-0.87, p<0.01) 
PPT=pressure pain threshold; CPM=conditioned pain modulation; CPT=cold pressor test. 
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Table 9.8: Relationship between baseline characteristics and psychophysical outcomes 
Baseline characteristics 
Change in pain 
adaptability (Max-End) Adjusted 
significance1 
Change in potency of 
CPM at wrist Adjusted 
significance1 
Change in potency of 
CPM at lower back Adjusted 
significance1 Pearson 
Correlation, r p-value 
Pearson 
Correlation, r p-value 
Pearson 
Correlation, r p-value 
Acu expectancy 0.18 0.31 0.05 -0.16 0.35 0.05 -0.01 0.95 0.05 
Pain at moment (NRS1) -0.10 0.56 0.05 0.12 0.48 0.01 0.23 0.19 0.01 
Highest pain (NRS1) -0.19 0.28 0.02 0.04 0.81 0.05 0.18 0.30 0.02 
Average pain (NRS1) -0.15 0.39 0.03 0.11 0.52 0.01 0.22 0.21 0.01 
Pain Intensity (NRS2) -0.24 0.18 0.01 0.07 0.69 0.03 0.18 0.32 0.05 
Level of unpleasantness (NRS2) -0.24 0.16 0.01 0.10 0.58 0.02 0.18 0.30 0.03 
Duration of pain (hr) -0.37 0.03* 0.05 0.24 0.16 0.05 -0.19 0.28 0.05 
Analgesic intake (Pill count) 0.07 0.70 0.03 -0.34 0.07 0.03 0.03 0.86 0.05 
Analgesic intake (MQS) 0.05 0.77 0.05 -0.28 0.11 0.05 -0.04 0.81 0.03 
Sleep quality (PSQI) -0.16 0.35 0.05 -0.11 0.54 0.05 0.00 0.99 0.05 
Depression (DASS21) -0.08 0.64 0.02 -0.11 0.53 0.03 0.00 0.98 0.05 
Anxiety (DASS21) -0.12 0.50 0.03 -0.20 0.25 0.02 -0.28 0.11 0.02 
Stress (DASS21) -0.24 0.16 0.02 -0.01 0.98 0.05 0.10 0.57 0.03 
Function (RMQ) 0.07 0.68 0.05 -0.03 0.85 0.05 0.12 0.50 0.05 
Physical health (SF-36) 0.07 0.69 0.05 -0.07 0.70 0.05 -0.07 0.68 0.03 
Mental health (SF-36) 0.23 0.18 0.03 0.07 0.68 0.03 0.01 0.95 0.05 
Pain difference (Max-End)  -0.49 <0.01* 0.05 0.25 0.15 0.05 -0.33 0.06 0.05 
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%PPT change at knee -0.04 0.80 0.05 0.03 0.86 0.05 -0.19 0.28 0.03 
%PPT change at wrist 0.31 0.07 0.02 -0.55 <0.01* 0.02 0.16 0.37 0.05 
%PPT change at lower back -0.11 0.52 0.03 0.12 0.51 0.03 -0.62 <0.01* 0.02 
NRS1= numerical scale of 0-10, 0 being no pain at all and 10 the worst pain possible; NRS2= numerical scale 0-20, 0 being no sensation/ neutral, 20 being extremely intense/ extremely intolerable; hr=hour; 
MQS=Medication Quantification Scale: post-pre= difference in outcome measure between pre and post acupuncture treatment; DASS21=Depression, Anxiety and Stress Scale 21 items; RMQ= modified Roland 
Morris Questionnaire; PSQI= Pittsburgh Sleep Quality Index; SF-36= Short Form 36 items health survey, to measure quality of life; Max-END= Difference between maximum pain and pain at the end of the cold 
pressor test; PPT=pressure pain threshold; CPT=cold pressor test; 1= Holm-Bonferroni adjusted criterion of statistical significance;*=significant p- values. 
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Pain adaptive vs pain non-adaptive 
The pain adaptability of the participants was previously determined in the Pain Adaptability and MSK 
study (Chapter 8). Nine PA and 26 PNA were identified. A difference of two or more on a 0-10 scale 
between the maximum pain from the cold water and the pain at the end of the CPT was classified as 
PA and a difference of less than two was classified as PNA (Zheng et al., 2014). 
 
Clinical and psychophysical characteristics before treatment 
The characteristics of PA and PNA prior to the treatment were compared using independent t-tests 
and chi square tests. PA and PNA were comparable in their demographics, pain history and 
acupuncture expectancy (Table 9.9). 
 
Table 9.9: Baseline characteristics of PA and PNA before local acupuncture treatment (mean ± SD) 
Baseline characteristics PA (n=9) PNA (n=26) x
2
1/t33 
value 
p 
value 
Adjusted 
significance1 
Age 54.44 ± 11.16 58.85 ± 12.92 -0.86 0.40 0.01 
BMI 28.21 ± 4.39 29.25 ± 7.81 -0.37 0.71 0.01 
Gender M/F 5/4 15/11 0.01 0.91 0.03 
Duration of daily pain (yrs) 6.17 ± 7.42 8.57 ± 9.16 -0.71 0.48 0.01 
No. of painful areas across the 
body. 2.78 ± 1.48 2.58 ± 1.21 0.41 0.69 0.02 
No. of comorbidities 0.44 ± 0.53 1.04 ± 1.28 -1.34 0.19 0.01 
Medication/ no medication 4/5 16/10 0.80 0.37 0.01 
LBP/knee OA 3/6 12/14 0.45 0.50 0.01 
Acu expectancy (AES) 12.89 ± 5.33 12.96 ± 3.55 -0.05 0.96 0.05 
PA=pain adaptive; PNA= pain non-adaptive; BMI=body mass index; M=male; F=female; Medication=taking pain medication; 
no medication=not taking pain medication; LBP= suffering from chronic non-specific low back pain; OA=suffering from 
osteoarthritis; Acu= acupuncture; AES=Acupuncture Expectancy Scale; 1= Holm-Bonferroni adjusted criterion of statistical 
significance. 
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The clinical pain of PA and PNA was compared using independent t-tests. No significant difference 
was found between PA and PNA in their clinical pain and medication intake prior to the treatment 
(Table 9.10). 
 
Table 9.10: Clinical pain measured using pain and medication diaries for PA and PNA before local acupuncture treatment 
(mean ± SD) 
Pain diary outcome measures PA (n=9) PNA (n=26) t33 value 
p 
value 
Adjusted 
significance1 
Pain at moment (0-10 NRS1) 3.05 ± 1.96 3.69 ± 2.26 -0.75 0.46 0.01 
Highest pain (0-10 NRS1) 4.49 ± 2.25 4.77 ± 2.04 -0.35 0.73 0.01 
Average pain (0-10 NRS1) 3.38 ± 2.18 3.81 ± 2.11 -0.53 0.60 0.01 
Pain Intensity (0-20 NRS2) 7.75 ± 4.33 8.77 ± 3.70 -0.69 0.50 0.01 
Level of unpleasantness (0-20 
NRS2) 7.59 ± 4.18 7.58 ± 3.60 0.01 0.99 0.05 
Duration of daily pain (hr) 8.41 ± 6.55 6.84 ± 5.81 0.01 0.99 0.03 
Analgesic intake (Pill count) 8.22 ± 13.02 10.77 ± 14.48 -0.47 0.64 0.01 
Analgesic intake (MQS) 3.49 ± 5.97 3.77 ± 4.81 -0.14 0.89 0.02 
PA=pain adaptive; PNA=pain non-adaptive; NRS1= numerical scale of 0-10, 0 being no pain at all and 10 the worst pain 
possible; NRS2= numerical scale 0-20, 0 being no sensation/ neutral, 20 being extremely intense/ extremely intolerable; 
hr=hour; MQS=Medication Quantification Scale; 1= Holm-Bonferroni adjusted criterion of statistical significance. 
 
PA and PNA were also comparable in their psychological characteristics, function, sleep and quality 
of life (Table 9.11). PA appeared to have a higher stress level than PNA (t33=1.87, p=0.07), however 
this difference was not statistically significant. 
 
Table 9.11: Clinical characteristics of PA and PNA before local acupuncture treatment (mean ± SD) 
Clinical characteristics PA (n=9) PNA (n=26) t33 value 
p 
value 
Adjusted 
significance1 
Depression (DASS21) 2.44 ± 2.24 2.27 ± 2.31 0.20 0.85 0.05 
Anxiety (DASS21) 2.11 ± 2.37 1.46 ± 1.53 0.95 0.35 0.03 
Stress (DASS21) 6.00 ± 5.17 3.15 ± 3.46 1.87 0.07 0.01 
Function (RMQ) 5.89 ± 2.67 6.88 ± 4.42 -0.63 0.53 0.01 
Sleep quality (PSQI) 7.00 ± 4.80 6.27 ± 2.55 0.44 0.67 0.03 
Physical health (SF-36) 45.32 ± 5.63 42.39 ± 7.70 1.04 0.31 0.01 
Mental health (SF-36) 51.23 ± 10.88 53.16 ± 7.44 -0.59 0.56 0.02 
DASS21=Depression, Anxiety and Stress Scale 21 items; RMQ= modified Roland Morris Questionnaire; PSQI= Pittsburgh 
Sleep Quality Index; SF-36= Short Form 36 items health survey, to measure quality of life; PA=pain adaptive; PNA=pain non-
adaptive; 1= Holm-Bonferroni adjusted criterion of statistical significance. 
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No significance difference was observed between PA and PNA in the potency of their CPM 
(measured at the wrist and lower back) and SEG (measured at the knee) (Table 9.12). 
 
Table 9.12: Percentage PPT change at the knee, wrist and lower back during CPT for PA and PNA pre-treatment (mean ± 
SD) 
Sites for %PPT 
change PA (n=9) PNA (n=26) 
t33 
value p value 
Adjusted 
significance1 
Knee 30.47 ± 44.66 8.47 ± 27.60 1.75 0.09 0.02 
Wrist -10.70 ± 27.42 5.90 ± 29.96 -1.46 0.15 0.03 
Lower back 46.48 ± 114.16 13.50 ± 36.68 1.32 0.20 0.05 
%PPT= percentage pressure pain threshold; PA=pain adaptive; PNA- pain non-adaptive; 1= Holm-Bonferroni adjusted 
criterion of statistical significance. 
 
 
Change in clinical and psychophysical characteristics pre and post treatment 
The change in clinical pain in PA and PNA was analysed using two-way (group by time) with one 
repeated measure (time, 2 levels) mixed ANOVAs (Table 9.13). A time effect was found for a 
decrease in clinical pain, daily duration of pain and medication intake (MQS) in both PA and PNA 
(Table 9.13). Further, a group by time interaction was observed in their daily duration of pain 
(F(1,33)=4.43, p=0.04), with PA showing a greater decrease in daily duration of pain than PNA (Table 
9.13). PA also showed greater reduction of clinical pain and medication intake but the there was no 
statistical significant difference between the two groups in those outcome measures. No group 
effect was observed in all the clinical pain outcome measures, including clinical pain intensity, 
duration of daily pain and medication intake. 
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Table 9.13: Pain and medication diary outcome measures for PA and PNA pre and post local acupuncture treatment (mean ± SD) 
Outcome measures 
PA (n=9) PNA (n=26) 
Group 
effect 
F(1,33) 
Time 
effect 
F(1,33) 
Group x 
time 
effect 
F(1,33) 
Pre Post ∆ post-pre Pre Post ∆ post-pre p value p value p value 
Pain at moment (0-10 NRS1) 3.05 ± 1.96 2.35 ± 1.72 -0.70 ± 1.61 3.69 ± 2.26 2.94 ± 1.90 -0.75 ± 1.53 0.40 0.02* 0.94 
Highest pain (0-10 NRS1) 4.49 ± 2.25 3.22 ± 2.20 -1.27 ± 0.95 4.78 ± 2.04 3.91 ± 1.69 -0.87 ± 1.16 0.51 <0.01* 0.36 
Average pain (0-10 NRS1) 3.38 ± 2.18 2.22 ± 1.49 -1.16 ± 1.11 3.81 ± 2.11 3.16 ± 1.73 -0.66 ± 1.07 0.34 <0.01* 0.24 
Pain Intensity (0-20 NRS2) 7.75 ± 4.33 5.51 ± 3.85 -2.24 ± 1.72 8.77 ± 3.70 7.43 ± 3.97 -1.34 ± 2.16 0.32 <0.01* 0.32 
Level of unpleasantness (0-
20 NRS2) 7.59 ± 4.18 5.57 ± 4.01 -2.02 ± 2.62 7.58 ± 3.60 6.47 ± 3.65 -1.10 ± 1.68 0.75 <0.01* 0.24 
Duration of daily pain (hr) 8.41 ± 6.55 4.79 ± 5.48 -3.63 ± 5.89 6.84 ± 5.81 6.14 ± 5.86 -0.70 ± 2.44 0.96 <0.01* 0.04* 
Analgesic intake (Pill count) 8.22 ± 13.02 4.11 ± 9.25 -4.11 ± 7.39 10.77 ± 14.48 10.15 ± 15.82 -0.62 ± 6.71 0.43 0.09 0.20 
Analgesic intake (MQS) 3.49 ± 5.97 0.98 ± 1.60 -2.51 ± 5.58 3.77 ± 4.81 2.75 ± 4.13 -1.03 ± 3.29 0.51 0.03* 0.34 
PA=pain adaptive; PNA- pain non-adaptive; NRS1= numerical scale of 0-10, 0 being no pain at all and 10 the worst pain possible; NRS2= numerical scale 0-20, 0 being no sensation/ neutral, 20 being extremely 
intense/ extremely intolerable; hr=hour; MQS=Medication Quantification Scale; pre=pre-acupuncture treatment; post=post-acupuncture treatment; ∆ post-pre= change between pre- and post- acupuncture 
treatment, a negative value indicating a decrease and a positive value indicating an increase; *=significant p values. 
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Two-way (group by time) with one repeated measure (time, 2 levels) mixed ANOVAs were used to 
compare the clinical characteristics of PA and PNA before and after treatment (Table 9.14). A time 
effect (F(1,33)=8.88, p=0.01) was observed in their physical health, with improvement in both groups 
(Table 9.14). A trend for a group by time interaction (F(1,33)=3.98, p=0.05) was observed in their level 
of stress; after the treatment the stress level in PA tended to decrease whereas that of PNA tended 
to increase. No other significant effect or interaction was identified. 
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Table 9.14: Clinical characteristics of PA and PNA pre and post local acupuncture treatment (mean ± SD) 
Clinical characteristics 
PA (n=9) PNA (n=26) 
Group 
effect 
F(1,33) 
Time 
effect 
F(1,33) 
Group x 
time 
effect 
F(1,33) 
Pre Post ∆ post-pre Pre  Post ∆ post-pre p value p value p value 
Depression (DASS21) 2.44 ± 2.24 3.44 ± 2.40 1.00 ± 2.78 2.27 ± 2.31 2.46 ± 3.47 0.19 ± 2.12 0.56 0.19 0.83 
Anxiety (DASS21) 2.11 ± 2.37 1.56 ± 1.67 -0.56 ± 2.07 1.46 ± 1.53 1.62 ± 1.63 0.15 ± 1.49 0.61 0.53 0.27 
Stress (DASS21) 6.00 ± 5.17 4.22 ± 4.52 -1.78 ± 3.03 3.15 ± 3.46 3.81 ± 4.61 0.65 ± 3.29 0.30 0.36 0.05 
Function (RMQ) 5.89 ± 2.67 5.78 ± 4.82 -0.11 ± 5.75 6.89 ± 4.42 5.54 ± 3.50 -1.35 ± 3.33 0.78 0.36 0.44 
Sleep quality (PSQI) 7.00 ± 4.80 6.67 ± 4.30 -0.33 ± 1.50 6.27 ± 2.55 6.08 ± 2.70 -0.19 ± 1.98 0.58 0.47 0.85 
Physical health (SF-36) 45.32 ± 5.63 48.38 ± 6.08 3.06 ± 4.57 42.39 ± 7.70 44.79 ± 5.99 2.40 ± 4.80 0.19 0.01* 0.13 
Mental health (SF-36) 51.23 ± 10.88 50.59 ± 7.50 -0.64 ± 6.35 53.16 ± 7.44 53.64 ± 7.37 0.48 ± 8.87 0.35 0.96 0.73 
DASS21=Depression Anxiety and Stress Scale 21 items; RMQ= modified Roland Morris Questionnaire; PSQI= Pittsburgh Sleep Quality Index; SF-36= Short Form 36 items health survey, to measure quality of life; 
PA=pain adaptive; PNA= pain non-adaptive; pre=pre-acupuncture treatment; post=post-acupuncture treatment; ∆ post-pre= change between pre- and post-acupuncture treatment, negative value indicating a 
decrease and positive value indicating an increase; *=significant p values. 
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The experimental pain parameters of PA and PNA during the CPTs were analysed using two-way 
(group by time) with one repeated measure (time, 2 levels) mixed ANOVAs. No significant group 
effect (F(1,33)=3.15, p=0.09), time effect (F(1,33)<0.01, p=0.97) or group by time interaction (F(1,33)=1.64, 
p=0.21) were observed in their average pain from the CPTs. 
 
A time effect (F(1,33)=6.05, p=0.02) was found in their maximum pain from the CPTs. After the 
treatment, the maximum pain decreased in both groups. There was a trend (F(1,33)=3.27, p=0.08) for 
a group by time interaction in their maximum pain from the cold pressor. PA seemed to show a 
greater decrease than PNA in their maximum pain (Figure 9.9). No group effect was observed. 
 
The difference between the maximum pain and pain at the end of the cold pressor reflects pain 
adaptability. A group by time interaction (F(1,33)=15.40, p<0.01) was observed in PA and PNA (Figure 
9.10); PNA showed a significant increase (from 0.41 ± 0.66 to 1.01 ± 1.39, t25=-2.70, p=0.01) whereas 
PA showed no significant change, but a trend for a decrease (from 6.86 ± 1.37 to 5.28 ± 2.56, t8=2.25, 
p=0.05). A group effect was observed between PA and PNA in their difference between the 
maximum pain and pain at the end of the CPT as expected as they were subgrouped base on this 
outcome measure (F(1,33)=136.55, p<0.01). No significant time effect was observed (F(1,33)=3.02, 
p=0.09). 
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Figure 9.9: Maximum pain from CPT in PA and PNA pre and post local acupuncture (PA n=9; PNA n=26; mean ± SE) 
CPT= cold pressor test; PA= pain adaptive; PNA=pain non-adaptive. Trend (F(1,33)=3.27, p=0.08) for a group by time 
interaction, PA seemed to show a greater decrease than PNA in their maximum pain; VAS=visual analogue scale 0-10, 0 
being no pain at all and 10 the worst pain possible. 
 
 
 
Figure 9.10: Pain difference between maximum pain and pain at the end of cold pressor test in PA and PNA pre and post 
local acupuncture (PA n=9; PNA n=26; mean ± SE). PNA showed a significant increase whereas the PA showed no 
significant change, reflecting pain adaptability was improved after acupuncture in PNA. 
Max-End= Difference between maximum pain and pain at the end of cold pressor test; PA= pain adaptive; PNA=pain non-
adaptive; *= group by time interaction; #= significant change. 
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Raw values and percentage changes in PPT were both used to analyse the change in the potency of 
endogenous pain controls. The results from the analyses with raw values did not differ from those 
with percentage changes. This section will present the percentage changes data. 
 
The changes in potency of endogenous pain controls as assessed with PPT changes to cold pressor in 
PA and PNA were compared using two-way (group by time) with one repeated measure (time, 2 
levels) mixed ANOVAs (Table 9.15). A time effect was found in their percentage change in PPT at the 
wrist (F(1,33)=5.73, p=0.02). The percentage change in PPT at the wrist increased in both PA and PNA 
indicating that CPM was improved in both PA and PNA. There was neither group by time interaction 
nor group effect between PA and PNA in any PPT changes (Table 9.15). 
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Table 9.15: Percentage PPT change at the knee, wrist and lower back during CPT in PA and PNA pre and post the local acupuncture treatment (mean ± SD) 
Sites for %PPT 
change 
PA (n=9) PNA (n=26) 
Group 
effect 
F(1,33) 
Time 
effect 
F(1,33) 
Group x 
time 
effect 
F(1,33) 
Pre Post ∆ post-pre Pre Post ∆ post-pre p value p value p value 
Knee 30.47 ± 44.66 15.53 ± 24.52 -14.94 ± 36.82 8.47 ± 27.60 12.28 ± 33.13 3.81 ± 45.32 0.17 0.51 0.27 
Wrist -10.70 ± 27.42 22.42 ± 36.05 33.12 ± 52.02 5.90 ± 29.96 18.95 ± 41.72 13.05 ± 49.18 0.50 0.02* 0.31 
Lower back 46.48 ± 114.16 10.87 ± 24.89 -35.60 ± 116.58 13.50 ± 36.68 21.20 ± 38.67 7.70 ± 48.01 0.45 0.32 0.12 
%PPT= percentage pressure pain threshold; Max-E=difference between maximum experimental pain and pain at the end of the cold pressor test; Acu= acupuncture; pre=pre-acupuncture treatment; post=post-
acupuncture treatment; ∆ post-pre= change between pre- and post- acupuncture treatment, a negative value indicating a decrease and a positive value indicating an increase; PA=pain adaptive; PNA= pain non-
adaptive; *=significant p values. 
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Low back pain vs osteoarthritis 
Additional analyses were performed to compare the change in clinical and psychophysical outcome 
measures after the local acupuncture treatment in LBP and knee OA participants (Appendices 33-36). 
No group by time interaction was observed between the LBP and knee OA participants in their 
clinical and psychophysical outcome measures. This indicates that the LBP and knee OA participants 
did not differ in their response to local acupuncture. 
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Acupuncture setting 
Duration of session 
Among the 35 participants, in total there were 332 sessions of acupuncture, all delivered by the 
same acupuncturist at the same trial site. A one-way repeated measures (acupuncture sessions, 8 
levels) of ANOVA was used to compare the duration among the eight acupuncture sessions. A 
significant difference was observed among the acupuncture sessions (F(7,238)=102.94, p<0.01). 
Pairwise comparisons resulted in a significant difference between the first acupuncture session and 
the rest of the sessions, and no significant difference among the rest of the sessions (Figure 9.11). At 
the first session, in addition to the acupuncture treatment, the session also involved taking the 
participants’ pain history and explaining the treatment to the participants. Thus, it is understandable 
that the first session would take longer than the other sessions. 
 
 
Figure 9.11: Mean duration of each acupuncture session (n=35, mean ± SE) 
Acu 1= first acupuncture session; *=significant difference with the rest of the sessions, adjusted for multiple comparisons 
using Bonferroni. 
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The duration of each session of acupuncture was compared between the PA and PNA using a two- 
way (session by group), with one repeated measure (session, 8 levels) of mixed ANOVA. No 
difference was found between PA and PNA in their duration of each acupuncture session. A 
significant session effect was found with the first treatment session being significantly longer than 
the seven other sessions (Appendix 37). 
 
Duration of treatment 
A similar finding was made in the mean duration of each treatment with a significant time effect 
(F=7,238=26.14, p<0.01) (Figure 9.12). This is again due to the first treatment taking longer time. Again 
no difference was found between PA and PNA (Appendix 38). At the first treatment, the 
acupuncturist palpated and examined the affected area (lower back or knee); this required a longer 
time than the other sessions as the acupuncturist was not familiar with the affected area. Once the 
acupuncturist was familiar with the affected area, palpation became easier as well as point selection 
and thus the remaining treatments were not as long as the first treatment. 
 
 
Figure 9.12: Mean duration of each treatment (n=35, mean ± SE) 
Acu 1= first acupuncture session; *=significant difference with the rest of the sessions, adjusted for multiple comparisons 
using Bonferroni. 
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Average pain since last acupuncture session 
Starting from the second acupuncture session, the acupuncturist asked each participant how intense 
their clinical pain was on average since the last session on a numerical scale of 0-10, where 0 is no 
pain at all and 10 the worst pain possible. This was to monitor the oscillation of their clinical pain in 
between the sessions (sessions 1-7). Data was complete for 24 participants, thus the analysis was 
conducted for those 24 participants. A one-way repeated measures (acupuncture sessions, 7 levels) 
of ANOVA was performed to analyse the oscillation in clinical pain in between the sessions. The 
average pain significantly oscillated (F(7,140)=22.82, p<0.01). Pairwise comparisons showed that the 
clinical pain was higher after the second acupuncture session than after the first session, and was 
lower after the fifth, sixth and seventh sessions than after the first session (Figure 9.13). 
 
 
Figure 9.13: Average clinical pain after each session of acupuncture (n=24, mean ± SE) 
Acu 1=first acupuncture session; NRS=numerical rating scale 0-10 where 0 is no pain at all and 10 the worst pain possible; 
*=significant difference compared with Acu 1. 
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The oscillation in clinical pain in between the acupuncture sessions were compared between the PA 
and PNA using two-way (session by group) with one repeated measure (session, 7 levels) of ANOVA. 
Significant session effect was found for both groups, showing a decrease in clinical pain (Appendix 
39). No group effect or interaction was observed between the two groups. 
 
 
Tender points identified pre treatment 
At the first session of acupuncture, each participant was examined for tender points around the area 
in pain (lower back or knee). The 10 most observed tender points for the LBP and knee OA 
participants are listed in Table 9.16. Out of the 35 participants, the most common tender points 
identified at the first session were BL24 in LBP participants (10 participants) and SP9 in knee OA 
participants (13 participants). 
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Table 9.16: Tender points identified at first acupuncture session 
Rank 
Tender points 
for LBP 
Location# 
No. of 
cases 
 
Tender points 
for knee OA 
Location# 
No. of 
cases 
1 
BL24 气海俞
Qihaishu 
Same level as inferior border of spinous process of 
the L3, 1.5 cun lateral to the median line 10 
 SP9 阴陵泉
Yinlingquan 
Depression between the inferior border of medial 
condyle of tibia and medial border of tibia 13 
2 
BL25 大肠俞
Dachangshu 
Same level as the inferior border of L4, 1.5 cun 
lateral to the median line 10 
 
SP10 血海
Xuehai 
Anteromedial aspect of thigh, on the bulge of vastus 
medialis muscle, 2 cun superior to medial end of base 
of patella 
10 
3 
BL22 三焦俞
Sanjiaoshu 
Same level as the inferior border of L1, 1.5 cun 
lateral to the median line 8 
 Ex-LE-4内膝
眼 Neixiyan 
Depression medial to the patellar ligament 9 
4 
BL31 上髎
Shangliao 
In the 1st posterior sacral foramen 8 
 
LR8 曲泉
Ququan 
Depression medial to tendons of semitendinous and 
semimembranosus muscles, at medial end of 
popliteal crease 
9 
5 
BL23 肾俞
Shenshu 
Same level as the inferior border of L2, 1.5 cun 
lateral to the median line 7 
 ST36 足三里
Zusanli 
Anterior aspect of leg, 3 cun inferior to ST35 
(depression lateral to patellar ligament) 9 
6 
BL32 次髎
Ciliao 
In the 2nd posterior sacral foramen 7  GB32 中渎
Zhongdu 
Lateral thigh, posterior to iliotibial band, 7 cun 
superior to popliteal crease 8 
7 
BL33 中髎
Zhongliao 
In the 3rd posterior sacral foramen 7  GB34 阳陵泉 
Yanglingquan 
Fibular aspect of leg, depression anterior and distal to 
head of fibula 7 
8 
BL26 关元俞
Guanyuanshu 
Same level as the inferior border of L5, 1.5 cun 
lateral to the median line 6 
 
GB31 风市
Fengshi 
Lateral thigh, depression posterior to the iliotibial 
band where the tip of middle finger rests, when 
standing up with arms hanging alongside thigh 
6 
9 
BL28 膀胱俞
Pangguangshu 
Same level as the 2nd posterior sacral foramen, 1.5 
cun lateral to the median line 6 
 
GB33 膝阳关
Xiyangguan 
Lateral aspect of knee, depression between biceps 
femoris tendon and iliotibial band, posterior and 
proximal to lateral epicondyle of femur 
6 
10 
BL34 下髎
Xialiao 
In the 4th posterior sacral foramen 5  LR9 阴包
Yinbao 
Between the gracilis and Sartorius muscles, 4 cun 
proximal to base of patella 6 
BL=bladder; SP= spleen; Ex-LE= extra point on the leg; ST= stomach; LR=liver; GB= gall bladder; L1=1st lumbar vertebra; cun=traditional measurements for points location, B-cun methods were used (Yin et al., 
2005); #= point location based on the World Health Organization standard acupuncture point locations (World Health Organization, 2008). 
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Points used in treatments 
The 10 most common points used in the 332 acupuncture session are displayed in Tables 9.17 and 
9.18. The points were ranked based on the number of sessions when they were used. Out of 144 
acupuncture sessions in 15 LBP participants, the most used acupuncture points was BL22 in 41 
sessions and 13 participants (Table 9.17). A total of 188 acupuncture session was delivered to 20 
participants with knee OA. The point Ex-LE-4 was the most used point, in 123 sessions and 19 
participants (Table 9.18). 
 
Table 9.17: 10 most frequently used points in the LBP participants 
Rank Points used Location# 
No. of 
LBP 
sessions 
No. of LBP 
participants 
1 
BL22 三焦俞 
Sanjiaoshu 
Same level as the inferior border of L1, 
1.5 cun lateral to the median line 41 13 
2 
BL26 关元俞 
Guanyuanshu 
Same level as the inferior border of L5, 
1.5 cun lateral to the median line 41 13 
3 
BL31 上髎 
Shangliao In the 1st posterior sacral foramen 40 12 
4 
BL24 气海俞 
Qihaishu 
Same level as inferior border of 
spinous process of the L3, 1.5 cun 
lateral to the median line 35 11 
5 
BL25 大肠俞 
Dachangshu 
Same level as the inferior border of L4, 
1.5 cun lateral to the median line 34 14 
6 
BL32 次髎 
Ciliao In the 2nd posterior sacral foramen 33 10 
7 
BL27 小肠俞 
Xiaochangshu 
Same level as the 1st posterior sacral 
foramen, 1.5 cun lateral to the median 
line 29 10 
8 
BL33 中髎 
Zhongliao In the 3rd posterior sacral foramen 28 8 
9 
BL23 肾俞 
Shenshu 
Same level as the inferior border of L2, 
1.5 cun lateral to the median line 23 8 
10 
Du3 腰阳关 
Yaoyangguan 
Depression inferior border of L4 on 
median line 18 6 
LBP= chronic non-specific low back pain; BL=bladder; L1=1st lumbar vertebra; cun=traditional measurements for points 
location, B-cun methods were used (Yin et al., 2005); #= point location based on the World Health Organization standard 
acupuncture point locations (World Health Organization, 2008). 
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Table 9.18: 10 most frequently used points in the knee OA participants 
Rank Points used Location# No. of knee OA sessions 
No. of knee 
OA 
participants 
1 
Ex-LE-4 
内膝眼
Neixiyan 
Depression medial to the patellar 
ligament 123 19 
2 
SP9 阴陵泉 
Yinlingquan 
Depression between the inferior border 
of medial condyle of tibia and medial 
border of tibia 89 20 
3 
ST35 犊鼻 
Dubi Depression lateral to patellar ligament 87 19 
4 Ashi point 1 midpoint of medial border of patella 86 17 
5 
SP10 血海 
Xuehai 
Anteromedial aspect of thigh, on the 
bulge of vastus medialis muscle, 2 cun 
superior to medial end of base of patella 57 18 
6 
GB33 膝阳关 
Xiyangguan 
Lateral aspect of knee, depression 
between biceps femoris tendon and 
iliotibial band, posterior and proximal to 
lateral epicondyle of femur 55 16 
7 
ST36 足三里 
Zusanli 
Anterior aspect of leg, 3 cun inferior to 
ST35 (depression lateral to patellar 
ligament) 42 16 
8 
LR8 曲泉 
Ququan 
Depression medial to tendons of 
semitendinous and semimembranosus 
muscles, at medial end of popliteal crease 33 12 
9 Ashi point 2 
3 cun distal to GB32 (lateral thigh, 
posterior to iliotibial band, 7 cun superior 
to popliteal crease) 33 9 
10 Ashi point 3 
1 cun medial to midpoint of medial border 
of patella 33 9 
SP= spleen; Ex-Le= extra point on the leg; ST= stomach; LR=liver; GB= gall bladder; L1=1st lumbar vertebra; cun=traditional 
measurements for points location, B-cun methods were used (Yin et al., 2005); Ashi point= tender point classification under 
Chinese medicine terminology; #= point location based on the WHO standard acupuncture point locations (World Health 
Organization, 2007). 
 
 
 
 
 315 
 
Adverse events 
Twenty-three (23) cases (6.93%) of adverse events were recorded from 332 treatment sessions. Out 
of the 35 participants, 15 participants (42.86%) reported at least one adverse effect. These included 
adverse events after the previous session and adverse event at the current session. The most 
common adverse events were: bleeding or bruising after (8 cases) and at current the session (10 
cases) (Tables 9.19). No cases of fainting or dizziness, drowsiness or lethargy or sweating were 
observed. None of the reported adverse events required medical intervention. 
 
Table 9.19: Number of adverse events after the last session and current session of acupuncture 
Adverse events  
No. of events after 
last session 
No. of events at 
current session 
Bleeding/bruising 8 10 
Needling pain after treatment 
(PA=0, PNA=3) 
3 
0 
Symptom aggravation  
(PA=0, PNA=2) 
2 
0 
Fainting/dizziness 0 0 
Drowsiness/lethargy 0 0 
Sweating 0 0 
Total 13 10 
PA=pain adaptive; PNA=pain non-adaptive. 
 
 
Discussion 
Summary of results 
In this exploratory study, the participants showed a statistically significant decrease in their clinical 
pain, and improvement in their physical health after an acupuncture treatment with local points, 
and a trend was observed for a reduction of daily pain duration in hours and consumption of 
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analgesics. A trend was also found for an improvement of the potency of CPM. Those who had 
severer pain and poor CPM at the baseline showed better pain reduction after acupuncture. Those 
with poor CPM at baseline also showed better improvement in their potency of CPM after the 
treatment. PA and PNA did not differ in their response to acupuncture except for PA individuals 
reporting a greater reduction in daily pain duration than PNA did after acupuncture. Acupuncture 
improved pain adaptability in PNA individuals. Overall no other significant change was observed. The 
local acupuncture treatment was well tolerated with only 23 cases of adverse events from a total of 
332 treatment sessions; none of the adverse events needed medical interventions, the most 
common adverse events was bleeding or bruising. 
 
Overall effect of local acupuncture on clinical pain  
The current study showed that local acupuncture needling may improve pain and physical health in 
LBP and knee OA participants in the short-term. This is in line with the finding in of Chapter 3 (Wong 
Lit Wan et al., 2015). Consistently, a trend in the reduction of analgesic consumption was found. 
Previous studies have found that acupuncture can reduce the amount of pain medication intake. 
Zheng and Colleagues found that electro-acupuncture reduced the intake of opioid-like medications 
in chronic pain participants (Zheng et al., 2008). 
 
However, the effect size is smaller than the findings in Chapter 3 where local acupuncture was found 
to be effective in reducing pain compared with their controls with a large effect size of SMD 0.85, 
whereas this study had a moderate effect size of SMD 0.41 for reduction in average clinical pain, 
SMD 0.50 for reduction in highest pain and SMD 0.25 for reduction in daily pain duration. This 
discrepancy may be attributable to the different methodologies used in the studies. The effect size 
that resulted from the systematic review was from a pool of 17 studies with a total sample size of 
572 MSK participants, whereas the current study has a much smaller sample size of 35 participants. 
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It is also possible that the number of treatments contributed to the greater effect size reported in 
the systematic review compared with the current study. The number of treatment ranged from 3 to 
10 in the systematic review. The timing of measuring the clinical pain may also be a contributor to 
the difference in effect size. Studies that measured clinical pain ranging from immediately after the 
last acupuncture session to up to two weeks after the last acupuncture session were pooled 
together. Conversely in the present study the change in clinical pain was measured for one week 
after the last acupuncture session. It is possible that averaging the change in clinical pain lead to the 
smaller effect size in the current study. 
 
Characteristics of acupuncture responders 
In this study, those with severer clinical pain at baseline showed a greater pain reduction compared 
with those with lesser pain. This is in agreement with the findings of previous studies examining 
subgroups and acupuncture response (MacPherson and Fitter, 1998, Glazov, 2010, Witt et al., 2011). 
This is probably due to the fact that those with higher pain have greater room for improvement than 
those with lower pain before the treatment, thus the change is seen being smaller in those with a 
lower pain before the treatment. Some studies attributed this effect to the regression to the mean 
phenomenon. 
 
Those with poor CPM showed better pain reduction. This could also be due to the fact that there is 
more room for improvement in those with poor CPM. Local acupuncture enhanced CPM as shown in 
the correlation tests and thus reduced pain more in those with poor CPM, while those with a better 
CPM had less improvement in their CPM and thus less pain reduction. 
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Possible mechanisms underlying local acupuncture point needling  
Local acupuncture has a potential for clinical application for MSK. Compared with distant 
acupuncture, local acupuncture may be applied more easily as point selection seems to be direct 
and evident. By palpating for the tender points around the affected area clinicians can easily identify 
the points to be selected for the treatments, whereas the selection of distant points is more complex. 
Distant points could be selected based on the route of meridians, diagnosis bases on Chinese 
medicine theories, empirical use and neurophysiology such as segmental distribution (See Chapters 
2 and 3 for details). The use of local points is supported by the long history of the use of Ashi points 
clinically, and also the more recent popular use of dry needling of trigger points (a form of local 
acupuncture) for MSK. Trigger points are considered Ashi points by some researchers (Liu et al., 
2016, Birch, 2003). On the other hand, no difference was found in the direct comparison between 
local points and distant points in pain reduction (Wong Lit Wan et al., 2015). The importance of 
distant acupuncture needling and if it will improve CPM and pain adaptability in MSK should be 
studied. 
 
Although it is believed that local acupuncture reduces pain by activating SEG (Filshie and White, 
1998), in this study acupuncture had no effect on SEG as no significant effect in the percentage PPT 
change at the knee post acupuncture was observed. Instead a mild improvement in CPM was 
observed, indicated by the trend in percentage PPT increase at the wrist. This perhaps indicates the 
effect of local needling was mediated through activating the CPM. 
Previous studies have investigated the relationship between potency of CPM and response to 
pharmacological treatments. Yarnitsky and colleagues reported that painful diabetic neuropathy 
participants with poorer CPM responded better to treatment with a serotonin noradrenaline 
reuptake inhibitor (duloxetine) (Yarnitsky et al., 2012). A randomized controlled trial, also in painful 
diabetic neuropathy participants, reported that the group receiving a μ-opioid receptor agonist and 
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neuronal norepinephrine reuptake inhibitor (tapentadol) showed a better decrease in clinical pain 
and an improved CPM compared with the group receiving the placebo (Niesters et al., 2014). In that 
study the participants received four weeks of treatment. Significant difference in clinical pain 
reduction between the treatment group and placebo group was detected at the third and fourth 
weeks of treatment (Niesters et al., 2014). In the current study, significant clinical pain reduction 
(compared with baseline) was observed after the fifth, sixth and seventh treatment, which were 
during the third and fourth weeks of treatment. 
 
Albeit the current study is not designed to investigate of the mechanisms of local acupuncture, 
together with the findings of previous pharmacological studies, it can be highlighted that local 
acupuncture is closely related to descending inhibitory control of CPM. Those two types of 
medication are centrally acting analgesics enhancing the descending inhibitory control. A recent 
study on knee OA participants using diclofenac gel (an anti-inflammatory drug) reported that those 
with a better CPM before treatment showed a better pain reduction, which is contradictory to the 
results of the current study and the 2012 Yanitsky study (Edwards et al., 2016). However, diclofenac 
is a peripherally acting drug which inhibits prostaglandins, a different mechanism from that of 
duloxetine mentioned above, thus the difference in the findings. 
 
The similarity in the effect of acupuncture and those centrally-mediated analgesics supports the 
hypothesis that acupuncture is likely to exert its inhibition through modulating the central nervous 
system. 
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Local acupuncture and pain adaptability 
In the current study PA showed a greater decrease in daily pain duration (in hours) than PNA, 
although there was no difference in the reduction of clinical pain intensity between the two groups. 
This shows that pain adaptability is closely related to pain duration clinically. Aside from an increase 
in pain intensity, an increase in pain duration is also a feature of central sensitization, with prolonged 
pain duration in those who have more sensitised central nervous system (Woolf, 1994, Woolf, 2011). 
Thus, there is a possibility that being PA and receiving acupuncture to reduce the duration of clinical 
pain may decrease central sensitization. 
 
It is worth mentioning that duration of pain or hours in pain each day differs from history of pain. 
Previously a shorter history of clinical pain was associated with better outcomes (less pain and 
better function) after surgery in participants with herniated lumbar disc (Jansson et al., 2005, Rihn et 
al., 2011). Those participants with leg pain or back pain for less than six months showed a better 
improvement in quality of life after surgery (Jansson et al., 2005). The impact of hours in pain has 
been rarely studied. This study shows that reduced duration in pain after treatment is not related to 
intensity of pain at baseline and is associated with high level of anxiety, reflecting intensity of pain 
and duration of pain are two different concepts and the improvement of one does not necessarily 
translate to the improvement of the other. The current study shows that potency of CPM is related 
to reduction of pain intensity whereas being adaptive to pain is related to reduction in daily pain 
duration, further highlighting the difference between CPM and pain adaptability, and pain intensity 
and pain duration. 
The findings of this study also highlight the possibility that pain adaptability is associated with the 
mode of acupuncture. In the present study, the PA and PNA were given similar acupuncture 
treatment (similar depth and manipulation), and no difference were identified in their reduction in 
clinical pain. However, the results from Chapter 7, the Pain Adaptability and Acupuncture Response 
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Study, suggested that sham/shallow needling produced a better analgesia in PA based on pressure 
pain sensitivity. The PA seemed to respond better to shallower needling and less manipulation 
whereas the PNA seemed to respond better to needling with stronger stimulation. It should however 
be taken into consideration that the Pain Adaptability and Acupuncture Response Study was in 
healthy participants and that their analgesia was measured using PPT. In the current study of a 
clinical sample, two participants dropped out because of acupuncture being too painful or caused 
more pain. Both were PA individuals. It is possible that within PA participants, some would be more 
sensitive to local needling than others. It is not clear if they are also sensitive to distant needling. 
 
Relationship between local acupuncture and CPM 
This current study shows a trend for an improvement in CPM. This differs from the findings by 
Tobbackx and colleagues (Tobbackx et al., 2013). In their study on whiplash-associated disorders 
participants, after a session of 20 minutes of combined acupuncture (local and distant points), 
Tobbackx and colleagues found that the potency of CPM was not affected by acupuncture. The 
difference between the two studies is most likely due to that they only had one session of 
acupuncture compared to the eight sessions of treatment in the current study. One session of 
acupuncture might have not been enough to affect CPM. 
 
In the current study it was observed that those with a poorer CPM before the treatment tend to 
have a better CPM after the treatment. This parallels the findings from previous studies that CPM 
can be improved or restored after treatments such as surgery or pharmacological therapy (Graven-
Nielsen et al., 2012, Niesters et al., 2014). 
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It has been long debated if changes in potency of CPM are the result from or the cause of the pain 
reduction. Yarnitsky and colleagues found that healthy individuals with potent CPM before 
thoracotomy is correlated with less chronic post-operative pain (Yarnitsky et al., 2008). Knee OA 
participants, with impaired CPM before surgery, had an improved CPM after surgery (Graven-Nielsen 
et al., 2012). Whether an intervention can improve CPM and whether improved CPM will lead to less 
pain to follow-up injuries are important clinically. Chronic pain participants have been consistently 
shown to have poor CPM. Any treatments that can improve their CPM will not only reduce their pain, 
but also will likely to improve their resilience to other injuries. The current study was not designed to 
answer this question. It is however for the first time that acupuncture is found to improve CPM. 
 
Controlling of confounding factors 
The PA and PNA did not differ in any of their psychological factors before treatment, and no 
significant correlations were found between clinical pain reduction and baseline psychological 
characteristics. Further, the there was no difference in expectancy from acupuncture and in the 
duration of each session and each treatment between PA and PNA (contact time with acupuncturist). 
Thus, it is less likely that the analgesic effect from local acupuncture was influenced by these 
psychological factors (depression, stress, anxiety and expectancy). 
 
The PA and PNA also did not differ in baseline sleep quality, function and quality of life. Indicating 
any difference observed between PA and PNA are less likely mediated via those factors. 
Limitations  
Being an exploratory study, this study has a few limitations. Firstly, the sample size may be too small, 
with only 9 PA and 26 PNA. Secondly, the design of this study only allows the examination of the 
short-term effects of the acupuncture treatment. No follow-up was undertaken. Thirdly, this study 
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was a single arm trial without a control. A control arm could have been used to control the natural 
recovery or placebo effect of the local acupuncture treatment. Nevertheless, the improvement in 
pain was less likely to be the natural cycle of pain reduction seen in some conditions. LBP and knee 
OA are debilitating conditions that usually last for years and usually do not improve unless treated 
(Hestbaek et al., 2003, Hernborg and Nilsson, 1977). Lastly, the treatment could have been limited 
by using local points only. The choice of using local points only was based on the results of the 
systematic review on local and distant points (Chapter 3), the experience of an acupuncturist 
specialised in local acupuncture needling and due to the complexity of selecting distant points. 
Acupuncture has been reported to improve quality of life in terms of both physical and mental 
health (Lu et al., 2011). However, in the current study physical health improved after the treatment 
but not mental health. This is perhaps a limitation due to the use of local points only. It is possible 
that using the combination of local and distant points could have different treatment outcomes. 
 
Conclusion 
The participants of the present study showed improvement in their clinical pain and physical health 
after the acupuncture treatment with local points. For the first time, psychophysical features were 
found to impact on how people respond to local acupuncture. Those with a higher baseline pain or 
poorer baseline CPM showed a better pain relief after local acupuncture treatment. Although PA and 
PNA did not differ in their clinical pain reduction, being PA was related to a better reduction in hours 
in pain. Also, importantly, local acupuncture improved the potency of CPM in those individuals who 
had a poorer CPM and improved pain adaptability in PNA individuals. Future studies with a control 
group and larger sample size are needed to investigate the short-term and long-term effects of local 
acupuncture. 
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 Chapter 10 : General discussion 
Summary of findings 
The aim of this project was to examine the effects of needle placement, pain adaptability and 
endogenous pain controls on acupuncture analgesia in the treatment for MSK. 
Objectives 
To achieve this aim, the following objectives were addressed by completing six studies: 
1. To identify the difference in analgesia induced by local and distant acupuncture and to 
determine whether combined points stimulation was better than local or distant points 
alone by conducting a systematic review so as to develop the acupuncture protocol for the 
Acupuncture Response Study; 
2. To identify the psychophysical tests that could potentially be used to differentiate subgroups 
of knee OA through systematically reviewing studies reporting the psychophysical 
characteristics of subgroups in knee OA participants; 
3. To assess whether vibration could be used to induce analgesia so as to determine the 
potency of SEG and to investigate whether PA and PNA differed in vibration analgesia; 
4. To explore if pain adaptability impacted on acupuncture analgesia in healthy humans; 
5. To develop a feasible protocol to determine whether pain adaptability exists in MSK 
participants; to investigate if there was any differences in demographics, thermal sensitivity, 
clinical pain, endogenous pain controls and autonomic response between PA and PNA; and 
to compare pain adaptability and potency of CPM between healthy and MSK participants; 
6. To examine the effects of local acupuncture on the clinical characteristics, pain adaptability 
and endogenous pain controls; to investigate the relationship between baseline 
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characteristics and changes in clinical and psychophysical outcomes after local acupuncture 
treatment; and to compare the effect of local acupuncture between PA and PNA individuals. 
The following sections summarise the findings from all studies in this PhD project.  
 
The first systematic review (Chapter 3, addressing Objective 1) has a meta-analysis of 17 studies 
(randomised controlled trials and quasi-randomised controlled trials) of acupuncture, and showed 
that needling of local points had a better acupuncture analgesia compared with needling of distant 
points in the short-term, when multiple treatment sessions were given to MSK participants (Wong 
Lit Wan et al., 2015). Further, needling local tender points was found to be more effective than local 
classical acupuncture points. These results contributed to the design of the acupuncture protocol for 
the Acupuncture Response Study. These findings from the systematic review should however be 
considered with caution as they resulted from subgroup analyses and not from the direct 
comparisons. 
 
The second systematic review was carried out to investigate which quantitative sensory test could 
be used to differentiate subgroups in knee OA participants (Chapter 4, addressing Objective 4). Due 
to the high heterogeneity of the included studies, a meta-analysis could not be performed, and 
qualitative analyses were carried out. PPT at the knee and temporal summation of punctate pain 
away from the knee consistently predicted the subgroups. That is those with lower PPT at the knee 
or enhanced temporal summation away from the knee had more severe knee pain, more knee 
osteoarthritis symptoms or more negative psychological factors. Thus, those two measures could be 
used in future studies to subgroup knee osteoarthritis participants. 
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The SEG study (Chapter 6, addressing Objective 3) was designed to test a vibration protocol to 
induce SEG and to examine the association between pain adaptability and the potency of SEG. No 
analgesia was induced with vibration among 21 healthy volunteers, and the potency of SEG could 
not be tested. Therefore, this vibration protocol was not used in the Acupuncture Response Study. 
 
A cross-over study was performed (the Pain Adaptability and Acupuncture Analgesia study, Chapter 
7, addressing Objective 4) to investigate if pain adaptability impacted on acupuncture analgesia (real 
and sham acupuncture) in 22 healthy participants. Pain adaptability, that is, being PA or PNA, but not 
mode of acupuncture, that is, real and sham acupuncture, determined acupuncture analgesia. The 
PA and PNA responded to real and sham acupuncture differently. Twenty minutes after allocated 
treatment, PA presented with better analgesia after sham acupuncture than after real acupuncture 
whereas the PNA responded to both types of acupuncture similarly. Further, PA presented with 
better analgesia at distant sites (right arm and right leg) from the needling site (left arm) whereas 
the PNA showed better analgesia at the needling site. This study highlights the possibility that pain 
adaptability might explain the discrepancies in acupuncture analgesia in clinical practice and trials. 
 
It was unclear whether pain adaptability also existed in individuals with MSK. An exploratory study, 
using cold pressor tests at 2°C and 7°C, investigated pain adaptability in 43 MSK participants and 23 
of their age- and gender-matched healthy controls (Chapter 8, addressing Objective 5). The 
dichotomy of PA and PNA was found in the MSK and healthy participants using cold pressor tests 
with either temperature. The PA and PNA in MSK participants did not differ in their thermal and 
mechanical sensitivity, the potency of their endogenous pain controls or autonomic activity. PA had 
a shorter latency to the maximum pain, which was supported by previous studies in healthy 
participants (Devoize et al., 2015, Zheng et al., 2014). PNA tended to have more severe clinical pain 
in the past 24 hours and more comorbidities compared to PA. No difference was found between the 
 327 
 
MSK and healthy participants in their pain adaptability. Pain adaptability could be a combination of 
physical and psychological response to a continuous noxious stimulus. Either 2°C or 7°C CPT can be 
used to test pain adaptability. The 7°C CPT might be more suitable for MSK patients as it was less 
painful. 
 
The MSK participants then took part in the Acupuncture Response Study (Chapter 9, addressing 
Objective 6). After eight sessions of acupuncture treatment with local points, the MSK participants 
experienced pain relief and improved physical health. Those who reported a better pain relief from 
local acupuncture had higher clinical pain before the treatment. Those with poor CPM at baseline 
showed a better improvement in their clinical pain. Hours in pain within 24 hours was reduced in PA 
but not in PNA, and PA and PNA did not differ in any other changes of clinical pain. More importantly, 
potency of CPM (measured with changes in PPT in the wrist) and pain adaptability (measured with 
the difference between the maximum pain and pain at the end of the cold pressor test) improved 
after acupuncture in those who had poor CPM or were PNA individuals, respectively. 
 
Figure 10.1 summarizes the contribution made by this project to the knowledge gaps previously 
identified in Chapter 2: 
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Figure 10.1: Summary of findings contributing to knowledge gaps (1= Needling Local points could be more effective than needling distant points in reducing MSK pain in the short-term with multiple 
treatment sessions; 2= Vibration used in this study is not an effective method to induce SEG. Consequently the relationship between pain adaptability and SEG could not be determined; 3= Pain adaptability 
exists in MSK participants, and can be safely tested with cold pressor. PA and PNA do not differ in many clinical features except two. Pain adaptability is not associated with potency of CPM. 4= Pain 
adaptability could affect how individuals respond to sham acupuncture. In MSK patients, the PA have better decrease in their daily pain duration after local acupuncture. Those with poor CPM have better 
pain reduction in response to local acupuncture; 5= Local acupuncture regulates pain modulation improving CPM in those who have poor CPM, and improving pain adaptability in PNA). 
MSK=chronic musculoskeletal pain; QST=quantitative sensory tests; PPT= pressure pain thresholds; PIN=pain intensity to pin prick; SUPRA=pain intensity to suprathreshold pressure stimulus; CPM=conditioned 
pain modulation; SEG=segmental pain inhibition; TS=temporal summation of pain. 
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This project had some additional findings: 
• Psychophysical subgroups in knee OA participants exist; PPT and temporal summation of 
punctate pain could be used to identify the subgroups. 
• The status of pain adaptability does not depend on temperature of the conditioning stimulus or 
the level of clinical pain of the individual. 
 
 
 
Interpretation  
This project shows a dissociation between pain adaptability and CPM in MSK population, which is 
consistent with the results by Zheng and colleagues in healthy volunteers (Zheng et al., 2014). The PA 
and PNA did not differ in their potency of CPM (Pain Adaptability and MSK Study, Chapter 8). These two 
parameters were not correlated. Furthermore, treatment responses to acupuncture of the two also 
differed (Chapter 9). Those with poorer CPM had better pain reduction whereas those adaptive to pain 
have reduced hours in pain. And reduction in pain intensity and hours in pain are not correlated in this 
study. All of those lines of evidence suggest that CPM and pain adaptability are not the same 
phenomenon and may be mediated via different mechanisms of pain modulation. This study is not 
designed to elucidate those different mechanisms, but provides sufficient evidence to warrant further 
studies investigating the meaning of pain adaptability and its underlying mechanisms. 
 
Results of this project show that pain adaptability possibly affects how one responds to therapies, rather 
than defining pain sensitivity. There were no differences in baseline PPT in healthy volunteers and no 
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difference in many clinical pain features at baseline between PA and PNA in MSK participants. However 
after acupuncture, PA had enhanced analgesia to shallow and gentle needling in healthy humans (Pain 
Adaptability and Acupuncture Analgesia Study, Chapter 7), and in MSK PA had a better reduction in 
hours in pain (Acupuncture Response Study, Chapter 9). In the last study, sham acupuncture was not 
used, therefore it is unknown if PA of MSK participants might have better pain reduction than PNA. 
Nevertheless the evidence so far support pain adaptability is perhaps a good candidate for predicting 
treatment response. 
 
This study was not designed to elucidate the mechanisms underlying pain adaptability, but have 
provided sufficient evidence to warrant further studies investigating the meaning of pain adaptability 
and its underlying mechanisms. 
 
It should also be noted that from the results of the current project, the cold pressor test may have 
induced different levels of inhibition depending on the site of the test stimulus. The percentage change 
in PPT at the wrist and the lower back were considered reflecting the potency of CPM while that 
measured at the knee reflecting potency of SEG. The percentage PPT change at the lower back was 
found to be better than at the wrist to cold pressor (Chapter 8). A similar observation was found in the 
Acupuncture Response Study (Chapter 9), although the difference was not statistically significant. The 
results indicate that changes in PPT observed at these three sites may reflect different forms of 
endogenous pain inhibition. The inhibitory effects experienced at the lower back, due to its location 
with respect to the foot where the CPT was applied, might have been attributed to a summative effect 
of SEG and CPM, thus resulting in a better inhibition. The foot is innervated by spinal nerves from 
lumbar 3 to sacrum 2, and the testing areas in the lower back are innovated by lumbar 4 and 5. The foot 
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and the testing areas are innervated by the same spinal nerves, therefore the effect observed may 
reflect SEG. Ge and colleagues found that electrical stimulation at the leg resulted in a better decrease 
of the nociceptive withdrawal reflex at the ipsilateral and contralateral legs than at the trapezius, a 
heterosegmental site (Ge et al., 2007). The results from Ge’s study imply that the inhibitory effect was 
better at segmental sites than at the heterosegmental site, which is consistent with an acupuncture 
study (Zheng et al., 2010b). SEG inhibition is rarely studied and the test means is also limited. The model 
used in this study may be a suitable method. Future studies should explore this possibility. 
 
Finally, these findings on the response to local acupuncture further confirm that acupuncture impacts 
on central pain modulation. Human studies show that acupuncture increases the availability of μ opioid 
receptors in the brain (Harris et al., 2009), enhances the functional brain connectivity between brain 
areas related to pain modulation (Chen et al., 2014, Egorova et al., 2015) and generates somatosensory 
cortical plasticity (Chen et al., 2014, Napadow et al., 2007). This current study adds to the body of 
evidence by providing psychophysical data, that is acupuncture improves CPM and pain adaptability in 
the current study. 
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Strengths  
The systematic reviews (Chapters 3 and 4) in this project followed the PRISMA reporting guidelines. This 
project also introduced the first study on pain adaptability in MSK participants (Chapter 8, Pain 
Adaptability and MSK study). Confounding factors such as psychological status, sleep quality, room 
temperature and water temperature of the CPTs were controlled in the Pain Adaptability and MSK Study 
(Chapter 8). Further, the first study on acupuncture analgesia and pain adaptability in healthy 
participants (Chapter 7) and MSK participants (Chapter 9) respectively were conducted. The 
Acupuncture Response Study (Chapter 9) in the MSK participants used different scales to assess the 
different aspects of clinical pain. The common psychophysical test in the four experimental studies is 
PPT which is a validated measure for pain sensitivity in MSK participants. 
 
 
Limitations 
The main limitations of this project were the small sample sizes and the lack of a control group in the 
Acupuncture Response Study. It should be noted that recruitment of the MSK and healthy participants 
was challenging. This is perhaps due to the lack of understanding of acupuncture or fear of pain 
sensitivity tests. The small sample size could have increased the risk of having type II errors. The lack of 
control group did not allow the assessment of the efficacy of local acupuncture. Nevertheless, factors 
known to affect clinical pain, such as psychological factors and sleep quality, were controlled. Further, 
the acupuncturist was blinded from the pain adaptability status and the potency of CPM of the 
participants. The duration of treatment did not differ between the subgroups. Thus, it is less likely that 
the improvement in clinical pain was a placebo effect. 
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Implications for clinical practice 
Currently, there is no evidence-based recommendation on when to use local needling, when to use 
distant needling and when to use the combine approach, and how to choose different acupuncture 
modes for individuals. The findings of this project provided critical data towards addressing these 
questions. That is, the results showed that the level of clinical pain before treatment was associated 
with the treatment outcomes. Those with severer clinical pain before treatment showed a better 
reduction in pain in the short-term from local acupuncture. Practitioners may perhaps consider distant 
needling or other interventions, when treating those with milder pain. Clinicians also need to be mindful 
about individual variations to acupuncture which could impact on the choice of acupuncture, for 
instance in terms of site of needling, that is, local or distant, and mode of needling, that is, strong or 
gentle, such as that in sham acupuncture. This study shows a section of the population who are PA 
would respond better to gentle needling. 
 
The neural modulation effect of acupuncture may be used to prevent the development of chronic post-
operative pain. A previous study showed that individuals with potent CPM before thoracotomy 
correlated with less chronic post-operative pain (Yarnitsky et al., 2008). A course of acupuncture could 
be provided prior to surgery to improve CPM, therefore to produce better surgical outcomes. 
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Implications for future studies 
Acupuncture analgesia: Needling site, pain adaptability and endogenous pain controls 
Local acupuncture for MSK has potential for clinical use. It improved the potency of CPM and pain 
adaptability in individuals with inefficient pain modulation. This finding needs to be further assessed 
with a larger sample size. It is also necessary to understand what factors mediate this result. 
 
It is yet to be explored if distant acupuncture or combined local and distant acupuncture can also 
improve CPM and pain adaptability. Likewise, it is unclear whether those with poor CPM and the PA 
would respond to these two types of acupuncture the same way they respond to local acupuncture. 
There is however a lack of guidelines on how to identify distant points. Studies are needed to determine 
the usefulness of distant point in the treatment of MSK and methods to select these points. 
 
The PA in the Acupuncture Response Study presented with a greater decrease in clinical pain duration 
(hours in pain) after a treatment with local acupuncture points. Further studies with a control group and 
a larger sample size are needed to confirm these results. Another question is whether acupuncture can 
alter pain adaptability status, that is, turning PNA to PA. Future studies in this area are needed to 
confirm local acupuncture can alter pain adaptability status and to determine the appropriate 
acupuncture protocol for this purpose in terms of dosage (number of points, number of treatment and 
treatment frequency). Also the findings that PA respond better to sham acupuncture warrant further 
investigation in clinical samples as it could impact on future clinical trial design. 
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Models of endogenous pain modulation  
Models for inducing SEG are limited. Vibration-induced analgesia is still inconclusive. More studies are 
needed to determine the vibration and other protocols to induce SEG. Such studies should emphasize 
on reporting stimulation parameters such as duration of stimulation, surface area being stimulated, 
frequency used and site. 
 
Pain adaptability has been identified using continuous noxious thermal stimuli. It is yet to be determined 
whether other forms of stimuli could be used for the same purpose, and also whether a shorter duration 
of stimulation would have the same result. It is unclear whether pain adaptability is a state or trait 
characteristic. Future studies should also investigate which are the factors that contribute to the 
dichotomy of pain adaptability and the role of psychological factors for assessing pain adaptability. 
Whether pain adaptability can impact on treatment response from other types of therapies, such as 
analgesics, is yet to be investigated. 
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骨性关节炎[主题] 
类风湿[主题] 
纤维肌痛[主题] 
颈椎[主题] 
脊椎关节强硬[主题] 
脱垂[主题] 
GROUP  1 
针灸[全文] 
电针[全文] 
针刺[全文] 
激光针[全文] 
指压[全文] 
经皮穴位电刺激[全文] 
 
GROUP 2 
远端取穴 [全文] 
远部取穴[全文] 
上病下治[全文] 
下病上治[全文] 
近端取穴[全文] 
交叉取穴[全文] 
交叉刺[全文] 
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 Appendix 3 : Search history in PubMed 
Search Query Items found 
#1 
"conditioned pain modulation" OR “CPM” “DNIC” OR “diffuse noxious inhibitory control” 
OR psychophysics OR "temporal summation" OR QST OR "quantitative sensory test" OR 
"cold pressor" OR "endogenous pain control" OR sensitivity OR hypersensitivity OR 
"pressure pain threshold" OR threshold OR tolerance 1609061 
#2  "knee osteoarthritis" OR “knee osteoarthrosis” OR "knee pain" OR knee[Title/Abstract]  5074 
#3 pain [Title]  595798 
#4  ((#1) AND #2) AND #3) 218 
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 Appendix 4 : Studies in the subgroup category- Arendt-Nielsen 2010 (n=48) 
Modalities (No. of trials) PPT (x2) 
temporal 
summation of 
pressure pain (x10) 
Pain severity 
from hypertonic 
saline injection 
(x1) 
CPM (x1) 
Sites/ device used 
algometer 
(somedic) 
computer-controlled 
pressure algometer- 
(mean VAS ratings- 
eVAS scale 0 to 10) 
syringe pump- 
(eVAS scale 0 to 
10) 
conditioning stimulus: 
Ischemic compression 
cuff around left arm 
testing stimulus: PPT 
site1: 2 cm distal to the 
inferior medial edge of 
patella  
   
 
site 2: 2 cm distal to the 
inferior lateral edge of 
patella  
   site 3: 3 cm lateral to the 
mid-point on the lateral 
edge of patella 
   site 4: 2 cm proximal to 
the superior lateral edge 
of patella  
   site 5: 2 cm proximal to 
the superior edge of 
patella  
   site 6: 2 cm proximal to 
the superior medial edge 
of patella  
   site 7: 3 cm medial to the 
mid-point on the medial 
edge of patella  
   
site 8: at centre of 
patella  
group B> 
group A (p < 
0.05) 
  tibialis anterior (5 cm 
distal to the tibial 
tuberosity)  
   
 
extensor carpi radialis 
longus (5 cm distal to 
lateral epicondyle 
of humerus)  
   most sensitive 
peripatellar region 
(lowest PPT) 
    tibialis anterior  
    1 cm distal to the test 
site on 
tibialis anterior 
          = significant;    = non-significant;       = site not tested; PPT= Pressure Pain Threshold; CPM= Conditioned Pain 
Modulation; eVAS= Electronic Visual Analogue Scale; group A= VAS>6; group B=VAS<6. 
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 Appendix 5 : Studies in the subgroup category- Arendt-Nielsen 2014 
(n=217) 
Modalities (No. of 
trials) PPT TS of pressure pain CPM 
Sites/ device used 
computer-controlled 
pressure algometer  
computer-controlled 
pressure algometer x10 
successive stimuli with an 
inten-sity at mean PPT, 
frequency of 0.5 Hz 
test stimulus: algometer  
conditioning stimulus: 
tourniquet cuff on 
contralateral arm 
(1) 2 cm distal to the 
inferomedial edge of 
patella; 
 
(mean TS at 10 sites) 
  
VAS (10-39) < VAS( 40-69) 
and VAS( 70-100) p<0.001 
(mean CPM effect at 10 
sites)  
 
VAS (10-39)> (VAS (70-100) 
p<0.001 
(2) 2 cm distal to the 
inferolateral edge of 
patella;  
(3) 3 cm lateral to the 
centre of the lateral 
edge of patella;  
(4) 2 cm proximal to 
the superolateral edge 
of patella;  
(5) 2 cm proximal to 
the superior edge of 
patella;  
(6) 2 cm proximal to 
the superomedial edge 
of patella;  
(7) 3 cm medial to the 
centre of the medial 
edge of patella;  
(8) on the centre of 
patella;  
(9) the belly of the 
tibialis anterior muscle 
 
(10) the belly of the 
extensor carpi radialis 
muscle 
      = significant;      = non-significant; PPT= Pressure Pain Threshold; TS= temporal summation; CPM= Conditioned Pain 
Modulation; VAS= Visual Analogue Scale. 
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 Appendix 6 : Studies in the subgroup category- Creamer 1998 (n=58) 
Modalities (No. of trials) Pain threshold 
Sites/ device used Dolorimter 
mean of 6 sites (ipsilateral medial knee, ipsilateral 
lateral knee, contralateral hip, lateral forearm, 
lateral epicondyle and contralateral trapezius) p value not reported 
      = non-significant. 
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 Appendix 7 : Studies in the subgroup category- Cruz-Almeida 2013 (n=194) 
Modalities 
(No. of trials) 
heat pain 
threshold 
(x3) 
heat pain 
tolerance (x3) 
TS of heat pain 
(x5) 
TS of heat pain 
(x5) 
TS of heat pain 
(x5) PPT (x3) 
pain rating 1st 
trial (punctuate 
mechanical 
stimuli) 
punctuate 
mechanical TS 
(x10) 
CPM 
Sites/ device 
used 
Medoc 
pathway pain 
& sensory 
evaluation 
system-) 
Medoc 
pathway pain 
& sensory 
evaluation 
system-  
Medoc CHEAP 
stimulator @44°C  
Medoc CHEAP 
stimulator @46°C  
Medoc CHEAP 
stimulator @48°C  
handheld digital 
algometer 
calibrated nylon 
monofilament 
delivering a target 
force of 300gm  
calibrated nylon 
monofilament 
delivering a 
target force of 
300gm  
test stimulus: heat 
temporal summation 
on left hand  
conditioning stimulus: 
right hand immersed 
in cold water 
knee (most 
affected) 
   
cluster 1< cluster 4 
(p<0.01) 
cluster 1<  
cluster 4 (p<0.01) 
cluster 1> cluster 
3 & cluster 4 
(p=0.05) 
   ventral 
forearm 
(ipsilateral) 
    
cluster 1< cluster 4 
& cluster 3 
(p<0.01) 
cluster 1> cluster 
4 (p=0.05) 
   quadriceps 
(ipsilateral) 
     
cluster 1> cluster 
4 (p=0.05) 
   
trapezius 
(ipsilateral) 
     
cluster 1> cluster 
3 & cluster 4 
(p=0.05) 
   patella (most 
affected 
knee) 
      
cluster 1< cluster 4 
& cluster3 
(p<0.01) 
cluster 1< cluster 
4 & cluster 3 
(p<0.01) 
 
back of hand 
(ipsilateral) 
      
cluster 1< cluster 4 
& cluster 3 
(p<0.01) 
cluster 1< cluster 
4 (p<0.01) 
 
right hand 
               = significant;      = non-significant;     = site not tested; PPT= Pressure Pain Threshold; TS: temporal summation; CPM= Conditioned Pain Modulation; CHEAP= Contact Heat-Evoked Potential; Cluster 1= high 
optimism and low negative affect; Cluster 2= low positive affect; Cluster 3= low optimism; Cluster 4= pain hypervigilance. 
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 Appendix 8 : Studies in the subgroup category- Egsgaard 2015 (n=212) 
Modalities (No. 
of times 
measured) 
PPT (x3) temporal summation of pressure pain (x10) CPM (x1) 
Sites/ device 
used 
A computer-controlled 
pressure algometer (SMI, 
Aalborg University,  
Aalborg) 
computer-controlled pressure 
algometer (mean VAS ratings- 
eVAS scale 0 to 100) 
conditioning stimulus: 
Ischemic compression cuff 
around contralateral arm 
testing stimulus: PPT from all 
the 10 sites 
most sensitive 
site on the knee 
A>B (3.37±1.46vs 2.44±0.98; 
p=<0.001); 
A>C (3.37±1.46vs 1.83 ±0.90; 
p=<0.001); 
A>D (3.37±1.46vs 1.34 ±0.78; 
p=<0.001); 
B>D (2.44±0.98vs 1.34 ±0.78); 
p=<0.001; 
B>C (2.44±0.98vs 1.83 ±0.90; 
p=<0.05); 
A<C (19.19± 19.63 vs 35.57 ± 
25.18, p=<0.05);  
A<D(19.19± 19.63 vs 47.92 ± 
40.19, p=<0.001);  
B<C (22.53± 22.32 vs 35.57 ± 
25.18, p=<0.05);  
B<D(22.53± 22.32 vs 47.92 ± 
40.19, p=<0.001) 
(PPT at most sensitive site at 
the knee)  
A>B (3.46±0.88vs 1.69 ± 0.41; 
p=<0.001); 
A>C (3.46±0.88vs 0.46 ± 0.37; 
p=<0.001);  
A>D (3.46±0.88vs 0.21 ± 0.37; 
p=<0.001);  
B>C (1.69 ± 0.41 vs 0.46 ± 
0.37; p=<0.001);  
B>D (1.69 ± 0.41 vs 0.21 ± 
0.37; p=<0.001) 
belly of tibialis 
anterior muscle 
A>B (4.65±1.75vs 3.41±1.26; 
p=<0.001); 
A>C 4.65±1.75 vs 2.85 ±0.84; 
p=<0.001);  
A>D (4.65±1.75vs 2.13 ± 1.28; 
p=<0.001);  
B>D (3.41±1.26 vs 2.13 ± 1.28 
p=<0.001 );  
C>D (2.85 ±0.84 vs 2.13 ± 
1.28; p=<0.05); 
 
belly of extensor 
carpi radialis 
muscle 
A>B (3.71±1.64vs 2.651±1.06; 
p=<0.001); 
A>C (3.71±1.64 vs 2.05 ±0.84; 
p=<0.001);  
A>D (3.71±1.64 vs 1.54 ± 075; 
p=<0.001);  
B>C (2.651±1.06 vs 2.05 
±0.84; p=<0.05);  
B>D (2.651±1.06 vs 1.54 ± 
075; p=<0.001) 
 
      = significant;     = non-significant; PPT= Pressure Pain Threshold; CPM= Conditioned Pain Modulation; VAS=visual 
analogue scale; A= higher pain threshold and a higher CPM effect than those of controls, B= enhanced temporal 
summation as compared with controls, C= lower pressure pain thresholds, enhanced pain responses to temporal 
summation compared with controls, D= higher scores in physical health questionnaires, and pain catastrophizing compared 
with C. 
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 Appendix 9 : Studies in the subgroup category- Finan 2013 (n=113) 
Modalities (No. 
of trials) 
PPT (x2) 
mechanical 
phasic stimuli 
(x10) 
thermal phasic 
stimuli (x10) CPT (x2) CPM (x2) 
Sites/ device 
used algometer 
(somedic) 
punctuate 
noxious probes 
256 mN (average 
pain ratings- scale  
0 to 100 pain) 
Medoc CHEAP 
stimulator @ 51°C 
(average pain 
ratings - scale 0 to 
100 pain) 
~4°C / 45 sec 
(scale 0 to 100) 
Conditioning 
stimulus: CPT  
testing 
stimulus: PPT  
trapezius 
(bilaterally) 
group 3 
<group 2  
(p < 0.05) 
    quadriceps (most 
painful knee) 
     dorsal surface of 
middle finger 
(non-dominant 
side) 
 
group 3> the 
other 3 groups (p 
< 0.05) 
   patella (most 
painful knee) 
     Dorsal forearm 
(non-dominant 
side) 
  
group 3> group 2 
& group 4 (p < 
0.05) 
  hand (non-
dominant side) 
   
group3 > group 
2 (p < 0.05) 
       = significant;       = non-significant;       = site not tested; PPT= Pressure Pain Threshold; CPT= Cold Pressor Test; CPM= 
Conditioned Pain Modulation; CHEAP= Contact Heat-Evoked Potential; group 1= low pain/low knee radiographic grade; 
group 2=low pain/high knee radiographic grade; group 3= high knee pain/low knee radiographic grade; group 4= high knee 
pain/high knee radiographic grade. 
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 Appendix 10 : Studies in the subgroup category- King 2013 (209) 
Modalities (No. 
of trials) 
warmth 
threshold, 
heat pain 
threshold, 
heat pain 
tolerance 
pain rating 
at heat pain 
threshold 
TS of heat 
pain (x5) 
pain rating 
at heat 
pain 
tolerance 
pain rating at 
1st trial 
(temporal 
summation of 
heat pain) 
PPT 
(x not 
mentioned) 
cutaneous 
mechanical TS 
(x10) 
pain rating at 
1st trial 
(cutaneous 
mechanical 
stimulation) 
pain rating at 
10th trial 
(cutaneous 
mechanical 
stimulation) 
cold pain 
threshold, 
cold pain 
tolerance, 
cold pain 
unpleasantn
ess 
CPM 
Sites/ device 
used computer-
controlled 
Medoc 
Pathway  
computer-
controlled 
Medoc 
Pathway  
computer-
controlled 
Medoc 
Pathway@ 
44°C, 46°C, 
48°C 
computer-
controlled 
Medoc 
Pathway  
computer-
controlled 
Medoc 
Pathway @ 
44°C, 46°C, 
48°C not mentioned not mentioned not mentioned not mentioned 
Thermo 
Scientific 
Refrigerated 
Bath- @16°C, 
12°C, 8°C x3/ 
1min  
Conditioning 
stimulus: CPT 
Testing 
stimulus: heat 
pain on left 
forearm 
most painful 
knee (medial 
joint line, patella, 
and 
tibial tuberosity 
distal to the 
joint) 
 
high 
symptomati
c> low 
symptomati
c (p=0.01) 
 
high 
symptomat
ic> low 
symptomat
ic (p=0.07) 
high 
symptomatic> 
low 
symptomatic 
(p=0.02) 
 
high 
symptomatic> 
low 
symptomatic 
(p<0.01) 
high 
symptomatic> 
low 
symptomatic 
(p<0.01) 
high 
symptomatic> 
low 
symptomatic 
(p<0.01) 
  
ventral ipsilateral 
forearm  
 
high 
symptomati
c> low 
symptomati
c (p=0.011) 
 
high 
symptomat
ic> low 
symptomat
ic 
(p=0.015) 
high 
symptomatic> 
low 
symptomatic 
(p=0.001) 
      
hand (ipsilateral) 
      
high 
symptomatic> 
low 
symptomatic 
(p<0.01) 
high 
symptomatic> 
low 
symptomatic 
(p<0.01) 
high 
symptomatic> 
low 
symptomatic 
(p<0.01) 
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right hand 
           
medial joint line 
     
low 
symptomatic> 
high 
symptomatic 
(p<0.01) 
     
lateral joint line 
     
low 
symptomatic> 
high 
symptomatic 
(p<0.01) 
     quadriceps 
(ipsilateral) 
           forearm 
(ipsilateral) 
           trapezius 
(ipsilateral) 
                 = significant;       = non-significant;       = site not tested; PPT= Pressure Pain Threshold; TS= temporal summation; CPM= Conditioned Pain Modulation; low symptomatic= Western Ontario and McMaster 
Universities Index of Osteoarthritis (WOMAC) score<33; high symptomatic=WOMAC score≥34. 
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 Appendix 11 : Studies in the subgroup category- Skou 2014 (n=73) 
Modalities (No. of trials) PPT (x2) 
temporal summation of 
pressure pain (x10) 
Sites/ device used algometer (Somedic) 
computer-controlled pressure 
algometer (sum of VAS ratings- 
eVAS scale 0 to 10) 
tibialis anterior (5 cm distal to the 
tibial tuberosity)  
Group 4< Group 1, Group 2& 
Group 3 (p<0.05) 
Group 3 & Group 4 > Group 1 & 
Group 2 (p<0.05) 
Group 2 & Group 3 < Group1 
(p<0.05) 
extensor carpi radialis longus (5 
cm distal to lateral epicondyle of 
humerus)  
Group 4< Group 1, Group 2 
&Group 3 (p<0.05) 
 
 Group 2 & Group 3 < Group 1 
(p<0.05) 
most sensitive peripatellar region 
(lowest PPT)  
 
Group 3 & Group 4 > Group 1 & 
Group 2 (p<0.05) 
      = significant;       = site not tested; PPT= Pressure Pain Threshold; eVAS= Electronic Visual Analogue Scale; Group 1= Knee 
OA participants with high mean PPT; Group 2= Knee OA participants with low mean PPT; Group 3= post-operative 
participants with high mean PPT; Group 4= post-operative participants with low mean PPT.  
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 Appendix 12 : Ethics approval for the SEG Study and Pain Adaptability 
and Acupuncture Analgesia Study 
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 Appendix 13 : External ethics approval endorsed by RMIT 
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 Appendix 14 : Ethics approval for the Pain Adaptability and MSK Study 
and Acupuncture Response Study 
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 Appendix 15 : Participant Information and Consent Form for the SEG 
Study and Pain Adaptability and Acupuncture Analgesia Study 
 
 376 
 
 
 377 
 
 
 378 
 
 
 379 
 
 
 380 
 
 
 381 
 
 
 382 
 
 
 383 
 
 
 384 
 
 
 
 
 
 
 385 
 
Informed Consent to Participation in a Biomedical Research Project 
 
Title of the research project: The role of pain sensitivity and endogenous pain modulation 
systems in determining acupuncture analgesia and needle placement for treatment of 
musculoskeletal pain  
 
Declaration by the Volunteer: 
I have received information about the research project both in writing and orally, and I have 
sufficient knowledge of the objective, method, advantages and disadvantages to confirm my 
participation.  
I know that participation is voluntary and that I can always withdraw my consent without losing 
my present or future rights to treatment. 
I hereby give my consent to participation in the research project and confirm that I have received 
a copy of this form and of all written information for my own use.  
Name of the Volunteer: 
 
Date:    Signature:                                                                                               
 
Would you like to be informed of the results of the research project and of the consequences for 
you, if any? 
 
Yes_____         No _____ (tick the appropriate field) 
 
Declaration by the Responsible Researcher: 
I hereby declare that the Volunteer has received information both in writing and orally about the 
research project and that the Volunteer has had the opportunity to ask questions. 
 
I believe that the information given is sufficient for making a decision on participation in the 
research project.  
 
Name of the Responsible Researcher: Kelun Wang 
 
Date:    Signature:                                                                                               
 
 
 
 
 
 
Project identification: (e.g. project ID of the Committee, EudraCT No., version No./date etc.) 
 
N-20120079 
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 Appendix 16 : Participant Information and Consent Form for the healthy 
participants in the Pain Adaptability and MSK Study 
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 388 
 
 
 
 389 
 
 
 
 390 
 
 
 
 391 
 
 
 
 392 
 
 Appendix 17 : Participant Information and Consent Form for the MSK 
participants in the Pain Adaptability and MSK Study and the Acupuncture 
Response Study 
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 394 
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 396 
 
 
 
 397 
 
 
 398 
 
 Appendix 18 : Screening form for the SEG Study and Pain Adaptability 
and Acupuncture Analgesia Study 
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 Appendix 19 : Screening form for the Pain Adaptability and MSK Study 
and Acupuncture Response Study 
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 401 
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 403 
 
 
 404 
 
 Appendix 20 : Pain Catastrophizing Scale 
 
 405 
 
 Appendix 21 : Depression Anxiety and Stress Scale, 21 items 
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 Appendix 22 : State Trait Anxiety Inventory 
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 Appendix 23 : Acupuncture Expectancy Scale 
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 Appendix 24 : Short Form 36 items 
 
 409 
 
 
 410 
 
 
 411 
 
 
 412 
 
 
 413 
 
 Appendix 25 : Modified Roland Morris Questionnaire 
 
 
 
 414 
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 Appendix 26 : Pittsburgh Sleep Quality Index 
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 Appendix 27 : Pain and medication diary 
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 Appendix 28 : Acupuncture protocol 
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 450 
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 453 
 
 
 454 
 
 
 455 
 
 
 456 
 
 
 
 457 
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 Appendix 29 : Modes of advertising and number of enquiries received from MSK and healthy individuals for the Pain 
Adaptability and MSK Study 
Months Modes of advertising 
MSK participants Healthy participants 
Included Excluded Total no. of enquiries Included Excluded 
Total no. of 
enquiries 
Feb-15 
professional association newsletters, RMIT campus, RMIT clinic, 
RMIT Facebook, RMIT website, seniors club, sport centres, lawn 
bowling clubs 1 8 9 1 0 1 
Mar-15 newspaper, RMIT campus, RMIT clinic, local libraries 4 7 11 0 0 0 
Apr-15 newspaper, RMIT campus, RMIT clinic, RMIT update 8 29 37 0 0 0 
May-15 newspaper, RMIT campus, RMIT clinic, RMIT update 10 15 25 0 0 0 
Jun-15 newspaper, RMIT campus, RMIT clinic 9 5 14 0 1 1 
Jul-15 newspaper, sport centres, RMIT campus, RMIT clinic, RMIT Facebook 7 12 19 0 0 0 
Aug-15 newspaper, RMIT campus, RMIT clinic 2 3 5 0 0 0 
Sep-15 retirement villages, RMIT campus, RMIT clinic, RMIT update 3 2 5 2 0 2 
Oct-15 newspaper, RMIT campus, RMIT clinic 5 7 12 6 1 7 
Nov-15 RMIT campus, RMIT clinic 0 1 1 9 0 9 
Dec-15 RMIT campus, RMIT clinic 0 0 0 1 0 1 
Jan-16 
retirement villages, sport centres, RMIT campus, RMIT clinic, seniors 
club, lawn bowling clubs 0 0 0 5 0 5 
Feb-16 retirement villages, RMIT campus, RMIT clinic 0 0 0 1 0 1 
Total 
 
49 89 138 25 2 27 
MSK= chronic musculoskeletal pain; RMIT=Royal Melbourne Institute of Technology. 
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 Appendix 30 : Number of enquiries and mode of advertisement for MSK 
participants 
Mode of advertisement No. of enquiries 
AAMT newsletter 0 
FCMA newsletter 0 
AOA newsletter 0 
MAA newsletter 0 
AIMA newsletter 0 
Arthritis Victoria website 2 
Chronic Pain Australia 4 
Whittlesea Leader 60 
Diamond Valley leader 32 
Preston Leader 1 
RMIT campus 6 
RMIT Facebook 3 
RMIT website 1 
RMIT update 5 
RMIT clinic 12 
Recommended by relatives, 
friends or colleagues 12 
Retirement village 0 
Total 138 
AAMT= Australian Association of Massage Therapists; FCMA= Federation of Chinese Medicine & Acupuncture Societies of 
Australia; AOA= Australian Osteopathic Association; MAA= Massage Association of Australia; AIMA= Australia integrative 
medicine association; RMIT= Royal Melbourne Institute of Technology. 
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 Appendix 31  Baseline characteristics of the PA and PNA identified at 7°C 
(mean ± SD) 
Baseline 
characteristics 
PA (n=17) PNA (n=26) 
X21 / t41-
test 
P value 
Adjusted 
significance1 
Age (yrs) 53.82 ± 9.73 58.08 ± 15.09 -1.12 0.27 <0.01 
BMI 27.69 ± 3.59 28.96 ± 8.05 -0.61 0.55 0.01 
Gender M/F 12/5 14/12 1.21 0.27 0.01 
Duration of pain (yrs) 7.63 ± 9.70 6.88 ± 7.19 0.29 0.77 0.02 
Maximum Pain in the 
past week (NRS) 5.94 ± 2.54 5.60 ± 2.25 0.47 0.64 0.01 
No. of painful areas 2.53 ± 1.55 2.58 ± 1.30 -0.11 0.91 0.03 
No. of comorbidities 0.71 ± 1.05 0.85 ± 1.12 -0.41 0.68 0.01 
Sleep quality (PSQI) 7.29 ± 4.99 6.15 ± 2.33 0.88 0.39 0.01 
Pain catastrophizing 15.00 ± 11.07 15.27 ± 10.53 -0.08 0.94 0.05 
SF-36 physical 
component summary 46.22 ± 6.19 42.55 ± 7.68 1.65 0.11 0.01 
SF-36 mental 
component summary 52.02 ± 8.24 54.27 ± 6.24 -1.02 0.32 0.01 
medication/ no 
medication 6/11 17/9 2.63 0.11 0.01 
LBP/Knee OA 9/8 11/15 0.14 0.71 0.01 
PA=pain adaptive; PNA=pain non-adaptive; BMI=body mass index; M=male; F=female; NRS=numerical rating scale 0-10, 
0being no pain at all and 10 the worst pain possible; PSQI=Pittsburgh Sleep Quality index; SF-36= short from 36 to measure 
quality of life: 1= Holm-Bonferroni adjusted significance. 
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 Appendix 32 : Thermal sensitivity of the PA and PNA identified at 7°C (mean ± SD) 
Thermal sensitivity 
tests Sites Sides PA (n=17) PNA (n=26) 
Group effect Site effect Group x site effect 
F(1,41) 
value 
p 
value 
F(2,82) 
value 
p 
value 
F(2,82) 
value 
p 
value 
Cold Sensation 
threshold 
knees 
R 27.12 ± 2.11 27.51 ± 1.93 
1.45 0.24 0.93 0.40 0.42 0.66 
L 26.53 ± 2.80 27.59 ± 1.51 
wrist 
R 26.76 ± 4.94 27.42 ± 2.99 
L 27.75 ± 2.46 28.04 ± 2.43 
Lower back 
R 27.01 ± 2.87 27.95 ± 1.92 
L 27.18 ± 4.45 28.42 ± 1.65 
Warm Sensation 
threshold 
knees 
R 36.48 ±  2.07 36.28 ± 1.92 
0.17 0.68 28.47 <0.01* 0.08 0.92 
L 35.88 ± 1.88 36.99 ± 2.62 
wrist 
R 38.98 ± 5.03 39.72 ± 4.82 
L 27.75 ± 2.46 28.04 ± 2.43 
Lower back 
R 35.55 ± 1.70 35.58 ± 1.47 
L 35.61 ± 1.28 35.74 ± 2.03 
Cold Pain threshold 
knees 
R 10.92 ± 10.25 11.65 ± 10.96 
0.06 0.81 8.53 <0.01* 0.30 0.74 
L 11.72 ± 10.54 13.86 ± 11.91 
wrist 
R 10.54 ± 9.92 9.47 ± 10.33 
L 7.89 ± 9.02 10.65 ± 10.37 
Lower back 
R 12.99 ± 11.64 13.45 ± 11.97 
L 14.93 ± 11.74 14.16 ± 10.31 
Heat Pain threshold 
knees 
R 46.17 ± 3.29 45.81 ± 3.53 
4.70 0.04* 42.40 <0.01* 2.79 0.07 
L 46.07 ± 2.87 45.75 ± 3.22 
wrist 
R 49.03 ± 1.31 47.41 ± 2.94 
L 49.79 ± 2.68 47.18 ± 3.14 
Lower back 
R 45.96 ± 2.62 43.19 ± 4.24 
L 44.96 ± 2.71 43.54 ± 3.43 
PA=pain adaptive; PNA=pain non-adaptive; R=right; L=left;*significant p values.
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 Appendix 33 : Pain and medication diary outcome measures for LBP and knee OA participants pre and post acupuncture 
treatment (mean ± SD) 
Outcome measures 
LBP (n=15) Knee OA (n=20) 
Group 
effect 
F(1,33) 
Time 
effect 
F(1,33) 
Group x 
time 
effect 
F(1,33) 
Pre Post ∆ post-pre Pre  Post ∆ post-pre p value p value p value 
Pain at moment (NRS1) 3.34 ± 2.21 2.69 ± 1.71 -0.66 ± 1.05 3.66 ± 2.20 2.86 ± 1.99 -0.79 ± 1.83 0.71 0.01* 0.80 
Highest pain (NRS1) 4.11 ± 2.01 3.34 ± 1.51 -0.76 ± 1.17 5.15 ± 2.04 4.02 ± 2.02 -1.13 ± 1.07 0.18 <0.01* 0.34 
Average pain (NRS1) 3.41 ± 2.11 2.69 ± 1.62 -0.72 ± 1.00 3.92 ± 2.12 3.09 ± 1.78 -0.83 ± 1.18 0.47 <0.01* 0.78 
Pain Intensity (NRS2) 7.06 ± 3.32 5.03 ± 2.88 -2.03 ± 1.82 9.59 ± 3.90 8.36 ± 4.15 -1.23 ± 2.61 0.02* <0.01* 0.32 
Level of unpleasantness 
(NRS2) 6.07 ± 2.91 4.51 ± 2.70 -1.55 ± 1.35 8.71 ± 3.88 7.54 ± 3.88 -1.18 ± 2.34 0.02* <0.01* 0.59 
Duration of pain (hr) 5.01 ± 3.61 3.86 ± 3.78 -1.15 ± 2.94 8.91 ± 6.85 7.24 ± 6.55 -1.68 ± 4.91 0.05 0.04* 0.69 
Analgesic intake (Pill count) 5.27 ± 8.11 1.93 ± 3.75 -3.33 ± 7.91  13.75 ± 16.39 13.60 ± 17.50 -0.15 ± 5.98 0.03* 0.15 0.18 
Analgesic intake (MQS) 2.00 ± 2.92 1.27 ± 2.57 -0.73 ± 3.03 4.98 ± 5.93 3.06 ± 4.27 -1.92 ± 4.55 0.08 0.06 0.39 
LBP= chronic non-specific low back pain; OA=osteoarthritis; NRS1= numerical scale of 0-10, 0 being no pain at all and 10 the worst pain possible; NRS2= numerical scale 0-20, 0 being no sensation/ neutral, 20 
being extremely intense/ extremely intolerable; hr=hour; MQS=medication quantification scale; ∆ post-pre= change between pre and post, negative value indicating a decrease and positive value indicating an 
increase; *=significant p values. 
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 Appendix 34 : Clinical characteristics of LBP and knee OA participants pre and post the acupuncture treatment (mean ± SD) 
Clinical characteristics 
LBP (n=15) Knee OA (n=20) 
Group 
effect 
F(1,33) 
Time 
effect 
F(1,33) 
Group x 
time 
effect 
F(1,33) 
Pre Post ∆ post-pre Pre  Post ∆ post-pre p value p value p value 
Depression (DASS21) 2.80 ± 2.83 2.93 ± 3.92 0.13 ± 2.61 1.95 ± 1.70 2.55 ± 2.69 0.60 ± 2.06 0.49 0.36 0.56 
Anxiety (DASS21) 1.60 ± 1.80 1.47 ± 1.89 -0.13 ± 1.96 1.65 ± 1.79 1.70 ± 1.42 0.05 ± 1.43 0.78 0.89 0.75 
Stress (DASS21) 4.40 ± 4.40 5.13 ± 5.53 0.73 ± 4.01 3.50 ± 3.90 3.00 ± 3.48 -0.50 ± 2.61 0.27 0.84 0.28 
Function (RMQ) 6.27 ± 3.33 4.33 ± 3.44 -1.93 ± 2.22 6.90 ± 4.55 6.55 ± 3.87 -0.35 ± 4.93 0.22 0.11 0.26 
Sleep quality (PSQI) 6.07 ± 2.87 5.73 ± 2.84 -0.33 ± 1.99 6.75 ± 3.49 6.60 ± 3.35 -0.15 ± 1.79 0.46 0.46 0.78 
Physical health (SF-36) 47.34 ± 5.88 48.64 ± 5.04 1.30 ± 5.16 40.00 ± 6.68 43.52 ± 6.06 3.53 ± 4.17 <0.01* <0.01* 0.17 
Mental health (SF-36) 50.31 ± 7.27 52.96 ± 7.10 2.65 ± 5.40 54.43 ± 8.80 52.78 ± 7.83 -1.65 ± 9.55 0.40 0.72 0.13 
DASS21=Depression Anxiety and Stress Scale 21 items; RMQ= modified Roland Morris Questionnaire; PSQI= Pittsburgh sleep quality index; SF-36= short form 36 items health survey, to measure quality of life; ∆ 
post-pre= change between pre and post acupuncture treatment, negative value indicating a decrease and positive value indicating an increase; LBP= chronic non-specific low back pain; OA=osteoarthritis; 
*=significant p values. 
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 Appendix 35 : Percentage PPT change at the knee, wrist and lower back during CPTs in LBP and knee OA participants pre and 
post the acupuncture treatment (mean ± SD) 
Sites for %PPT 
change  
LBP (n=15) Knee OA (n=20) 
Group 
effect 
F(1,33) 
Time 
effect 
F(1,33) 
Group x 
time 
effect 
F(1,33) 
Pre Post ∆ post-pre Pre  Post ∆ post-pre p value p value p value 
knee 17.40 ± 38.49 24.46 ± 36.18 7.06 ± 57.21 11.68 ± 30.10 4.61 ± 23.63 -7.07 ± 29.93 0.12 1.00 0.35 
wrist 5.16 ± 23.22 16.60 ± 27.00 11.44 ± 29.18 -1.01 ± 34.35 22.27 ± 47.85 23.29 ± 61.43 0.98 0.05 0.50 
lower back 4.36 ± 30.74 13.01 ± 40.69 8.66 ± 43.74 35.20 ± 80.72 22.69 ± 31.68 -12.51 ± 88.34 0.12 0.88 0.40 
%PPT= percentage pressure pain threshold; Acu= acupuncture; ∆ post-pre= change between pre and post acupuncture treatment, negative value indicating a decrease and positive value indicating an increase; 
LBP= chronic non-specific low back pain; OA=osteoarthritis. 
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 Appendix 36 : CPT pain parameters of LBP and knee OA participants during the CPTs pre and post the acupuncture treatment 
(mean ± SD) 
CPT pain parameters 
LBP (n=15) Knee OA (n=20) 
Group 
effect 
F(1,33) 
Time 
effect 
F(1,33) 
Group x 
time 
effect 
F(1,33) 
Pre Post ∆ post-pre Pre  Post ∆ post-pre p value p value p value 
Average pain (VAS) 5.50 ± 2.16 5.34 ± 2.18 -0.16 ± 1.00 5.53 ± 1.57 5.38 ± 1.42 -0.15 ± 1.42 0.94 0.47 0.99 
Maximum pain (VAS) 8.47 ± 1.70 8.13 ± 2.14 -0.34 ± 1.00 8.18 ± 1.48 7.88 ± 1.61 -0.29 ± 1.13 0.63 0.09 0.90 
Pain difference (Max-
End) 1.59 ± 2.72 2.17 ± 2.54 0.58 ± 1.54 2.43 ± 3.20 2.07 ± 2.64 -0.35 ± 1.76 0.69 0.69 0.11 
CPT= cold pressor test; VAS=visual analogue scale 0-10 where 0 is no pain at all and 10 the worst pain possible; Max-End=difference between maximum pain and pain at the end during the cold pressor test; 
Acu= acupuncture; ∆ post-pre= change between pre and post acupuncture treatment, negative value indicating a decrease and positive value indicating an increase; LBP= chronic non-specific low back pain; 
OA=osteoarthritis. 
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 Appendix 37 : Duration of each session for PA and PNA (mean ± SD) 
Sessions PA PNA 
Group effect Session effect Group by session effect 
F(1,33) 
value 
p 
value 
F(1,7) 
value 
p 
value 
F(1,7) 
value 
p 
value 
1 49.11 ± 4.48 46.04 ± 5.85 
0.30 0.59 92.36 <0.01* 1.92 0.07 
2 33.33 ± 2.92 34.58 ± 2.48 
3 33.67 ± 1.94 34.00 ± 2.67 
4 31.89 ± 2.03 33.19 ± 2.67 
5 31.89 ± 1.83 33.35 ± 2.262 
6 32.78 ± 1.79 32.77 ± 2.50 
7 31.89 ± 1.90 33.08 ± 2.73 
8 33.11 ± 1.96 33.35 ± 2.78 
PA=pain adaptive; PNA- pain non-adaptive, * significant p values. 
 
 
 Appendix 38 : Duration of each treatment for PA and PNA (mean ± SD) 
Sessions PA PNA 
Group effect Session effect Group by session effect 
F(1,33) 
value 
p 
value 
F(1,7) 
value 
p 
value 
F(1,7) 
value 
p 
value 
1 32.22 ± 2.82 32.92 ± 2.68 
3.08 0.09 19.77 <0.01* 0.51 0.83 
2 28.44 ± 2.88 28.88 ± 1.45 
3 28.11 ± 1.54 29.23 ± 2.34 
4 27.67 ± 1.22 28.88 ± 1.95 
5 27.78 ± 1.86 28.54 ± 1.27 
6 28.33 ± 1.32 28.27 ± 1.76 
7 27.56 ± 1.59 28.96 ± 2.24 
8 28.22 ± 1.39 28.73 ± 1.78 
PA=pain adaptive; PNA- pain non-adaptive, * significant p values. 
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 Appendix 39 : Average clinical pain after each session of acupuncture for 
PA and PNA (mean ± SD) 
After 
sessions PA PNA 
Group effect Session effect Group by session effect 
F(1,33) 
value 
p 
value 
F(1,7) 
value 
p 
value 
F(1,7) 
value 
p 
value 
1 2.50 ± 1.05 4.06 ± 1.76 
3.86 0.06 20.45 <0.01* 0.32 0.92 
2 4.17 ± 0.75 5.53 ± 2.23 
3 2.50 ± 0.84 3.50 ± 1.92 
4 2.33 ± 1.03 3.33 ± 1.41 
5 2.00 ± 0.89 2.81 ± 1.23 
6 1.50 ± 0.84 2.61 ± 1.29 
7 1.33 ± 1.03 2.39 ± 1.24 
PA=pain adaptive; PNA- pain non-adaptive, * significant p values. 
 
 
 
 
 
 
 
